<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33643421</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1745-1981</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>10</Volume>
                    <PubDate>
                        <Year>2021</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Drugs in context</Title>
                <ISOAbbreviation>Drugs Context</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The race to a COVID-19 vaccine: opportunities and challenges in development and distribution.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">2020-12-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.7573/dic.2020-12-2</ELocationID>
            <Abstract>
                <AbstractText>The unprecedented toll of severe acute respiratory syndrome coronavirus 2, the virus responsible for coronavirus 2019 disease (COVID-19), jumpstarted the race towards the development and distribution of effective treatment and prevention options. With an urgent need to slow viral transmission, lessen disease severity, and reduce mortality, biopharmaceutical companies rapidly began investigating potential COVID-19 vaccinations. While typical vaccine development can take upwards of 10-15 years, COVID-19 vaccines were developed in less than a year after the identification of COVID-19. To accomplish this feat, clinical development, manufacturing scale-up and distribution are occurring in parallel for the four COVID-19 vaccine front-runners. This remarkable opportunity will forever change the drug development process and would not be possible without tremendous dedication from the public and private sectors, researchers, and clinical trial volunteers. However, many challenges still lie ahead. Comprehensive plans for equitable vaccine education, distribution, administration and post-marketing surveillance must be implemented successfully to overcome vaccine hesitancy, supply-chain obstacles and healthcare provider shortages in an already overburdened healthcare system. We are moving forward at a remarkable pace but worldwide immunity through vaccination will take time to achieve. Thus, current prevention efforts of masking, hand hygiene and social distancing must remain in effect for the foreseeable future. We must remain diligent and not fatigue in our efforts. Ending the COVID-19 pandemic cannot rest on the promise of vaccination alone - it will require a continued, robust and multi-faceted approach to disease treatment and prevention.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 Burgos RM, Badowski ME, Drwiega E, Ghassemi S, Griffith N, Herald F, Johnson M, Smith RO, Michienzi SM.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Burgos</LastName>
                    <ForeName>Rodrigo M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Chicago, IL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Badowski</LastName>
                    <ForeName>Melissa E</ForeName>
                    <Initials>ME</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Chicago, IL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Drwiega</LastName>
                    <ForeName>Emily</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Chicago, IL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ghassemi</LastName>
                    <ForeName>Samaneh</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Chicago, IL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Griffith</LastName>
                    <ForeName>Nikki</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Chicago, IL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Herald</LastName>
                    <ForeName>Fischer</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Chicago, IL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Johnson</LastName>
                    <ForeName>Mikayla</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Chicago, IL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Smith</LastName>
                    <ForeName>Renata O</ForeName>
                    <Initials>RO</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Chicago, IL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Michienzi</LastName>
                    <ForeName>Sarah M</ForeName>
                    <Initials>SM</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Chicago, IL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Drugs Context</MedlineTA>
            <NlmUniqueID>101262187</NlmUniqueID>
            <ISSNLinking>1740-4398</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">coronavirus</Keyword>
            <Keyword MajorTopicYN="N">vaccine</Keyword>
        </KeywordList>
        <CoiStatement>Disclosure and potential conflicts of interest: MEB and SG have nothing to disclose. RMB, SMM and ROS have received grant funding from Merck and salary support from Moderna and Janssen. ED, NG, FH and MJ have received salary support from Moderna. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2021/01/dic.2020-12-2-COI.pdf</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>1</Day>
                <Hour>5</Hour>
                <Minute>36</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33643421</ArticleId>
            <ArticleId IdType="doi">10.7573/dic.2020-12-2</ArticleId>
            <ArticleId IdType="pii">dic-2020-12-2</ArticleId>
            <ArticleId IdType="pmc">PMC7889064</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Aug;20(8):451-452</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32555401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Public Health. 2019 Dec 18;19(1):1698</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31852470</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):467-478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):594-599</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32998157</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 12;383(20):1920-1931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32663912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Nov 27;69(47):1782-1786</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33237895</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):589-593</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32785213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Public Health. 2019 Apr 15;19(1):404</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30987613</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Oct 29;383(18):1701-1703</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32846056</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2006 Jan;12(1):34-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16494714</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32915166</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):699-704</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32525856</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2018 Sep 19;9:1963</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30283434</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):591-593</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32407298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):795-800</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32584802</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Manag Care. 2020 Aug;26(8):327-328</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32835458</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Health Syst Pharm. 2003 Jul 1;60(13):1371-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12901040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Nov 30;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33257891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Public Health. 2009 Oct;99 Suppl 2:S389-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19797753</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">33640286</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>29</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>30</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2212-0289</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>161</Volume>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Apr</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen</Title>
                <ISOAbbreviation>Z Evid Fortbild Qual Gesundhwes</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Vaccination against influenza: International inventory and perspectives for Germany].</ArticleTitle>
            <Pagination>
                <MedlinePgn>42-49</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1865-9217(21)00027-1</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.zefq.2021.01.007</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The current SARS-CoV-2 pandemic requires high influenza vaccination rates for the chronically ill in order to avoid additional strain on the health care system. Despite clear evidence of the safety and effectiveness of influenza vaccination, vaccination coverage has internationally remained at inadequate levels in recent years. The general practitioner is of central importance for the care of this population. Therefore, the aim of this systematic review was to evaluate various measures in general practice to increase seasonal influenza vaccination rates for the chronically ill, taking into account various international health systems.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature search was carried out in MEDLINE, CENTRAL, EMBASE and ERIC as well as manually in trial registers and literature lists. Only randomized controlled studies were taken into account. The methodology was defined in advance in a study protocol and published (PROSPERO CRD42018114163).</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 14 studies within the framework of a national health service (United Kingdom), a state (Australia) and social (Switzerland) health insurance system and a private health care system (USA) were included in our review. Analog patient reminders and automated physician reminders as well as changes in professional roles have led to a significant increase in influenza vaccination rates, but only in the private health care system. In the national health service, none of the interventions we analyzed achieved a significant increase in vaccination rates, although the National Health Service in the United Kingdom documented relatively good basic influenza vaccination rates before the studies were carried out, regardless of the intervention. Good results were achieved in the social and state health insurance systems of Switzerland and Australia by training events for practice teams and SMS reminders.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In Germany, training events for medical teams and centrally organized invitation and monitoring systems might improve vaccination rates among the chronically ill. That the federal government pays for the vaccination costs seems to ensure a good basic influenza vaccination coverage for indicated patients in various health systems.</AbstractText>
                <CopyrightInformation>Copyright .. 2021. Published by Elsevier GmbH.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Brombacher</LastName>
                    <ForeName>Felix</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institut f..r Allgemeinmedizin, Klinikum der Universit..t M..nchen, Ludwig-Maximilians-Universit..t M..nchen, Deutschland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sanftenberg</LastName>
                    <ForeName>Linda</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institut f..r Allgemeinmedizin, Klinikum der Universit..t M..nchen, Ludwig-Maximilians-Universit..t M..nchen, Deutschland. Electronic address: Linda.sanftenberg@med.uni-muenchen.de.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Klug</LastName>
                    <ForeName>Stefanie J</ForeName>
                    <Initials>SJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Lehrstuhl f..r Epidemiologie, Fakult..t f..r Sport und Gesundheitswissenschaften, Technische Universit..t M..nchen, Deutschland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schelling</LastName>
                    <ForeName>J..rg</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institut f..r Allgemeinmedizin, Klinikum der Universit..t M..nchen, Ludwig-Maximilians-Universit..t M..nchen, Deutschland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gensichen</LastName>
                    <ForeName>Jochen</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institut f..r Allgemeinmedizin, Klinikum der Universit..t M..nchen, Ludwig-Maximilians-Universit..t M..nchen, Deutschland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>ger</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D000078182">Systematic Review</PublicationType>
            </PublicationTypeList>
            <VernacularTitle>Impfen gegen Influenza ... Internationale Bestandsaufnahme und Perspektiven f..r Deutschland.</VernacularTitle>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Z Evid Fortbild Qual Gesundhwes</MedlineTA>
            <NlmUniqueID>101477604</NlmUniqueID>
            <ISSNLinking>1865-9217</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013222" MajorTopicYN="N">State Medicine</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013557" MajorTopicYN="N" Type="Geographic">Switzerland</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Chronic disease</Keyword>
            <Keyword MajorTopicYN="N">Chronisch Kranke</Keyword>
            <Keyword MajorTopicYN="N">Gesundheitssystem</Keyword>
            <Keyword MajorTopicYN="N">Health care system</Keyword>
            <Keyword MajorTopicYN="N">Impfung</Keyword>
            <Keyword MajorTopicYN="N">Influenza</Keyword>
            <Keyword MajorTopicYN="N">Review</Keyword>
            <Keyword MajorTopicYN="N">Vaccination</Keyword>
            <Keyword MajorTopicYN="N">..bersichtsarbeit</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>28</Day>
                <Hour>20</Hour>
                <Minute>29</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33640286</ArticleId>
            <ArticleId IdType="pii">S1865-9217(21)00027-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.zefq.2021.01.007</ArticleId>
            <ArticleId IdType="pmc">PMC7903904</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">33640145</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>27</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>39</Volume>
                    <Issue>22</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>05</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition &amp; guidelines for data collection, analysis, and presentation of immunization safety data.</ArticleTitle>
            <Pagination>
                <MedlinePgn>3037-3049</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0264-410X(21)00093-1</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2021.01.054</ELocationID>
            <Abstract>
                <AbstractText>This is a Brighton Collaboration Case Definition of the term &quot;Multisystem Inflammatory Syndrome in Children and Adults (MIS-C/A)&quot; to be utilized in the evaluation of adverse events following immunization. The case definition was developed by topic experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for SARS-CoV-2. The format of the Brighton Collaboration was followed, including an exhaustive review of the literature, to develop a consensus definition and defined levels of certainty. The document underwent peer review by the Brighton Collaboration Network and by selected expert external reviewers prior to submission. The comments of the reviewers were taken into consideration and edits incorporated into this final manuscript.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Vogel</LastName>
                    <ForeName>Tiphanie P</ForeName>
                    <Initials>TP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Section of Rheumatology, Baylor College of Medicine, Houston, TX, USA; Texas Children's Hospital, Houston, TX, USA. Electronic address: bc-coordinator@taskforce.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Top</LastName>
                    <ForeName>Karina A</ForeName>
                    <Initials>KA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Pediatrics, Division of Infectious Diseases, and Community Health and Epidemiology, Canadian Center for Vaccinology, Dalhousie University, Halifax, NS, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karatzios</LastName>
                    <ForeName>Christos</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Division of Infectious Diseases, McGill University Health Centre, Montreal, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hilmers</LastName>
                    <ForeName>David C</ForeName>
                    <Initials>DC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Medicine and Pediatrics, and Center for Space Medicine, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tapia</LastName>
                    <ForeName>Lorena I</ForeName>
                    <Initials>LI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Hospital Roberto del R..o and Virology Program, Faculty of Medicine, University of Chile, Santiago, Chile.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moceri</LastName>
                    <ForeName>Pamela</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>UR2CA, Department of Cardiology, Centre Hospitalier Universitaire de Nice, Universit.. C..te d'Azur, Nice, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Giovannini-Chami</LastName>
                    <ForeName>Lisa</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Pulmonology and Allergology, H..pitaux p..diatriques de Nice CHU- Lenval, Universit.. de Nice Sophia-Antipolis, Nice, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wood</LastName>
                    <ForeName>Nicholas</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Child and Adolescent Health, University of Sydney, Sydney, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chandler</LastName>
                    <ForeName>Rebecca E</ForeName>
                    <Initials>RE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Uppsala Monitoring Center, Uppsala, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Klein</LastName>
                    <ForeName>Nicola P</ForeName>
                    <Initials>NP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schlaudecker</LastName>
                    <ForeName>Elizabeth P</ForeName>
                    <Initials>EP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Poli</LastName>
                    <ForeName>M Cecilia</ForeName>
                    <Initials>MC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Immunology and Rheumatology, Hospital Roberto del R..o, Facultad de Medicina, Cl..nica Alemana Universidad del Desarrollo, Santiago, Chile.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Muscal</LastName>
                    <ForeName>Eyal</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Section of Rheumatology, Baylor College of Medicine, Houston, TX, USA; Texas Children's Hospital, Houston, TX, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Munoz</LastName>
                    <ForeName>Flor M</ForeName>
                    <Initials>FM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Texas Children's Hospital, Houston, TX, USA; Departments of Pediatrics, Section of Infectious Diseases, and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <SupplMeshList>
            <SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018746" MajorTopicYN="N">Systemic Inflammatory Response Syndrome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Adults</Keyword>
            <Keyword MajorTopicYN="Y">Adverse event</Keyword>
            <Keyword MajorTopicYN="Y">Case definition</Keyword>
            <Keyword MajorTopicYN="Y">Children</Keyword>
            <Keyword MajorTopicYN="Y">Guidelines</Keyword>
            <Keyword MajorTopicYN="Y">Immunization</Keyword>
            <Keyword MajorTopicYN="Y">MIS-A</Keyword>
            <Keyword MajorTopicYN="Y">MIS-C</Keyword>
            <Keyword MajorTopicYN="Y">Multisystem inflammatory syndrome</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: NP Klein has received research support from Pfizer for COVID-19 vaccine clinical trials and from Pfizer, Merck, GSK, Sanofi Pasteur and Protein Science (now Sanofi Pasteur) for unrelated studies. FM Munoz is a consultant for the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of Brighton Collaboration Case Definitions for the Safety Platform for Emergency vACcines (SPEAC) Project. The following authors have no conflict of interests to disclose: TP Vogel, KA Top, C Karatzios, DC Hilmers, LI Tapia, P Moceri, L Giovannini-Chami, N Wood, R Chandler, EP Schlaudecker, MC Poli, E Muscal. The findings, opinions and assertions contained in the consensus document are those of the individual scientific professional members of the working group. They do not necessarily represent the official positions of each participant...s organization (e.g., government, university or corporation). Specifically, the findings and conclusions in the paper are those of the authors and do not necessarily represent the views of their respective institutions.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>5</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>28</Day>
                <Hour>20</Hour>
                <Minute>27</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33640145</ArticleId>
            <ArticleId IdType="pii">S0264-410X(21)00093-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2021.01.054</ArticleId>
            <ArticleId IdType="pmc">PMC7904456</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2020 Oct 1;183(1):158-168.e14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32979941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr. 2020 Sep;224:129-132</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32585239</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2020 Nov;146(5):1194-1200.e1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32853638</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2018 Jul 3;14(7):1782-1790</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29533129</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1994 Apr 7;330(14):949-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8121458</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Pharmacother. 2015 Jul-Sep;6(3):185-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26312010</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Vaccine Immunol. 2013 May;20(5):761-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23467774</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Nov 19;71(16):2027-2034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32221519</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2020 May 1;130(5):2620-2629</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32217835</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Mar;579(7798):270-273</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32015507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jul 21;324(3):259-269</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32511692</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2020 Nov 2;130(11):5967-5975</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32730233</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jul 23;383(4):334-346</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32598831</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2011 Jun 15;186(12):7264-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21576510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Aug 6;11(1):3924</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32764665</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med J Aust. 2009 Apr 20;190(8):451-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19374621</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Child Adolesc Health. 2020 Sep;4(9):669-677</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32653054</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Cardiol. 2021 Jan;42(1):19-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33015722</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Infect Dis J. 2012 Mar;31(3):292-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22173146</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2016 Apr 12;34(17):2008-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26954467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheumatol. 2020 Jul;72(7):1059-1063</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32293098</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Res. 2020 Jun;68(3):161-168</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32524333</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Aug;26(8):1200-1204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32555424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Dec 3;71(9):2469-2479</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32392337</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 Aug 21;5(50):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32826343</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ Case Rep. 2016 May 04;2016:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27147629</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pediatr (Phila). 2021 Feb;60(2):119-126</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32975439</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):450-456</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32698192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Apr 16;181(2):281-292.e6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32155444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2007 Apr 7;369(9568):1232</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17416267</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Oct 23;370(6515):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32972995</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Infect Dis J. 2009 May;28(5):438-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19319016</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian Pediatr. 2020 Nov 15;57(11):1015-1019</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32788432</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1999 Nov 27;354(9193):1896-900</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10584742</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Elife. 2020 Jul 07;9:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32633718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 May 23;395(10237):1607-1608</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32386565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Paediatr Perinat Epidemiol. 2018 Sep;32(5):448-457</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30048564</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Int. 2005 Apr;47(2):232-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15771703</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jul 9;383(2):187-190</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32356945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 Jul 6;38(32):4935-4939</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32536544</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2020 Jun 16;52(6):910-941</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32505227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Nov 12;183(4):968-981.e7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32966765</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2020 Aug 1;205(3):555-564</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32513850</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Rheumatol. 2010 Sep;22(5):551-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20616737</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2020 Nov 2;130(11):5619-5621</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32870815</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intensive Care. 2020 Jun 1;10(1):69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32488505</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2020 Dec 1;130(12):6194-6197</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33108354</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Oct 09;69(40):1450-1456</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33031361</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2017 Mar 27;35(14):1770-1779</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28259442</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 2017 Apr 25;135(17):e927-e999</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28356445</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatric Infect Dis Soc. 2020 Dec 02;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33263756</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Oct 23;370(6515):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32972996</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc. 2009 Nov;84(11):1001-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19880690</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2018 Jan 08;8:1902</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29358936</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med. 2011 Jul;124(7):588-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21592453</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann N Y Acad Sci. 2006 Oct;1078:1-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17114675</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2021 Mar 2;6(57):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33653907</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Jul;26(7):1070-1076</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32514174</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Jun 6;395(10239):1771-1778</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32410760</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2000 Apr 19;283(15):2008-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10789670</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2019 Oct 11;9(1):14705</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31604998</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2013 May 24;31(22):2578-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23579258</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr. 2021 Jan;228:290-293.e1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32768467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 Apr 16;38(18):3422-3428</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32178909</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Cardiol. 2016 Apr 12;67(14):1738-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27056781</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 Jul 15;5(49):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32669287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2012 Jul 13;30(33):5038-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22561144</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Immunol. 2019 Jun;16(6):602-610</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30327490</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jul 23;383(4):347-358</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32598830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Nov;26(11):1701-1707</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32812012</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Nov 12;183(4):982-995.e14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32991843</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 14;369(6505):812-817</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32434946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 Sep 11;38(40):6299-6303</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32736940</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 May 28;181(5):1036-1045.e9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32416070</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2020 Jul;75(7):1730-1741</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32077115</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 Oct 8;5(52):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33033172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Med. 2019 Jul 2;16(7):e1002844</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31265459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jul 21;324(3):294-296</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32511676</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2020 Nov 2;130(11):5942-5950</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32701511</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Immunol. 2020 Mar;199(3):303-313</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31758701</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 2020 Aug 4;142(5):429-436</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32418446</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 2021 Jan 5;143(1):4-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32787714</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1074-1080</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32790663</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Euro Surveill. 2020 Jun;25(22):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32524957</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 7;369(6504):718-724</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32661059</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 May;26(5):681-687</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32327758</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Acad Dermatol. 2017 May;76(5):811-817.e4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28285784</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33640052</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>16</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1474-547X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>397</Volume>
                    <Issue>10276</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>27</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Lancet (London, England)</Title>
                <ISOAbbreviation>Lancet</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Peruvian COVID-19 vaccine scandal spreads.</ArticleTitle>
            <Pagination>
                <MedlinePgn>783</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0140-6736(21)00508-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(21)00508-0</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chauvin</LastName>
                    <ForeName>Lucien</ForeName>
                    <Initials>L</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016433">News</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Lancet</MedlineTA>
            <NlmUniqueID>2985213R</NlmUniqueID>
            <ISSNLinking>0140-6736</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="ErratumIn">
                <RefSource>Lancet. 2021 May 15;397(10287):1808</RefSource>
                <PMID Version="1">33992144</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000600" MajorTopicYN="Y">supply &amp; distribution</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
                <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000071296" MajorTopicYN="Y">Government Employees</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007857" MajorTopicYN="N">Leadership</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010568" MajorTopicYN="N" Type="Geographic">Peru</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011057" MajorTopicYN="N">Politics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>28</Day>
                <Hour>20</Hour>
                <Minute>25</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33640052</ArticleId>
            <ArticleId IdType="pii">S0140-6736(21)00508-0</ArticleId>
            <ArticleId IdType="doi">10.1016/S0140-6736(21)00508-0</ArticleId>
            <ArticleId IdType="pmc">PMC7946602</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33639625</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1735-5249</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>20</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Iranian journal of allergy, asthma, and immunology</Title>
                <ISOAbbreviation>Iran J Allergy Asthma Immunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.</ArticleTitle>
            <Pagination>
                <MedlinePgn>106-113</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.18502/ijaai.v20i1.5417</ELocationID>
            <Abstract>
                <AbstractText>Bacillus Calmette Guerin (BCG) was designed for protecting children against tuberculosis. Also, it can protect against other infectious diseases through the induction of trained immunity. Due to its heterologous protective effects, the BCG vaccine has been proposed as atreatment option for coronavirus disease-2019 (COVID-19). Epidemiological studies have found that countries without BCG vaccination policy have experienced higher mortality rates related toCOVID-19 infection than those with BCG vaccination policy. However, there are some confounding factors such as age, population intensity, immigration, the pandemic phase, and data accuracy that may affect these results. Therefore, this hypothesis should be evaluated by clinical trial studies. Large-scale clinical trials are in progress to investigate ifthe BCG vaccine could be used as a useful tool for protection against COVID-19 infection.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Alyasin</LastName>
                    <ForeName>Soheila</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran AND Department of Allergy and Clinical Immunology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. alyasins@sums.ac.ir.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kanannejad</LastName>
                    <ForeName>Zahra</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. zkanannejad@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Esmaeilzadeh</LastName>
                    <ForeName>Hossein</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran AND Department of Allergy and Clinical Immunology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. esmailzadeh@sums.ac.ir.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nabavizadeh</LastName>
                    <ForeName>Hesamedin</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran AND Department of Allergy and Clinical Immunology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. drhesamnabavi@yahoo.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ghatee</LastName>
                    <ForeName>Mohammad Amin</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran. ghateea1980@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Amin</LastName>
                    <ForeName>Reza</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran AND Department of Allergy and Clinical Immunology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. aminr@sums.ac.ir.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Iran</Country>
            <MedlineTA>Iran J Allergy Asthma Immunol</MedlineTA>
            <NlmUniqueID>101146178</NlmUniqueID>
            <ISSNLinking>1735-1502</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D001500">BCG Vaccine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D001500" MajorTopicYN="N">BCG Vaccine</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009163" MajorTopicYN="N">Mycobacterium bovis</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057766" MajorTopicYN="N">Policy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014376" MajorTopicYN="N">Tuberculosis</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Mycobacterium bovis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>27</Day>
                <Hour>21</Hour>
                <Minute>15</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33639625</ArticleId>
            <ArticleId IdType="doi">10.18502/ijaai.v20i1.5417</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33639165</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1083-351X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>24</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of biological chemistry</Title>
                <ISOAbbreviation>J Biol Chem</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and Influenza virus.</ArticleTitle>
            <Pagination>
                <MedlinePgn>100470</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0021-9258(21)00243-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbc.2021.100470</ELocationID>
            <Abstract>
                <AbstractText>The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health. Vaccines are ideal solutions to prevent infection, but treatments are also needed for those who have contracted the virus to limit negative outcomes, when vaccines are not applicable. Viruses must cross host cell membranes during their lifecycle, creating a dependency on processes involving membrane dynamics. Thus, in this study we examined whether the synthetic machinery for glycosphingolipids, biologically active components of cell membranes, can serve as a therapeutic target to combat SARS-CoV-2. We examined the antiviral effect of two specific inhibitors of glucosylceramide synthase (GCS); (i) Genz-123346, an analogue of the FDA-approved drug Cerdelga.., and (ii) GENZ-667161, an analogue of venglustat which is currently under phase III clinical trials. We found that both GCS inhibitors inhibit replication of SARS-CoV-2. Moreover, these inhibitors also disrupt replication of influenza virus A/PR/8/34 (H1N1). Our data imply that synthesis of glycosphingolipids is necessary to support viral life cycles, and suggest that GCS inhibitors should be further explored as antiviral therapies.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Vitner</LastName>
                    <ForeName>Einat B</ForeName>
                    <Initials>EB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Infectious diseases, Israel institute for Biological Research, Ness-Ziona, 7410000, Israel. Electronic address: einatv@iibr.gov.il.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Achdout</LastName>
                    <ForeName>Hagit</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Infectious diseases, Israel institute for Biological Research, Ness-Ziona, 7410000, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Avraham</LastName>
                    <ForeName>Roy</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Infectious diseases, Israel institute for Biological Research, Ness-Ziona, 7410000, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Politi</LastName>
                    <ForeName>Boaz</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Infectious diseases, Israel institute for Biological Research, Ness-Ziona, 7410000, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cherry</LastName>
                    <ForeName>Lilach</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Infectious diseases, Israel institute for Biological Research, Ness-Ziona, 7410000, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tamir</LastName>
                    <ForeName>Hadas</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Infectious diseases, Israel institute for Biological Research, Ness-Ziona, 7410000, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yahalom-Ronen</LastName>
                    <ForeName>Yfat</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Infectious diseases, Israel institute for Biological Research, Ness-Ziona, 7410000, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paran</LastName>
                    <ForeName>Nir</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Infectious diseases, Israel institute for Biological Research, Ness-Ziona, 7410000, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Melamed</LastName>
                    <ForeName>Sharon</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Infectious diseases, Israel institute for Biological Research, Ness-Ziona, 7410000, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Erez</LastName>
                    <ForeName>Noam</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Infectious diseases, Israel institute for Biological Research, Ness-Ziona, 7410000, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Israely</LastName>
                    <ForeName>Tomer</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Infectious diseases, Israel institute for Biological Research, Ness-Ziona, 7410000, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Biol Chem</MedlineTA>
            <NlmUniqueID>2985121R</NlmUniqueID>
            <ISSNLinking>0021-9258</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">GlucosylCeramide Synthase</Keyword>
            <Keyword MajorTopicYN="N">Glucosylceramide</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">Sphingolipids</Keyword>
            <Keyword MajorTopicYN="N">antiviral drugs</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>27</Day>
                <Hour>20</Hour>
                <Minute>8</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33639165</ArticleId>
            <ArticleId IdType="pii">S0021-9258(21)00243-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jbc.2021.100470</ArticleId>
            <ArticleId IdType="pmc">PMC7904475</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Rep. 2016 Jun 28;16(1):186-200</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27320924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2020 Feb 7;15(2):e0228735</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32032363</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2016 Jul 04;17(7):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27384562</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2020 Sep;101(9):925-940</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32568027</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Med. 2015 Apr 30;21:389-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25938659</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Microbiol. 2010 Jul;18(7):323-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20452219</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2016 Oct 10;11(10):e0164377</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27723844</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Lipid Res. 2014 Jul;55(7):1357-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24868094</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2019 May 29;93(12):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30918081</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2017 Apr 7;13(4):e1006316</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28388693</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2000 Jan;74(1):564-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10590151</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2011 Mar;55(3):1036-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21173177</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Handb Exp Pharmacol. 2013;(216):405-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23563668</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroinflammation. 2016 May 12;13(1):104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27175482</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2015 Feb 17;313(7):695-706</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25688781</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drugs Future. 2010 Aug 1;35(8):613-620</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22563139</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2008 Aug;82(16):8030-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18524833</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Ther. 2016 Jun;24(6):1019-1029</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26948439</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2015 Jan;70(1):136-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25223974</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2018 Feb 15;14(2):e1006853</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29447265</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1994 Mar 18;269(11):8362-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8132559</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2014 Nov;88(21):12276-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25122779</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biol Pharm Bull. 2006 Aug;29(8):1575-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16880607</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Intern Med. 2017 Jan;37:25-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27522145</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mem Inst Oswaldo Cruz. 2020 Oct 23;115:e200342</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33111751</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Microbiol. 2004 Sep;2(9):704-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15372081</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1822-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9050863</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2001 Jun;33(6):1488-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11391538</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(8):e43310</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22912851</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Drug Discov. 2020 Apr;15(4):397-401</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31847616</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2014 Jun 5;510(7503):68-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24899306</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes. 2007 May;56(5):1210-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17470562</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 2012 Jul 12;55(13):6061-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22712544</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1996 Oct;70(10):7153-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8794362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2008 Oct 1;22(15):1961-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18753929</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Ther. 2017 Feb;34(2):396-420</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28054310</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2012 Dec;56(12):6379-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23070155</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Genet Metab. 2007 Jul;91(3):259-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17509920</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Negl Trop Dis. 2016 Mar 14;10(3):e0004524</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26974655</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2020 May 15;295(20):6785-6797</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32284326</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">33637387</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>27</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>39</Volume>
                    <Issue>22</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>05</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.</ArticleTitle>
            <Pagination>
                <MedlinePgn>3053-3066</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0264-410X(21)00094-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2021.01.055</ELocationID>
            <Abstract>
                <AbstractText>This is a Brighton Collaboration Case Definition of the term &quot;Vaccine Associated Enhanced Disease&quot; to be utilized in the evaluation of adverse events following immunization. The Case Definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for SARS-CoV-2 vaccines and other emerging pathogens. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by selected Expert Reviewers prior to submission.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Munoz</LastName>
                    <ForeName>Flor M</ForeName>
                    <Initials>FM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Pediatrics, Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA. Electronic address: florm@bcm.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cramer</LastName>
                    <ForeName>Jakob P</ForeName>
                    <Initials>JP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Coalition for Epidemic Preparedness Innovations, CEPI, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dekker</LastName>
                    <ForeName>Cornelia L</ForeName>
                    <Initials>CL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Stanford University School of Medicine, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dudley</LastName>
                    <ForeName>Matthew Z</ForeName>
                    <Initials>MZ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Graham</LastName>
                    <ForeName>Barney S</ForeName>
                    <Initials>BS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gurwith</LastName>
                    <ForeName>Marc</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Safety Platform for Emergency Vaccines, Los Altos Hills, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Law</LastName>
                    <ForeName>Barbara</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Safety Platform for Emergency Vaccines, Manta, Ecuador.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Perlman</LastName>
                    <ForeName>Stanley</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Department of Pediatrics, University of Iowa, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Polack</LastName>
                    <ForeName>Fernando P</ForeName>
                    <Initials>FP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Fundacion Infant, Argentina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Spergel</LastName>
                    <ForeName>Jonathan M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy and Immunology, Children's Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at University of Pennsylvania, PA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Van Braeckel</LastName>
                    <ForeName>Eva</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Ghent University Hospital, and Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ward</LastName>
                    <ForeName>Brian J</ForeName>
                    <Initials>BJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Didierlaurent</LastName>
                    <ForeName>Arnaud M</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center of Vaccinology, University of Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lambert</LastName>
                    <ForeName>Paul Henri</ForeName>
                    <Initials>PH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center of Vaccinology, University of Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>Brighton Collaboration Vaccine-associated Enhanced Disease Working Group</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014612">Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Adverse event</Keyword>
            <Keyword MajorTopicYN="Y">Case definition</Keyword>
            <Keyword MajorTopicYN="Y">Enhanced disease</Keyword>
            <Keyword MajorTopicYN="Y">Guidelines</Keyword>
            <Keyword MajorTopicYN="Y">Immunization</Keyword>
            <Keyword MajorTopicYN="Y">Respiratory</Keyword>
            <Keyword MajorTopicYN="Y">Systemic disease</Keyword>
            <Keyword MajorTopicYN="Y">Vaccine</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: F. M. Munoz is a consultant for the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of Brighton Collaboration Case Definitions for the Safety Platform for Emergency vACcines (SPEAC) Project. J. Cramer is a member of the Coalition for Epidemic Preparedness Innovations (CEPI). C. Dekker is a consultant for the Coalition for Epidemic Preparedness Innovations (CEPI) via Brighton Collaboration for the Safety Platform for Emergency vACcines (SPEAC) Project and a consultant for Medicago Inc. M. Dudley is a consultant for the Coalition for Epidemic Preparedness Innovations (CEPI) via Brighton Collaboration, for the Safety Platform for Emergency vACcines (SPEAC) Project. B. Graham is inventor on pending patent applications related to coronavirus vaccines and monoclonal antibodies. M. Gurwith is a consultant for the Coalition for Epidemic Preparedness Innovations (CEPI) via Brighton Collaboration for the Safety Platform for Emergency vACcines (SPEAC) Project; and is Chief Medical Officer for Verndari, Inc., which is developing vaccines for influenza and Covid-19. S. Perlman is a member of the ACIP COVID-19 Vaccine Work Group. F. Polack is an investigator in the Pfizer's COVID-19 vaccine trial. B. Ward is Chief Medical Officer for Medicago Inc., which is developing vaccines for influenza and Covid-19. PH Lambert is a consultant for the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of Case Definitions in the Brighton Collaboration format and for DSMB members training. He is also member of several vaccine DSMBs. The following authors have no conflict of interests to disclose: J. Spergel, B. Law, E. Van Braeckel, A. Didierlaurent.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>5</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>27</Day>
                <Hour>5</Hour>
                <Minute>31</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33637387</ArticleId>
            <ArticleId IdType="pii">S0264-410X(21)00094-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2021.01.055</ArticleId>
            <ArticleId IdType="pmc">PMC7901381</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Exp Med. 2002 Sep 16;196(6):859-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12235218</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2007 Aug;81(16):8692-706</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17537853</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2005 Aug 1;175(3):1876-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16034131</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Apr 7;323(13):1239-1242</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32091533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2017 Dec 16;216(suppl_10):S906-S911</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29267924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dis Child. 2017 Jun;102(6):487-495</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28292743</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2005 Apr 15;171(8):850-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15657466</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomed Sci. 2015 Oct 14;22:83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26462910</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Infect. 2020 Jun;26(6):767-772</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32304745</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viral Immunol. 2001;14(4):297-309</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11792060</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2013 Sep;87(18):10070-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23843644</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Pediatr. 2017 Oct 2;171(10):e172352</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28783810</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2012 Jul 15;206(2):258-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22561365</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Roentgenol Radium Ther Nucl Med. 1970 Nov;110(3):439-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5489681</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2005 Feb;75(2):185-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15602737</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Immunol. 2018 Oct;39:14-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29801750</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2020 Apr;8(4):420-422</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32085846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Radiology. 2020 Jul;296(1):172-180</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32255413</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2016 Feb 10;19(2):181-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26867177</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2016 Feb 23;315(8):801-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26903338</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31978945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br Med J. 1968 May 25;2(5603):449-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5648287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2014 May 1;209(9):1331-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24065148</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2012 Feb 8;30(7):1265-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22197579</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Radiol. 2020 Aug;30(8):4417-4426</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32279115</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2020 Sep;26(9):2005-2015</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32437316</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019 Sep 28;44(9):996-1002</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31645488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care Med. 2013 Jul;41(7):1761-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23685639</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Intern Med. 2020 Aug 1;180(8):1081-1089</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32396163</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Immunol. 2017 Aug;47:93-102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28755542</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intensive Care Med. 2018 Feb;44(2):179-188</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29256116</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32171076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2009 Jan;15(1):34-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19079256</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Minerva Pediatr. 2018 Dec;70(6):566-578</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30334621</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2003 Sep;9(9):1209-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12925847</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JCI Insight. 2019 Feb 21;4(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30830861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2019 Jan 26;393(10169):350-363</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30696575</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2017 Jan 2;13(1):19-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27636098</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2005 Jun;79(12):7819-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15919935</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2008 Nov 15;181(10):6692-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18981084</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2011 Dec;85(23):12201-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21937658</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 May 23;395(10237):1607-1608</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32386565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2008 Feb 15;180(4):2376-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18250447</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care Med. 2009 May;37(5):1649-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19325482</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Oncol. 2020 Mar 24;10:354</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32266139</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>An Pediatr (Engl Ed). 2020 May;92(5):277-285</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31784324</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2017 Aug 10;377(6):562-572</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28792873</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care. 2011 Aug 03;15(4):R184</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21812993</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Apr;20(4):425-434</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32105637</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 1999 Jun;5(6):629-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10371500</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Paediatr Nurs. 2005 Feb;17(1):32-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15751446</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2014 Jun;88(11):6281-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24672024</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2020 May;19(5):305-306</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32273591</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Top Microbiol Immunol. 2009;329:3-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19198559</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Vaccines. 2016;15(4):455-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26560015</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Rev. 2005 Jul;18(3):541-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16020689</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr. 1978 Oct;93(4):565-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">702235</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Vaccines. 2016;15(2):173-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26641318</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1992 Dec;66(12):7444-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1433525</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biologicals. 2020 Jul;66:35-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32600951</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Formos Med Assoc. 2013 Jan;112(1):3-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23332423</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care Med. 1986 Apr;14(4):271-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3956214</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2987-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23382205</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2016 Sep 29;6:34108</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27682426</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2001 May;75(10):4499-505</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11312320</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intensive Care Med. 2003 Feb;29(2):278-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12541154</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1994 Aug;68(8):5321-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8035532</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2005 Oct 1;106(7):2366-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15860669</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2006 Jun 5;24(23):5027-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16675071</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care Med. 2005 Jul;33(7):1484-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16003052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Anti Infect Ther. 2017 Feb;15(2):111-119</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27796143</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2017 Aug 29;20(9):2251-2261</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28854372</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Med. 1977 Jul 1;146(1):201-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">406347</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Med. 2006 Dec;3(12):e525</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17194199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Burns Fire Disasters. 2019 Jun 30;32(2):135-142</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31528154</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2011 Jan;85(1):217-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20980507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Biosci. 2008 Jan 01;13:1352-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17981635</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Transl Med. 2019 Oct;7(19):502</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31728355</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2017 Nov 17;358(6365):929-932</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29097492</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Immunol. 1997 Dec;27(12):3341-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9464822</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2012 Jun 20;307(23):2526-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22797452</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Jun 6;395(10239):1771-1778</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32410760</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Med. 1997 Aug 4;186(3):421-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9236194</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2008 Nov 29;372(9653):1881-1893</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19012954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytokine. 2005 Oct 7;32(1):30-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16129616</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2016 Sep;12(9):2351-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27269431</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2006 Aug;12(8):905-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16862151</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 29;368(6494):945-946</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32385100</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Epidemiol. 1969 Apr;89(4):422-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4305198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Vaccine Immunol. 2015 Dec 16;23(3):189-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26677198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2018 Jul 26;379(4):327-340</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29897841</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Resuscitation. 2016 Dec;109:87-109</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27496259</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2013 May;87(9):5300-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23449793</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care Med. 1988 Nov;16(11):1110-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3048900</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Decis Making. 1999 Oct-Dec;19(4):399-410</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10520678</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Immunol. 2017 Aug;47:1-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28715767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Radiology. 2020 Aug;296(2):E32-E40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32101510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2016 Mar 29;34(14):1643-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26873054</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1960 Jul 28;263:180-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14404830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2000 Jul;6(7):776-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10888926</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intensive Care Med. 1996 Jul;22(7):707-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8844239</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Traffic. 2013 Jan;14(1):25-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22998156</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Crit Care Med. 2009 Sep;10(5):562-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19741445</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 Jun 26;38(31):4783-4791</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32507409</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microbiol Mol Biol Rev. 2017 Feb 8;81(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28179396</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2015 Sep 24;373(13):1195-206</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26214039</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Scand J Infect Dis. 1970 Dec;2(3):161-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25607573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2016 Feb 23;315(8):762-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26903335</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Epidemiol. 1969 Apr;89(4):449-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4305200</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2001 Oct 10;286(14):1754-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11594901</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2015 Mar 13;11(3):e1004757</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25769044</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytokine. 2020 Sep;133:155151</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32544563</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Crit Care Med. 2017 Mar;18(3_suppl Suppl 1):S4-S16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28248829</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Immunol. 2004 Apr;136(1):95-103</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15030519</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1988 Jan 29;239(4839):476-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3277268</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2008 Nov 1;181(9):6337-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18941225</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Epidemiol. 1969 Apr;89(4):405-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4305197</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2013 Dec;94(Pt 12):2679-2690</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24077366</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Epidemiol. 1969 Apr;89(4):435-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4305199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trials. 2015 Jun 02;16:245</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26033094</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Emerg Med. 2019 Nov 27;19(1):74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31771517</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Biol Ther. 2018 Nov;18(11):1171-1179</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30235422</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 1993 Aug 15;151(4):2032-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8345194</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33635275</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>03</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2369-2960</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>26</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JMIR public health and surveillance</Title>
                <ISOAbbreviation>JMIR Public Health Surveill</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Expert Opinions on the Most Promising Treatments and Vaccine Candidates for COVID-19: Global Cross-sectional Survey of Virus Researchers in the Early Months of the Pandemic.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e22483</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2196/22483</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">The COVID-19 pandemic presents a great public health challenge worldwide, especially given the urgent need to identify effective drugs and develop a vaccine in a short period of time. Globally, several drugs and vaccine candidates are in clinical trials. However, because these drugs and vaccines are still being tested, there is still no definition of which ones will succeed.</AbstractText>
                <AbstractText Label="OBJECTIVE">This study aimed to assess the opinions of over 1000 virus researchers with knowledge on the prevention and treatment of coronavirus-related human diseases to determine the most promising drug and vaccine candidates to address COVID-19.</AbstractText>
                <AbstractText Label="METHODS">We mapped the clinical trials related to COVID-19 registered at ClinicalTrials.gov. These data were used to prepare a survey questionnaire about treatments and vaccine candidates for COVID-19. In May 2020, a global survey was conducted with authors of recent scientific publications indexed in the Web of Science Core Collection related to viruses, severe acute respiratory syndrome coronavirus, coronaviruses, and COVID-19.</AbstractText>
                <AbstractText Label="RESULTS">Remdesivir, immunoglobulin from cured patients, and plasma were considered to be the most promising treatments in May 2020, while ChAdOx1 and mRNA-1273 were considered to be the most promising vaccine candidates. Almost two-thirds of the respondents (766/1219, 62.8%) believed that vaccines for COVID-19 were likely to be available in the next 18 months. Slightly fewer than 25% (289/1219, 23.7%) believed that a vaccine was feasible, but probably not within 18 months.</AbstractText>
                <AbstractText Label="CONCLUSIONS">The issues addressed in this study are constantly evolving; therefore, the current state of knowledge has changed since the survey was conducted. However, for several months after the survey, the respondents' expectations were in line with recent results related to treatments and vaccine candidates for COVID-19.</AbstractText>
                <CopyrightInformation>..Bernardo Pereira Cabral, Luiza Braga, Fabio Mota. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 26.02.2021.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Cabral</LastName>
                    <ForeName>Bernardo Pereira</ForeName>
                    <Initials>BP</Initials>
                    <Identifier Source="ORCID">0000-0001-8242-1244</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Economics, Federal University of Bahia, Salvador, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Strategic Studies, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Braga</LastName>
                    <ForeName>Luiza</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">0000-0002-1726-2643</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Center for Strategic Studies, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Economics, Fluminense Federal University, Niter..i, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Mota</LastName>
                    <ForeName>Fabio</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">0000-0003-2401-7336</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Center for Strategic Studies, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>26</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Canada</Country>
            <MedlineTA>JMIR Public Health Surveill</MedlineTA>
            <NlmUniqueID>101669345</NlmUniqueID>
            <ISSNLinking>2369-2960</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>H</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005104" MajorTopicYN="Y">Expert Testimony</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012108" MajorTopicYN="Y">Research Personnel</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">clinical trial</Keyword>
            <Keyword MajorTopicYN="Y">drug</Keyword>
            <Keyword MajorTopicYN="Y">public health</Keyword>
            <Keyword MajorTopicYN="Y">survey</Keyword>
            <Keyword MajorTopicYN="Y">treatment</Keyword>
            <Keyword MajorTopicYN="Y">vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>12</Hour>
                <Minute>11</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33635275</ArticleId>
            <ArticleId IdType="pii">v7i2e22483</ArticleId>
            <ArticleId IdType="doi">10.2196/22483</ArticleId>
            <ArticleId IdType="pmc">PMC7919842</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2020 May 21;382(21):1969-1973</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32227757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):467-478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Jul;92(7):814-818</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32253759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 May 16;395(10236):1569-1578</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32423584</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Apr 28;323(16):1582-1589</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32219428</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Oct 6;324(13):1330-1341</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32876694</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Sep 26;396(10255):887-897</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32896291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Jun 13;395(10240):1845-1854</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32450106</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Med. 2020 May 4;217(5):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32289152</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Heart Assoc. 2020 Apr 7;9(7):e016219</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32233755</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 May 12;323(18):1824-1836</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32282022</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Apr 28;323(16):1561-1562</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32219429</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 25;384(8):693-704</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32678530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Jul 30;370:m2924</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32732352</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2010 Jun 17;28(28):4445-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20394720</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Travel Med Infect Dis. 2020 May - Jun;35:101647</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32247927</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Intern Med. 2020 May;35(5):1545-1549</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32133578</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32187464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 May 30;395(10238):1670-1671</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32401712</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Engineering (Beijing). 2020 Oct;6(10):1192-1198</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32346491</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2020 May;19(5):305-306</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32273591</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):589-593</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32785213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Metab Syndr. 2020 Jul - Aug;14(4):637-639</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32428864</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Cardiol. 2020 Sep 1;5(9):986-987</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32936259</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2020 Mar 25;21(7):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32218340</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Aug 5;370:m3096</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32759299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32350134</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jun 11;382(24):2327-2336</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32275812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2020 Jun;178:104791</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32275914</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Apr 8;369:m1432</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32269046</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32205204</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Apr 3;368(6486):14-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32241928</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33635184</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>29</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">2222-1751</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Emerging microbes &amp; infections</Title>
                <ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants.</ArticleTitle>
            <Pagination>
                <MedlinePgn>439-441</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2021.1896956</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Su</LastName>
                    <ForeName>Shan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Medical Molecular Virology (MOE/MOH/CAM), School of Basic Medical Sciences, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shao</LastName>
                    <ForeName>Yiming</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Infectious Disease Prevention and Control (SKLID), National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Shibo</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Medical Molecular Virology (MOE/MOH/CAM), School of Basic Medical Sciences, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Emerg Microbes Infect</MedlineTA>
            <NlmUniqueID>101594885</NlmUniqueID>
            <ISSNLinking>2222-1751</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <SupplMeshList>
            <SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>12</Hour>
                <Minute>10</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33635184</ArticleId>
            <ArticleId IdType="doi">10.1080/22221751.2021.1896956</ArticleId>
            <ArticleId IdType="pmc">PMC7971202</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2020 Jul 3;369(6499):77-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32376603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Jun;20(6):669-677</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32240634</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Sep 3;383(10):e63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32610006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2020 Nov 17;117(46):28538-28542</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33122444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2021 Apr;592(7853):277-282</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33545711</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 May 19;38(24):3987-3988</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32331807</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33634346</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>21</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-7284</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>36</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Mar</Month>
                    </PubDate>
                </JournalIssue>
                <Title>European journal of epidemiology</Title>
                <ISOAbbreviation>Eur J Epidemiol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population.</ArticleTitle>
            <Pagination>
                <MedlinePgn>319-324</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10654-021-00729-5</ELocationID>
            <Abstract>
                <AbstractText>Initial results from various phase-III trials on vaccines against SARS-CoV-2 are promising. For proper translation of these results to clinical guidelines, it is essential to determine how well the general population is reflected in the study populations of these trials. This study was conducted among 7162 participants (age-range: 51-106..years; 58% women) from the Rotterdam Study. We quantified the proportion of participants that would be eligible for the nine ongoing phase-III trials. We further quantified the eligibility among participants at high risk to develop severe COVID-19. Since many trials were not explicit in their exclusion criterion with respect to 'acute' or 'unstable preexisting' diseases, we performed two analyses. First, we included all participants irrespective of this criterion. Second, we excluded persons with acute or 'unstable preexisting' diseases. 97% of 7162 participants was eligible for any trial with eligibility for separate trials ranging between 11-97%. For high-risk individuals the corresponding numbers were 96% for any trial with separate trials ranging from 5-96%. Importantly, considering persons ineligible due to 'acute' or 'unstable pre-existing' disease drastically dropped the eligibilities for all trials below 43% for the total population and below 36% for high-risk individuals. The eligibility for ongoing vaccine trials against SARS-CoV-2 can reduce by half depending on interpretation and application of a single unspecified exclusion criterion. This exclusion criterion in our study would especially affect the elderly and those with pre-existing morbidities. These findings thus indicate the difficulty as well as importance of developing clinical recommendations for vaccination and applying these to the appropriate target populations. This becomes especially paramount considering the fact that many countries worldwide have initiated their vaccination programs by first targeting the elderly and most vulnerable persons.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Terzikhan</LastName>
                    <ForeName>Natalie</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, the Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hofman</LastName>
                    <ForeName>Albert</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goudsmit</LastName>
                    <ForeName>Jaap</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Human Immunomics Initiative, Department of Epidemiology, Harvard T.H. Chan School of Public Health and Human Vaccines Project, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ikram</LastName>
                    <ForeName>Mohammad Arfan</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, the Netherlands. m.a.ikram@erasmusmc.nl.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>26</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Eur J Epidemiol</MedlineTA>
            <NlmUniqueID>8508062</NlmUniqueID>
            <ISSNLinking>0393-2990</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Epidemiology</Keyword>
            <Keyword MajorTopicYN="N">External validity</Keyword>
            <Keyword MajorTopicYN="N">Generalizability</Keyword>
            <Keyword MajorTopicYN="N">Phase III trials</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">Vaccines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>4</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>6</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33634346</ArticleId>
            <ArticleId IdType="doi">10.1007/s10654-021-00729-5</ArticleId>
            <ArticleId IdType="pii">10.1007/s10654-021-00729-5</ArticleId>
            <ArticleId IdType="pmc">PMC7906827</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>RIVM. Risicogroepen en COVID-19. 2020 10-11-2020]; Available from: https://www.rivm.nl/coronavirus-covid-19/risicogroepen .</Citation>
            </Reference>
            <Reference>
                <Citation>Ikram MA, et al. The rotterdam study: 2018 update on objectives, design and main results. Eur J Epidemiol. 2017;32(9):807...50.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1007/s10654-017-0321-4</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dekkers OM, et al. How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol. 2010;39(1):89...94.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1093/ije/dyp174</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pibouleau L, et al. Applicability and generalisability of published results of randomised controlled trials and non-randomised studies evaluating four orthopaedic procedures: methodological systematic review. BMJ. 2009;339:b4538.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1136/bmj.b4538</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Braend AM, Straand J, Klovning A. Clinical drug trials in general practice: how well are external validity issues reported? Bmc Fam Pract. 2017;18:1...11.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1186/s12875-017-0680-7</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Licher S, et al. Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: a population-based cohort study. PLoS Med. 2019;16(2):e1002741.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1371/journal.pmed.1002741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vernooij MW, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357(18):1821...8.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1056/NEJMoa070972</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vektis. Factsheet Chronische aandoeningen bij 40-plussers. 2019; Available from: https://www.vektis.nl/intelligence/publicaties/factsheet-chronische-aandoeningen-bij-40-plussers .</Citation>
            </Reference>
            <Reference>
                <Citation>Winkler V, et al. Response in individuals with and without foreign background and application to the National Cohort in Germany: which factors have an effect? Int J Public Health. 2014;59(3):555...63.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1007/s00038-013-0539-1</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33632828</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>09</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1095-9203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>371</Volume>
                    <Issue>6532</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>26</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Science (New York, N.Y.)</Title>
                <ISOAbbreviation>Science</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Vaccine trials ramp up in children and adolescents.</ArticleTitle>
            <Pagination>
                <MedlinePgn>874-875</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1126/science.371.6532.874</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Couzin-Frankel</LastName>
                    <ForeName>Jennifer</ForeName>
                    <Initials>J</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016433">News</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Science</MedlineTA>
            <NlmUniqueID>0404511</NlmUniqueID>
            <ISSNLinking>0036-8075</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>5</Hour>
                <Minute>53</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33632828</ArticleId>
            <ArticleId IdType="pii">371/6532/874</ArticleId>
            <ArticleId IdType="doi">10.1126/science.371.6532.874</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33632286</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>03</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1745-6215</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>22</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>25</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Trials</Title>
                <ISOAbbreviation>Trials</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Traditional Chinese medicine auricular point acupressure for the relief of pain, fatigue, and gastrointestinal adverse reactions after the injection of novel coronavirus-19 vaccines: a structured summary of a study protocol for a multicentre, three-arm, single-blind, prospective randomized controlled trial.</ArticleTitle>
            <Pagination>
                <MedlinePgn>162</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-021-05138-3</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To investigate if traditional Chinese medicine (TCM) auricular point acupressure (APA) can alleviate and (or) reduce the pain (including injection site pain, headache, other muscle and joint pain), fatigue, and gastrointestinal adverse reactions (including nausea, vomiting, diarrhea), after the injection of novel coronavirus-19 vaccines (NCVs).</AbstractText>
                <AbstractText Label="TRIAL DESIGN" NlmCategory="METHODS">The study is designed as a multicentre, parallel-group, three-arm, single-blind, prospective, randomized (1:1:1 ratio) study.</AbstractText>
                <AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">More than 360 participants will be recruited from healthy people who vaccinate NCVs in 5 community healthcare centres in the Sichuan province of China and 1 university hospital (Hospital of Chengdu University of Traditional Chinese Medicine).</AbstractText>
                <AbstractText Label="INCLUSION CRITERIA" NlmCategory="METHODS">...Vaccinators meets the conditions of NCVs injection and have no contraindications to it. The details shall be subject to the instructions of the NCVs used and the statement of medical institutions. The first dose of NCVs injection shall be completed within 24 hours from the time of injection to the time of enrolment; ...No redness, swelling, injury or infection of the skin or soft tissue of both ears, which is not suitable for APA; ...No history of alcohol and adhesive tape contact allergy; ...18-59 years old, regardless of gender; ...Those who were able to complete the questionnaire independently at the time of the first and second dose of NCVs and on the 3rd, 7th and 15th day after the first and second dose of NCVs respectively; ...Those who agree to participate in the trial and sign the informed consent, and can seriously abide by the precautions after the injection of NCVs and the requirements of traditional Chinese medicine auricular point plasters sticking and acupressure.</AbstractText>
                <AbstractText Label="EXCLUSION CRITERIA" NlmCategory="METHODS">...Those who are not suitable to be vaccinated because they belong to the contraindication or cautious population; ...Those who have participated in other clinical trials within 4 weeks before the start of this study; ...No chronic/habitual/persistent headache, Muscle or joint pain, fatigue, diarrhea, nausea, retching or vomiting before the injection of NCVs, and no related diseases present (details of this item is listed in full protocol); ...Those who are in use or have received TCMAPA within 2 weeks before the trial; ...Pregnant or lactating women; ...Participants with other serious primary diseases and psychosis.</AbstractText>
                <AbstractText Label="INTERVENTION AND COMPARATOR" NlmCategory="UNASSIGNED">...Auricular point acupressure group: participants receive bilateral, symptom-specific TCMAPA in 5 auricular points (per side, 10 points bilateral) for 5 days, 3-4 times (about 1 min each time) of self-acupressure per day, after each NCVs injection (10 days in total). ...Sham auricular point acupressure group: participants receive bilateral, none symptom-specific, sham APA in 5 auricular points (per side, 10 points bilateral) for 5 days, 3-4 times (about 1 min each time) of self-acupressure per day, after each NCVs injection (10 days in total). ...Blank control group: Non-intervention blank control. The Hebei medical device Co. Ltd, Hebei, China manufactured the auricular point sticking plasters.</AbstractText>
                <AbstractText Label="MAIN OUTCOMES" NlmCategory="RESULTS">Primary outcomes are all scores of visual analogue scale (VAS) based on subjective judgment of the participants included, including VAS score of pain at injection site, headache, muscle and joint pain, fatigue, nausea, retching, vomiting and diarrhea. Time points for outcomes above are the same: ...Immediately after first and second injection of the vaccine (Baseline assessment); ...Three days after first and second injection of the vaccine; ...Seven days after first and second injection of the vaccine; ...Fifteen days after first and second injection of the vaccine.</AbstractText>
                <AbstractText Label="RANDOMISATION" NlmCategory="UNASSIGNED">Participants will be randomized in 1:1:1 ratio to each group by computerized random number generator, and independently in each sub-centre.</AbstractText>
                <AbstractText Label="BLINDING (MASKING)" NlmCategory="UNASSIGNED">Participants, information collectors and statistical evaluators will be blinded between APA group and sham APA group. No blinding in the control group.</AbstractText>
                <AbstractText Label="NUMBERS TO BE RANDOMISED (SAMPLE SIZE)" NlmCategory="UNASSIGNED">No less than 360 participants will be randomized in 1:1:1 ratio to each group.</AbstractText>
                <AbstractText Label="TRIAL STATUS" NlmCategory="UNASSIGNED">Protocol version 2.0 of February 3rd, 2021. Recruitment is expected to start on February 18th, 2021, and to finish on March 12th, 2021.</AbstractText>
                <AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">This trial was registered in the China Clinical Trial Registry (ChiCTR) ( ChiCTR2100043210 ) on 8th February, 2021.</AbstractText>
                <AbstractText Label="FULL PROTOCOL" NlmCategory="UNASSIGNED">The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fu</LastName>
                    <ForeName>Qinwei</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital of Chengdu university of Traditional Chinese Medicine, Chengdu university of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Xie</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital of Chengdu university of Traditional Chinese Medicine, Chengdu university of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital of Chengdu university of Traditional Chinese Medicine, Chengdu university of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Xinrong</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital of Chengdu university of Traditional Chinese Medicine, Chengdu university of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Yang</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital of Chengdu university of Traditional Chinese Medicine, Chengdu university of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Min</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Du Jiang Yan Medical Center, Du Jinag Yan, 611830, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Chaoyu</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Xiaocen</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital of Chengdu university of Traditional Chinese Medicine, Chengdu university of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Zhiqiao</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital of Chengdu university of Traditional Chinese Medicine, Chengdu university of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tang</LastName>
                    <ForeName>Jinfan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xiao</LastName>
                    <ForeName>Huan</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Eye School of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xiao</LastName>
                    <ForeName>Zhiyong</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Eye School of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Feng</LastName>
                    <ForeName>Chengzhi</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ao</LastName>
                    <ForeName>Zhimin</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Xi</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital of Chengdu university of Traditional Chinese Medicine, Chengdu university of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Su</LastName>
                    <ForeName>Chang</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Xuanyu</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital of Chengdu university of Traditional Chinese Medicine, Chengdu university of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Maolan</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Sihan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Hanwen</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital of Chengdu university of Traditional Chinese Medicine, Chengdu university of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Jiali</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Guo</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Qinxiu</ForeName>
                    <Initials>Q</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8746-0277</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Hospital of Chengdu university of Traditional Chinese Medicine, Chengdu university of Traditional Chinese Medicine, Chengdu, 610075, China. zhqinxiu@163.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. zhqinxiu@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Luyun</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital of Chengdu university of Traditional Chinese Medicine, Chengdu university of Traditional Chinese Medicine, Chengdu, 610075, China. jly666@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>No. 21LL2X03</GrantID>
                    <Agency>the scientific project of Hospital of Chengdu University of Traditional Chinese Medicine</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType>
                <PublicationType UI="D016422">Letter</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Trials</MedlineTA>
            <NlmUniqueID>101263253</NlmUniqueID>
            <ISSNLinking>1745-6215</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D019050" MajorTopicYN="Y">Acupressure</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015669" MajorTopicYN="N">Acupuncture Points</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D054644" MajorTopicYN="N">Ear Auricle</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005767" MajorTopicYN="N">Gastrointestinal Diseases</DescriptorName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000075662" MajorTopicYN="N">Injection Site Reaction</DescriptorName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007273" MajorTopicYN="N">Injections, Intramuscular</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Auricular point; Acupressure; Adverse reactions; COVID-19 vaccines</Keyword>
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Randomised controlled trial</Keyword>
            <Keyword MajorTopicYN="N">Traditional Chinese medicine</Keyword>
            <Keyword MajorTopicYN="N">protocol</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>5</Hour>
                <Minute>39</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33632286</ArticleId>
            <ArticleId IdType="doi">10.1186/s13063-021-05138-3</ArticleId>
            <ArticleId IdType="pii">10.1186/s13063-021-05138-3</ArticleId>
            <ArticleId IdType="pmc">PMC7905419</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33628952</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2421-4248</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>61</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of preventive medicine and hygiene</Title>
                <ISOAbbreviation>J Prev Med Hyg</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Drive-through vaccinations prove successful in immunizing mountain communities against tick-borne encephalitis during the COVID-19 pandemic.</ArticleTitle>
            <Pagination>
                <MedlinePgn>E497-E500</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.15167/2421-4248/jpmh2020.61.4.1814</ELocationID>
            <Abstract>
                <AbstractText>In March 2020, the COVID-19 pandemic disrupted most of the routine outpatient activities in Italian hospitals and Prevention Departments, including those vaccinations which were not urgent and/or scheduled for children aged 0-6 years. Since June 2020, when the pandemic entered a milder phase, in the alpine Province of Belluno (Veneto, North-Eastern Italy), 12,152 doses of vaccine against tick-borne encephalitis have been administered by means of the innovative &quot;drive-through&quot; modality. No significant adverse events have occurred and popular demand has steadily grown, proving the &quot;drive-through&quot; approach to be safe, efficient and successful.</AbstractText>
                <CopyrightInformation>..2020 Pacini Editore SRL, Pisa, Italy.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>DE Polo</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Padova, School of Specialization in Hygiene and Public Health, Padova, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Prevention Department, A.U.L.S.S. 1 Dolomiti, Veneto Region, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schiavon</LastName>
                    <ForeName>Chiara</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Prevention Department, A.U.L.S.S. 1 Dolomiti, Veneto Region, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brancher</LastName>
                    <ForeName>Marika</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Prevention Department, A.U.L.S.S. 1 Dolomiti, Veneto Region, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cian</LastName>
                    <ForeName>Serena</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Prevention Department, A.U.L.S.S. 1 Dolomiti, Veneto Region, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zallot</LastName>
                    <ForeName>Chiara</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Prevention Department, A.U.L.S.S. 1 Dolomiti, Veneto Region, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pupo</LastName>
                    <ForeName>Anita</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Prevention Department, A.U.L.S.S. 1 Dolomiti, Veneto Region, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rizzato</LastName>
                    <ForeName>Donatella</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Prevention Department, A.U.L.S.S. 1 Dolomiti, Veneto Region, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cinquetti</LastName>
                    <ForeName>Sandro</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Prevention Department, A.U.L.S.S. 1 Dolomiti, Veneto Region, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Italy</Country>
            <MedlineTA>J Prev Med Hyg</MedlineTA>
            <NlmUniqueID>9214440</NlmUniqueID>
            <ISSNLinking>1121-2233</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000554" MajorTopicYN="N">Ambulatory Care Facilities</DescriptorName>
                <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002669" MajorTopicYN="N">Child Welfare</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004675" MajorTopicYN="N">Encephalitis, Tick-Borne</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Drive-through</Keyword>
            <Keyword MajorTopicYN="N">TBE vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>5</Hour>
                <Minute>47</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33628952</ArticleId>
            <ArticleId IdType="doi">10.15167/2421-4248/jpmh2020.61.4.1814</ArticleId>
            <ArticleId IdType="pmc">PMC7888386</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Disaster Med Public Health Prep. 2014 Jun;8(3):243-246</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24846519</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Med (Lond). 2020 May;20(3):290-291</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32414716</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pa Nurse. 2007 Dec;62(4):25-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18286844</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Disaster Med Public Health Prep. 2013 Apr;7(2):175-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24618169</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2018 Nov 6;169(9):656</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30398638</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Infect. 2018 Mar;24(3):221-228</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29274465</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Disaster Med Public Health Prep. 2020 Apr 16;:1-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32295659</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Korean Med Sci. 2020 Mar 23;35(11):e123</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32193904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2009 Aug 25;339:b3462</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19706667</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33628442</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2050-0068</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>10</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical &amp; translational immunology</Title>
                <ISOAbbreviation>Clin Transl Immunology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e1241</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/cti2.1241</ELocationID>
            <Abstract>
                <AbstractText Label="Objectives" NlmCategory="UNASSIGNED">The emergence of a SARS-CoV-2 variant with a point mutation in the spike (S) protein, D614G, has taken precedence over the original Wuhan isolate by May 2020. With an increased infection and transmission rate, it is imperative to determine whether antibodies induced against the D614 isolate may cross-neutralise against the G614 variant.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">Antibody profiling against the SARS-CoV-2 S protein of the D614 variant by flow cytometry and assessment of neutralising antibody titres using pseudotyped lentiviruses expressing the SARS-CoV-2 S protein of either the D614 or G614 variant tagged with a luciferase reporter were performed on plasma samples from COVID-19 patients with known D614G status (<i>n</i>..=..44 infected with D614, <i>n</i>..=..6 infected with G614, <i>n</i>..=..7 containing all other clades: O, S, L, V, G, GH or GR).</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Profiling of the anti-SARS-CoV-2 humoral immunity reveals similar neutralisation profiles against both S protein variants, albeit waning neutralising antibody capacity at the later phase of infection. Of clinical importance, patients infected with either the D614 or G614 clade elicited a similar degree of neutralisation against both pseudoviruses, suggesting that the D614G mutation does not impact the neutralisation capacity of the elicited antibodies.</AbstractText>
                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Cross-reactivity occurs at the functional level of the humoral response on both the S protein variants, which suggests that existing serological assays will be able to detect both D614 and G614 clades of SARS-CoV-2. More importantly, there should be negligible impact towards the efficacy of antibody-based therapies and vaccines that are currently being developed.</AbstractText>
                <CopyrightInformation>.. 2021 The Authors. Clinical &amp; Translational Immunology published by John Wiley &amp; Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Cheryl Yi-Pin</ForeName>
                    <Initials>CY</Initials>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Amrun</LastName>
                    <ForeName>Siti Naqiah</ForeName>
                    <Initials>SN</Initials>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chee</LastName>
                    <ForeName>Rhonda Sin-Ling</ForeName>
                    <Initials>RS</Initials>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goh</LastName>
                    <ForeName>Yun Shan</ForeName>
                    <Initials>YS</Initials>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mak</LastName>
                    <ForeName>Tze-Minn</ForeName>
                    <Initials>TM</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Centre for Infectious Diseases Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Public Health Laboratory National Centre for Infectious Diseases Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Octavia</LastName>
                    <ForeName>Sophie</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Centre for Infectious Diseases Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Public Health Laboratory National Centre for Infectious Diseases Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yeo</LastName>
                    <ForeName>Nicholas Kim-Wah</ForeName>
                    <Initials>NK</Initials>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chang</LastName>
                    <ForeName>Zi Wei</ForeName>
                    <Initials>ZW</Initials>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tay</LastName>
                    <ForeName>Matthew Zirui</ForeName>
                    <Initials>MZ</Initials>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Torres-Ruesta</LastName>
                    <ForeName>Anthony</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biochemistry Yong Loo Lin School of Medicine National University of Singapore Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carissimo</LastName>
                    <ForeName>Guillaume</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Poh</LastName>
                    <ForeName>Chek Meng</ForeName>
                    <Initials>CM</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0059-3937</Identifier>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fong</LastName>
                    <ForeName>Siew-Wai</ForeName>
                    <Initials>SW</Initials>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biological Sciences National University of Singapore Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bei</LastName>
                    <ForeName>Wang</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Sandy</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Young</LastName>
                    <ForeName>Barnaby Edward</ForeName>
                    <Initials>BE</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Centre for Infectious Diseases Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases Tan Tock Seng Hospital Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Lee Kong Chian School of Medicine Nanyang Technological University Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>Seow-Yen</ForeName>
                    <Initials>SY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases Changi General Hospital Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Leo</LastName>
                    <ForeName>Yee-Sin</ForeName>
                    <Initials>YS</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Centre for Infectious Diseases Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases Tan Tock Seng Hospital Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Lee Kong Chian School of Medicine Nanyang Technological University Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Yong Loo Lin School of Medicine National University of Singapore and National University Health System Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lye</LastName>
                    <ForeName>David C</ForeName>
                    <Initials>DC</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Centre for Infectious Diseases Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases Tan Tock Seng Hospital Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Lee Kong Chian School of Medicine Nanyang Technological University Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Yong Loo Lin School of Medicine National University of Singapore and National University Health System Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Raymond Tp</ForeName>
                    <Initials>RT</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Public Health Laboratory National Centre for Infectious Diseases Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology Yong Loo Lin School of Medicine National University of Singapore Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maurer-Stroh</LastName>
                    <ForeName>Sebastien</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Centre for Infectious Diseases Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Public Health Laboratory National Centre for Infectious Diseases Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biological Sciences National University of Singapore Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Bioinformatics Institute Agency for Science Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Bernett</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Cheng-I</ForeName>
                    <Initials>CI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Renia</LastName>
                    <ForeName>Laurent</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ng</LastName>
                    <ForeName>Lisa Fp</ForeName>
                    <Initials>LF</Initials>
                    <AffiliationInfo>
                        <Affiliation>ASTAR Infectious Diseases Labs Agency for Science, Technology and Research (A*STAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Singapore Immunology Network Agency for Science, Technology and Research (ASTAR) Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biochemistry Yong Loo Lin School of Medicine National University of Singapore Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute of Health Research Health Protection Research Unit in Emerging and Zoonotic Infections University of Liverpool Liverpool UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institute of Infection, Veterinary and Ecological Sciences University of Liverpool Liverpool UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Australia</Country>
            <MedlineTA>Clin Transl Immunology</MedlineTA>
            <NlmUniqueID>101638268</NlmUniqueID>
            <ISSNLinking>2050-0068</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID...19</Keyword>
            <Keyword MajorTopicYN="N">D614G variant</Keyword>
            <Keyword MajorTopicYN="N">SARS...CoV...2</Keyword>
            <Keyword MajorTopicYN="N">clade</Keyword>
            <Keyword MajorTopicYN="N">cross...reactivity</Keyword>
            <Keyword MajorTopicYN="N">neutralising antibodies</Keyword>
        </KeywordList>
        <CoiStatement>All authors declare no conflicts.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>5</Hour>
                <Minute>45</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33628442</ArticleId>
            <ArticleId IdType="doi">10.1002/cti2.1241</ArticleId>
            <ArticleId IdType="pii">CTI21241</ArticleId>
            <ArticleId IdType="pmc">PMC7899292</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Front Immunol. 2020 Apr 24;11:879</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32391022</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1039-1046</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32192580</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Jan 17;367(6475):234-235</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31949058</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 May 13;111(19):E2018-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24778221</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2006 May;87(Pt 5):1203-1208</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16603522</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2008 Nov;4(11):e1000197</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18989460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2015 Jun 22;5:11451</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26099036</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2021 Jan 13;29(1):23-31.e4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33306985</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep Med. 2021 Feb 16;2(2):100193</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33495757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2010 Oct;84(19):9733-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20660197</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2021 Mar 29;223(6):957-970</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33367897</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Dec 18;370(6523):1464-1468</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33184236</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virus Res. 2014 Dec 19;194:90-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25451065</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Nov 19;71(16):2027-2034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32221519</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EBioMedicine. 2020 Aug;58:102911</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32711254</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Genet Evol. 2020 Jul;81:104260</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32092483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Nov 26;11(1):6013</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33243994</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2021 Apr;592(7852):116-121</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33106671</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):353-363</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32659783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunome Res. 2010 Nov 03;6 Suppl 2:S5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21067547</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 Jul;96:459-460</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32464271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Transfusion. 2006 Oct;46(10):1770-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17002634</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Aug 20;182(4):812-827.e19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32697968</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Surg Oncol. 2020 Apr;46(4 Pt A):667-674</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31864827</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2021 Mar 3;223(5):802-804</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33257936</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Aug 20;182(4):794-795</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32697970</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Aug 20;182(4):828-842.e16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32645326</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2430-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15695582</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Jun 1;11(1):2806</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32483236</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33627824</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1530-0447</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>24</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pediatric research</Title>
                <ISOAbbreviation>Pediatr Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41390-021-01402-z</ELocationID>
            <Abstract>
                <AbstractText>As the nation implements SARS-CoV-2 vaccination in adults at an unprecedented scale, it is now essential to focus on the prospect of SARS-CoV-2 vaccinations in pediatric populations. To date, no children younger than 12 years have been enrolled in clinical trials. Key challenges and knowledge gaps that must be addressed include (1) rationale for vaccines in children, (2) possible effects of immune maturation during childhood, (3) ethical concerns, (4) unique needs of children with developmental disorders and chronic conditions, (5) health inequities, and (6) vaccine hesitancy. Because COVID-19 is minimally symptomatic in the vast majority of children, a higher acceptable risk threshold is required when evaluating pediatric clinical trials. Profound differences in innate and adaptive immunity during childhood and adolescence are known to affect vaccine responsiveness for a variety of childhood diseases. COVID-19 and the accompanying social disruption, such as the school shutdowns, has been disproportionately damaging to minority and low-income children. In this commentary, we briefly address each of these key issues, specify research gaps, and suggest a broader learning health system approach to accelerate testing and clinical trial development for an ethical and effective strategy to implement a pediatric SARS-CoV-2 vaccine as rapidly and safely as possible. IMPACT: As the US begins an unprecedented implementation of SARS-CoV-2 vaccination, substantial knowledge gaps have yet to be addressed regarding vaccinations in the pediatric population. Maturational changes in the immune system during childhood have influenced the effectiveness of pediatric vaccines for other diseases and conditions, and could affect SARS-CoV-2 vaccine responsiveness in children. Given that COVID-19 disease is far milder in the majority of children than in adults, the risk-benefit of a pediatric SARS-CoV-2 vaccine must be carefully weighed. The needs of children with developmental disabilities and with chronic disease must be addressed. Minority and low-income children have been disproportionately adversely affected by the COVID-19 pandemic; care must be taken to address issues of health equity regarding pediatric SARS-CoV-2 vaccine trials and allocation. Research and strategies to address general vaccine hesitancy in communities must be addressed in the context of pediatric SARS-CoV-2 vaccines.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cooper</LastName>
                    <ForeName>Dan M</ForeName>
                    <Initials>DM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Clinical and Translational Science, UC Irvine, Irvine, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Afghani</LastName>
                    <ForeName>Behnoush</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, UC Irvine School of Medicine, Irvine, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Byington</LastName>
                    <ForeName>Carrie L</ForeName>
                    <Initials>CL</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of California Health, Oakland, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cunningham</LastName>
                    <ForeName>Coleen K</ForeName>
                    <Initials>CK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Golub</LastName>
                    <ForeName>Sidney</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Clinical and Translational Science, UC Irvine, Irvine, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lu</LastName>
                    <ForeName>Kim D</ForeName>
                    <Initials>KD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pediatric Exercise and Genomics Research Center, UC Irvine School of Medicine, Irvine, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Radom-Aizik</LastName>
                    <ForeName>Shlomit</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pediatric Exercise and Genomics Research Center, UC Irvine School of Medicine, Irvine, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ross</LastName>
                    <ForeName>Lainie Friedman</ForeName>
                    <Initials>LF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, University of Chicago, Chicago, IL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Singh</LastName>
                    <ForeName>Jasjit</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, CHOC Children's Hospital, Orange, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Smoyer</LastName>
                    <ForeName>William E</ForeName>
                    <Initials>WE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, The Ohio State University and Nationwide Children's Hospital, Columbus, OH, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lucas</LastName>
                    <ForeName>Candice Taylor</ForeName>
                    <Initials>CT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Clinical and Translational Science, UC Irvine, Irvine, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tunney</LastName>
                    <ForeName>Jessica</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>TLC Public Charter School, Orange, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zaldivar</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of California Health, Oakland, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ulloa</LastName>
                    <ForeName>Erlinda R</ForeName>
                    <Initials>ER</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Clinical and Translational Science, UC Irvine, Irvine, CA, USA. chulie.ulloa@uci.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, CHOC Children's Hospital, Orange, CA, USA. chulie.ulloa@uci.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Pediatr Res</MedlineTA>
            <NlmUniqueID>0100714</NlmUniqueID>
            <ISSNLinking>0031-3998</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>5</Hour>
                <Minute>40</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33627824</ArticleId>
            <ArticleId IdType="doi">10.1038/s41390-021-01402-z</ArticleId>
            <ArticleId IdType="pii">10.1038/s41390-021-01402-z</ArticleId>
            <ArticleId IdType="pmc">PMC7903864</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Immunity. 2017 Mar 21;46(3):350-363</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28329702</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Public Health. 2020 Sep;186:78-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32791340</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1122-1126</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32817602</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1081-1088</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32790664</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Mar;20(3):e28-e37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32014117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Am Thorac Soc. 2017 Nov;14(Supplement_5):S406-S409</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29161078</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dis Child. 2020 Jul;105(7):618-619</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32371442</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr. 2020 Aug;223:183-185</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32445649</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Acad Child Adolesc Psychiatry. 2020 Nov;59(11):1218-1239.e3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32504808</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Netw Open. 2020 Sep 1;3(9):e2020495</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32897374</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Sep 04;69(35):1216-1220</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32881850</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Pediatr. 2020 Oct 1;174(10):922-923</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32401283</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2017 May;139(5):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28557757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Perspect Clin Res. 2013 Jan;4(1):80-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23533988</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Oct 02;69(39):1410-1415</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33001869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 1985 Dec 13;254(22):3187-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2933532</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2020 May;145(5):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32312910</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Public Health. 2018 May;158:1-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29524610</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Pediatr. 2021 Feb 1;175(2):125-126</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32926083</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Clin Immunol. 2014 Sep;10(9):1171-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25088080</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Med Inform Assoc. 2015 Jan;22(1):43-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25342177</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Blood Cancer. 2015 Aug;62(8):1337-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25755225</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2021 Feb;21(2):e26-e35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33125914</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Nov 6;370(6517):691-697</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33154136</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2016 Sep;138(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27573088</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetol Metab Syndr. 2018 Nov 3;10:78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30410582</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Vaccines. 2019 Oct;18(10):1053-1067</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31587585</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2020 Dec;146(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33168671</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2019;15(7-8):1615-1627</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30633623</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2016 Dec 20;34(52):6681-6690</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27876197</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ther Adv Infect Dis. 2018 Jan;5(1):29-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29344358</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatric Infect Dis Soc. 2020 Dec 31;9(6):746-751</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32924059</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2016 Sep;138(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27573087</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Obes Res Clin Pract. 2020 Jul - Aug;14(4):375-379</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32536475</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Public Health. 2020 Sep 4;20(1):1351</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32887592</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dialogues Clin Neurosci. 2017 Dec;19(4):403-407</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29398935</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Public Health Rep. 2018 Nov;133(6):667-676</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30300560</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Autoimmunity. 2006 Mar;39(2):137-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16698670</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Microbiol. 2020 Mar 17;11:372</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32256465</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Transplant. 2020 Jul;20(7):1930-1931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32596921</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33627440</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">2056-5933</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                    </PubDate>
                </JournalIssue>
                <Title>RMD open</Title>
                <ISOAbbreviation>RMD Open</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">e001594</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1136/rmdopen-2021-001594</ELocationID>
            <Abstract>
                <AbstractText>In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.</AbstractText>
                <CopyrightInformation>.. Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Furer</LastName>
                    <ForeName>Victoria</ForeName>
                    <Initials>V</Initials>
                    <Identifier Source="ORCID">0000-0001-5193-4207</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel furer.rheum@gmail.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rondaan</LastName>
                    <ForeName>Christien</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">0000-0002-4558-1270</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Medical Microbiology and Infection Prevention, UMCG, Groningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Agmon-Levin</LastName>
                    <ForeName>Nancy</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Clinical Immunology, Angioedema and Allergy Unit, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>van Assen</LastName>
                    <ForeName>Sander</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Internal Medicine (Infectious Diseases), Treant Care Group, Hoogeveen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bijl</LastName>
                    <ForeName>Marc</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Internal Medicine and Rheumatology, Martini Hospital, Groningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kapetanovic</LastName>
                    <ForeName>Meliha Crnkic</ForeName>
                    <Initials>MC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Sciences, Lund, Section for Rheumatology, Lund University, Lund and Sk..ne University Hospital, Lund, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Thurah</LastName>
                    <ForeName>Annette</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">0000-0003-0103-4328</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Rheumatology, Aarhus University Hospital, ..rhus N, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mueller-Ladner</LastName>
                    <ForeName>Ulf</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University, Giessen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paran</LastName>
                    <ForeName>Daphna</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schreiber</LastName>
                    <ForeName>Karen</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Danish Hospital for Rheumatic Diseases, University of Southern Denmark, S..nderborg, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Thrombosis and Haemophilia, Guy's King's College and Saint Thomas' Hospitals, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Warnatz</LastName>
                    <ForeName>Klaus</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Chronic Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Freiburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wulffraat</LastName>
                    <ForeName>Nico M</ForeName>
                    <Initials>NM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pediatric Rheumatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Elkayam</LastName>
                    <ForeName>Ori</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>RMD Open</MedlineTA>
            <NlmUniqueID>101662038</NlmUniqueID>
            <ISSNLinking>2056-5933</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">autoimmune diseases</Keyword>
            <Keyword MajorTopicYN="Y">vaccination</Keyword>
        </KeywordList>
        <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>5</Hour>
                <Minute>35</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33627440</ArticleId>
            <ArticleId IdType="pii">rmdopen-2021-001594</ArticleId>
            <ArticleId IdType="doi">10.1136/rmdopen-2021-001594</ArticleId>
            <ArticleId IdType="pmc">PMC7907831</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Rheumatol. 2021 Feb;3(2):e131-e137</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33392516</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Oct 15;383(16):1544-1555</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32722908</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Pharmacol Sin. 2020 Sep;41(9):1141-1149</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32747721</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2020 Sep;79(9):1252-1253</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32345617</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2020 Sep;79(9):1156-1162</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32457048</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2021 Jan;80(1):e10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32312768</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytokine Growth Factor Rev. 2020 Dec 1;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33293238</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Arthritis Rheum. 2020 Oct;50(5):1150-1157</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32927376</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Biotechnol. 2007 Dec;18(6):546-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18063357</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2020 Jan;79(1):39-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31413005</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32007145</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2020 Dec 2;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33268442</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2021 Jan 9;397(10269):99-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33306989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2021 Jan 8;39(2):197-201</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33279318</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 24;383(26):2586-2588</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33259154</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):467-478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Haematol. 2020 Jul;190(1):31-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32369626</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Oct 1;183(1):158-168.e14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32979941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2020 Jun 5;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32503849</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thromb Res. 2020 Aug;192:113-115</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32425261</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Rheumatol. 2020 Oct 28;4:65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33123675</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Rheumatol. 2020 Sep;39(9):2789-2796</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32720259</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 12;383(20):1920-1931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32663912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Rheumatol. 2020 Sep;2(9):e557-e564</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32838309</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2020 Dec;79(12):1659-1661</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32606046</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32360285</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheumatol. 2016 Jul;68(7):1677-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26815287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Palliat Med. 2020 Nov 02;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33183020</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2014 Jun 15;192(12):5459-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24907379</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheumatol. 2020 Dec 10;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33305544</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Rheumatol. 2020 Nov;39(11):3195-3204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32852623</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Life Sci. 2020 Sep 15;257:118056</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32645344</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2017 Sep;76(9):1559-1565</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28468794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Sep 26;396(10255):887-897</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32896291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2018 Jun;77(6):898-904</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29572291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Oct 23;370(6515):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32972996</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):430-436</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32640463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Transl Sci. 2020 Nov;13(6):1077-1086</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32315487</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 4;384(5):403-416</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33378609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>TH Open. 2020 Sep 11;4(3):e207-e210</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32935073</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2018 Apr;17(4):261-279</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29326426</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2021 Jan 27;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33504483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2020 May;79(5):667-668</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32241793</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2020 Sep;79(9):1170-1173</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32532753</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rheumatology (Oxford). 2006 Jan;45(1):106-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16287919</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 10;383(24):2320-2332</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32877576</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rheumatology (Oxford). 2020 Dec 28;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33369663</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 17;383(25):2427-2438</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32991794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2020 Jun;79(6):837-839</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32332072</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 May 20;11(1):2601</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32433465</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2020 May 31;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32475835</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2020 Jul;79(7):859-866</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32471903</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2020 Nov 30;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33257496</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2021 Dec 19;396(10267):1979-1993</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33220855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jul 23;383(4):347-358</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32598830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>RMD Open. 2019 Sep 9;5(2):e001035</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31565247</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jul 2;383(1):85-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32348641</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Neurosci. 2020 Jun;76:233-235</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32312628</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2019 Mar 27;10:594</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30972078</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Apr 23;382(17):e38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32268022</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 13;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33440088</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheumatol. 2021 Mar;73(3):374-380</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33146001</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Rheumatol. 2020 Aug 1;47(8):1296</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32335513</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Haematol. 2020 Jul;190(1):29-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32374906</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Behav Immun. 2020 Jul;87:155-158</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32389697</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 31;383(27):2603-2615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 7;369(6504):718-724</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32661059</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 17;383(25):2439-2450</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33053279</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2017 Jan 26;376(4):330-341</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25830322</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Dec 16;11(1):6402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33328475</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheum. 2011 Dec;63(12):3723-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21834061</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2020 Nov;79(11):1393-1399</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32769150</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">33627357</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1756-1833</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>372</Volume>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>24</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMJ (Clinical research ed.)</Title>
                <ISOAbbreviation>BMJ</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Optimal dosing interval for covid-19 vaccines: we need clinical trial evidence and to consider past infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>n522</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.n522</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>M..ller-Sedgwick</LastName>
                    <ForeName>Ulrich</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Barnet, Enfield, and Haringey Mental Health NHS Trust, London N15 3TH, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, University of Cambridge, Cambridge, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
                <PublicationType UI="D016420">Comment</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMJ</MedlineTA>
            <NlmUniqueID>8900488</NlmUniqueID>
            <ISSNLinking>0959-8138</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentOn">
                <RefSource>BMJ. 2021 Jan 25;372:n226</RefSource>
                <PMID Version="1">33495166</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <CoiStatement>Competing interests: I had the first dose of the Pfizer vaccine more than three weeks ago.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>5</Hour>
                <Minute>34</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33627357</ArticleId>
            <ArticleId IdType="doi">10.1136/bmj.n522</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">33627051</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>08</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1654-9880</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>01</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Global health action</Title>
                <ISOAbbreviation>Glob Health Action</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Making a COVID-19 vaccine that works for everyone: ensuring equity and inclusivity in clinical trials.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1892309</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/16549716.2021.1892309</ELocationID>
            <Abstract>
                <AbstractText>Coronavirus disease 2019 (COVID-19) mortality and morbidity have been shown to increase with deprivation and impact non-White ethnicities more severely. Despite the extra risk Black, Asian and Minority Ethnicity (BAME) groups face in the pandemic, our current medical research system seems to prioritise innovation aimed at people of European descent. We found significant difficulties in assessing baseline demographics in clinical trials for COVID-19 vaccines, displaying a lack of transparency in reporting. Further, we found that most of these trials take place in high-income countries, with only 25 of 219 trials (11.4%) taking place in lower middle- or low-income countries. Trials for the current best vaccine candidates (BNT162b2, ChadOx1, mRNA-173) recruited 80.0% White participants. Underrepresentation of BAME groups in medical research will perpetuate historical distrust in healthcare processes, and poses a risk of unknown differences in efficacy and safety of these vaccines by phenotype. Limiting trial demographics and settings will mean a lack of global applicability of the results of COVID-19 vaccine trials, which will slow progress towards ending the pandemic.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pepperrell</LastName>
                    <ForeName>Toby</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine, Imperial College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rodgers</LastName>
                    <ForeName>Florence</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine, Imperial College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tandon</LastName>
                    <ForeName>Pranav</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Global Health Office, McMaster University, Hamilton, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sarsfield</LastName>
                    <ForeName>Kelly</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>London School of Economics, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pugh-Jones</LastName>
                    <ForeName>Molly</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>London School of Economics, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rashid</LastName>
                    <ForeName>Theo</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Imperial College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Keestra</LastName>
                    <ForeName>Sarai</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>AUMC, University of Amsterdam, Amsterdam, Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Glob Health Action</MedlineTA>
            <NlmUniqueID>101496665</NlmUniqueID>
            <ISSNLinking>1654-9880</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005006" MajorTopicYN="Y">Ethnic Groups</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000069576" MajorTopicYN="Y">Health Equity</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008913" MajorTopicYN="Y">Minority Groups</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Covid-19</Keyword>
            <Keyword MajorTopicYN="Y">clinical trials</Keyword>
            <Keyword MajorTopicYN="Y">ethnic minorities</Keyword>
            <Keyword MajorTopicYN="Y">health equity</Keyword>
            <Keyword MajorTopicYN="Y">vaccines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>5</Hour>
                <Minute>31</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33627051</ArticleId>
            <ArticleId IdType="doi">10.1080/16549716.2021.1892309</ArticleId>
            <ArticleId IdType="pmc">PMC7919886</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2021 Jan 9;397(10269):99-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33306989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2007 Nov 30;21(18):2455-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18025882</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Discov. 2020 Feb 24;6:11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32133153</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 12;383(20):1920-1931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32663912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Appl Basic Med Res. 2019 Jan-Mar;9(1):3-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30820412</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jul 16;383(3):e11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32302075</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Cardiol. 2013 Apr 30;61(17):1787-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23500320</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chronic Stress (Thousand Oaks). 2017 Jan-Dec;1:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28856337</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7828):197-199</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33024330</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 4;384(5):403-416</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33378609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 17;383(25):2427-2438</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32991794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2019 Aug 29;381(9):803-815</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31339677</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Evol Hum Behav. 2020 Sep;41(5):330-340</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33100820</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Public Health (Oxf). 2020 Aug 18;42(3):451-460</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32556213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 31;383(27):2603-2615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Public Health. 1995 Jul;85(7):903-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7604907</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 2006 Feb;61(2):148-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16433869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2020 Jun 16;94(13):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32303592</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychol Med. 2020 Dec 11;:1-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33305716</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Epidemiol Community Health. 2017 Jun;71(6):544-549</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27531844</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Glob Health. 2020 Aug;8(8):e1018-e1026</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32622400</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33626250</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>23</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1533-4406</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>384</Volume>
                    <Issue>15</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>04</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The New England journal of medicine</Title>
                <ISOAbbreviation>N Engl J Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1412-1423</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMoa2101765</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">As mass vaccination campaigns against coronavirus disease 2019 (Covid-19) commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes across diverse populations in a noncontrolled setting. In this study, data from Israel's largest health care organization were used to evaluate the effectiveness of the BNT162b2 mRNA vaccine.</AbstractText>
                <AbstractText Label="METHODS">All persons who were newly vaccinated during the period from December 20, 2020, to February 1, 2021, were matched to unvaccinated controls in a 1:1 ratio according to demographic and clinical characteristics. Study outcomes included documented infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), symptomatic Covid-19, Covid-19-related hospitalization, severe illness, and death. We estimated vaccine effectiveness for each outcome as one minus the risk ratio, using the Kaplan-Meier estimator.</AbstractText>
                <AbstractText Label="RESULTS">Each study group included 596,618 persons. Estimated vaccine effectiveness for the study outcomes at days 14 through 20 after the first dose and at 7 or more days after the second dose was as follows: for documented infection, 46% (95% confidence interval [CI], 40 to 51) and 92% (95% CI, 88 to 95); for symptomatic Covid-19, 57% (95% CI, 50 to 63) and 94% (95% CI, 87 to 98); for hospitalization, 74% (95% CI, 56 to 86) and 87% (95% CI, 55 to 100); and for severe disease, 62% (95% CI, 39 to 80) and 92% (95% CI, 75 to 100), respectively. Estimated effectiveness in preventing death from Covid-19 was 72% (95% CI, 19 to 100) for days 14 through 20 after the first dose. Estimated effectiveness in specific subpopulations assessed for documented infection and symptomatic Covid-19 was consistent across age groups, with potentially slightly lower effectiveness in persons with multiple coexisting conditions.</AbstractText>
                <AbstractText Label="CONCLUSIONS">This study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA vaccine is effective for a wide range of Covid-19-related outcomes, a finding consistent with that of the randomized trial.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 Massachusetts Medical Society.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Dagan</LastName>
                    <ForeName>Noa</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv (N.D., N.B., E.K., O.M., S.P., M.A.K., R.D.B.), and the School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva (O.M., M.A.K., R.D.B.) - both in Israel; University of Michigan School of Public Health, Ann Arbor (M.A.K.); and the Department of Biomedical Informatics (N.D., N.B.), Harvard Medical School (B.R.), the Departments of Epidemiology and Biostatistics (M.A.H.), and the Center for Communicable Disease Dynamics, Departments of Epidemiology and of Immunology and Infectious Diseases (M.L.), Harvard T.H. Chan School of Public Health, Harvard-MIT Division of Health Sciences and Technology (M.A.H.), and the Predictive Medicine Group, Computational Health Informatics Program, Boston Children's Hospital (B.R.) - all in Boston.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barda</LastName>
                    <ForeName>Noam</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">0000-0002-3400-235X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>From the Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv (N.D., N.B., E.K., O.M., S.P., M.A.K., R.D.B.), and the School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva (O.M., M.A.K., R.D.B.) - both in Israel; University of Michigan School of Public Health, Ann Arbor (M.A.K.); and the Department of Biomedical Informatics (N.D., N.B.), Harvard Medical School (B.R.), the Departments of Epidemiology and Biostatistics (M.A.H.), and the Center for Communicable Disease Dynamics, Departments of Epidemiology and of Immunology and Infectious Diseases (M.L.), Harvard T.H. Chan School of Public Health, Harvard-MIT Division of Health Sciences and Technology (M.A.H.), and the Predictive Medicine Group, Computational Health Informatics Program, Boston Children's Hospital (B.R.) - all in Boston.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kepten</LastName>
                    <ForeName>Eldad</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv (N.D., N.B., E.K., O.M., S.P., M.A.K., R.D.B.), and the School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva (O.M., M.A.K., R.D.B.) - both in Israel; University of Michigan School of Public Health, Ann Arbor (M.A.K.); and the Department of Biomedical Informatics (N.D., N.B.), Harvard Medical School (B.R.), the Departments of Epidemiology and Biostatistics (M.A.H.), and the Center for Communicable Disease Dynamics, Departments of Epidemiology and of Immunology and Infectious Diseases (M.L.), Harvard T.H. Chan School of Public Health, Harvard-MIT Division of Health Sciences and Technology (M.A.H.), and the Predictive Medicine Group, Computational Health Informatics Program, Boston Children's Hospital (B.R.) - all in Boston.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Miron</LastName>
                    <ForeName>Oren</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv (N.D., N.B., E.K., O.M., S.P., M.A.K., R.D.B.), and the School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva (O.M., M.A.K., R.D.B.) - both in Israel; University of Michigan School of Public Health, Ann Arbor (M.A.K.); and the Department of Biomedical Informatics (N.D., N.B.), Harvard Medical School (B.R.), the Departments of Epidemiology and Biostatistics (M.A.H.), and the Center for Communicable Disease Dynamics, Departments of Epidemiology and of Immunology and Infectious Diseases (M.L.), Harvard T.H. Chan School of Public Health, Harvard-MIT Division of Health Sciences and Technology (M.A.H.), and the Predictive Medicine Group, Computational Health Informatics Program, Boston Children's Hospital (B.R.) - all in Boston.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Perchik</LastName>
                    <ForeName>Shay</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv (N.D., N.B., E.K., O.M., S.P., M.A.K., R.D.B.), and the School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva (O.M., M.A.K., R.D.B.) - both in Israel; University of Michigan School of Public Health, Ann Arbor (M.A.K.); and the Department of Biomedical Informatics (N.D., N.B.), Harvard Medical School (B.R.), the Departments of Epidemiology and Biostatistics (M.A.H.), and the Center for Communicable Disease Dynamics, Departments of Epidemiology and of Immunology and Infectious Diseases (M.L.), Harvard T.H. Chan School of Public Health, Harvard-MIT Division of Health Sciences and Technology (M.A.H.), and the Predictive Medicine Group, Computational Health Informatics Program, Boston Children's Hospital (B.R.) - all in Boston.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Katz</LastName>
                    <ForeName>Mark A</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv (N.D., N.B., E.K., O.M., S.P., M.A.K., R.D.B.), and the School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva (O.M., M.A.K., R.D.B.) - both in Israel; University of Michigan School of Public Health, Ann Arbor (M.A.K.); and the Department of Biomedical Informatics (N.D., N.B.), Harvard Medical School (B.R.), the Departments of Epidemiology and Biostatistics (M.A.H.), and the Center for Communicable Disease Dynamics, Departments of Epidemiology and of Immunology and Infectious Diseases (M.L.), Harvard T.H. Chan School of Public Health, Harvard-MIT Division of Health Sciences and Technology (M.A.H.), and the Predictive Medicine Group, Computational Health Informatics Program, Boston Children's Hospital (B.R.) - all in Boston.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hern..n</LastName>
                    <ForeName>Miguel A</ForeName>
                    <Initials>MA</Initials>
                    <Identifier Source="ORCID">0000-0003-1619-8456</Identifier>
                    <AffiliationInfo>
                        <Affiliation>From the Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv (N.D., N.B., E.K., O.M., S.P., M.A.K., R.D.B.), and the School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva (O.M., M.A.K., R.D.B.) - both in Israel; University of Michigan School of Public Health, Ann Arbor (M.A.K.); and the Department of Biomedical Informatics (N.D., N.B.), Harvard Medical School (B.R.), the Departments of Epidemiology and Biostatistics (M.A.H.), and the Center for Communicable Disease Dynamics, Departments of Epidemiology and of Immunology and Infectious Diseases (M.L.), Harvard T.H. Chan School of Public Health, Harvard-MIT Division of Health Sciences and Technology (M.A.H.), and the Predictive Medicine Group, Computational Health Informatics Program, Boston Children's Hospital (B.R.) - all in Boston.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lipsitch</LastName>
                    <ForeName>Marc</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">0000-0003-1504-9213</Identifier>
                    <AffiliationInfo>
                        <Affiliation>From the Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv (N.D., N.B., E.K., O.M., S.P., M.A.K., R.D.B.), and the School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva (O.M., M.A.K., R.D.B.) - both in Israel; University of Michigan School of Public Health, Ann Arbor (M.A.K.); and the Department of Biomedical Informatics (N.D., N.B.), Harvard Medical School (B.R.), the Departments of Epidemiology and Biostatistics (M.A.H.), and the Center for Communicable Disease Dynamics, Departments of Epidemiology and of Immunology and Infectious Diseases (M.L.), Harvard T.H. Chan School of Public Health, Harvard-MIT Division of Health Sciences and Technology (M.A.H.), and the Predictive Medicine Group, Computational Health Informatics Program, Boston Children's Hospital (B.R.) - all in Boston.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reis</LastName>
                    <ForeName>Ben</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv (N.D., N.B., E.K., O.M., S.P., M.A.K., R.D.B.), and the School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva (O.M., M.A.K., R.D.B.) - both in Israel; University of Michigan School of Public Health, Ann Arbor (M.A.K.); and the Department of Biomedical Informatics (N.D., N.B.), Harvard Medical School (B.R.), the Departments of Epidemiology and Biostatistics (M.A.H.), and the Center for Communicable Disease Dynamics, Departments of Epidemiology and of Immunology and Infectious Diseases (M.L.), Harvard T.H. Chan School of Public Health, Harvard-MIT Division of Health Sciences and Technology (M.A.H.), and the Predictive Medicine Group, Computational Health Informatics Program, Boston Children's Hospital (B.R.) - all in Boston.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Balicer</LastName>
                    <ForeName>Ran D</ForeName>
                    <Initials>RD</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv (N.D., N.B., E.K., O.M., S.P., M.A.K., R.D.B.), and the School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva (O.M., M.A.K., R.D.B.) - both in Israel; University of Michigan School of Public Health, Ann Arbor (M.A.K.); and the Department of Biomedical Informatics (N.D., N.B.), Harvard Medical School (B.R.), the Departments of Epidemiology and Biostatistics (M.A.H.), and the Center for Communicable Disease Dynamics, Departments of Epidemiology and of Immunology and Infectious Diseases (M.L.), Harvard T.H. Chan School of Public Health, Harvard-MIT Division of Health Sciences and Technology (M.A.H.), and the Predictive Medicine Group, Computational Health Informatics Program, Boston Children's Hospital (B.R.) - all in Boston.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>N Engl J Med</MedlineTA>
            <NlmUniqueID>0255562</NlmUniqueID>
            <ISSNLinking>0028-4793</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>N38TVC63NU</RegistryNumber>
                <NameOfSubstance UI="C000706168">BNT162 vaccine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>Travel Med Infect Dis. 2021 May-Jun;41:102029</RefSource>
                <PMID Version="1">33737163</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>N Engl J Med. 2021 May 20;384(20):1968-1970</RefSource>
                <PMID Version="1">33882226</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000071497" MajorTopicYN="N">Immunogenicity, Vaccine</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007557" MajorTopicYN="N" Type="Geographic">Israel</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D032541" MajorTopicYN="Y">Mass Vaccination</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>4</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>17</Hour>
                <Minute>11</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33626250</ArticleId>
            <ArticleId IdType="doi">10.1056/NEJMoa2101765</ArticleId>
            <ArticleId IdType="pmc">PMC7944975</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33625817</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>08</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1488-2310</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>64</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Canadian journal of surgery. Journal canadien de chirurgie</Title>
                <ISOAbbreviation>Can J Surg</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Lessons (so far) from the COVID-19 pandemic.</ArticleTitle>
            <Pagination>
                <MedlinePgn>E108</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1503/cjs.002921</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Harvey</LastName>
                    <ForeName>Edward J</ForeName>
                    <Initials>EJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Department of Surgery, McGill University, Montreal, Que.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016421">Editorial</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Canada</Country>
            <MedlineTA>Can J Surg</MedlineTA>
            <NlmUniqueID>0372715</NlmUniqueID>
            <ISSNLinking>0008-428X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000600" MajorTopicYN="N">supply &amp; distribution</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003299" MajorTopicYN="N">Cooperative Behavior</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000072499" MajorTopicYN="N">Manufacturing and Industrial Facilities</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <CoiStatement>E.J. Harvey is the cofounder and head of medical innovation of NXTSens Inc.; the cofounder and chief medical officer of MY01 Inc., and Sensia Diagnostics Inc.; and the cofounder and director of Strathera Inc. He receives institutional support from J &amp; J DePuy Synthes, Stryker, MY01, and Zimmer. No other competing interests were declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>14</Hour>
                <Minute>49</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33625817</ArticleId>
            <ArticleId IdType="doi">10.1503/cjs.002921</ArticleId>
            <ArticleId IdType="pmc">PMC7955817</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33625462</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>23</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1538-3598</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>325</Volume>
                    <Issue>11</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Mar</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JAMA</Title>
                <ISOAbbreviation>JAMA</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1027-1028</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2021.2264</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rubin</LastName>
                    <ForeName>Rita</ForeName>
                    <Initials>R</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016433">News</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>JAMA</MedlineTA>
            <NlmUniqueID>7501160</NlmUniqueID>
            <ISSNLinking>0098-7484</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011247" MajorTopicYN="Y">Pregnancy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>12</Hour>
                <Minute>11</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33625462</ArticleId>
            <ArticleId IdType="pii">2777024</ArticleId>
            <ArticleId IdType="doi">10.1001/jama.2021.2264</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33623865</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2523-8973</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>SN comprehensive clinical medicine</Title>
                <ISOAbbreviation>SN Compr Clin Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-3</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s42399-021-00827-1</ELocationID>
            <Abstract>
                <AbstractText>Convalescent plasma therapy has been used successfully in the past to treat respiratory infections. In SARS-CoV-2, there was initially strong evidence in favor of convalescent plasma therapy from a large observational study but the evidence from recent randomized controlled trials has been mixed. However, two of those studies provided convalescent plasma therapy on average 8 days after diagnosis despite earlier data proving that the therapy is most effective when given within 3 days of diagnosis. Another more recent randomized controlled trial found evidence in support of convalescent plasma therapy and we believe that it is no coincidence that they administered convalescent plasma therapy within 3 days of symptom onset. We call for more robustly planned randomized controlled studies to further reliably determine the efficacy of convalescent plasma therapy against SARS-CoV-2. Progress has been made with developing a vaccine but there is likely to be a substantial lag in widespread administration of the vaccine, especially in poorer countries. We therefore propose that patients with SARS-CoV-2 infection should be considered for early ambulatory administration of high-dose convalescent plasma in order to reduce the burden of severe SARS-CoV-2 disease.</AbstractText>
                <CopyrightInformation>.. The Author(s), under exclusive licence to Springer Nature Switzerland AG part of Springer Nature 2021.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fisher</LastName>
                    <ForeName>David L</ForeName>
                    <Initials>DL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Kaplan Medical Center, Derech Pasternak 1, 76100 Rehovot, Israel.</Affiliation>
                        <Identifier Source="GRID">grid.415014.5</Identifier>
                        <Identifier Source="ISNI">0000 0004 0575 3669</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alin</LastName>
                    <ForeName>Pavel</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Kaplan Medical Center, Derech Pasternak 1, 76100 Rehovot, Israel.</Affiliation>
                        <Identifier Source="GRID">grid.415014.5</Identifier>
                        <Identifier Source="ISNI">0000 0004 0575 3669</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Malnick</LastName>
                    <ForeName>Stephen</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">0000-0003-1865-8313</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Kaplan Medical Center, Derech Pasternak 1, 76100 Rehovot, Israel.</Affiliation>
                        <Identifier Source="GRID">grid.415014.5</Identifier>
                        <Identifier Source="ISNI">0000 0004 0575 3669</Identifier>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>SN Compr Clin Med</MedlineTA>
            <NlmUniqueID>101740833</NlmUniqueID>
            <ISSNLinking>2523-8973</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Ambulatory therapy</Keyword>
            <Keyword MajorTopicYN="N">Convalescent plasma</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
        </KeywordList>
        <CoiStatement>Competing InterestsThe authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>5</Hour>
                <Minute>45</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33623865</ArticleId>
            <ArticleId IdType="doi">10.1007/s42399-021-00827-1</ArticleId>
            <ArticleId IdType="pii">827</ArticleId>
            <ArticleId IdType="pmc">PMC7891121</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>Am J Pathol. 2021 Jan;191(1):90-107</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33157066</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 21;384(3):229-237</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33113295</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 13;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33523609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32648959</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>QJM. 2021 Jan 08;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33416888</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 21;384(3):238-251</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33332778</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 1995 Jul;21(1):150-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7578724</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Oct 22;371:m3939</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33093056</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 18;384(7):619-629</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33232588</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 18;384(7):610-618</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33406353</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33623151</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>05</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1476-4687</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>591</Volume>
                    <Issue>7848</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Nature</Title>
                <ISOAbbreviation>Nature</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Why COVID vaccines are so difficult to compare.</ArticleTitle>
            <Pagination>
                <MedlinePgn>16-17</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/d41586-021-00409-0</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ledford</LastName>
                    <ForeName>Heidi</ForeName>
                    <Initials>H</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016433">News</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nature</MedlineTA>
            <NlmUniqueID>0410462</NlmUniqueID>
            <ISSNLinking>0028-0836</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <SupplMeshList>
            <SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013019" MajorTopicYN="N" Type="Geographic">South Africa</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D035501" MajorTopicYN="Y">Uncertainty</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Immunology</Keyword>
            <Keyword MajorTopicYN="Y">Infection</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">Vaccines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>5</Hour>
                <Minute>41</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33623151</ArticleId>
            <ArticleId IdType="doi">10.1038/d41586-021-00409-0</ArticleId>
            <ArticleId IdType="pii">10.1038/d41586-021-00409-0</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Madhi, S. A. et al. Preprint at medRxiv https://doi.org/10.1101/2021.02.10.21251247 (2021).</Citation>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33622695</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1756-1833</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>372</Volume>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMJ (Clinical research ed.)</Title>
                <ISOAbbreviation>BMJ</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Behind the scenes of the Pfizer BioNTech covid-19 vaccine trial.</ArticleTitle>
            <Pagination>
                <MedlinePgn>n271</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.n271</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Silberner</LastName>
                    <ForeName>Joanne</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>The BMJ.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMJ</MedlineTA>
            <NlmUniqueID>8900488</NlmUniqueID>
            <ISSNLinking>0959-8138</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>5</Hour>
                <Minute>36</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33622695</ArticleId>
            <ArticleId IdType="doi">10.1136/bmj.n271</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33620014</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>07</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1744-8409</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>17</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>04</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Expert review of clinical immunology</Title>
                <ISOAbbreviation>Expert Rev Clin Immunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Convalescent plasma and hyperimmune globulin therapy in COVID-19.</ArticleTitle>
            <Pagination>
                <MedlinePgn>309-316</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/1744666X.2021.1894927</ELocationID>
            <Abstract>
                <AbstractText><b>Introduction</b>: Severe acute respiratory syndrome causing coronavirus SARS-CoV-2 (coronavirus disease 2019 (COVID-19)) has recently resulted in the recent global pandemic. As convalescent plasma (CP) therapy has been used with success in several viral infections before, it has become a treatment of choice. Medical literature is reviewed for randomized controlled studies using convalescent plasma therapy.<b>Areas covered</b>: More than one type of neutralizing antibody against a specific microorganism may be found in both CP and hyperimmune globulins. To give a standard titer of a specific neutralizing antibody to a patient, a reliable antibody titration assay should be developed. It is challenging to test the efficacy of the CP and HIG therapies with double-blind studies. There is a difficulty in the standardization of the CP and HIG study groups, as patients use various additional therapies. Different amounts and titers of CP and HIG and different titers of CP are used in patients. This review discusses the current knowledge on CP and HIG therapies used in COVID-19 disease.<b>Expert opinion</b>: The immune response to COVID-19 have diverse characteristics. The antibody produced after COVID-19 disease and vaccination is short-lived. Thus, CP should be an alternative especially in patients with lymphopenia and primary/secondary antibody deficiency.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cagdas</LastName>
                    <ForeName>Deniz</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">0000-0003-2213-4627</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Immunology, Department of Pediatrics, ..hsan Do..ramac.. Children's Hospital, Hacettepe University Medical Faculty, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Section of Pediatric Immunology, Institutes of Child Health, Health Science Institute, Hacettepe University, Hacettepe, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>03</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Expert Rev Clin Immunol</MedlineTA>
            <NlmUniqueID>101271248</NlmUniqueID>
            <ISSNLinking>1744-666X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <SupplMeshList>
            <SupplMeshName Type="Protocol" UI="C000705128">COVID-19 serotherapy</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005104" MajorTopicYN="N">Expert Testimony</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007116" MajorTopicYN="N">Immunization, Passive</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012015" MajorTopicYN="N">Reference Standards</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">Convalescent Plasma</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">adverse effects</Keyword>
            <Keyword MajorTopicYN="Y">antibody</Keyword>
            <Keyword MajorTopicYN="Y">application</Keyword>
            <Keyword MajorTopicYN="Y">autoantibody</Keyword>
            <Keyword MajorTopicYN="Y">efficacy</Keyword>
            <Keyword MajorTopicYN="Y">hyperimmune globulin</Keyword>
            <Keyword MajorTopicYN="Y">use</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>5</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>8</Hour>
                <Minute>37</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33620014</ArticleId>
            <ArticleId IdType="doi">10.1080/1744666X.2021.1894927</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33619489</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>17</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>bioRxiv : the preprint server for biology</Title>
                <ISOAbbreviation>bioRxiv</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">2021.02.15.431215</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1101/2021.02.15.431215</ELocationID>
            <Abstract>
                <AbstractText>There is an urgent need to understand the nature of immune responses generated against SARS-CoV-2, to better inform risk-mitigation strategies for people living with HIV (PLWH). Although not all PLWH are considered immunosuppressed, residual cellular immune deficiency and ongoing inflammation could influence COVID-19 disease severity, the evolution and durability of protective memory responses. Here, we performed an integrated analysis, characterizing the nature, breadth and magnitude of SARS-CoV-2-specific immune responses in PLWH, controlled on ART, and HIV negative subjects. Both groups were in the convalescent phase of predominately mild COVID-19 disease. The majority of PLWH mounted SARS-CoV-2 Spike- and Nucleoprotein-specific antibodies with neutralizing activity and SARS-CoV-2-specific T cell responses, as measured by ELISpot, at levels comparable to HIV negative subjects. T cell responses against Spike, Membrane and Nucleocapsid were the most prominent, with SARS-CoV-2-specific CD4 T cells outnumbering CD8 T cells. Notably, the overall magnitude of SARS-CoV-2-specific T cell responses related to the size of the naive CD4 T cell pool and the CD4:CD8 ratio in PLWH, in whom disparate antibody and T cell responses were observed. Both humoral and cellular responses to SARS-CoV-2 were detected at 5-7 months post-infection, providing evidence of medium-term durability of responses irrespective of HIV serostatus. Incomplete immune reconstitution on ART and a low CD4:CD8 ratio could, however, hamper the development of immunity to SARS-CoV-2 and serve as a useful tool for risk stratification of PLWH. These findings have implications for the individual management and potential effectiveness of vaccination against SARS-CoV-2 in PLWH.</AbstractText>
                <AbstractText Label="One Sentence Summary" NlmCategory="UNASSIGNED">Adaptive immune responses to SARS-CoV-2 in the setting of HIV infection.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Alrubayyi</LastName>
                    <ForeName>Aljawharah</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gea-Mallorqu..</LastName>
                    <ForeName>Ester</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Touizer</LastName>
                    <ForeName>Emma</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hameiri-Bowen</LastName>
                    <ForeName>Dan</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kopycinski</LastName>
                    <ForeName>Jakub</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Charlton</LastName>
                    <ForeName>Bethany</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fisher-Pearson</LastName>
                    <ForeName>Natasha</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Muir</LastName>
                    <ForeName>Luke</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rosa</LastName>
                    <ForeName>Annachiara</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roustan</LastName>
                    <ForeName>Chloe</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Earl</LastName>
                    <ForeName>Christopher</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cherepanov</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pellegrino</LastName>
                    <ForeName>Pierre</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Waters</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Burns</LastName>
                    <ForeName>Fiona</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kinloch</LastName>
                    <ForeName>Sabine</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dong</LastName>
                    <ForeName>Tao</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dorrell</LastName>
                    <ForeName>Lucy</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rowland-Jones</LastName>
                    <ForeName>Sarah</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McCoy</LastName>
                    <ForeName>Laura E</ForeName>
                    <Initials>LE</Initials>
                    <Identifier Source="ORCID">0000-0001-9503-7946</Identifier>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peppa</LastName>
                    <ForeName>Dimitra</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">0000-0002-9281-5471</Identifier>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <Acronym>WT_</Acronym>
                    <Agency>Wellcome Trust</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MR/M008614/2</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MR/R008698/1</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D000076942">Preprint</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>bioRxiv</MedlineTA>
            <NlmUniqueID>101680187</NlmUniqueID>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>15</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33619489</ArticleId>
            <ArticleId IdType="doi">10.1101/2021.02.15.431215</ArticleId>
            <ArticleId IdType="pmc">PMC7899453</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2020 Dec 11;370(6522):1339-1343</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33159009</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1998 Dec 17;396(6712):690-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9872319</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Rev. 2017 Jan;275(1):33-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28133792</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2011 Dec;53(11):1120-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21998278</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Med. 2012;9(3):e1001194</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22448150</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Apr 7;323(13):1239-1242</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32091533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Med. 2021 Apr 5;218(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33533915</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):437-442</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32555388</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Sep;26(9):1428-1434</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32661393</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2020 Sep 24;16(9):e1008817</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32970782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):457-462</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32668444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2011 Jun 15;186(12):7264-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21576510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):467-478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 Jul 17;5(49):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32680954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Oct 1;183(1):158-168.e14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32979941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Leukemia. 2021 Jan;35(1):289-292</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33299142</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2015 Jun 1;211(11):1726-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25489001</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2013 Jun;31(6):545-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23685480</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2020 Dec 09;11:571481</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33362759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2017 Oct 23;8:1380</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29109730</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Jun 25;181(7):1489-1501.e15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32473127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32109013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 Jul;96:148-150</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32335339</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Aug 29;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32860699</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Oct 23;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33095853</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Nov 12;183(4):996-1012.e19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33010815</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Jul 6;11(1):3434</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32632085</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2014 May 15;10(5):e1004078</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24831517</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Microbiol. 2020 Dec;5(12):1598-1607</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33106674</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet HIV. 2021 Jan;8(1):e24-e32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33316211</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>HIV Med. 2020 Dec 27;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33368966</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2020 Nov 17;53(5):925-933.e4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33129373</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2012 Aug 2;120(5):985-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22692510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2005 May 17;102(20):7239-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15872023</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2021 Jan 7;184(1):169-183.e17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33296701</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2020 Nov 09;12(11):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33182268</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2018 Jul 31;32(12):1563-1569</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29762172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Dec 31;71(11):2933-2938</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32594164</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2021 Feb 9;34(6):108728</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33516277</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Sep;20(9):529-536</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32728222</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>HIV Med. 2014 Jan;15(1):40-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24007533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2015 Jun 15;211(12):1959-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25556252</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 11;384(6):533-540</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33369366</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2013 Sep 1;191(5):2194-204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23918986</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet HIV. 2020 May;7(5):e314-e316</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32304642</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2020 Oct 1;34(12):1775-1780</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32773471</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Sep 4;369(6508):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32669297</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Jul 8;11(1):3410</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32641700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 1995 May;95(5):2061-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7738173</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):430-436</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32640463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Nov;587(7833):270-274</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32726801</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Dec 4;370(6521):1227-1230</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33115920</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Microbiol. 2021 Jan;6(1):51-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33199863</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2009 Jan 26;338:a3172</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19171560</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2016 Feb;16(2):102-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26781939</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2021 Feb 5;371(6529):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33408181</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 17;383(25):2427-2438</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32991794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Immunol. 2020 May;17(5):533-535</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32203188</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 Dec 23;5(54):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33361161</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pathol. 2008 Jan;214(2):231-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18161758</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2020 Dec 1;130(12):6477-6489</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32833687</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr HIV/AIDS Rep. 2008 Feb;5(1):13-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18417030</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>HIV Med. 2020 Oct;21(9):567-577</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32671970</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 14;369(6505):806-811</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32434945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol Methods. 2007 Sep 30;326(1-2):93-115</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17707394</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 1997 Sep;15(9):871-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9306402</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2019 Apr;568(7751):244-248</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30836379</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2020 Oct 13;53(4):864-877.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32791036</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2014 Jan 30;9(1):e85798</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24497929</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2020 Nov;21(11):1336-1345</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32887977</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2021 Jan 12;54(1):44-52.e3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33338412</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Immunol. 2020 Dec;50(12):1998-2012</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33073359</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2019 Feb 1;33(2):259-268</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30325781</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 31;383(27):2603-2615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2015 Mar;15(3):185-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25677493</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33619260</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2059-0105</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>6</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>NPJ vaccines</Title>
                <ISOAbbreviation>NPJ Vaccines</ISOAbbreviation>
            </Journal>
            <ArticleTitle>SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates.</ArticleTitle>
            <Pagination>
                <MedlinePgn>28</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41541-021-00292-w</ELocationID>
            <Abstract>
                <AbstractText>The new SARS-CoV-2 virus is an RNA virus that belongs to the Coronaviridae family and causes COVID-19 disease. The newly sequenced virus appears to originate in China and rapidly spread throughout the world, becoming a pandemic that, until January 5th, 2021, has caused more than 1,866,000 deaths. Hence, laboratories worldwide are developing an effective vaccine against this disease, which will be essential to reduce morbidity and mortality. Currently, there more than 64 vaccine candidates, most of them aiming to induce neutralizing antibodies against the spike protein (S). These antibodies will prevent uptake through the human ACE-2 receptor, thereby limiting viral entrance. Different vaccine platforms are being used for vaccine development, each one presenting several advantages and disadvantages. Thus far, thirteen vaccine candidates are being tested in Phase 3 clinical trials; therefore, it is closer to receiving approval or authorization for large-scale immunizations.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kyriakidis</LastName>
                    <ForeName>Nikolaos C</ForeName>
                    <Initials>NC</Initials>
                    <AffiliationInfo>
                        <Affiliation>One Health Research Group, Universidad de Las Am..ricas (UDLA), Quito, Ecuador. nickyriakidis82@yahoo.gr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>L..pez-Cort..s</LastName>
                    <ForeName>Andr..s</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centro de Investigacion Genetica y Genomica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gonz..lez</LastName>
                    <ForeName>Eduardo V..sconez</ForeName>
                    <Initials>EV</Initials>
                    <AffiliationInfo>
                        <Affiliation>One Health Research Group, Universidad de Las Am..ricas (UDLA), Quito, Ecuador.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grimaldos</LastName>
                    <ForeName>Alejandra Barreto</ForeName>
                    <Initials>AB</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7477-9721</Identifier>
                    <AffiliationInfo>
                        <Affiliation>One Health Research Group, Universidad de Las Am..ricas (UDLA), Quito, Ecuador.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Prado</LastName>
                    <ForeName>Esteban Ortiz</ForeName>
                    <Initials>EO</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1895-7498</Identifier>
                    <AffiliationInfo>
                        <Affiliation>One Health Research Group, Universidad de Las Am..ricas (UDLA), Quito, Ecuador. e.ortizprado@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>NPJ Vaccines</MedlineTA>
            <NlmUniqueID>101699863</NlmUniqueID>
            <ISSNLinking>2059-0105</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>10</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33619260</ArticleId>
            <ArticleId IdType="doi">10.1038/s41541-021-00292-w</ArticleId>
            <ArticleId IdType="pii">10.1038/s41541-021-00292-w</ArticleId>
            <ArticleId IdType="pmc">PMC7900244</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):578-582</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32731258</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2021 Jan 9;397(10269):99-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33306989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Jul 3;369(6499):14-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32631873</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12283-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25136134</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Influenza Other Respir Viruses. 2011 Sep;5(5):299-305</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21668694</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Dis Ther. 2020 Apr 23;:1-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32328406</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):E7348-E7357</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28807998</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Sep 8;324(10):951-960</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32789505</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vet Immunol Immunopathol. 2016 Jan;169:15-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26827834</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):467-478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 Nov 25;38(50):7892-7896</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33139139</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Oct 1;183(1):158-168.e14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32979941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 12;383(20):1920-1931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32663912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ther Adv Vaccines. 2015 Jul;3(4):97-108</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26478817</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Vaccines. 2012 May;11(5):609-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22827246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EClinicalMedicine. 2021 Jan;31:100689</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33392485</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 1977 Dec;136 Suppl:S450-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">342620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Microbiol. 2009 Mar;7(3):226-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19198616</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep Med. 2020 Sep 22;1(6):100092</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32904468</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Jul 3;369(6499):77-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32376603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JCI Insight. 2019 Feb 21;4(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30830861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2003 Oct 1;21(27-30):4105-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14505886</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Oct;20(10):581-582</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32839569</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Sep 18;369(6510):1501-1505</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32703906</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2017 Feb 14;91(5):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28077633</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2021 Jan;27(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33261718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biologicals. 2009 Jun;37(3):182-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19297194</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Zhejiang Univ Sci B. 2007 Mar;8(3):153-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17323426</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):479-488</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1982 Jul 22;298(5872):347-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7045698</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2021 Jan;21(1):39-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33069281</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Sep 26;396(10255):887-897</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32896291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Sep 9;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32908295</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Oct;20(10):615-632</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32887954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1993 Dec;67(12):6929-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8230414</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2013 May 16;4:114</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23720661</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2018 Nov 15;19(11):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30445702</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Public Health. 2013 Aug;103(8):1393-401</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23763422</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Nov 20;371:m4552</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33219049</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hist Philos Life Sci. 1985;7(1):87-104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3895282</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2013 Sep;9(9):e1003618</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24068931</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2018 Apr;17(4):261-279</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29326426</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Jun 13;395(10240):1845-1854</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32450106</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine X. 2019 Jan 29;1:100009</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31384731</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 10;383(24):2320-2332</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32877576</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 17;383(25):2427-2438</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32991794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Aug 6;182(3):713-721.e9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32778225</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2016 Sep 06;6:32973</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27596047</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Ther Pat. 2011 Jun;21(6):927-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21406035</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2019 Aug 2;365(6452):505-509</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31371616</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2007 Jul 26;25(30):5563-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17292514</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):583-588</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32731257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Oct 1;183(1):169-184.e13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32931734</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2015 May;479-480:379-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25864107</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Aug 14;11(1):4081</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32796842</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Nov;26(11):1694-1700</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32884153</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diagn Microbiol Infect Dis. 2020 Sep;98(1):115094</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32623267</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>NPJ Vaccines. 2020 Jul 27;5:69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32793398</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Dec;588(7837):205-206</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33288887</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Vaccines. 2012 Mar;11(3):349-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22380826</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 Oct 8;5(52):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33033173</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Public Health Nations Health. 1962 Apr;52(4):632-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18017912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2014;10(10):2875-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25483662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1993 Apr;67(4):1936-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8383219</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 13;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33440088</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2017 Aug 17;13(8):e1006565</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28817732</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2020 Nov;21(11):1336-1345</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32887977</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2015;11(2):477-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25692535</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2021 Jan 14;12(1):372</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33446655</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1949 Jan 28;109(2822):85-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17794160</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 17;383(25):2439-2450</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33053279</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33619178</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1091-6490</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>118</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Influence of a COVID-19 vaccine's effectiveness and safety profile on vaccination acceptance.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">e2021726118</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2021726118</ELocationID>
            <Abstract>
                <AbstractText>Although a safe and effective vaccine holds the greatest promise for resolving the COVID-19 pandemic, hesitancy to accept vaccines remains common. To explore vaccine acceptance decisions, we conducted a national survey of 1,000 people from all US states in August of 2020 and a replication in December of 2020. Using a 3 .. 3 .. 3 factorial experimental design, we estimated the impact of three factors: probability of 1) protection against COVID-19, 2) minor side effects, and 3) a serious adverse reactions. The outcome was respondents' reported likelihood of receiving a vaccine for the coronavirus. Probability of vaccine efficacy (50%, 70%, or 90%) had the largest effect among the three factors. The probability of minor side effects (50%, 75%, 90%) including fever and sore arm, did not significantly influence likelihood of receiving the vaccine. The chances of a serious adverse reaction, such as temporary or permanent paralysis, had a small but significant effect. A serious adverse reaction rate of 1/100,000 was more likely to discourage vaccine use in comparison to rates of 1/million or 1/100 million. All interactions between the factors were nonsignificant. A replication following the announcement that vaccines were 95% effective showed small, but significant increases in the likelihood of taking a vaccine. The main effects and interactions in the model remained unchanged. Expected benefit was more influential in respondents' decision making than expected side effects. The absence of interaction effects suggests that respondents consider the side effects and benefits independently.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kaplan</LastName>
                    <ForeName>Robert M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Excellence Research Center, Stanford University School of Medicine, Stanford, CA 94305 bob.kaplan@stanford.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Milstein</LastName>
                    <ForeName>Arnold</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">0000-0002-2794-2378</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Clinical Excellence Research Center, Stanford University School of Medicine, Stanford, CA 94305.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
            <NlmUniqueID>7505876</NlmUniqueID>
            <ISSNLinking>0027-8424</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006306" MajorTopicYN="N">Health Surveys</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010342" MajorTopicYN="Y">Patient Acceptance of Health Care</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011057" MajorTopicYN="N">Politics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">conjoint analysis</Keyword>
            <Keyword MajorTopicYN="Y">decision analysis</Keyword>
            <Keyword MajorTopicYN="Y">vaccine acceptance</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare no competing interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2021</Year>
                <Month>08</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>9</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33619178</ArticleId>
            <ArticleId IdType="pii">2021726118</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.2021726118</ArticleId>
            <ArticleId IdType="pmc">PMC7958192</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):135-139</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30763298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2016 Aug;16(8):942-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27061888</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Urology. 2017 Jan;99:246-253</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27645527</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EClinicalMedicine. 2020 Sep;26:100495</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32838242</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ Glob Health. 2020 Oct;5(10):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33097547</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cardiol. 2018 Jun;41(6):855-861</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29696664</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Netw Open. 2020 Oct 1;3(10):e2025594</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33079199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2013 Aug;9(8):1763-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23584253</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2017 Jan 26;12(1):e0170550</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28125629</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Paediatr Drugs. 2020 Apr;22(2):105-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32072472</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):125-129</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33507892</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Recomm Rep. 2002 Apr 12;51(RR-3):1-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12002171</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Public Health Nations Health. 1958 Feb;48(2):139-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">13521059</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33619170</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>03</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1756-1833</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>372</Volume>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMJ (Clinical research ed.)</Title>
                <ISOAbbreviation>BMJ</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Vaccines for older adults.</ArticleTitle>
            <Pagination>
                <MedlinePgn>n188</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.n188</ELocationID>
            <Abstract>
                <AbstractText>The proportion of the global population aged 65 and older is rapidly increasing. Infections in this age group, most recently with SARS-CoV-2, cause substantial morbidity and mortality. Major improvements have been made in vaccines for older people, either through the addition of novel adjuvants-as in the new recombinant zoster vaccine and an adjuvanted influenza vaccine-or by increasing antigen concentration, as in influenza vaccines. In this article we review improvements in immunization for the three most important vaccine preventable diseases of aging. The recombinant zoster vaccine has an efficacy of 90% that is minimally affected by the age of the person being vaccinated and persists for more than four years. Increasing antigen dose or inclusion of adjuvant has improved the immunogenicity of influenza vaccines in older adults, although the relative effectiveness of the enhanced influenza vaccines and the durability of the immune response are the focus of ongoing clinical trials. Conjugate and polysaccharide pneumococcal vaccines have similar efficacy against invasive pneumococcal disease and pneumococcal pneumonia caused by vaccine serotypes in older adults. Their relative value varies by setting, depending on the prevalence of vaccine serotypes, largely related to conjugate vaccine coverage in children. Improved efficacy will increase public confidence and uptake of these vaccines. Co-administration of these vaccines is feasible and important for maximal uptake in older people. Development of new vaccine platforms has accelerated following the arrival of SARS-CoV-2, and will likely result in new vaccines against other pathogens in the future.</AbstractText>
                <CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cunningham</LastName>
                    <ForeName>Anthony L</ForeName>
                    <Initials>AL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Virus Research, The Westmead Institute for Medical Research, Faculty of Medicine and Health, University of Sydney, Australia tony.cunningham@sydney.edu.au.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McIntyre</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Subbarao</LastName>
                    <ForeName>Kanta</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>WHO CollaboratingCentre for Reference and Research on Influenza and Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Booy</LastName>
                    <ForeName>Robert</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital at Westmead, New South Wales, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Biological Sciences and Sydney Medical School, University of Sydney, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Levin</LastName>
                    <ForeName>Myron J</ForeName>
                    <Initials>MJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Pediatrics and Medicine, University of Colorado School of Medicine Anschutz Medical Campus, Aurora, Colorado, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMJ</MedlineTA>
            <NlmUniqueID>8900488</NlmUniqueID>
            <ISSNLinking>0959-8138</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D053061">Herpes Zoster Vaccine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053061" MajorTopicYN="N">Herpes Zoster Vaccine</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000068884" MajorTopicYN="N">Immunosenescence</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <CoiStatement>Competing interests: ALC has consulted on vaccines for Merck, BioCSL/Sequirus, and GlaxoSmithKline, and his institution has received resulting honoraria. MJL received fees for serving on advisory boards from Merck, GlaxoSmithKline, and Curevo, and grant support from Merck and GlaxoSmithKline.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>9</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33619170</ArticleId>
            <ArticleId IdType="doi">10.1136/bmj.n188</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33618668</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>02</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1471-2180</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>21</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC microbiology</Title>
                <ISOAbbreviation>BMC Microbiol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Identification and functional analysis of the SARS-COV-2 nucleocapsid protein.</ArticleTitle>
            <Pagination>
                <MedlinePgn>58</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12866-021-02107-3</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">A severe form of pneumonia, named coronavirus disease 2019 (COVID-19) by the World Health Organization is widespread on the whole world. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was proved to be the main agent of COVID-19. In the present study, we conducted an in depth analysis of the SARS-COV-2 nucleocapsid to identify potential targets that may allow identification of therapeutic targets.</AbstractText>
                <AbstractText Label="METHODS">The SARS-COV-2...N protein subcellular localization and physicochemical property was analyzed by PSORT II Prediction and ProtParam tool. Then SOPMA tool and swiss-model was applied to analyze the structure of N protein. Next, the biological function was explored by mass spectrometry analysis and flow cytometry. At last, its potential phosphorylation sites were analyzed by NetPhos3.1 Server and PROVEAN PROTEIN.</AbstractText>
                <AbstractText Label="RESULTS">SARS-COV-2...N protein composed of 419 aa, is a 45.6...kDa positively charged unstable hydrophobic protein. It has 91 and 49% similarity to SARS-CoV and MERS-CoV and is predicted to be predominantly a nuclear protein. It mainly contains random coil (55.13%) of which the tertiary structure was further determined with high reliability (95.76%). Cells transfected with SARS-COV-2...N protein usually show a G1/S phase block company with an increased expression of TUBA1C, TUBB6. At last, our analysis of SARS-COV-2...N protein predicted a total number of 12 phosphorylated sites and 9 potential protein kinases which would significantly affect SARS-COV-2...N protein function.</AbstractText>
                <AbstractText Label="CONCLUSION">In this study, we report the physicochemical properties, subcellular localization, and biological function of SARS-COV-2...N protein. The 12 phosphorylated sites and 9 potential protein kinase sites in SARS-COV-2...N protein may serve as promising targets for drug discovery and development for of a recombinant virus vaccine.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Tianyi</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of clinical Laboratory, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, Jiangsu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Yingdong</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of clinical Laboratory, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, Jiangsu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Xiangxiang</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Central Laboratory, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, Jiangsu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nie</LastName>
                    <ForeName>Zhenlin</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of clinical Laboratory, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, Jiangsu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Huilin</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Central Laboratory, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, Jiangsu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Kang</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of clinical Laboratory, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, Jiangsu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peng</LastName>
                    <ForeName>Hongxin</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of clinical Laboratory, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, Jiangsu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Shukui</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of clinical Laboratory, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, Jiangsu, China. sk_wang@njmu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Central Laboratory, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, Jiangsu, China. sk_wang@njmu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Collaborative Innovation Center on Cancer Personalized Medicine, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, Jiangsu, China. sk_wang@njmu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMC Microbiol</MedlineTA>
            <NlmUniqueID>100966981</NlmUniqueID>
            <ISSNLinking>1471-2180</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D019590">Nucleocapsid Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D045325" MajorTopicYN="N">HCT116 Cells</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019590" MajorTopicYN="N">Nucleocapsid Proteins</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Nucleocapsid protein (N protein)</Keyword>
            <Keyword MajorTopicYN="Y">Phosphorylation</Keyword>
            <Keyword MajorTopicYN="Y">SARS-COV-2</Keyword>
            <Keyword MajorTopicYN="Y">Structure</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>5</Hour>
                <Minute>39</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33618668</ArticleId>
            <ArticleId IdType="doi">10.1186/s12866-021-02107-3</ArticleId>
            <ArticleId IdType="pii">10.1186/s12866-021-02107-3</ArticleId>
            <ArticleId IdType="pmc">PMC7898026</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Trends Cell Biol. 2019 Jan;29(1):80-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30213517</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Cycle. 2007 Apr 1;6(7):863-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17426449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2014 Mar;88(5):2775-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24352467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2015 Aug;89(16):8416-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26041293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol Methods. 2020 Mar;277:113806</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31911390</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2014 Mar;103:39-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24418573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Mol Cell Biol. 2009 Jan;10(1):9-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19197328</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2015 Mar;115:9-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25542975</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Res Microb Sci. 2020 Sep;1:53-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33236001</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2017 Apr 10;8:15092</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28393837</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2017 Oct 27;91(22):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28878070</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2014 Feb;88(3):1421-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24257600</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2014 Aug 07;6(8):2991-3018</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25105276</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2020 Jan 31;94(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31776274</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proteomics. 2004 Jun;4(6):1633-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15174133</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2015 Aug 15;31(16):2745-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25851949</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Health. 2003 Nov 20;2(1):15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14629774</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Oncol. 2020 Feb 14;10:49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32117719</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Biol Evol. 2014 Aug 27;6(9):2274-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25169981</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Biochem Sci. 2000 Mar;25(3):147-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10694887</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2003 Jul 1;31(13):3784-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12824418</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Biol. 1996 Nov 22;264(1):121-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8950272</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Microbiol. 2021 Jan;203(1):59-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32749662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Comput Struct Biotechnol J. 2020;18:2174-2184</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32837710</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Apr;92(4):418-423</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31967327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Microbiol. 2019 Mar;17(3):181-192</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30531947</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2017 Jan 4;45(D1):D313-D319</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27899672</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29788355</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33618607</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1744-8336</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Mar</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Expert review of anti-infective therapy</Title>
                <ISOAbbreviation>Expert Rev Anti Infect Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-10</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/14787210.2021.1893692</ELocationID>
            <Abstract>
                <AbstractText><b>Introduction</b>: The novel coronavirus has caused significant mortality worldwide and is primarily associated with severe acute respiratory distress syndrome (ARDS). Apart from ARDS, clinical reports have shown noticeable cardiovascular complications among the patients of COVID-19. Infection from virus, stimulation of cytokine storm, altered immune response, and damage to myocardial tissue are some of the proposed mechanisms of cardiovascular complications in COVID-19.<b>Areas covered</b>: Based on the clinical reports of CVDs among COVID-19 patients, we have discussed the molecular mechanisms involved in cardiovascular pathogenesis, its prevalence, and association with COVID-19, and various available therapeutic modality for the treatment.<b>Expert opinion</b>: Seeing the cardiovascular complications in COVID-19 patients and its association with the existing drug, risk-benefit ratio of treatment paradigm, as well as the level of cardiac injury biomarkers must be monitored regularly. Additionally, a well-designed clinical trial should be conducted where head to head comparison can be made with anti-COVID-19 drugs and cardioprotective anti-inflammatory drugs. Nevertheless, vaccines are the best-suited approach, but until then, sanitization, social distancing, and active lifestyle are the best ways to beat this global pandemic situation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Iqubal</LastName>
                    <ForeName>Ashif</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Iqubal</LastName>
                    <ForeName>Mohammad Kashif</ForeName>
                    <Initials>MK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hoda</LastName>
                    <ForeName>Farazul</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Najmi</LastName>
                    <ForeName>Abul Kalam</ForeName>
                    <Initials>AK</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-9299-414X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haque</LastName>
                    <ForeName>Syed Ehtaishamul</ForeName>
                    <Initials>SE</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-2333-1577</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>03</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Expert Rev Anti Infect Ther</MedlineTA>
            <NlmUniqueID>101181284</NlmUniqueID>
            <ISSNLinking>1478-7210</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cytokine storm; Pneumocytes; Cardiotoxicity; NLRP3 inflammasome and COVID-19</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>5</Hour>
                <Minute>39</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33618607</ArticleId>
            <ArticleId IdType="doi">10.1080/14787210.2021.1893692</ArticleId>
            <ArticleId IdType="pmc">PMC7938651</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">33618278</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>30</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>30</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1876-035X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Mar</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of infection and public health</Title>
                <ISOAbbreviation>J Infect Public Health</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Risk management strategies and therapeutic modalities to tackle COVID-19/SARS-CoV-2.</ArticleTitle>
            <Pagination>
                <MedlinePgn>331-346</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1876-0341(20)30779-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jiph.2020.12.023</ELocationID>
            <Abstract>
                <AbstractText>The recent emergence of novel coronavirus disease (COVID-19) triggered by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has resulted in substantial mortality worldwide. Presently, there is no approved treatment for COVID-19. Consequently, the clinical, scientific, and regulatory authorities have joint efforts to reduce the severe impact of COVID-19. To date, there is minimal arsenal with no definite curative drugs, licensed-vaccines, or therapeutic conducts to combat the COVID-19 infections. Keeping in view the threats of this pandemic, various global organizations, physicians, researchers, and scientists, are trying to recognize the epidemiological characteristics and pathogenic mechanisms of COVID-19 to discover potential treatment regimens, vaccines, and therapeutic modes for future anticipation. Herein, we summarize a contemporary overview of curative invasions and vaccines for COVID-19 based on the earlier information and considerate of similar earlier RNA coronaviruses. The information reviewed here establishes a paramount intellectual basis to promote ongoing research to develop vaccines and curative agents. Thus, this review suggests the furthermost accessible frontiers in the vaccine development to tackle or combat the COVID-19/SARS-CoV-2.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Shah</LastName>
                    <ForeName>Syed Muhammad Ali</ForeName>
                    <Initials>SMA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Aziz Bhatti Shaheed Teaching Hospital Gujrat, Gujrat 50700, Pakistan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rasheed</LastName>
                    <ForeName>Tahir</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rizwan</LastName>
                    <ForeName>Komal</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, University of Sahiwal, Sahiwal 57000, Pakistan. Electronic address: Komal.rizwan45@yahoo.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bilal</LastName>
                    <ForeName>Muhammad</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Iqbal</LastName>
                    <ForeName>Hafiz M N</ForeName>
                    <Initials>HMN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, 64849, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rasool</LastName>
                    <ForeName>Nasir</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, Government College University, Faisalabad 38000, Pakistan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Toma</LastName>
                    <ForeName>Sebastian</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Transilvania University of Brasov, Brasov 500036, Romania. Electronic address: sebitom2002@yahoo.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marceanu</LastName>
                    <ForeName>Luigi Geo</ForeName>
                    <Initials>LG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Transilvania University of Brasov, Brasov 500036, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bobescu</LastName>
                    <ForeName>Elena</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Transilvania University of Brasov, Brasov 500036, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Infect Public Health</MedlineTA>
            <NlmUniqueID>101487384</NlmUniqueID>
            <ISSNLinking>1876-0341</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <SupplMeshList>
            <SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012308" MajorTopicYN="Y">Risk Management</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Anti-viral drugs</Keyword>
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Personal-level prevention</Keyword>
            <Keyword MajorTopicYN="N">Therapeutics</Keyword>
            <Keyword MajorTopicYN="N">Transmission</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>22</Day>
                <Hour>20</Hour>
                <Minute>16</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33618278</ArticleId>
            <ArticleId IdType="pii">S1876-0341(20)30779-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jiph.2020.12.023</ArticleId>
            <ArticleId IdType="pmc">PMC7837232</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33617777</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>17</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1474-547X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>397</Volume>
                    <Issue>10277</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Lancet (London, England)</Title>
                <ISOAbbreviation>Lancet</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.</ArticleTitle>
            <Pagination>
                <MedlinePgn>881-891</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0140-6736(21)00432-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(21)00432-3</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, with a regimen of two standard doses given with an interval of 4-12 weeks. The planned roll-out in the UK will involve vaccinating people in high-risk categories with their first dose immediately, and delivering the second dose 12 weeks later. Here, we provide both a further prespecified pooled analysis of trials of ChAdOx1 nCoV-19 and exploratory analyses of the impact on immunogenicity and efficacy of extending the interval between priming and booster doses. In addition, we show the immunogenicity and protection afforded by the first dose, before a booster dose has been offered.</AbstractText>
                <AbstractText Label="METHODS">We present data from three single-blind randomised controlled trials-one phase 1/2 study in the UK (COV001), one phase 2/3 study in the UK (COV002), and a phase 3 study in Brazil (COV003)-and one double-blind phase 1/2 study in South Africa (COV005). As previously described, individuals 18 years and older were randomly assigned 1:1 to receive two standard doses of ChAdOx1 nCoV-19 (5........10<sup>10</sup> viral particles) or a control vaccine or saline placebo. In the UK trial, a subset of participants received a lower dose (2..2........10<sup>10</sup> viral particles) of the ChAdOx1 nCoV-19 for the first dose. The primary outcome was virologically confirmed symptomatic COVID-19 disease, defined as a nucleic acid amplification test (NAAT)-positive swab combined with at least one qualifying symptom (fever ...37..8..C, cough, shortness of breath, or anosmia or ageusia) more than 14 days after the second dose. Secondary efficacy analyses included cases occuring at least 22 days after the first dose. Antibody responses measured by immunoassay and by pseudovirus neutralisation were exploratory outcomes. All cases of COVID-19 with a NAAT-positive swab were adjudicated for inclusion in the analysis by a masked independent endpoint review committee. The primary analysis included all participants who were SARS-CoV-2 N protein seronegative at baseline, had had at least 14 days of follow-up after the second dose, and had no evidence of previous SARS-CoV-2 infection from NAAT swabs. Safety was assessed in all participants who received at least one dose. The four trials are registered at ISRCTN89951424 (COV003) and ClinicalTrials.gov, NCT04324606 (COV001), NCT04400838 (COV002), and NCT04444674 (COV005).</AbstractText>
                <AbstractText Label="FINDINGS">Between April 23 and Dec 6, 2020, 24...422 participants were recruited and vaccinated across the four studies, of whom 17...178 were included in the primary analysis (8597 receiving ChAdOx1 nCoV-19 and 8581 receiving control vaccine). The data cutoff for these analyses was Dec 7, 2020. 332 NAAT-positive infections met the primary endpoint of symptomatic infection more than 14 days after the second dose. Overall vaccine efficacy more than 14 days after the second dose was 66..7% (95% CI 57..4-74..0), with 84 (1..0%) cases in the 8597 participants in the ChAdOx1 nCoV-19 group and 248 (2..9%) in the 8581 participants in the control group. There were no hospital admissions for COVID-19 in the ChAdOx1 nCoV-19 group after the initial 21-day exclusion period, and 15 in the control group. 108 (0..9%) of 12...282 participants in the ChAdOx1 nCoV-19 group and 127 (1..1%) of 11...962 participants in the control group had serious adverse events. There were seven deaths considered unrelated to vaccination (two in the ChAdOx1 nCov-19 group and five in the control group), including one COVID-19-related death in one participant in the control group. Exploratory analyses showed that vaccine efficacy after a single standard dose of vaccine from day 22 to day 90 after vaccination was 76..0% (59..3-85..9). Our modelling analysis indicated that protection did not wane during this initial 3-month period. Similarly, antibody levels were maintained during this period with minimal waning by day 90 (geometric mean ratio [GMR] 0..66 [95% CI 0..59-0..74]). In the participants who received two standard doses, after the second dose, efficacy was higher in those with a longer prime-boost interval (vaccine efficacy 81..3% [95% CI 60..3-91..2] at ...12 weeks) than in those with a short interval (vaccine efficacy 55..1% [33..0-69..9] at &lt;6 weeks). These observations are supported by immunogenicity data that showed binding antibody responses more than two-fold higher after an interval of 12 or more weeks compared with an interval of less than 6 weeks in those who were aged 18-55 years (GMR 2..32 [2..01-2..68]).</AbstractText>
                <AbstractText Label="INTERPRETATION">The results of this primary analysis of two doses of ChAdOx1 nCoV-19 were consistent with those seen in the interim analysis of the trials and confirm that the vaccine is efficacious, with results varying by dose interval in exploratory analyses. A 3-month dose interval might have advantages over a programme with a short dose interval for roll-out of a pandemic vaccine to protect the largest number of individuals in the population as early as possible when supplies are scarce, while also improving protection after receiving a second dose.</AbstractText>
                <AbstractText Label="FUNDING">UK Research and Innovation, National Institutes of Health Research (NIHR), The Coalition for Epidemic Preparedness Innovations, the Bill &amp; Melinda Gates Foundation, the Lemann Foundation, Rede D'Or, the Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Voysey</LastName>
                    <ForeName>Merryn</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Costa Clemens</LastName>
                    <ForeName>Sue Ann</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Global Health, University of Siena, Siena, Italy; Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Madhi</LastName>
                    <ForeName>Shabir A</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weckx</LastName>
                    <ForeName>Lily Y</ForeName>
                    <Initials>LY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Universidade Federal de S..o Paulo, S..o Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Folegatti</LastName>
                    <ForeName>Pedro M</ForeName>
                    <Initials>PM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aley</LastName>
                    <ForeName>Parvinder K</ForeName>
                    <Initials>PK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Angus</LastName>
                    <ForeName>Brian</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baillie</LastName>
                    <ForeName>Vicky L</ForeName>
                    <Initials>VL</Initials>
                    <AffiliationInfo>
                        <Affiliation>South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barnabas</LastName>
                    <ForeName>Shaun L</ForeName>
                    <Initials>SL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bhorat</LastName>
                    <ForeName>Qasim E</ForeName>
                    <Initials>QE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Soweto Clinical Trials Centre, Soweto, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bibi</LastName>
                    <ForeName>Sagida</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Briner</LastName>
                    <ForeName>Carmen</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cicconi</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Clutterbuck</LastName>
                    <ForeName>Elizabeth A</ForeName>
                    <Initials>EA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Collins</LastName>
                    <ForeName>Andrea M</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cutland</LastName>
                    <ForeName>Clare L</ForeName>
                    <Initials>CL</Initials>
                    <AffiliationInfo>
                        <Affiliation>South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Darton</LastName>
                    <ForeName>Thomas C</ForeName>
                    <Initials>TC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dheda</LastName>
                    <ForeName>Keertan</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pulmonology, Groote Schuur Hospital and the University of Cape Town, Cape Town, South Africa; Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dold</LastName>
                    <ForeName>Christina</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Duncan</LastName>
                    <ForeName>Christopher J A</ForeName>
                    <Initials>CJA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Emary</LastName>
                    <ForeName>Katherine R W</ForeName>
                    <Initials>KRW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ewer</LastName>
                    <ForeName>Katie J</ForeName>
                    <Initials>KJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Flaxman</LastName>
                    <ForeName>Amy</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fairlie</LastName>
                    <ForeName>Lee</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Faust</LastName>
                    <ForeName>Saul N</ForeName>
                    <Initials>SN</Initials>
                    <AffiliationInfo>
                        <Affiliation>NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, University of Southampton, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Feng</LastName>
                    <ForeName>Shuo</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ferreira</LastName>
                    <ForeName>Daniela M</ForeName>
                    <Initials>DM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Finn</LastName>
                    <ForeName>Adam</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Population Health Sciences, University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Galiza</LastName>
                    <ForeName>Eva</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>St George's Vaccine Institute, St George's, University of London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goodman</LastName>
                    <ForeName>Anna L</ForeName>
                    <Initials>AL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infection, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK; MRC Clinical Trials Unit, University College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Green</LastName>
                    <ForeName>Catherine M</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical BioManufacturing Facility, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Green</LastName>
                    <ForeName>Christopher A</ForeName>
                    <Initials>CA</Initials>
                    <AffiliationInfo>
                        <Affiliation>NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Greenland</LastName>
                    <ForeName>Melanie</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hill</LastName>
                    <ForeName>Catherine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hill</LastName>
                    <ForeName>Helen C</ForeName>
                    <Initials>HC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hirsch</LastName>
                    <ForeName>Ian</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>AstraZeneca BioPharmaceuticals, Cambridge, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Izu</LastName>
                    <ForeName>Alane</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jenkin</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Joe</LastName>
                    <ForeName>Carina C D</ForeName>
                    <Initials>CCD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kerridge</LastName>
                    <ForeName>Simon</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Koen</LastName>
                    <ForeName>Anthonet</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kwatra</LastName>
                    <ForeName>Gaurav</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lazarus</LastName>
                    <ForeName>Rajeka</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Severn Pathology, North Bristol NHS Trust, Bristol, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Libri</LastName>
                    <ForeName>Vincenzo</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lillie</LastName>
                    <ForeName>Patrick J</ForeName>
                    <Initials>PJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infection, Hull University Teaching Hospitals NHS Trust, Hull, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marchevsky</LastName>
                    <ForeName>Natalie G</ForeName>
                    <Initials>NG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marshall</LastName>
                    <ForeName>Richard P</ForeName>
                    <Initials>RP</Initials>
                    <AffiliationInfo>
                        <Affiliation>AstraZeneca BioPharmaceuticals, Cambridge, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mendes</LastName>
                    <ForeName>Ana V A</ForeName>
                    <Initials>AVA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Escola Bahiana de Medicina e Sa..de P..blica, Salvador, Braziland Hospital S..o Rafael, Salvador, Brazil; Instituto D'Or, Salvador, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Milan</LastName>
                    <ForeName>Eveline P</ForeName>
                    <Initials>EP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Universidade Federal do Rio Grande do Norte, Natal, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Minassian</LastName>
                    <ForeName>Angela M</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McGregor</LastName>
                    <ForeName>Alastair</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>London Northwest University Healthcare, Harrow, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mujadidi</LastName>
                    <ForeName>Yama F</ForeName>
                    <Initials>YF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nana</LastName>
                    <ForeName>Anusha</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Padayachee</LastName>
                    <ForeName>Sherman D</ForeName>
                    <Initials>SD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Setshaba Research Centre, Pretoria, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Phillips</LastName>
                    <ForeName>Daniel J</ForeName>
                    <Initials>DJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pittella</LastName>
                    <ForeName>Ana</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital Quinta D'Or, Rede D'Or, Rio De Janeiro, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Plested</LastName>
                    <ForeName>Emma</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pollock</LastName>
                    <ForeName>Katrina M</ForeName>
                    <Initials>KM</Initials>
                    <AffiliationInfo>
                        <Affiliation>NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ramasamy</LastName>
                    <ForeName>Maheshi N</ForeName>
                    <Initials>MN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ritchie</LastName>
                    <ForeName>Adam J</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Robinson</LastName>
                    <ForeName>Hannah</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schwarzbold</LastName>
                    <ForeName>Alexandre V</ForeName>
                    <Initials>AV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Smith</LastName>
                    <ForeName>Andrew</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Medical, Veterinary &amp; Life Sciences, Glasgow Dental Hospital &amp; School, University of Glasgow, Glasgow, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Song</LastName>
                    <ForeName>Rinn</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Snape</LastName>
                    <ForeName>Matthew D</ForeName>
                    <Initials>MD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sprinz</LastName>
                    <ForeName>Eduardo</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sutherland</LastName>
                    <ForeName>Rebecca K</ForeName>
                    <Initials>RK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thomson</LastName>
                    <ForeName>Emma C</ForeName>
                    <Initials>EC</Initials>
                    <AffiliationInfo>
                        <Affiliation>MRC-University of Glasgow Centre for Virus Research &amp; Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>T..r..k</LastName>
                    <ForeName>M Est..e</ForeName>
                    <Initials>ME</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, University of Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Toshner</LastName>
                    <ForeName>Mark</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Heart Lung Research Institute, Dept of Medicine, University of Cambridge and NIHR Cambridge Clinical Research Facility, Cambridge University Hospital and Royal Papworth NHS Foundation Trusts, Cambridge, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Turner</LastName>
                    <ForeName>David P J</ForeName>
                    <Initials>DPJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vekemans</LastName>
                    <ForeName>Johan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>AstraZeneca BioPharmaceuticals, Cambridge, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Villafana</LastName>
                    <ForeName>Tonya L</ForeName>
                    <Initials>TL</Initials>
                    <AffiliationInfo>
                        <Affiliation>AstraZeneca BioPharmaceuticals, Cambridge, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>White</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>AstraZeneca BioPharmaceuticals, Cambridge, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Williams</LastName>
                    <ForeName>Christopher J</ForeName>
                    <Initials>CJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Wales, Cardiff, Wales; Aneurin Bevan University Health Board, Newport, Wales.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Douglas</LastName>
                    <ForeName>Alexander D</ForeName>
                    <Initials>AD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hill</LastName>
                    <ForeName>Adrian V S</ForeName>
                    <Initials>AVS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lambe</LastName>
                    <ForeName>Teresa</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gilbert</LastName>
                    <ForeName>Sarah C</ForeName>
                    <Initials>SC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pollard</LastName>
                    <ForeName>Andrew J</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>Oxford COVID Vaccine Trial Group</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NCT04324606</AccessionNumber>
                        <AccessionNumber>NCT04444674</AccessionNumber>
                        <AccessionNumber>NCT04400838</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D017418">Meta-Analysis</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Lancet</MedlineTA>
            <NlmUniqueID>2985213R</NlmUniqueID>
            <ISSNLinking>0140-6736</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>B5S3K2V0G8</RegistryNumber>
                <NameOfSubstance UI="C000706713">ChAdOx1 COVID-19 vaccine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>Lancet. 2021 Mar 6;397(10277):854-855</RefSource>
                <PMID Version="1">33676614</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="ErratumIn">
                <RefSource>Lancet. 2021 Mar 6;397(10277):880</RefSource>
                <PMID Version="1">33676625</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>QJM. 2021 May 19;114(3):163-165</RefSource>
                <PMID Version="1">33677593</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000917" MajorTopicYN="N">Antibody Formation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058345" MajorTopicYN="N">Asymptomatic Infections</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007115" MajorTopicYN="Y">Immunization Schedule</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007117" MajorTopicYN="Y">Immunization, Secondary</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <InvestigatorList>
            <Investigator ValidYN="Y">
                <LastName>Aban</LastName>
                <ForeName>Marites</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Abeyskera</LastName>
                <ForeName>Kushala W M</ForeName>
                <Initials>KWM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Aboagye</LastName>
                <ForeName>Jeremy</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Adam</LastName>
                <ForeName>Matthew</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Adams</LastName>
                <ForeName>Kirsty</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Adamson</LastName>
                <ForeName>James P</ForeName>
                <Initials>JP</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Adewatan</LastName>
                <ForeName>Gbadebo</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Adlou</LastName>
                <ForeName>Syed</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ahmed</LastName>
                <ForeName>Khatija</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Akhalwaya</LastName>
                <ForeName>Yasmeen</ForeName>
                <Initials>Y</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Akhalwaya</LastName>
                <ForeName>Saajida</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Alcock</LastName>
                <ForeName>Andrew</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ali</LastName>
                <ForeName>Aabidah</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Allen</LastName>
                <ForeName>Elizabeth R</ForeName>
                <Initials>ER</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Allen</LastName>
                <ForeName>Lauren</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Alvernaz</LastName>
                <ForeName>Felipe B</ForeName>
                <Initials>FB</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Amorim</LastName>
                <ForeName>Fabio Santos</ForeName>
                <Initials>FS</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Andrade</LastName>
                <ForeName>Claudia Sala</ForeName>
                <Initials>CS</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Andritsou</LastName>
                <ForeName>Foteini</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Anslow</LastName>
                <ForeName>Rachel</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Arbe-Barnes</LastName>
                <ForeName>Edward H</ForeName>
                <Initials>EH</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ariaans</LastName>
                <ForeName>Mark P</ForeName>
                <Initials>MP</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Arns</LastName>
                <ForeName>Beatriz</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Arruda</LastName>
                <ForeName>Laiana</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Assad</LastName>
                <ForeName>Luiza</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Azi</LastName>
                <ForeName>Paula De Almeida</ForeName>
                <Initials>PA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Azi</LastName>
                <ForeName>Lorena De Almeida</ForeName>
                <Initials>LA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Babbage</LastName>
                <ForeName>Gavin</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bailey</LastName>
                <ForeName>Catherine</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Baker</LastName>
                <ForeName>Kenneth F</ForeName>
                <Initials>KF</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Baker</LastName>
                <ForeName>Megan</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Baker</LastName>
                <ForeName>Natalie</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Baker</LastName>
                <ForeName>Philip</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Baleanu</LastName>
                <ForeName>Ioana</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bandeira</LastName>
                <ForeName>Danieli</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bara</LastName>
                <ForeName>Anna</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Barbosa</LastName>
                <ForeName>Marcella A S</ForeName>
                <Initials>MAS</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Barker</LastName>
                <ForeName>Debbie</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Barlow</LastName>
                <ForeName>Gavin D</ForeName>
                <Initials>GD</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Barnes</LastName>
                <ForeName>Eleanor</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Barr</LastName>
                <ForeName>Andrew S</ForeName>
                <Initials>AS</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Barrett</LastName>
                <ForeName>Jordan R</ForeName>
                <Initials>JR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Barrett</LastName>
                <ForeName>Jessica</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Barrett</LastName>
                <ForeName>Kelly</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bates</LastName>
                <ForeName>Louise</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Batten</LastName>
                <ForeName>Alexander</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Beadon</LastName>
                <ForeName>Kirsten</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Beales</LastName>
                <ForeName>Emily</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Beckley</LastName>
                <ForeName>Rebecca</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Belij-Rammerstorfer</LastName>
                <ForeName>Sandra</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bell</LastName>
                <ForeName>Jonathan</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bellamy</LastName>
                <ForeName>Duncan</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Belton</LastName>
                <ForeName>Sue</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Berg</LastName>
                <ForeName>Adam</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bermejo</LastName>
                <ForeName>Laura</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Berrie</LastName>
                <ForeName>Eleanor</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Berry</LastName>
                <ForeName>Lisa</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Berzenyi</LastName>
                <ForeName>Daniella</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Beveridge</LastName>
                <ForeName>Amy</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bewley</LastName>
                <ForeName>Kevin R</ForeName>
                <Initials>KR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bharaj</LastName>
                <ForeName>Inderjeet</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bhikha</LastName>
                <ForeName>Sutika</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bhorat</LastName>
                <ForeName>Asad E</ForeName>
                <Initials>AE</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bhorat</LastName>
                <ForeName>Zaheda E</ForeName>
                <Initials>ZE</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bijker</LastName>
                <ForeName>Else Margreet</ForeName>
                <Initials>EM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Birch</LastName>
                <ForeName>Sarah</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Birch</LastName>
                <ForeName>Gurpreet</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Birchall</LastName>
                <ForeName>Kathryn</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bird</LastName>
                <ForeName>Adam</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bird</LastName>
                <ForeName>Olivia</ForeName>
                <Initials>O</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bisnauthsing</LastName>
                <ForeName>Karen</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bittaye</LastName>
                <ForeName>Mustapha</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Blackwell</LastName>
                <ForeName>Luke</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Blacow</LastName>
                <ForeName>Rachel</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bletchly</LastName>
                <ForeName>Heather</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Blundell</LastName>
                <ForeName>Caitlin L</ForeName>
                <Initials>CL</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Blundell</LastName>
                <ForeName>Susannah R</ForeName>
                <Initials>SR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bodalia</LastName>
                <ForeName>Pritesh</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bolam</LastName>
                <ForeName>Emma</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Boland</LastName>
                <ForeName>Elena</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bormans</LastName>
                <ForeName>Daan</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Borthwick</LastName>
                <ForeName>Nicola</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bowring</LastName>
                <ForeName>Francesca</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Boyd</LastName>
                <ForeName>Amy</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bradley</LastName>
                <ForeName>Penny</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Brenner</LastName>
                <ForeName>Tanja</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bridges-Webb</LastName>
                <ForeName>Alice</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Brown</LastName>
                <ForeName>Phillip</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Brown</LastName>
                <ForeName>Claire</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Brown-O'Sullivan</LastName>
                <ForeName>Charlie</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bruce</LastName>
                <ForeName>Scott</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Brunt</LastName>
                <ForeName>Emily</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Budd</LastName>
                <ForeName>William</ForeName>
                <Initials>W</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bulbulia</LastName>
                <ForeName>Yusuf A</ForeName>
                <Initials>YA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Bull</LastName>
                <ForeName>Melanie</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Burbage</LastName>
                <ForeName>Jamie</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Burn</LastName>
                <ForeName>Aileen</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Buttigieg</LastName>
                <ForeName>Karen R</ForeName>
                <Initials>KR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Byard</LastName>
                <ForeName>Nicholas</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cabrera Puig</LastName>
                <ForeName>Ingrid</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Calvert</LastName>
                <ForeName>Anna</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Camara</LastName>
                <ForeName>Susana</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cao</LastName>
                <ForeName>Michelangelo</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cappuccini</LastName>
                <ForeName>Federica</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cardona</LastName>
                <ForeName>Rita</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cardoso</LastName>
                <ForeName>Jo..o R</ForeName>
                <Initials>JR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Carr</LastName>
                <ForeName>Melanie</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Carroll</LastName>
                <ForeName>Miles W</ForeName>
                <Initials>MW</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Carson-Stevens</LastName>
                <ForeName>Andrew</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Carvalho</LastName>
                <ForeName>Yasmin de M</ForeName>
                <Initials>YM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Casey</LastName>
                <ForeName>Helen R</ForeName>
                <Initials>HR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cashen</LastName>
                <ForeName>Paul</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Castro</LastName>
                <ForeName>Thais R Y</ForeName>
                <Initials>TRY</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Castro</LastName>
                <ForeName>Lucia Carratala</ForeName>
                <Initials>LC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cathie</LastName>
                <ForeName>Katrina</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cavey</LastName>
                <ForeName>Ana</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cerbino-Neto</LastName>
                <ForeName>Jos..</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cezar</LastName>
                <ForeName>Luiz Fernando F</ForeName>
                <Initials>LFF</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Chadwick</LastName>
                <ForeName>Jim</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Chanice</LastName>
                <ForeName>Chanice</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Chapman</LastName>
                <ForeName>David</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Charlton</LastName>
                <ForeName>Sue</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cheliotis</LastName>
                <ForeName>Katerina S</ForeName>
                <Initials>KS</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Chelysheva</LastName>
                <ForeName>Irina</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Chester</LastName>
                <ForeName>Oliver</ForeName>
                <Initials>O</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Chiplin</LastName>
                <ForeName>Emily</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Chita</LastName>
                <ForeName>Sunder</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cho</LastName>
                <ForeName>Jee-Sun</ForeName>
                <Initials>JS</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cifuentes</LastName>
                <ForeName>Liliana</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Clark</LastName>
                <ForeName>Elizabeth</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Clark</LastName>
                <ForeName>Matthew</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Colin-Jones</LastName>
                <ForeName>Rachel</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Collins</LastName>
                <ForeName>Sarah L K</ForeName>
                <Initials>SLK</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Colton</LastName>
                <ForeName>Hayley</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Conlon</LastName>
                <ForeName>Christopher P</ForeName>
                <Initials>CP</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Connarty</LastName>
                <ForeName>Sean</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Coombes</LastName>
                <ForeName>Naomi</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cooper</LastName>
                <ForeName>Cushla</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cooper</LastName>
                <ForeName>Rachel</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cornelissen</LastName>
                <ForeName>Lynne</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Corrah</LastName>
                <ForeName>Tumena</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cosgrove</LastName>
                <ForeName>Catherine A</ForeName>
                <Initials>CA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Costa</LastName>
                <ForeName>Fernanda Barroso</ForeName>
                <Initials>FB</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cox</LastName>
                <ForeName>Tony</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Crocker</LastName>
                <ForeName>Wendy E M</ForeName>
                <Initials>WEM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Crosbie</LastName>
                <ForeName>Sarah</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cullen</LastName>
                <ForeName>Dan</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cunha</LastName>
                <ForeName>Debora R M F</ForeName>
                <Initials>DRMF</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cunningham</LastName>
                <ForeName>Christina J</ForeName>
                <Initials>CJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Cuthbertson</LastName>
                <ForeName>Fiona C</ForeName>
                <Initials>FC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>da Costa</LastName>
                <ForeName>Daniel Marinho</ForeName>
                <Initials>DM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Da Guarda</LastName>
                <ForeName>Suzete N Farias</ForeName>
                <Initials>SNF</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>da Silva</LastName>
                <ForeName>Larissa P</ForeName>
                <Initials>LP</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>da Silva Moraes</LastName>
                <ForeName>Antonio Carlos</ForeName>
                <Initials>AC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Damratoski</LastName>
                <ForeName>Brad E</ForeName>
                <Initials>BE</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Danos</LastName>
                <ForeName>Zsofia</ForeName>
                <Initials>Z</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Dantas</LastName>
                <ForeName>Maria T D C</ForeName>
                <Initials>MTDC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Datoo</LastName>
                <ForeName>Mehreen S</ForeName>
                <Initials>MS</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Datta</LastName>
                <ForeName>Chandrabali</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Davids</LastName>
                <ForeName>Malika</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Davies</LastName>
                <ForeName>Sarah L</ForeName>
                <Initials>SL</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Davies</LastName>
                <ForeName>Kelly</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Davies</LastName>
                <ForeName>Hannah</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Davies</LastName>
                <ForeName>Sophie</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Davies</LastName>
                <ForeName>Judith</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Davis</LastName>
                <ForeName>Elizabeth J</ForeName>
                <Initials>EJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Davis</LastName>
                <ForeName>John</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>de Carvalho</LastName>
                <ForeName>Jos.. A M</ForeName>
                <Initials>JAM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>De Jager</LastName>
                <ForeName>Jeanne</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>de Jesus Jnr</LastName>
                <ForeName>Sergio</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>De Oliveira Kalid</LastName>
                <ForeName>Lis Moreno</ForeName>
                <Initials>LM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Dearlove</LastName>
                <ForeName>David</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Demissie</LastName>
                <ForeName>Tesfaye</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Desai</LastName>
                <ForeName>Amisha</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Di Marco</LastName>
                <ForeName>Stefania</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Di Maso</LastName>
                <ForeName>Claudio</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Dinesh</LastName>
                <ForeName>Tanya</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Docksey</LastName>
                <ForeName>Claire</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Dong</LastName>
                <ForeName>Tao</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Donnellan</LastName>
                <ForeName>Francesca R</ForeName>
                <Initials>FR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Dos Santos</LastName>
                <ForeName>Tannyth Gomes</ForeName>
                <Initials>TG</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Dos Santos</LastName>
                <ForeName>Thain.. G</ForeName>
                <Initials>TG</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Dos Santos</LastName>
                <ForeName>Erika Pachecho</ForeName>
                <Initials>EP</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Douglas</LastName>
                <ForeName>Naomi</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Downing</LastName>
                <ForeName>Charlotte</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Drake</LastName>
                <ForeName>Jonathan</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Drake-Brockman</LastName>
                <ForeName>Rachael</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Drury</LastName>
                <ForeName>Ruth</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Du Plessis</LastName>
                <ForeName>Joan</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Dunachie</LastName>
                <ForeName>Susanna J</ForeName>
                <Initials>SJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Duncan</LastName>
                <ForeName>Andrew</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Easom</LastName>
                <ForeName>Nicholas J W</ForeName>
                <Initials>NJW</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Edwards</LastName>
                <ForeName>Mandy</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Edwards</LastName>
                <ForeName>Nick J</ForeName>
                <Initials>NJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Edwards</LastName>
                <ForeName>Frances</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>El Muhanna</LastName>
                <ForeName>Omar M</ForeName>
                <Initials>OM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Elias</LastName>
                <ForeName>Sean C</ForeName>
                <Initials>SC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ellison-Handley</LastName>
                <ForeName>Branwen</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Elmore</LastName>
                <ForeName>Michael J</ForeName>
                <Initials>MJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>English</LastName>
                <ForeName>Marcus Rex</ForeName>
                <Initials>MR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Esmail</LastName>
                <ForeName>Alisgair</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Essack</LastName>
                <ForeName>Yakub Moosa</ForeName>
                <Initials>YM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Farooq</LastName>
                <ForeName>Mutjaba</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Fedosyuk</LastName>
                <ForeName>Sofiya</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Felle</LastName>
                <ForeName>Sally</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ferguson</LastName>
                <ForeName>Susie</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ferreira Da Silva</LastName>
                <ForeName>Carla</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Field</LastName>
                <ForeName>Samantha</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Fisher</LastName>
                <ForeName>Richard</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Fletcher</LastName>
                <ForeName>James</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Fofie</LastName>
                <ForeName>Hazel</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Fok</LastName>
                <ForeName>Henry</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ford</LastName>
                <ForeName>Karen J</ForeName>
                <Initials>KJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Fothergill</LastName>
                <ForeName>Ross</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Fowler</LastName>
                <ForeName>Jamie</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Fraiman</LastName>
                <ForeName>Pedro H A</ForeName>
                <Initials>PHA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Francis</LastName>
                <ForeName>Emma</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Franco</LastName>
                <ForeName>Marilia M</ForeName>
                <Initials>MM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Frater</LastName>
                <ForeName>John</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Freire</LastName>
                <ForeName>Maril..cia S M</ForeName>
                <Initials>MSM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Fry</LastName>
                <ForeName>Samantha H</ForeName>
                <Initials>SH</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Fudge</LastName>
                <ForeName>Sabrina</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Furlan Filho</LastName>
                <ForeName>Renato</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Furze</LastName>
                <ForeName>Julie</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Fuskova</LastName>
                <ForeName>Michelle</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Galian-Rubio</LastName>
                <ForeName>Pablo</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Garlant</LastName>
                <ForeName>Harriet</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gavrila</LastName>
                <ForeName>Madita</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gibbons</LastName>
                <ForeName>Karyna A</ForeName>
                <Initials>KA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gilbride</LastName>
                <ForeName>Ciaran</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gill</LastName>
                <ForeName>Hardeep</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Godwin</LastName>
                <ForeName>Kerry</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gokani</LastName>
                <ForeName>Karishma</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gon..alves</LastName>
                <ForeName>Maria Luisa Freire</ForeName>
                <Initials>MLF</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gonzalez</LastName>
                <ForeName>Isabela G S</ForeName>
                <Initials>IGS</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Goodall</LastName>
                <ForeName>Jack</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Goodwin</LastName>
                <ForeName>Jayne</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Goondiwala</LastName>
                <ForeName>Amina</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gordon-Quayle</LastName>
                <ForeName>Katherine</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gorini</LastName>
                <ForeName>Giacomo</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Goyanna</LastName>
                <ForeName>Alvaro</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Grab</LastName>
                <ForeName>Janet</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gracie</LastName>
                <ForeName>Lara</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Green</LastName>
                <ForeName>Justin</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Greenwood</LastName>
                <ForeName>Nicola</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Greffrath</LastName>
                <ForeName>Johann</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Groenewald</LastName>
                <ForeName>Marisa M</ForeName>
                <Initials>MM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gunawardene</LastName>
                <ForeName>Anishka</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gupta</LastName>
                <ForeName>Gaurav</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hackett</LastName>
                <ForeName>Mark</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hallis</LastName>
                <ForeName>Bassam</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hamaluba</LastName>
                <ForeName>Mainga</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hamilton</LastName>
                <ForeName>Elizabeth</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hamlyn</LastName>
                <ForeName>Joseph</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hammersley</LastName>
                <ForeName>Daniel</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hanrath</LastName>
                <ForeName>Aidan T</ForeName>
                <Initials>AT</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hanumunthadu</LastName>
                <ForeName>Brama</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Harris</LastName>
                <ForeName>Stephanie A</ForeName>
                <Initials>SA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Harris</LastName>
                <ForeName>Clair</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Harrison</LastName>
                <ForeName>Thomas D</ForeName>
                <Initials>TD</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Harrison</LastName>
                <ForeName>Daisy</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Harris-Wright</LastName>
                <ForeName>Tara A</ForeName>
                <Initials>TA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hart</LastName>
                <ForeName>Thomas C</ForeName>
                <Initials>TC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hartnell</LastName>
                <ForeName>Birgit</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Haughney</LastName>
                <ForeName>John</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hawkins</LastName>
                <ForeName>Sophia</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hayano</LastName>
                <ForeName>La..s Y M</ForeName>
                <Initials>LYM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Head</LastName>
                <ForeName>Ian</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Heath</LastName>
                <ForeName>Paul T</ForeName>
                <Initials>PT</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Henry</LastName>
                <ForeName>John Aaron</ForeName>
                <Initials>JA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hermosin Herrera</LastName>
                <ForeName>Macarena</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hettle</LastName>
                <ForeName>David B</ForeName>
                <Initials>DB</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Higa</LastName>
                <ForeName>Cristhiane</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hill</LastName>
                <ForeName>Jennifer</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hodges</LastName>
                <ForeName>Gina</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hodgson</LastName>
                <ForeName>Susanne</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Horne</LastName>
                <ForeName>Elizea</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hou</LastName>
                <ForeName>Mimi M</ForeName>
                <Initials>MM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Houlihan</LastName>
                <ForeName>Catherine F</ForeName>
                <Initials>CF</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Howe</LastName>
                <ForeName>Elizabeth</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Howell</LastName>
                <ForeName>Nicola</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Humphreys</LastName>
                <ForeName>Jonathan</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Humphries</LastName>
                <ForeName>Holly E</ForeName>
                <Initials>HE</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hurley</LastName>
                <ForeName>Katrina</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Huson</LastName>
                <ForeName>Claire</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hyams</LastName>
                <ForeName>Catherine</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hyder-Wright</LastName>
                <ForeName>Angela</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ikram</LastName>
                <ForeName>Sabina</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ishwarbhai</LastName>
                <ForeName>Alka</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Iveson</LastName>
                <ForeName>Poppy</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Iyer</LastName>
                <ForeName>Vidyashankara</ForeName>
                <Initials>V</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Jackson</LastName>
                <ForeName>Frederic</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Jackson</LastName>
                <ForeName>Susan</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Jaumdally</LastName>
                <ForeName>Shameem</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Jeffers</LastName>
                <ForeName>Helen</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Jesudason</LastName>
                <ForeName>Natasha</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Jones</LastName>
                <ForeName>Carina</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Jones</LastName>
                <ForeName>Christopher</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Jones</LastName>
                <ForeName>Kathryn</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Jones</LastName>
                <ForeName>Elizabeth</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Jorge</LastName>
                <ForeName>Marianna Rocha</ForeName>
                <Initials>MR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Joshi</LastName>
                <ForeName>Amar</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>J..nior</LastName>
                <ForeName>Eduardo A M S</ForeName>
                <Initials>EAMS</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kailath</LastName>
                <ForeName>Reshma</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kana</LastName>
                <ForeName>Faeeza</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kar</LastName>
                <ForeName>Arnab</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Karampatsas</LastName>
                <ForeName>Konstantinos</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kasanyinga</LastName>
                <ForeName>Mwila</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kay</LastName>
                <ForeName>Linda</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Keen</LastName>
                <ForeName>Jade</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kellett Wright</LastName>
                <ForeName>Johanna</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kelly</LastName>
                <ForeName>Elizabeth J</ForeName>
                <Initials>EJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kelly</LastName>
                <ForeName>Debbie</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kelly</LastName>
                <ForeName>Dearbhla M</ForeName>
                <Initials>DM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kelly</LastName>
                <ForeName>Sarah</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kerr</LastName>
                <ForeName>David</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Khan</LastName>
                <ForeName>Liaquat</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Khozoee</LastName>
                <ForeName>Baktash</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Khurana</LastName>
                <ForeName>Ankush</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kidd</LastName>
                <ForeName>Sarah</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Killen</LastName>
                <ForeName>Annabel</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kinch</LastName>
                <ForeName>Jasmin</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kinch</LastName>
                <ForeName>Patrick</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>King</LastName>
                <ForeName>Lloyd D W</ForeName>
                <Initials>LDW</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>King</LastName>
                <ForeName>Thomas B</ForeName>
                <Initials>TB</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kingham</LastName>
                <ForeName>Lucy</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Klenerman</LastName>
                <ForeName>Paul</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kluczna</LastName>
                <ForeName>Diana M</ForeName>
                <Initials>DM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Knapper</LastName>
                <ForeName>Francesca</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Knight</LastName>
                <ForeName>Julian C</ForeName>
                <Initials>JC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Knott</LastName>
                <ForeName>Daniel</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Koleva</LastName>
                <ForeName>Stanislava</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lages</LastName>
                <ForeName>Pedro M</ForeName>
                <Initials>PM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lang</LastName>
                <ForeName>Matilda</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lang</LastName>
                <ForeName>Gail</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Larkworthy</LastName>
                <ForeName>Colin W</ForeName>
                <Initials>CW</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Larwood</LastName>
                <ForeName>Jessica P J</ForeName>
                <Initials>JPJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Law</LastName>
                <ForeName>Rebecca</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lawrie</LastName>
                <ForeName>Alison M</ForeName>
                <Initials>AM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lazarus</LastName>
                <ForeName>Erica M</ForeName>
                <Initials>EM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Leach</LastName>
                <ForeName>Amanda</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lees</LastName>
                <ForeName>Emily A</ForeName>
                <Initials>EA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lelliott</LastName>
                <ForeName>Alice</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lemm</LastName>
                <ForeName>Nana-Marie</ForeName>
                <Initials>NM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lessa</LastName>
                <ForeName>Alvaro Edson Ramos</ForeName>
                <Initials>AER</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Leung</LastName>
                <ForeName>Stephanie</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Li</LastName>
                <ForeName>Yuanyuan</ForeName>
                <Initials>Y</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lias</LastName>
                <ForeName>Amelia M</ForeName>
                <Initials>AM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Liatsikos</LastName>
                <ForeName>Konstantinos</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Linder</LastName>
                <ForeName>Aline</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lipworth</LastName>
                <ForeName>Samuel</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Liu</LastName>
                <ForeName>Shuchang</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Liu</LastName>
                <ForeName>Xinxue</ForeName>
                <Initials>X</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lloyd</LastName>
                <ForeName>Adam</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lloyd</LastName>
                <ForeName>Stephanie</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Loew</LastName>
                <ForeName>Lisa</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lopez Ramon</LastName>
                <ForeName>Raquel</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Lora</LastName>
                <ForeName>Leandro Bonecker</ForeName>
                <Initials>LB</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Luz</LastName>
                <ForeName>Kleber Giovanni</ForeName>
                <Initials>KG</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>MacDonald</LastName>
                <ForeName>Jonathan C</ForeName>
                <Initials>JC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>MacGregor</LastName>
                <ForeName>Gordon</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Madhavan</LastName>
                <ForeName>Meera</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mainwaring</LastName>
                <ForeName>David O</ForeName>
                <Initials>DO</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Makambwa</LastName>
                <ForeName>Edson</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Makinson</LastName>
                <ForeName>Rebecca</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Malahleha</LastName>
                <ForeName>Mookho</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Malamatsho</LastName>
                <ForeName>Ross</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mallett</LastName>
                <ForeName>Garry</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Manning</LastName>
                <ForeName>Nicola</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mansatta</LastName>
                <ForeName>Kushal</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Maoko</LastName>
                <ForeName>Takalani</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Marinou</LastName>
                <ForeName>Spyridoula</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Marlow</LastName>
                <ForeName>Emma</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Marques</LastName>
                <ForeName>Gabriela N</ForeName>
                <Initials>GN</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Marriott</LastName>
                <ForeName>Paula</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Marshall</LastName>
                <ForeName>Richard P</ForeName>
                <Initials>RP</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Marshall</LastName>
                <ForeName>Julia L</ForeName>
                <Initials>JL</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Masenya</LastName>
                <ForeName>Masebole</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Masilela</LastName>
                <ForeName>Mduduzi</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Masters</LastName>
                <ForeName>Shauna K</ForeName>
                <Initials>SK</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mathew</LastName>
                <ForeName>Moncy</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Matlebjane</LastName>
                <ForeName>Hosea</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Matshidiso</LastName>
                <ForeName>Kedidimetse</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mazur</LastName>
                <ForeName>Olga</ForeName>
                <Initials>O</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mazzella</LastName>
                <ForeName>Andrea</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>McCaughan</LastName>
                <ForeName>Hugh</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>McEwan</LastName>
                <ForeName>Joanne</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>McGlashan</LastName>
                <ForeName>Joanna</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>McInroy</LastName>
                <ForeName>Lorna</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>McRobert</LastName>
                <ForeName>Nicky</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>McSwiggan</LastName>
                <ForeName>Steve</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Megson</LastName>
                <ForeName>Clare</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mehdipour</LastName>
                <ForeName>Savviz</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Meijs</LastName>
                <ForeName>Wilma</ForeName>
                <Initials>W</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mendon..a</LastName>
                <ForeName>Renata N ..</ForeName>
                <Initials>RN..</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mentzer</LastName>
                <ForeName>Alexander J</ForeName>
                <Initials>AJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mesquita</LastName>
                <ForeName>Ana Carolina F</ForeName>
                <Initials>ACF</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Miralhes</LastName>
                <ForeName>Patricia</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mirtorabi</LastName>
                <ForeName>Neginsadat</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mitton</LastName>
                <ForeName>Celia</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mnyakeni</LastName>
                <ForeName>Sibusiso</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Moghaddas</LastName>
                <ForeName>Fiona</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Molapo</LastName>
                <ForeName>Kgaogelo</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Moloi</LastName>
                <ForeName>Mapule</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Moore</LastName>
                <ForeName>Maria</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Moran</LastName>
                <ForeName>Marni</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Morey</LastName>
                <ForeName>Ella</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Morgans</LastName>
                <ForeName>R..is..n</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Morris</LastName>
                <ForeName>Susan J</ForeName>
                <Initials>SJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Morris</LastName>
                <ForeName>Sheila</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Morrison</LastName>
                <ForeName>Hazel</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Morselli</LastName>
                <ForeName>Franca</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Morshead</LastName>
                <ForeName>Gertraud</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Morter</LastName>
                <ForeName>Richard</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mottay</LastName>
                <ForeName>Lynelle</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Moultrie</LastName>
                <ForeName>Andrew</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Moyo</LastName>
                <ForeName>Nathifa</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mpelembue</LastName>
                <ForeName>Mushiya</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Msomi</LastName>
                <ForeName>Sibekezelo</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mugodi</LastName>
                <ForeName>Yvonne</ForeName>
                <Initials>Y</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mukhopadhyay</LastName>
                <ForeName>Ekta</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Muller</LastName>
                <ForeName>Jilly</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Munro</LastName>
                <ForeName>Alasdair</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Murphy</LastName>
                <ForeName>Sarah</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Mweu</LastName>
                <ForeName>Philomena</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Myerscough</LastName>
                <ForeName>Christopher</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Naik</LastName>
                <ForeName>Gurudutt</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Naker</LastName>
                <ForeName>Kush</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Nastouli</LastName>
                <ForeName>Eleni</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ndlovu</LastName>
                <ForeName>Bongani</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Nikolaou</LastName>
                <ForeName>Elissavet</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Njenga</LastName>
                <ForeName>Cecilia</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Noal</LastName>
                <ForeName>Helena C</ForeName>
                <Initials>HC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>No..</LastName>
                <ForeName>Andr..s</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Novaes</LastName>
                <ForeName>Gabrielle</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Nugent</LastName>
                <ForeName>Fay L</ForeName>
                <Initials>FL</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Nunes</LastName>
                <ForeName>G..ssika Lanzillo A</ForeName>
                <Initials>GLA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>O'Brien</LastName>
                <ForeName>Katie</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>O'Connor</LastName>
                <ForeName>Daniel</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Oelofse</LastName>
                <ForeName>Suzette</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Oguti</LastName>
                <ForeName>Blanche</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Olchawski</LastName>
                <ForeName>Victoria</ForeName>
                <Initials>V</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Oldfield</LastName>
                <ForeName>Neil J</ForeName>
                <Initials>NJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Oliveira</LastName>
                <ForeName>Marianne G</ForeName>
                <Initials>MG</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Oliveira</LastName>
                <ForeName>Catarina</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Oliveira</LastName>
                <ForeName>Isabelle Silva Queiroz</ForeName>
                <Initials>ISQ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Oommen-Jose</LastName>
                <ForeName>Aylin</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Oosthuizen</LastName>
                <ForeName>Angela</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>O'Reilly</LastName>
                <ForeName>Paula</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>O'Reilly</LastName>
                <ForeName>Peter J</ForeName>
                <Initials>PJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Osborne</LastName>
                <ForeName>Piper</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Owen</LastName>
                <ForeName>David R J</ForeName>
                <Initials>DRJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Owen</LastName>
                <ForeName>Lydia</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Owens</LastName>
                <ForeName>Daniel</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Owino</LastName>
                <ForeName>Nelly</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Pacurar</LastName>
                <ForeName>Mihaela</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Paiva</LastName>
                <ForeName>Brenda V B</ForeName>
                <Initials>BVB</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Palhares</LastName>
                <ForeName>Edna M F</ForeName>
                <Initials>EMF</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Palmer</LastName>
                <ForeName>Susan</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Parracho</LastName>
                <ForeName>Helena M R T</ForeName>
                <Initials>HMRT</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Parsons</LastName>
                <ForeName>Karen</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Patel</LastName>
                <ForeName>Dipak</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Patel</LastName>
                <ForeName>Bhumika</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Patel</LastName>
                <ForeName>Faeezah</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Patrick-Smith</LastName>
                <ForeName>Maia</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Payne</LastName>
                <ForeName>Ruth O</ForeName>
                <Initials>RO</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Peng</LastName>
                <ForeName>Yanchun</ForeName>
                <Initials>Y</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Penn</LastName>
                <ForeName>Elizabeth J</ForeName>
                <Initials>EJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Pennington</LastName>
                <ForeName>Anna</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Peralta Alvarez</LastName>
                <ForeName>Marco Polo</ForeName>
                <Initials>MP</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Pereira Stuchi</LastName>
                <ForeName>Bruno Pereira</ForeName>
                <Initials>BP</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Perez</LastName>
                <ForeName>Ana Luiza</ForeName>
                <Initials>AL</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Perinpanathan</LastName>
                <ForeName>Tanaraj</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Perring</LastName>
                <ForeName>James</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Perumal</LastName>
                <ForeName>Rubeshan</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Petkar</LastName>
                <ForeName>Sahir Yusuf</ForeName>
                <Initials>SY</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Philip</LastName>
                <ForeName>Tricia</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Phillips</LastName>
                <ForeName>Jennifer</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Phohu</LastName>
                <ForeName>Mary Kgomotso</ForeName>
                <Initials>MK</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Pickup</LastName>
                <ForeName>Lorinda</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Pieterse</LastName>
                <ForeName>Sonja</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Pinheiro</LastName>
                <ForeName>Jessica Morgana</ForeName>
                <Initials>JM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Piper</LastName>
                <ForeName>Jo</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Pipini</LastName>
                <ForeName>Dimitra</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Plank</LastName>
                <ForeName>Mary</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Plant</LastName>
                <ForeName>Sin..ad</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Pollard</LastName>
                <ForeName>Samuel</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Pooley</LastName>
                <ForeName>Jennifer</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Pooran</LastName>
                <ForeName>Anil</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Poulton</LastName>
                <ForeName>Ian</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Powers</LastName>
                <ForeName>Claire</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Presa</LastName>
                <ForeName>Fernando B</ForeName>
                <Initials>FB</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Price</LastName>
                <ForeName>David A</ForeName>
                <Initials>DA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Price</LastName>
                <ForeName>Vivien</ForeName>
                <Initials>V</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Primeira</LastName>
                <ForeName>Marcelo R</ForeName>
                <Initials>MR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Proud</LastName>
                <ForeName>Pamela C</ForeName>
                <Initials>PC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Provstgaard-Morys</LastName>
                <ForeName>Samuel</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Pueschel</LastName>
                <ForeName>Sophie</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Pulido</LastName>
                <ForeName>David</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Quaid</LastName>
                <ForeName>Sheena</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rabara</LastName>
                <ForeName>Ria</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Radia</LastName>
                <ForeName>Kajal</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rajapaska</LastName>
                <ForeName>Durga</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rajeswaran</LastName>
                <ForeName>Thurkka</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ramos</LastName>
                <ForeName>Leonardo</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ramos</LastName>
                <ForeName>Alberto San Francisco</ForeName>
                <Initials>ASF</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ramos Lopez</LastName>
                <ForeName>Fernando</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rampling</LastName>
                <ForeName>Tommy</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rand</LastName>
                <ForeName>Jade</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ratcliffe</LastName>
                <ForeName>Helen</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rawlinson</LastName>
                <ForeName>Tom</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rea</LastName>
                <ForeName>David</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rees</LastName>
                <ForeName>Byron</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Resuello-Dauti</LastName>
                <ForeName>Mila</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Reyes Pabon</LastName>
                <ForeName>Emilia</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rhead</LastName>
                <ForeName>Sarah</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Riaz</LastName>
                <ForeName>Tawassal</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ricamara</LastName>
                <ForeName>Marivic</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Richards</LastName>
                <ForeName>Alexander</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Richter</LastName>
                <ForeName>Alex</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ritchie</LastName>
                <ForeName>Neil</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ritchie</LastName>
                <ForeName>Adam J</ForeName>
                <Initials>AJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Robbins</LastName>
                <ForeName>Alexander J</ForeName>
                <Initials>AJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Roberts</LastName>
                <ForeName>Hannah</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Robinson</LastName>
                <ForeName>Ryan E</ForeName>
                <Initials>RE</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Roche</LastName>
                <ForeName>Sophie</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rollier</LastName>
                <ForeName>Christine</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rose</LastName>
                <ForeName>Louisa</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ross Russell</LastName>
                <ForeName>Amy L</ForeName>
                <Initials>AL</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rossouw</LastName>
                <ForeName>Lindie</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Royal</LastName>
                <ForeName>Simon</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rudiansyah</LastName>
                <ForeName>Indra</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ryalls</LastName>
                <ForeName>Kim</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sabine</LastName>
                <ForeName>Charlotte</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Saich</LastName>
                <ForeName>Stephen</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sale</LastName>
                <ForeName>Jessica C</ForeName>
                <Initials>JC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Salman</LastName>
                <ForeName>Ahmed M</ForeName>
                <Initials>AM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Salvador</LastName>
                <ForeName>Natalia</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Salvador</LastName>
                <ForeName>Stephannie</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sampaio</LastName>
                <ForeName>Milla Dias</ForeName>
                <Initials>MD</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Samson</LastName>
                <ForeName>Annette D</ForeName>
                <Initials>AD</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sanchez-Gonzalez</LastName>
                <ForeName>Amada</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sanders</LastName>
                <ForeName>Helen</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sanders</LastName>
                <ForeName>Katherine</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Santos</LastName>
                <ForeName>Erika</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Santos Guerra</LastName>
                <ForeName>Mayara F S</ForeName>
                <Initials>MFS</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Satti</LastName>
                <ForeName>Iman</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Saunders</LastName>
                <ForeName>Jack E</ForeName>
                <Initials>JE</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Saunders</LastName>
                <ForeName>Caroline</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sayed</LastName>
                <ForeName>Aakifah Bibi Arif</ForeName>
                <Initials>ABA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Schim van der Loeff</LastName>
                <ForeName>Ina</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Schmid</LastName>
                <ForeName>Annina B</ForeName>
                <Initials>AB</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Schofield</LastName>
                <ForeName>Ella</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Screaton</LastName>
                <ForeName>Gavin R</ForeName>
                <Initials>GR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Seddiqi</LastName>
                <ForeName>Samiullah</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Segireddy</LastName>
                <ForeName>Rameswara R</ForeName>
                <Initials>RR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Senger</LastName>
                <ForeName>Roberta</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Serrano</LastName>
                <ForeName>Sonia</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Shaik</LastName>
                <ForeName>Imam</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sharpe</LastName>
                <ForeName>Hannah R</ForeName>
                <Initials>HR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sharrocks</LastName>
                <ForeName>Katherine</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Shaw</LastName>
                <ForeName>Robert</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Shea</LastName>
                <ForeName>Adam</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sheehan</LastName>
                <ForeName>Emma</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Shepherd</LastName>
                <ForeName>Amy</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Shiham</LastName>
                <ForeName>Farah</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Silk</LastName>
                <ForeName>Sarah E</ForeName>
                <Initials>SE</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Silva-Reyes</LastName>
                <ForeName>Laura</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Silveira</LastName>
                <ForeName>Lidiana B T D</ForeName>
                <Initials>LBTD</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Silveira</LastName>
                <ForeName>Mariana B V</ForeName>
                <Initials>MBV</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Singh</LastName>
                <ForeName>Nisha</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sinha</LastName>
                <ForeName>Jaisi</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Skelly</LastName>
                <ForeName>Donal T</ForeName>
                <Initials>DT</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Smith</LastName>
                <ForeName>Daniel C</ForeName>
                <Initials>DC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Smith</LastName>
                <ForeName>Nick</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Smith</LastName>
                <ForeName>Holly E</ForeName>
                <Initials>HE</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Smith</LastName>
                <ForeName>David J</ForeName>
                <Initials>DJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Smith</LastName>
                <ForeName>Catherine C</ForeName>
                <Initials>CC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Soares</LastName>
                <ForeName>Airanu..dida S</ForeName>
                <Initials>AS</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sol..rzano</LastName>
                <ForeName>Carla</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sorio</LastName>
                <ForeName>Guilherme L</ForeName>
                <Initials>GL</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sorley</LastName>
                <ForeName>Kim</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sosa-Rodriguez</LastName>
                <ForeName>Tiffany</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Souza</LastName>
                <ForeName>Cinthia M C D L</ForeName>
                <Initials>CMCDL</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Souza</LastName>
                <ForeName>Bruno S D F</ForeName>
                <Initials>BSDF</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Souza</LastName>
                <ForeName>Alessandra R</ForeName>
                <Initials>AR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Souza Lopez</LastName>
                <ForeName>Thamyres</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sowole</LastName>
                <ForeName>Luciana</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Spencer</LastName>
                <ForeName>Alexandra J</ForeName>
                <Initials>AJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Spoors</LastName>
                <ForeName>Louise</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Stafford</LastName>
                <ForeName>Lizzie</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Stamford</LastName>
                <ForeName>Imogen</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Stein</LastName>
                <ForeName>Ricardo</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Stockdale</LastName>
                <ForeName>Lisa</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Stockwell</LastName>
                <ForeName>Lisa V</ForeName>
                <Initials>LV</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Strickland</LastName>
                <ForeName>Louise H</ForeName>
                <Initials>LH</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Stuart</LastName>
                <ForeName>Arabella</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sturdy</LastName>
                <ForeName>Ann</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Sutton</LastName>
                <ForeName>Natalina</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Szigeti</LastName>
                <ForeName>Anna</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tahiri-Alaoui</LastName>
                <ForeName>Abdessamad</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tanner</LastName>
                <ForeName>Rachel</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Taoushanis</LastName>
                <ForeName>Carol</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tarr</LastName>
                <ForeName>Alexander W</ForeName>
                <Initials>AW</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tarrant</LastName>
                <ForeName>Richard</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Taylor</LastName>
                <ForeName>Keja</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Taylor</LastName>
                <ForeName>Ursula</ForeName>
                <Initials>U</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Taylor</LastName>
                <ForeName>Iona Jennifer</ForeName>
                <Initials>IJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Taylor</LastName>
                <ForeName>Justin</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Te Water Naude</LastName>
                <ForeName>Rebecca</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Templeton</LastName>
                <ForeName>Kate</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Themistocleous</LastName>
                <ForeName>Yrene</ForeName>
                <Initials>Y</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Themistocleous</LastName>
                <ForeName>Andreas</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Thomas</LastName>
                <ForeName>Merin</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Thomas</LastName>
                <ForeName>Kelly</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Thomas</LastName>
                <ForeName>Tonia M</ForeName>
                <Initials>TM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Thombrayil</LastName>
                <ForeName>Asha</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Thompson</LastName>
                <ForeName>Julia</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Thompson</LastName>
                <ForeName>Fawziyah</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Thompson</LastName>
                <ForeName>Ameeka</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Thompson</LastName>
                <ForeName>Amber</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Thompson</LastName>
                <ForeName>Kevin</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Thornton-Jones</LastName>
                <ForeName>Viv</ForeName>
                <Initials>V</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Thotusi</LastName>
                <ForeName>Larissa H S</ForeName>
                <Initials>LHS</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tighe</LastName>
                <ForeName>Patrick J</ForeName>
                <Initials>PJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tinoco</LastName>
                <ForeName>Lygia Accioly</ForeName>
                <Initials>LA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tiongson</LastName>
                <ForeName>Gerlynn Ferreras</ForeName>
                <Initials>GF</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tladinyane</LastName>
                <ForeName>Bonolo</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tomasicchio</LastName>
                <ForeName>Michele</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tomic</LastName>
                <ForeName>Adriana</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tonks</LastName>
                <ForeName>Susan</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Towner</LastName>
                <ForeName>James</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tran</LastName>
                <ForeName>Nguyen</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tree</LastName>
                <ForeName>Julia A</ForeName>
                <Initials>JA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Trillana</LastName>
                <ForeName>Gerry</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Trinham</LastName>
                <ForeName>Charlotte</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Trivett</LastName>
                <ForeName>Rose</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Truby</LastName>
                <ForeName>Adam</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tsheko</LastName>
                <ForeName>Betty Lebogang</ForeName>
                <Initials>BL</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tubb</LastName>
                <ForeName>Philippa</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Turabi</LastName>
                <ForeName>Aadil</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Turner</LastName>
                <ForeName>Richard</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Turner</LastName>
                <ForeName>Cheryl</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Turner</LastName>
                <ForeName>Nicola</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Tyagi</LastName>
                <ForeName>Bhavya</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ulaszewska</LastName>
                <ForeName>Marta</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Underwood</LastName>
                <ForeName>Benjamin R</ForeName>
                <Initials>BR</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>van Eck</LastName>
                <ForeName>Samual</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Varughese</LastName>
                <ForeName>Rachel</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Verbart</LastName>
                <ForeName>Dennis</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Verheul</LastName>
                <ForeName>Marije K</ForeName>
                <Initials>MK</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Vichos</LastName>
                <ForeName>Iason</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Vieira</LastName>
                <ForeName>Taiane A</ForeName>
                <Initials>TA</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Walker</LastName>
                <ForeName>Gemma</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Walker</LastName>
                <ForeName>Laura</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Wand</LastName>
                <ForeName>Matthew E</ForeName>
                <Initials>ME</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Wardell</LastName>
                <ForeName>Theresa</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Warimwe</LastName>
                <ForeName>George M</ForeName>
                <Initials>GM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Warren</LastName>
                <ForeName>Sarah C</ForeName>
                <Initials>SC</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Watkins</LastName>
                <ForeName>Bridget</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Watson</LastName>
                <ForeName>Marion E E</ForeName>
                <Initials>MEE</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Watson</LastName>
                <ForeName>Ekaterina</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Webb</LastName>
                <ForeName>Stewart</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Webster</LastName>
                <ForeName>Angela</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Welch</LastName>
                <ForeName>Jessica</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Wellbelove</LastName>
                <ForeName>Zoe</ForeName>
                <Initials>Z</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Wells</LastName>
                <ForeName>Jeanette H</ForeName>
                <Initials>JH</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>West</LastName>
                <ForeName>Alison J</ForeName>
                <Initials>AJ</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>White</LastName>
                <ForeName>Beth</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>White</LastName>
                <ForeName>Caroline</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>White</LastName>
                <ForeName>Rachel</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Williams</LastName>
                <ForeName>Paul</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Williams</LastName>
                <ForeName>Rachel L</ForeName>
                <Initials>RL</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Willingham</LastName>
                <ForeName>Silvia</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Winslow</LastName>
                <ForeName>Rebecca</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Woods</LastName>
                <ForeName>Danielle</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Woodyer</LastName>
                <ForeName>Mark</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Worth</LastName>
                <ForeName>Andrew T</ForeName>
                <Initials>AT</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Wright</LastName>
                <ForeName>Danny</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Wroblewska</LastName>
                <ForeName>Marzena</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Yao</LastName>
                <ForeName>Andy</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Yim</LastName>
                <ForeName>Yee Ting Nicole</ForeName>
                <Initials>YTN</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Zambrano</LastName>
                <ForeName>Marina Bauer</ForeName>
                <Initials>MB</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Zimmer</LastName>
                <ForeName>Rafael Leal</ForeName>
                <Initials>RL</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Zizi</LastName>
                <ForeName>Dalila</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Zuidewind</LastName>
                <ForeName>Peter</ForeName>
                <Initials>P</Initials>
            </Investigator>
        </InvestigatorList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>22</Day>
                <Hour>20</Hour>
                <Minute>10</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33617777</ArticleId>
            <ArticleId IdType="pii">S0140-6736(21)00432-3</ArticleId>
            <ArticleId IdType="doi">10.1016/S0140-6736(21)00432-3</ArticleId>
            <ArticleId IdType="pmc">PMC7894131</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33617776</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>17</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>17</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1474-547X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>397</Volume>
                    <Issue>10277</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Lancet (London, England)</Title>
                <ISOAbbreviation>Lancet</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.</ArticleTitle>
            <Pagination>
                <MedlinePgn>878</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0140-6736(21)00357-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(21)00357-3</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sisa</LastName>
                    <ForeName>Ivan</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Health Sciences, Universidad San Francisco de Quito, Quito 170901, Ecuador. Electronic address: isisa@usfq.edu.ec.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Noblecilla</LastName>
                    <ForeName>Estefania</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institutional Review Board, Universidad San Francisco de Quito, Quito 170901, Ecuador.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Orozco</LastName>
                    <ForeName>Fadya</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Health Sciences, Universidad San Francisco de Quito, Quito 170901, Ecuador.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Lancet</MedlineTA>
            <NlmUniqueID>2985213R</NlmUniqueID>
            <ISSNLinking>0140-6736</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010919">Placebos</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000600" MajorTopicYN="N">supply &amp; distribution</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010919" MajorTopicYN="N">Placebos</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
                <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057212" MajorTopicYN="N">Therapeutic Equipoise</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>22</Day>
                <Hour>20</Hour>
                <Minute>10</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33617776</ArticleId>
            <ArticleId IdType="pii">S0140-6736(21)00357-3</ArticleId>
            <ArticleId IdType="doi">10.1016/S0140-6736(21)00357-3</ArticleId>
            <ArticleId IdType="pmc">PMC7906642</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">33616486</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1536-0075</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>21</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The American journal of bioethics : AJOB</Title>
                <ISOAbbreviation>Am J Bioeth</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Equitable Access to Research Benefits: Considerations for COVID-19 Vaccine Development and Clinical Trial Crossover.</ArticleTitle>
            <Pagination>
                <MedlinePgn>86-88</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/15265161.2020.1870768</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zaidi</LastName>
                    <ForeName>Danish</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">0000-0003-4629-5599</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Yale University School of Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Miller</LastName>
                    <ForeName>Jennifer</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Yale University School of Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Varma</LastName>
                    <ForeName>Tanvee</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Yale University School of Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boatright</LastName>
                    <ForeName>Dowin</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Yale University School of Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Friesen</LastName>
                    <ForeName>Phoebe</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>McGill University.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016420">Comment</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Bioeth</MedlineTA>
            <NlmUniqueID>100898738</NlmUniqueID>
            <ISSNLinking>1526-5161</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>E</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentOn">
                <RefSource>Am J Bioeth. 2021 Mar;21(3):56-74</RefSource>
                <PMID Version="1">33345745</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D063505" MajorTopicYN="Y">Racism</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>22</Day>
                <Hour>12</Hour>
                <Minute>13</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33616486</ArticleId>
            <ArticleId IdType="doi">10.1080/15265161.2020.1870768</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33615193</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2575-9108</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>4</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>ACS pharmacology &amp; translational science</Title>
                <ISOAbbreviation>ACS Pharmacol Transl Sci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Glycosylation of SARS-CoV-2 Steers Evolutionary Outcomes in the Postvaccination Phase.</ArticleTitle>
            <Pagination>
                <MedlinePgn>410-412</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1021/acsptsci.1c00015</ELocationID>
            <Abstract>
                <AbstractText>There is a need to assess evolutionary outcomes for SARS-CoV-2 in the postvaccination phase. The role of virus glycosylation in deterring the development of vaccine resistance is weighed against the epitopes of extant vaccines and the modulation of induced immune surveillance on antigens containing glycosylation sites.</AbstractText>
                <CopyrightInformation>.. 2021 American Chemical Society.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fern..ndez</LastName>
                    <ForeName>Ariel</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Daruma Institute for AI in Pharmaceutical Research, AF Innovation Pharma Consultancy, 4000 Pemberton Court, Winston-Salem, North Carolina 27106, United States.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>CONICET, National Research Council for Science and Technology, Buenos Aires 1033, Argentina.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>INQUISUR/UNS/CONICET, Avenida Alem 1253, Bah..a Blanca 8000, Argentina.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>ACS Pharmacol Transl Sci</MedlineTA>
            <NlmUniqueID>101721411</NlmUniqueID>
            <ISSNLinking>2575-9108</ISSNLinking>
        </MedlineJournalInfo>
        <CoiStatement>The author declares no competing financial interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2022</Year>
                <Month>01</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33615193</ArticleId>
            <ArticleId IdType="doi">10.1021/acsptsci.1c00015</ArticleId>
            <ArticleId IdType="pmc">PMC7887837</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2020 Sep 3;182(5):1295-1310.e20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32841599</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2020 Sep 14;10(1):14991</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32929138</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Biol. 2020 Nov 9;18(11):e3001000</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33166303</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33615191</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2575-9108</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>4</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>ACS pharmacology &amp; translational science</Title>
                <ISOAbbreviation>ACS Pharmacol Transl Sci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19 Evolution in the Post-Vaccination Phase: Endemic or Extinct?</ArticleTitle>
            <Pagination>
                <MedlinePgn>403-405</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1021/acsptsci.0c00220</ELocationID>
            <Abstract>
                <AbstractText>This piece addresses the urge to assess the evolutionary fate of SARS-CoV-2 in a post-vaccination phase. The possibilities of COVID-19 becoming endemic or extinct are weighed against verifiable properties of extant vaccines and observed genetic trends already apparent under the mild selection pressure exerted almost exclusively by social rules.</AbstractText>
                <CopyrightInformation>.. 2020 American Chemical Society.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fern..ndez</LastName>
                    <ForeName>Ariel</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Daruma Institute for AI in Pharmaceutical Research, AF Innovation Pharma Consultancy, 4000 Pemberton Court, Winston-Salem, North Carolina 27106, United States.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>CONICET, National Research Council for Science and Technology, Buenos Aires 1033, Argentina.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>INQUISUR/UNS/CONICET, Avenida Alem 1253, Bah..a Blanca 8000, Argentina.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>ACS Pharmacol Transl Sci</MedlineTA>
            <NlmUniqueID>101721411</NlmUniqueID>
            <ISSNLinking>2575-9108</ISSNLinking>
        </MedlineJournalInfo>
        <CoiStatement>The author declares no competing financial interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2021</Year>
                <Month>12</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33615191</ArticleId>
            <ArticleId IdType="doi">10.1021/acsptsci.0c00220</ArticleId>
            <ArticleId IdType="pmc">PMC7887839</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2020 Aug 20;182(4):812-827.e19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32697968</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Biol. 2020 Nov 9;18(11):e3001000</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33166303</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biol Evol. 2011 Jan;28(1):707-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20833694</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2011 Dec 3;378(9807):1962-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21492929</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ACS Pharmacol Transl Sci. 2020 Oct 15;3(6):1425-1426</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33344912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ACS Med Chem Lett. 2020 Aug 17;11(9):1667-1670</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32934770</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33612319</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>11</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1768-3122</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>42</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                    </PubDate>
                </JournalIssue>
                <Title>La Revue de medecine interne</Title>
                <ISOAbbreviation>Rev Med Interne</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[In subjects 16 years of age and older, is messenger RNA vaccine BNT162b2 against COVID-19 effective and safe?]</ArticleTitle>
            <Pagination>
                <MedlinePgn>227-228</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0248-8663(21)00026-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.revmed.2021.02.001</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lanthier</LastName>
                    <ForeName>L</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>D..partement de m..decine sp..cialis.., service de m..decine interne g..n..rale, Universit.. de Sherbrooke, Sherbrooke, QC, Canada. Electronic address: luc.lanthier@usherbrooke.ca.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carignan</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>D..partement de microbiologie et d'infectiologie, Universit.. de Sherbrooke, Sherbrooke, QC, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Plourde</LastName>
                    <ForeName>M-..</ForeName>
                    <Initials>M..</Initials>
                    <AffiliationInfo>
                        <Affiliation>D..partement de m..decine nucl..aire et radiobiologie, service de radio-oncologie, Universit.. de Sherbrooke, Sherbrooke, QC, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cauchon</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>D..partement de m..decine familiale et de m..decine d'urgence, Universit.. Laval, Qu..bec, QC, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>fre</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
            </PublicationTypeList>
            <VernacularTitle>Chez des sujets de 16..ans et plus, est-ce que le vaccin BNT162b2, un vaccin .. ARN messager contre la COVID-19, est efficace et s..curitaire..?</VernacularTitle>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Rev Med Interne</MedlineTA>
            <NlmUniqueID>8101383</NlmUniqueID>
            <ISSNLinking>0248-8663</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>N38TVC63NU</RegistryNumber>
                <NameOfSubstance UI="C000706168">BNT162 vaccine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
                <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
                <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016233" MajorTopicYN="N">Immunotherapy, Active</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName>
                <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>22</Day>
                <Hour>5</Hour>
                <Minute>48</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33612319</ArticleId>
            <ArticleId IdType="pii">S0248-8663(21)00026-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.revmed.2021.02.001</ArticleId>
            <ArticleId IdType="pmc">PMC7874978</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33608249</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>29</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Electronic-Print">
            <Journal>
                <ISSN IssnType="Electronic">2375-2548</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <Issue>12</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Science advances</Title>
                <ISOAbbreviation>Sci Adv</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">eabe8065</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.abe8065</ELocationID>
            <Abstract>
                <AbstractText>Multiple preventive vaccines are being developed to counter the coronavirus disease 2019 pandemic. The leading candidates have now been evaluated in nonhuman primates (NHPs) and human phase 1 and/or phase 2 clinical trials. Several vaccines have already advanced into phase 3 efficacy trials, while others will do so before the end of 2020. Here, we summarize what is known of the antibody and T cell immunogenicity of these vaccines in NHPs and humans. To the extent possible, we compare how the vaccines have performed, taking into account the use of different assays to assess immunogenicity and inconsistencies in how the resulting data are presented. We also review the outcome of challenge experiments with severe acute respiratory syndrome coronavirus 2 in immunized macaques, while noting variations in the protocols used, including but not limited to the virus challenge doses. Press releases on the outcomes of vaccine efficacy trials are also summarized.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Klasse</LastName>
                    <ForeName>P J</ForeName>
                    <Initials>PJ</Initials>
                    <Identifier Source="ORCID">0000-0001-8222-278X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nixon</LastName>
                    <ForeName>Douglas F</ForeName>
                    <Initials>DF</Initials>
                    <Identifier Source="ORCID">0000-0002-2801-1786</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moore</LastName>
                    <ForeName>John P</ForeName>
                    <Initials>JP</Initials>
                    <Identifier Source="ORCID">0000-0002-9902-6096</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065, USA. jpm2003@med.cornell.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>P01 AI110657</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 AI036082</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>03</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Sci Adv</MedlineTA>
            <NlmUniqueID>101653440</NlmUniqueID>
            <ISSNLinking>2375-2548</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000071497" MajorTopicYN="N">Immunogenicity, Vaccine</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008253" MajorTopicYN="N">Macaca mulatta</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>20</Day>
                <Hour>5</Hour>
                <Minute>30</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33608249</ArticleId>
            <ArticleId IdType="pii">sciadv.abe8065</ArticleId>
            <ArticleId IdType="doi">10.1126/sciadv.abe8065</ArticleId>
            <ArticleId IdType="pmc">PMC7978427</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2021 Jan 9;397(10269):99-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33306989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Jul 3;369(6499):77-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32376603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Oct 31;396(10260):e68-e69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33091364</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 14;369(6505):806-811</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32434945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Sep;585(7824):268-272</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32396922</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2020 May 13;27(5):695-698</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32407707</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Sep 8;324(10):951-960</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32789505</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):578-582</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32731258</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Oct 15;383(16):1544-1555</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32722908</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Med. 2020 Nov 2;217(11):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32692348</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):467-478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 Nov 25;38(50):7892-7896</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33139139</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2020 Oct 21;58(11):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32826322</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):567-571</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32756549</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):594-599</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32998157</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 12;383(20):1920-1931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32663912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>mBio. 2021 Feb 16;12(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33593976</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3880-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15004274</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2021 Jan 21;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33485468</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Microbiol. 2020 Dec;5(12):1598-1607</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33106674</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Aug 20;182(4):812-827.e19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32697968</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Microbes Infect. 2020 Dec;9(1):2653-2662</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33232205</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Sep 18;369(6510):1501-1505</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32703906</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 May;581(7809):465-469</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32235945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prog Mol Biol Transl Sci. 2015;129:327-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25595809</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2021 Feb;27(2):279-288</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33335322</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2021 Mar 1;12(1):1346</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33649323</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):589-593</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32785213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2021 Feb 24;223(4):699-708</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32851411</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):479-488</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2021 Jan;21(1):39-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33069281</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Sep 26;396(10255):887-897</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32896291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Oct 29;383(18):1701-1703</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32846056</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2021 Mar;591(7851):639-644</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33461210</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Microbes Infect. 2020 Dec;9(1):2606-2618</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33241728</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Nov 27;370(6520):1089-1094</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33082295</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Dec;20(12):727-738</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33139888</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2020 Aug 17;94(17):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32591466</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Jun 13;395(10240):1845-1854</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32450106</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Rev. 2011 Jan;239(1):109-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21198668</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 10;383(24):2320-2332</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32877576</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 17;383(25):2427-2438</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32991794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Aug 6;182(3):713-721.e9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32778225</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):583-588</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32731257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 29;368(6494):1012-1015</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32303590</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 May 20;11(1):2601</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32433465</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2020 Apr 8;27(4):507-518</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32272076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):516-527</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32967006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Oct 1;183(1):169-184.e13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32931734</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Aug 14;11(1):4081</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32796842</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Retrovirology. 2012 Oct 01;9:80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23025660</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Nov;26(11):1694-1700</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32884153</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>NPJ Vaccines. 2020 Sep 28;5:91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33083026</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Nov 09;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33165503</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 29;368(6494):945-946</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32385100</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2021 Dec 19;396(10267):1979-1993</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33220855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>NPJ Vaccines. 2020 Jul 27;5:69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32793398</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Pharmacol. 2020 Nov;177(21):4851-4865</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32462701</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Vaccine Immunol. 2010 Jul;17(7):1055-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20463105</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>mBio. 2021 Mar 2;12(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33653892</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 31;383(27):2603-2615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2021 Jan 14;12(1):372</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33446655</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Biol. 2014;2014:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27099867</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 17;383(25):2439-2450</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33053279</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 7;384(1):80-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33270381</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2013 Nov 1;342(6158):592-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24179220</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2020 Apr 14;52(4):583-589</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32259480</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 1993 Aug 15;151(4):2032-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8345194</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33606782</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>16</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS One</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Attitudes, current behaviours and barriers to public health measures that reduce COVID-19 transmission: A qualitative study to inform public health messaging.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0246941</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0246941</ELocationID>
            <Abstract>
                <AbstractText>Public health measures to reduce COVID-19 transmission include masking in public places, physical distancing, staying home when ill, avoiding high-risk locations, using a contact tracing app, and being willing to take a COVID-19 vaccine. However, adoption of these measures varies greatly. We aimed to improve health messaging to increase adherence to public health behaviours to reduce COVID-19 transmission by: 1) determining attitudes towards public health measures and current behaviours; 2) identifying barriers to following public health measures; and, 3) identifying public health communication strategies. We recruited participants from a random panel of 3000 phone numbers across Alberta to fill a predetermined quota: age (18-29; 30-59; 60+ years), geographic location (urban; rural), and whether they had school-age children. Two researchers coded and themed all transcripts. We performed content analysis and in-depth thematic analysis. Nine focus groups were conducted with 2-8 participants/group in August-September, 2020. Several themes were identified: 1) importance of public health measures; 2) compliance with public health measures; 3) critiques of public health messaging; and 4) suggestions for improving public health messaging. Physical distancing and masking were seen as more important than using a contact tracing app. There were mixed views around willingness to take COVID-19 vaccine. Current public health messaging was perceived as conflicting. Participants felt that consistent messaging and using social media to reach younger people would be helpful. In conclusion, these findings provide insights that can be used to inform targeted (e.g., by age, current behaviour) public health communications to encourage behaviors that reduce COVID-19 transmission.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Benham</LastName>
                    <ForeName>Jamie L</ForeName>
                    <Initials>JL</Initials>
                    <Identifier Source="ORCID">0000-0002-2233-4613</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lang</LastName>
                    <ForeName>Raynell</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kovacs Burns</LastName>
                    <ForeName>Katharina</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Data &amp; Analytics, Alberta Health Services, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, University of Alberta, Edmonton, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>MacKean</LastName>
                    <ForeName>Gail</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>L..veill..</LastName>
                    <ForeName>Tova</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Data &amp; Analytics, Alberta Health Services, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McCormack</LastName>
                    <ForeName>Brandi</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Data &amp; Analytics, Alberta Health Services, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sheikh</LastName>
                    <ForeName>Hasan</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fullerton</LastName>
                    <ForeName>Madison M</ForeName>
                    <Initials>MM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tang</LastName>
                    <ForeName>Theresa</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boucher</LastName>
                    <ForeName>Jean-Christophe</ForeName>
                    <Initials>JC</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Policy and Department of Political Science, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Constantinescu</LastName>
                    <ForeName>Cora</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mourali</LastName>
                    <ForeName>Mehdi</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Haskayne School of Business, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oxoby</LastName>
                    <ForeName>Robert J</ForeName>
                    <Initials>RJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Economics, Faculty of Arts, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Manns</LastName>
                    <ForeName>Braden J</ForeName>
                    <Initials>BJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Jia</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">0000-0002-6548-3985</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marshall</LastName>
                    <ForeName>Deborah A</ForeName>
                    <Initials>DA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016430">Clinical Trial</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000416" MajorTopicYN="N" Type="Geographic">Alberta</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016358" MajorTopicYN="Y">Contact Tracing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015438" MajorTopicYN="Y">Health Behavior</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007722" MajorTopicYN="Y">Health Knowledge, Attitudes, Practice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D061108" MajorTopicYN="Y">Social Media</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>19</Day>
                <Hour>17</Hour>
                <Minute>12</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33606782</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0246941</ArticleId>
            <ArticleId IdType="pii">PONE-D-20-35787</ArticleId>
            <ArticleId IdType="pmc">PMC7895406</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Hum Behav. 2020 May;4(5):460-471</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32355299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pers Individ Dif. 2021 Feb 15;170:110420</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33082614</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychol Sci. 2020 Nov;31(11):1363-1373</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32993455</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Aug;20(8):911-919</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32353347</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2021 Feb;27(2):225-228</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33082575</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Apr 14;323(14):1406-1407</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32083643</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pers Individ Dif. 2020 Nov 1;166:110220</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32834279</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Implement Sci. 2017 Jun 21;12(1):77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28637486</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Behav Med. 2012 Feb;43(1):101-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21993844</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 May 28;382(22):2081-2090</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32329971</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2020 Oct 23;15(10):e0241259</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33095836</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):751-758</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32555138</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Mar 5;382(10):970-971</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32003551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Euro Surveill. 2020 Mar;25(10):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32183930</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 8;368(6491):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32234805</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Educ Behav. 2000 Oct;27(5):591-615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11009129</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2020 Oct 7;15(10):e0239795</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33027281</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2020 Jul 21;173(2):100-109</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32271861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2020 May;26(5):1052-1054</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32091386</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Qual Health Care. 2007 Dec;19(6):349-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17872937</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33606033</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2574-3805</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>4</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JAMA network open</Title>
                <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e2037640</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2020.37640</ELocationID>
            <Abstract>
                <AbstractText Label="Importance">Medical research has not equitably included members of racial/ethnic minority groups or female and older individuals. There are limited data on participant demographic characteristics in vaccine trials despite the importance of these data to current trials aimed at preventing coronavirus disease 2019.</AbstractText>
                <AbstractText Label="Objective">To investigate whether racial/ethnic minority groups and female and older adults are underrepresented among participants in vaccine clinical trials.</AbstractText>
                <AbstractText Label="Design, Setting, and Participants">This cross-sectional study examined data from completed US-based vaccine trials registered on ClinicalTrials.gov from July 1, 2011, through June 30, 2020. The terms vaccine, vaccination, immunization, and inoculation were used to identify trials. Only those addressing vaccine immunogenicity or efficacy of preventative vaccines were included.</AbstractText>
                <AbstractText Label="Main Outcomes and Measures">The numbers and percentages of racial/ethnic minority, female, and older individuals compared with US census data from 2011 and 2018. Secondary outcome measures were inclusion by trial phase and year of completion.</AbstractText>
                <AbstractText Label="Results">A total of 230 US-based trials with 219...555 participants were included in the study. Most trials were randomized (180 [78.3%]), included viral vaccinations (159 [69.1%]), and represented all trial phases. Every trial reported age and sex; 134 (58.3%) reported race and 79 (34.3%) reported ethnicity. Overall, among adult study participants, White individuals were overrepresented (77.9%; 95% CI, 77.4%-78.4%), and Black or African American individuals (10.6%; 95% CI, 10.2%-11.0%) and American Indian or Alaska Native individuals (0.4%; 95% CI, 0.3%-0.5%) were underrepresented compared with US census data; enrollment of Asian individuals was similar (5.7%; 95% CI, 5.5%-6.0%). Enrollment of Hispanic or Latino individuals (11.6%; 95% CI, 11.1%-12.0%) was also low even among the limited number of adult trials reporting ethnicity. Adult trials were composed of more female participants (75...325 [56.0%]), but among those reporting age as a percentage, enrollment of participants who were aged 65 years or older was low (12.1%; 95% CI, 12.0%-12.3%). Black or African American participants (10.1%; 95% CI, 9.7%-10.6%) and Hispanic or Latino participants (22.5%; 95% CI, 21.6%-23.4%) were also underrepresented in pediatric trials. Among trials reporting race/ethnicity, 65 (48.5%) did not include American Indian or Alaska Native participants and 81 (60.4%) did not include Hawaiian or Pacific Islander participants.</AbstractText>
                <AbstractText Label="Conclusions and Relevance">This cross-sectional study found that among US-based vaccine clinical trials, members of racial/ethnic minority groups and older adults were underrepresented, whereas female adults were overrepresented. These findings suggest that diversity enrollment targets should be included for all vaccine trials targeting epidemiologically important infections.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Flores</LastName>
                    <ForeName>Laura E</ForeName>
                    <Initials>LE</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Allied Health Professions, University of Nebraska Medical Center, Omaha.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Frontera</LastName>
                    <ForeName>Walter R</ForeName>
                    <Initials>WR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Medicine, Rehabilitation and Sports Medicine and Department of Physiology, University of Puerto Rico School of Medicine, San Juan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andrasik</LastName>
                    <ForeName>Michele P</ForeName>
                    <Initials>MP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Del Rio</LastName>
                    <ForeName>Carlos</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Hubert Department of Global Health, Rollin School of Public Health of Emory University, Atlanta, Georgia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mondr..guez-Gonz..lez</LastName>
                    <ForeName>Antonio</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Universidad Central del Caribe, Bayam..n, Puerto Rico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Price</LastName>
                    <ForeName>Stephanie A</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hellen Keller International, New York, New York.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krantz</LastName>
                    <ForeName>Elizabeth M</ForeName>
                    <Initials>EM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pergam</LastName>
                    <ForeName>Steven A</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Silver</LastName>
                    <ForeName>Julie K</ForeName>
                    <Initials>JK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Spaulding Rehabilitation Hospital, Charlestown, Massachusetts.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Medicine and Rehabilitation, Massachusetts General Hospital, Boston.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Medicine and Rehabilitation, Brigham and Women's Hospital, Boston, Massachusetts.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>JAMA Netw Open</MedlineTA>
            <NlmUniqueID>101729235</NlmUniqueID>
            <ISSNLinking>2574-3805</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014612">Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D044383" MajorTopicYN="N">African Continental Ancestry Group</DescriptorName>
                <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D044466" MajorTopicYN="N">Asian Continental Ancestry Group</DescriptorName>
                <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
                <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D044469" MajorTopicYN="N">Continental Population Groups</DescriptorName>
                <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005006" MajorTopicYN="N">Ethnic Groups</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D044465" MajorTopicYN="N">European Continental Ancestry Group</DescriptorName>
                <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D044468" MajorTopicYN="N">Oceanic Ancestry Group</DescriptorName>
                <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018579" MajorTopicYN="Y">Patient Selection</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D063507" MajorTopicYN="N">Sexism</DescriptorName>
                <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>19</Day>
                <Hour>12</Hour>
                <Minute>12</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33606033</ArticleId>
            <ArticleId IdType="pii">2776562</ArticleId>
            <ArticleId IdType="doi">10.1001/jamanetworkopen.2020.37640</ArticleId>
            <ArticleId IdType="pmc">PMC7896193</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2014 Aug 14;371(7):635-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25119609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Oncol. 2019 Aug 15;:e191870</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31415071</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Aug 4;324(5):437-438</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32628244</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2018 Nov 29;36(50):7682-7688</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30377066</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2018 Sep 25;36(40):5940-5948</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30153995</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Oncol Pract. 2018 Jan;14(1):e1-e10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29099678</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4031-4033</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28396427</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Public Health. 2015 Dec;105(12):e60-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26469668</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Care. 2012 Apr;50(4):327-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22388557</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>SSM Popul Health. 2017 Nov 14;4:25-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29349270</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Med. 2020 Sep 4;18(1):271</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32883276</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Epidemiol. 2020 Jul;47:1-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32419765</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Soc Sci Med. 2017 Nov;193:70-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29028558</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Infect Dis J. 2018 Feb;37(2):126-131</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28777209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2020 Aug 11;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32780860</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 Sep 22;38(41):6381-6387</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32826103</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Epidemiol. 2020 Jul;47:37-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32419766</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 May 22;69(20):623-629</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32437342</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2015 Nov 27;33 Suppl 4:D60-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26116257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Open Forum Infect Dis. 2019 Jul 1;6(7):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31363771</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2021 Feb 16;72(4):703-706</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32562416</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2017 Jan 12;12(1):e0169679</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28081234</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Care. 2015 Oct;53(10):872-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26366519</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2018 May;557(7704):157-159</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29743700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Intern Med. 2020 Jul 15;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32667668</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Control. 2016 Oct;23(4):327-337</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27842322</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharm Pract (Granada). 2016 Jan-Mar;14(1):708</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27011778</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Geriatr Med. 2018 Feb;34(1):131-143</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29129213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Control Clin Trials. 1995 Oct;16(5):277-85; discussion 286-9, 293-309</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8582146</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2017 Nov;17(11):1099</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29115253</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Aug 27;383(9):e59</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32780573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2012 Dec;55(11):1450-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22806592</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2020 Dec 1;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33253040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2014 Apr 1;120 Suppl 7:1091-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24643646</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Patient Educ Couns. 2016 Jan;99(1):147-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26321294</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 2015 Mar;97(3):263-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25669658</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Serv Res. 2018 Oct;53(5):3640-3656</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29468669</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2020 Jan 1;126(9):1958-1968</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32147815</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Netw Open. 2020 May 1;3(5):e205202</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32437574</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Suppl. 2014 Apr 18;63(1):7-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24743661</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 31;383(27):2603-2615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Intern Med. 2002 Nov 25;162(21):2458-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12437405</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33605892</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>03</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2369-2960</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JMIR public health and surveillance</Title>
                <ISOAbbreviation>JMIR Public Health Surveill</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Influenza and Respiratory Virus Surveillance, Vaccine Uptake, and Effectiveness at a Time of Cocirculating COVID-19: Protocol for the English Primary Care Sentinel System for 2020-2021.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e24341</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2196/24341</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">The Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) and Public Health England (PHE) are commencing their 54th season of collaboration at a time when SARS-CoV-2 infections are likely to be cocirculating with the usual winter infections.</AbstractText>
                <AbstractText Label="OBJECTIVE">The aim of this study is to conduct surveillance of influenza and other monitored respiratory conditions and to report on vaccine uptake and effectiveness using nationally representative surveillance data extracted from primary care computerized medical records systems. We also aim to have general practices collect virology and serology specimens and to participate in trials and other interventional research.</AbstractText>
                <AbstractText Label="METHODS">The RCGP RSC network comprises over 1700 general practices in England and Wales. We will extract pseudonymized data twice weekly and are migrating to a system of daily extracts. First, we will collect pseudonymized, routine, coded clinical data for the surveillance of monitored and unexpected conditions; data on vaccine exposure and adverse events of interest; and data on approved research study outcomes. Second, we will provide dashboards to give general practices feedback about levels of care and data quality, as compared to other network practices. We will focus on collecting data on influenza-like illness, upper and lower respiratory tract infections, and suspected COVID-19. Third, approximately 300 practices will participate in the 2020-2021 virology and serology surveillance; this will include responsive surveillance and long-term follow-up of previous SARS-CoV-2 infections. Fourth, member practices will be able to recruit volunteer patients to trials, including early interventions to improve COVID-19 outcomes and point-of-care testing. Lastly, the legal basis for our surveillance with PHE is Regulation 3 of the Health Service (Control of Patient Information) Regulations 2002; other studies require appropriate ethical approval.</AbstractText>
                <AbstractText Label="RESULTS">The RCGP RSC network has tripled in size; there were previously 100 virology practices and 500 practices overall in the network and we now have 322 and 1724, respectively. The Oxford-RCGP Clinical Informatics Digital Hub (ORCHID) secure networks enable the daily analysis of the extended network; currently, 1076 practices are uploaded. We are implementing a central swab distribution system for patients self-swabbing at home in addition to in-practice sampling. We have converted all our primary care coding to Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) coding. Throughout spring and summer 2020, the network has continued to collect specimens in preparation for the winter or for any second wave of COVID-19 cases. We have collected 5404 swabs and detected 623 cases of COVID-19 through extended virological sampling, and 19,341 samples have been collected for serology. This shows our preparedness for the winter season.</AbstractText>
                <AbstractText Label="CONCLUSIONS">The COVID-19 pandemic has been associated with a groundswell of general practices joining our network. It has also created a permissive environment in which we have developed the capacity and capability of the national primary care surveillance systems and our unique public health institute, the RCGP and University of Oxford collaboration.</AbstractText>
                <CopyrightInformation>..Simon de Lusignan, Jamie Lopez Bernal, Rachel Byford, Gayatri Amirthalingam, Filipa Ferreira, Oluwafunmi Akinyemi, Nick Andrews, Helen Campbell, Gavin Dabrera, Alexandra Deeks, Alex J Elliot, Else Krajenbrink, Harshana Liyanage, Dylan McGagh, Cecilia Okusi, Vaishnavi Parimalanathan, Mary Ramsay, Gillian Smith, Manasa Tripathy, John Williams, William Victor, Maria Zambon, Gary Howsam, Brian David Nicholson, Victoria Tzortziou Brown, Christopher C Butler, Mark Joy, FD Richard Hobbs. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 19.02.2021.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>de Lusignan</LastName>
                    <ForeName>Simon</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">0000-0002-8553-2641</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Lopez Bernal</LastName>
                    <ForeName>Jamie</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">0000-0002-1301-5653</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Byford</LastName>
                    <ForeName>Rachel</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">0000-0002-4792-8995</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Amirthalingam</LastName>
                    <ForeName>Gayatri</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">0000-0003-2078-0975</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Ferreira</LastName>
                    <ForeName>Filipa</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">0000-0002-7717-8486</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Akinyemi</LastName>
                    <ForeName>Oluwafunmi</ForeName>
                    <Initials>O</Initials>
                    <Identifier Source="ORCID">0000-0003-0401-0145</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andrews</LastName>
                    <ForeName>Nick</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">0000-0003-2069-2684</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Campbell</LastName>
                    <ForeName>Helen</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">0000-0001-9840-8917</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dabrera</LastName>
                    <ForeName>Gavin</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">0000-0003-4606-5945</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Deeks</LastName>
                    <ForeName>Alexandra</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">0000-0001-8895-317X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Elliot</LastName>
                    <ForeName>Alex J</ForeName>
                    <Initials>AJ</Initials>
                    <Identifier Source="ORCID">0000-0002-6414-3065</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krajenbrink</LastName>
                    <ForeName>Else</ForeName>
                    <Initials>E</Initials>
                    <Identifier Source="ORCID">0000-0002-6563-9441</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liyanage</LastName>
                    <ForeName>Harshana</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">0000-0001-9738-6349</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McGagh</LastName>
                    <ForeName>Dylan</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">0000-0002-6772-2775</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Okusi</LastName>
                    <ForeName>Cecilia</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">0000-0002-5575-8527</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Parimalanathan</LastName>
                    <ForeName>Vaishnavi</ForeName>
                    <Initials>V</Initials>
                    <Identifier Source="ORCID">0000-0002-0458-9049</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ramsay</LastName>
                    <ForeName>Mary</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">0000-0002-7156-7640</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Smith</LastName>
                    <ForeName>Gillian</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">0000-0002-4257-0568</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tripathy</LastName>
                    <ForeName>Manasa</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">0000-0001-9840-3876</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Williams</LastName>
                    <ForeName>John</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">0000-0002-6118-0434</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Victor</LastName>
                    <ForeName>William</ForeName>
                    <Initials>W</Initials>
                    <Identifier Source="ORCID">0000-0003-3660-6517</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zambon</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">0000-0002-8897-7881</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Howsam</LastName>
                    <ForeName>Gary</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">0000-0001-6699-5504</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nicholson</LastName>
                    <ForeName>Brian David</ForeName>
                    <Initials>BD</Initials>
                    <Identifier Source="ORCID">0000-0003-0661-7362</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tzortziou Brown</LastName>
                    <ForeName>Victoria</ForeName>
                    <Initials>V</Initials>
                    <Identifier Source="ORCID">0000-0001-9819-6395</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Butler</LastName>
                    <ForeName>Christopher C</ForeName>
                    <Initials>CC</Initials>
                    <Identifier Source="ORCID">0000-0002-0088-645X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Joy</LastName>
                    <ForeName>Mark</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">0000-0002-4974-3724</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hobbs</LastName>
                    <ForeName>F D Richard</ForeName>
                    <Initials>FDR</Initials>
                    <Identifier Source="ORCID">0000-0001-7976-7172</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Canada</Country>
            <MedlineTA>JMIR Public Health Surveill</MedlineTA>
            <NlmUniqueID>101669345</NlmUniqueID>
            <ISSNLinking>2369-2960</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014612">Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>H</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002985" MajorTopicYN="Y">Clinical Protocols</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014612" MajorTopicYN="N">Vaccines</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">computerized medical record systems</Keyword>
            <Keyword MajorTopicYN="Y">coronavirus infections</Keyword>
            <Keyword MajorTopicYN="Y">general practice</Keyword>
            <Keyword MajorTopicYN="Y">influenza</Keyword>
            <Keyword MajorTopicYN="Y">records as topic</Keyword>
            <Keyword MajorTopicYN="Y">sentinel surveillance</Keyword>
            <Keyword MajorTopicYN="Y">serology</Keyword>
            <Keyword MajorTopicYN="Y">virology</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>19</Day>
                <Hour>12</Hour>
                <Minute>11</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33605892</ArticleId>
            <ArticleId IdType="pii">v7i2e24341</ArticleId>
            <ArticleId IdType="doi">10.2196/24341</ArticleId>
            <ArticleId IdType="pmc">PMC7899204</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Epidemiol Infect. 2008 Jul;136(7):866-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18047750</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2017 Dec 8;17(1):757</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29216845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Med. 2020 Feb 11;9(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32054124</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Inform Prim Care. 2005;13(1):65-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15949178</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JMIR Public Health Surveill. 2020 Apr 2;6(2):e18606</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32240095</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stud Health Technol Inform. 2020 Jun 16;270:1339-1340</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32570648</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2017 Mar;5(3):161-162</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28189521</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stud Health Technol Inform. 2018;247:151-155</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29677941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Netw Open. 2020 Jun 1;3(6):e2012005</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32530469</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Innov Health Inform. 2015 Nov 04;22(3):368-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26577427</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BJGP Open. 2020 Jun 23;4(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32295793</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Euro Surveill. 2017 Apr 6;22(14):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28422004</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2016 Sep 12;354:i4515</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27618829</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ Open. 2018 Aug 20;8(8):e020282</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30127048</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JMIR Public Health Surveill. 2020 Jul 2;6(3):e19773</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32484782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Aug 4;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32763192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 May 8;38(22):3869-3880</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32299719</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Data. 2016 Mar 15;3:160018</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26978244</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2013 Jun 26;31(30):3104-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23624093</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ Open. 2020 Nov 12;10(11):e042626</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33184088</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2020 Aug 2;16(8):1762-1771</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32118513</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Jun 25;369:m2484</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32586845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ Open. 2016 Apr 20;6(4):e011092</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27098827</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Euro Surveill. 2015 Mar 12;20(10):21058</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25788252</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Sep;20(9):1034-1042</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32422204</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Gen Pract. 2017 Oct;67(663):440-441</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28963401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Gen Pract. 2017 Jan;67(654):e29-e40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27993900</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2019;15(5):1048-1059</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30648923</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stud Health Technol Inform. 2018;255:60-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30306907</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2012 Feb 8;30(7):1371-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22178524</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JMIR Res Protoc. 2019 Nov 11;8(11):e14186</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31710303</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bull World Health Organ. 2018 Feb 1;96(2):122-128</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29403115</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2017 Jan 21;389(10066):250-251</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28118910</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Gen Pract. 2020 Jul 30;70(697):e555-e562</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32661013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2016 Aug 13;388(10045):728-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27059886</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Epidemiol. 2000 Apr;29(2):362-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10817137</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Gen Pract. 2020 Jul 30;70(697):e540-e547</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32661009</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ Open. 2019 Mar 8;9(3):e024285</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30852535</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2017 Nov 9;359:j5084</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29122753</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33605848</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>19</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1875-533X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Current medicinal chemistry</Title>
                <ISOAbbreviation>Curr Med Chem</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Advances of Inorganic Materials in the Detection and Therapeutic Uses Against Coronaviruses.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.2174/0929867328666210219142208</ELocationID>
            <Abstract>
                <AbstractText>Coronaviruses (CoVs) are enveloped viruses with particle-like characteristics and a diameter of 60-140 nm, positively charged, and single-stranded RNA genomes which produce a major outbreak of human fatal pneumonia since the beginning of the 21st century. COVID-19 is currently considered as a continuous potential pandemic threat across the globe. Therefore, considerable efforts have been made to develop innovative methods and technologies for suppressing the spread of viruses as well as inactivating the viruses but COVID-19 vaccines are still in the development phase. This perspective focuses on the sensing, detection and therapeutic applications of CoVs using inorganic-based nanomaterials, metal complexes, and metal-conjugates. Synthetic inorganic-based nanoparticles interact strongly with proteins of viruses due to their morphological similarities, and therefore, numerous antivirals have been tested for efficacy against different viruses in vitro through colorimetric and electrochemical assays. Metal complexes-based agents such as bismuth complexes form attractive class of drugs with a number of therapeutic applications including the inhibition and duplex-unwinding activity of SARS-CoV helicase by quantitative real-time PCR (Q-RT-PCR), phosphate release assay and radioassay studies. Metal-conjugates show major effects on inhibiting the 3C-like protease of SARS-CoV and the replication of RNA-dependent RNA polymerase (RdRp). We anticipate that these approaches will provide rapid and accurate antiviral strategies in the development of these innovative sensors for the detection, inhibition and antiviral activities of coronaviruses.</AbstractText>
                <CopyrightInformation>Copyright.. Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Veerasamy</LastName>
                    <ForeName>Sathish</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, Bannari Amman Institute of Technology, Sathyamangalam - 638 401. India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chandrakumar</LastName>
                    <ForeName>Manivannan</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, Bannari Amman Institute of Technology, Sathyamangalam - 638 401. India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Balasubramaniyan</LastName>
                    <ForeName>Malathi</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, Bannari Amman Institute of Technology, Sathyamangalam - 638 401. India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arumugam</LastName>
                    <ForeName>Ramesh Kumar</ForeName>
                    <Initials>RK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, Bannari Amman Institute of Technology, Sathyamangalam - 638 401. India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pounraj</LastName>
                    <ForeName>Thanasekaran</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, Fu Jen Catholic University, New Taipei City 242. Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United Arab Emirates</Country>
            <MedlineTA>Curr Med Chem</MedlineTA>
            <NlmUniqueID>9440157</NlmUniqueID>
            <ISSNLinking>0929-8673</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Coronavirus (CoV)</Keyword>
            <Keyword MajorTopicYN="N">RNA</Keyword>
            <Keyword MajorTopicYN="N">metal complexes</Keyword>
            <Keyword MajorTopicYN="N">metal-conjugates</Keyword>
            <Keyword MajorTopicYN="N">metallic nanoparticles</Keyword>
            <Keyword MajorTopicYN="N">sensing and inhibition.</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>19</Day>
                <Hour>12</Hour>
                <Minute>10</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33605848</ArticleId>
            <ArticleId IdType="pii">CMC-EPUB-114396</ArticleId>
            <ArticleId IdType="doi">10.2174/0929867328666210219142208</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33602838</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>08</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1095-9203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>371</Volume>
                    <Issue>6531</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Science (New York, N.Y.)</Title>
                <ISOAbbreviation>Science</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The long road.</ArticleTitle>
            <Pagination>
                <MedlinePgn>768-772</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1126/science.371.6531.768</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cohen</LastName>
                    <ForeName>Jon</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>San Diego.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Science</MedlineTA>
            <NlmUniqueID>0404511</NlmUniqueID>
            <ISSNLinking>0036-8075</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <SupplMeshList>
            <SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058345" MajorTopicYN="N">Asymptomatic Infections</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D032521" MajorTopicYN="N">Immunity, Herd</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000071497" MajorTopicYN="N">Immunogenicity, Vaccine</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D032541" MajorTopicYN="Y">Mass Vaccination</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>19</Day>
                <Hour>5</Hour>
                <Minute>55</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33602838</ArticleId>
            <ArticleId IdType="pii">371/6531/768</ArticleId>
            <ArticleId IdType="doi">10.1126/science.371.6531.768</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33602071</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>19</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1875-533X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Current medicinal chemistry</Title>
                <ISOAbbreviation>Curr Med Chem</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Viral Envelope Membrane: A Special Entry Pathway and a Promising Drug Target.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.2174/0929867328666210218182203</ELocationID>
            <Abstract>
                <AbstractText>Enveloped viruses belong to a large class of pathogens responsible for multiple serious diseases. Their spread into new territories has been the cause of major epidemics throughout human history, including the Spanish flu in 1918 and the latest COVID-19 pandemic. Thanks to their outer membrane, consisting essentially of host lipids, enveloped viruses are more resistant to enzymes, and are also less susceptible to host immune defenses than their naked counterparts. Therefore, the development of effective approaches to combat enveloped virus infections represents a major challenge for antiviral therapy in the current century. This review focuses on the characteristics of enveloped viruses, their importance in the entry phase, drugs targeting envelope membrane-mediated entry, and those specifically designed to target the envelope. The broad-spectrum antiviral activity of these compounds can be attributed to their ability to affect the envelope, an essential structural feature common to several viruses. This makes this class of compounds agents of great interest when no specific drugs or vaccines are available to block viral infections.</AbstractText>
                <CopyrightInformation>Copyright.. Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Palombi</LastName>
                    <ForeName>Nastasja</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, . Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brai</LastName>
                    <ForeName>Annalaura</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Lead Discovery Siena s.r.l., Castelnuovo Berardenga, . Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gerace</LastName>
                    <ForeName>Martina</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, . Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Di Maria</LastName>
                    <ForeName>Salvatore</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, . Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Orofino</LastName>
                    <ForeName>Francesco</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, . Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Corelli</LastName>
                    <ForeName>Federico</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, . Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United Arab Emirates</Country>
            <MedlineTA>Curr Med Chem</MedlineTA>
            <NlmUniqueID>9440157</NlmUniqueID>
            <ISSNLinking>0929-8673</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">broad-spectrum antiviral agents</Keyword>
            <Keyword MajorTopicYN="N">emerging viruses.</Keyword>
            <Keyword MajorTopicYN="N">entry</Keyword>
            <Keyword MajorTopicYN="N">envelope</Keyword>
            <Keyword MajorTopicYN="N">lipids</Keyword>
            <Keyword MajorTopicYN="N">membrane</Keyword>
            <Keyword MajorTopicYN="N">virus</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>19</Day>
                <Hour>5</Hour>
                <Minute>40</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33602071</ArticleId>
            <ArticleId IdType="pii">CMC-EPUB-114352</ArticleId>
            <ArticleId IdType="doi">10.2174/0929867328666210218182203</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">33600346</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>07</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1438-8871</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>23</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of medical Internet research</Title>
                <ISOAbbreviation>J Med Internet Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Comprehensive Overview of the COVID-19 Literature: Machine Learning-Based Bibliometric Analysis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e23703</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2196/23703</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">Shortly after the emergence of COVID-19, researchers rapidly mobilized to study numerous aspects of the disease such as its evolution, clinical manifestations, effects, treatments, and vaccinations. This led to a rapid increase in the number of COVID-19-related publications. Identifying trends and areas of interest using traditional review methods (eg, scoping and systematic reviews) for such a large domain area is challenging.</AbstractText>
                <AbstractText Label="OBJECTIVE">We aimed to conduct an extensive bibliometric analysis to provide a comprehensive overview of the COVID-19 literature.</AbstractText>
                <AbstractText Label="METHODS">We used the COVID-19 Open Research Dataset (CORD-19) that consists of a large number of research articles related to all coronaviruses. We used a machine learning-based method to analyze the most relevant COVID-19-related articles and extracted the most prominent topics. Specifically, we used a clustering algorithm to group published articles based on the similarity of their abstracts to identify research hotspots and current research directions. We have made our software accessible to the community via GitHub.</AbstractText>
                <AbstractText Label="RESULTS">Of the 196,630 publications retrieved from the database, we included 28,904 in our analysis. The mean number of weekly publications was 990 (SD 789.3). The country that published the highest number of COVID-19-related articles was China (2950/17,270, 17.08%). The highest number of articles were published in bioRxiv. Lei Liu affiliated with the Southern University of Science and Technology in China published the highest number of articles (n=46). Based on titles and abstracts alone, we were able to identify 1515 surveys, 733 systematic reviews, 512 cohort studies, 480 meta-analyses, and 362 randomized control trials. We identified 19 different topics covered among the publications reviewed. The most dominant topic was public health response, followed by clinical care practices during the COVID-19 pandemic, clinical characteristics and risk factors, and epidemic models for its spread.</AbstractText>
                <AbstractText Label="CONCLUSIONS">We provide an overview of the COVID-19 literature and have identified current hotspots and research directions. Our findings can be useful for the research community to help prioritize research needs and recognize leading COVID-19 researchers, institutes, countries, and publishers. Our study shows that an AI-based bibliometric analysis has the potential to rapidly explore a large corpus of academic publications during a public health crisis. We believe that this work can be used to analyze other eHealth-related literature to help clinicians, administrators, and policy makers to obtain a holistic view of the literature and be able to categorize different topics of the existing research for further analyses. It can be further scaled (for instance, in time) to clinical summary documentation. Publishers should avoid noise in the data by developing a way to trace the evolution of individual publications and unique authors.</AbstractText>
                <CopyrightInformation>..Alaa Abd-Alrazaq, Jens Schneider, Borbala Mifsud, Tanvir Alam, Mowafa Househ, Mounir Hamdi, Zubair Shah. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 08.03.2021.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Abd-Alrazaq</LastName>
                    <ForeName>Alaa</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">0000-0001-7695-4626</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Information and Computing Technology, College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schneider</LastName>
                    <ForeName>Jens</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">0000-0002-0546-2816</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Information and Computing Technology, College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mifsud</LastName>
                    <ForeName>Borbala</ForeName>
                    <Initials>B</Initials>
                    <Identifier Source="ORCID">0000-0003-3429-3094</Identifier>
                    <AffiliationInfo>
                        <Affiliation>College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alam</LastName>
                    <ForeName>Tanvir</ForeName>
                    <Initials>T</Initials>
                    <Identifier Source="ORCID">0000-0001-7033-3693</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Information and Computing Technology, College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Househ</LastName>
                    <ForeName>Mowafa</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">0000-0002-3648-6271</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Information and Computing Technology, College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hamdi</LastName>
                    <ForeName>Mounir</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">0000-0002-9766-0085</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Information and Computing Technology, College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shah</LastName>
                    <ForeName>Zubair</ForeName>
                    <Initials>Z</Initials>
                    <Identifier Source="ORCID">0000-0001-7389-3274</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Information and Computing Technology, College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>03</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Canada</Country>
            <MedlineTA>J Med Internet Res</MedlineTA>
            <NlmUniqueID>100959882</NlmUniqueID>
            <ISSNLinking>1438-8871</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D015706" MajorTopicYN="Y">Bibliometrics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">2019-nCoV</Keyword>
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">bibliometric analysis</Keyword>
            <Keyword MajorTopicYN="Y">literature</Keyword>
            <Keyword MajorTopicYN="Y">machine learning</Keyword>
            <Keyword MajorTopicYN="Y">novel coronavirus disease</Keyword>
            <Keyword MajorTopicYN="Y">research</Keyword>
            <Keyword MajorTopicYN="Y">review</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>4</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>18</Day>
                <Hour>17</Hour>
                <Minute>12</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33600346</ArticleId>
            <ArticleId IdType="pii">v23i3e23703</ArticleId>
            <ArticleId IdType="doi">10.2196/23703</ArticleId>
            <ArticleId IdType="pmc">PMC7942394</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>JMIR Public Health Surveill. 2020 Jul 21;6(3):e20478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32589151</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Orthop. 2020 Oct;91(5):538-542</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32573285</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Med. 2020 Feb 20;9(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32093211</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Medicine (Baltimore). 2020 May 29;99(22):e20137</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32481379</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol. 2021 Feb;268(2):403-408</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32691235</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Oncol. 2020 Apr;27(2):71-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32489248</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 May 19;323(19):1907-1908</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32301955</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3411-3421</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32271460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2020 Jul 23;58(8):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32513859</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ERJ Open Res. 2020 Jul 13;6(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32685435</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochemistry (Mosc). 2020 Jul;85(7):833-837</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33040727</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Saf Sci. 2020 Sep;129:104806</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32382213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Affect Disord. 2020 Nov 1;276:555-561</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32871686</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Hypertens. 2020 Nov 16;42(8):738-742</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32569491</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Model Earth Syst Environ. 2020 Jul 16;:1-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32838022</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>In Vivo. 2020 Jun;34(3 Suppl):1629-1632</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32503821</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cent Eur J Public Health. 2020 Jun;28(2):161-162</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32592550</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Endocr Relat Cancer. 2020 Sep;27(9):R307-R327</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32544879</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomed Res Int. 2020 Jun 25;2020:3452402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32685469</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Cardiol Rev. 2020;16(3):173-177</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32564757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Travel Med Infect Dis. 2020 Jan - Feb;33:101566</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32007621</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Diabetes Sci Technol. 2020 Jul;14(4):769-771</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32506937</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Clin Cases. 2020 Jun 6;8(11):2325-2331</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32548163</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Wellcome Open Res. 2020 Apr 9;5:67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32685698</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Care. 2020 Jul;43(7):1382-1391</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32409504</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Aug;26(8):1183-1192</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32770165</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Sep;26(9):1398-1404</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32647358</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2020 Jul 15;205(2):313-320</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32493812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Sep;26(9):1405-1410</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32678356</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2020 Jul;76(1):16-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32367746</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dev Ctries. 2020 Mar 31;14(3):246-253</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32235084</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World Neurosurg. 2020 Nov;143:e179-e187</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702490</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Med Res. 2020 May;151(5):444-449</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32611915</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2020 Aug;81(2):e39-e45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32504735</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJR Am J Roentgenol. 2020 Jul;215(1):127-132</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32186894</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Otolaryngol Head Neck Surg. 2020 Jun;162(6):816-817</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32312163</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cardiovasc Diabetol. 2020 Jul 20;19(1):114</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32690029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Paediatr Respir Rev. 2020 Sep;35:43-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32653463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Disaster Med Public Health Prep. 2020 Jul 14;:1-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32660690</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biosci Trends. 2020 May 21;14(2):134-138</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32188819</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2020 May 26;58(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32269100</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Microbiol Biotechnol. 2020 Jul 28;30(7):962-966</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32627759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Soc Psychol. 2020 Jul;59(3):641-652</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32621294</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Soc Psychiatry. 2020 Jul 8;:20764020939596</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32635837</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Heart Lung Transplant. 2020 Jun;39(6):610-611</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32340870</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2020 Aug;129:104544</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32663788</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Internet Res. 2020 Dec 15;22(12):e20756</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33284779</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Jul 16;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32674126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Chin Med Assoc. 2020 Jun;83(6):537-543</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32349035</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J ECT. 2020 Sep;36(3):152-155</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32483035</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pak Med Assoc. 2020 May;70(Suppl 3)(5):S21-S24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32515371</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc Innov Qual Outcomes. 2020 Dec;4(6):745-758</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32838206</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1174-1178</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32423908</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stem Cell Rev Rep. 2021 Feb;17(1):266-277</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32691370</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Affect Disord. 2020 Nov 1;276:446-452</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32871676</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Jul;26(7):1070-1076</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32514174</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Clin Transplant. 2020 Jun;18(3):270-274</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32519617</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Public Health. 2020 Jul;110(7):939-940</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32213081</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Med (Lond). 2020 Jul;20(4):e82-e86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32457133</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stroke. 2020 Sep;51(9):e254-e258</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32787707</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Anesth. 2020 Dec;67:110005</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32707517</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Epidemiol. 2020 May;35(5):401-409</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32424571</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Surg Int. 2020 Nov;36(11):1267-1273</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32691128</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 May;94:91-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32173574</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stroke. 2020 Aug;51(8):2593-2596</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32716828</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Gynaecol Obstet. 2020 Jul;150(1):126-128</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32369616</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2020 Sep;26(9):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32491983</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cureus. 2020 Mar 21;12(3):e7357</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32328369</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Immunol. 2020 May;17(5):555-557</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32235915</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Life Sci. 2020 Sep 1;256:117905</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32504757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Gynaecol Obstet. 2020 Sep;150(3):368-378</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32526044</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Emerg Med. 2020 Jul 20;13(1):40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32689925</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2020 Jul;39(7):1237-1246</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32407171</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2020 Aug 24;58(9):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32636214</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Gynaecol Obstet. 2020 Jun;149(3):273-286</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32248521</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJR Am J Roentgenol. 2020 Dec;215(6):1351-1353</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32432912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Panminerva Med. 2020 May 26;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32456404</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2020 Aug;76(2):294-299</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32476472</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Appl Microbiol. 2021 Jan;130(1):2-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32652813</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2020 Jul 23;58(8):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32341142</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Waste Manag Res. 2020 Aug;38(8):820-824</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32517547</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Care. 2020 Aug;43(8):1695-1703</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32546593</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Recenti Prog Med. 2020 Apr;111(4):259-260</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32319449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2021 Feb;93(2):803-811</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32667733</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 May;20(5):515-516</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32213336</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33599685</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>15</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1538-3598</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>325</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Mar</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JAMA</Title>
                <ISOAbbreviation>JAMA</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Price of Success-How to Evaluate COVID-19 Vaccines When They're Available Outside of Clinical Trials.</ArticleTitle>
            <Pagination>
                <MedlinePgn>918-921</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2021.0641</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rubin</LastName>
                    <ForeName>Rita</ForeName>
                    <Initials>R</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016433">News</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>JAMA</MedlineTA>
            <NlmUniqueID>7501160</NlmUniqueID>
            <ISSNLinking>0098-7484</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010919">Placebos</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
                <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010919" MajorTopicYN="N">Placebos</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012107" MajorTopicYN="Y">Research Design</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>18</Day>
                <Hour>12</Hour>
                <Minute>14</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33599685</ArticleId>
            <ArticleId IdType="pii">2776787</ArticleId>
            <ArticleId IdType="doi">10.1001/jama.2021.0641</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">33597145</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2044-6055</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>17</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMJ open</Title>
                <ISOAbbreviation>BMJ Open</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Association between cardiometabolic disease and severe COVID-19: a nationwide case-control study of patients requiring invasive mechanical ventilation.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e044486</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2020-044486</ELocationID>
            <Abstract>
                <AbstractText Label="AIMS">The risks associated with diabetes, obesity and hypertension for severe COVID-19 may be confounded and differ by sociodemographic background. We assessed the risks associated with cardiometabolic factors for severe COVID-19 when accounting for socioeconomic factors and in subgroups by age, sex and region of birth.</AbstractText>
                <AbstractText Label="METHODS AND RESULTS">In this nationwide case-control study, 1.086 patients admitted to intensive care with COVID-19 requiring mechanical ventilation (cases), and 10.860 population-based controls matched for age, sex and district of residency were included from mandatory national registries. ORs with 95% CIs for associations between severe COVID-19 and exposures with adjustment for confounders were estimated using logistic regression. The median age was 62 years (IQR 52-70), and 3003 (24.9%) were women. Type 2 diabetes (OR, 2.3 (95% CI 1.9 to 2.7)), hypertension (OR, 1.7 (95% CI 1.5 to 2.0)), obesity (OR, 3.1 (95% CI 2.4 to 4.0)) and chronic kidney disease (OR, 2.5 (95% CI 1.7 to 3.7)) were all associated with severe COVID-19. In the younger subgroup (below 57 years), ORs were significantly higher for all cardiometabolic risk factors. The risk associated with type 2 diabetes was higher in women (p=0.001) and in patients with a region of birth outside European Union(EU) (p=0.004).</AbstractText>
                <AbstractText Label="CONCLUSION">Diabetes, obesity and hypertension were all independently associated with severe COVID-19 with stronger associations in the younger population. Type 2 diabetes implied a greater risk among women and in non-EU immigrants. These findings, originating from high-quality Swedish registries, may be important to direct preventive measures such as vaccination to susceptible patient groups.</AbstractText>
                <AbstractText Label="TRIAL REGISTRATION NUMBER">Clinicaltrial.gov (NCT04426084).</AbstractText>
                <CopyrightInformation>.. Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Svensson</LastName>
                    <ForeName>Per</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">0000-0003-0372-6272</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Science and Education, S..dersjukhuset, Karolinska Institutet, Stockholm, Sweden Per.Svensson@ki.se.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, S..dersjukhuset, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hofmann</LastName>
                    <ForeName>Robin</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Science and Education, S..dersjukhuset, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, S..dersjukhuset, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>H..bel</LastName>
                    <ForeName>Henrike</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jernberg</LastName>
                    <ForeName>Tomas</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nordberg</LastName>
                    <ForeName>Per</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, S..dersjukhuset, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine Solna, Centre for Resuscitation Science, Karolinska institutet, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NCT04426084</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D064888">Observational Study</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMJ Open</MedlineTA>
            <NlmUniqueID>101552874</NlmUniqueID>
            <ISSNLinking>2044-6055</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D057911">Angiotensin Receptor Antagonists</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057911" MajorTopicYN="N">Angiotensin Receptor Antagonists</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">diabetes &amp; endocrinology</Keyword>
            <Keyword MajorTopicYN="Y">hypertension</Keyword>
            <Keyword MajorTopicYN="Y">intensive &amp; critical care</Keyword>
        </KeywordList>
        <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>18</Day>
                <Hour>5</Hour>
                <Minute>54</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33597145</ArticleId>
            <ArticleId IdType="pii">bmjopen-2020-044486</ArticleId>
            <ArticleId IdType="doi">10.1136/bmjopen-2020-044486</ArticleId>
            <ArticleId IdType="pmc">PMC7893210</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Intensive Care Med. 2012 Oct;38(10):1647-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22777516</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 2020 Jul 7;142(1):4-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32320270</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32171076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2020 Jan;75(1):229-236</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31786971</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Behav Immun. 2020 Aug;88:44-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32497776</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jul 14;324(2):168-177</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32558877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cardiovasc Res. 2018 Sep 1;114(11):1547-1563</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29800237</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jun 18;382(25):2431-2440</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32356627</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nutr Metab Cardiovasc Dis. 2010 Feb;20(2):140-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19833491</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 2020 Apr 21;141(16):1307-1317</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32148083</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Public Health. 2011 Jun 09;11:450</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21658213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32798471</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Diabetes Endocrinol. 2020 Jul;8(7):616-627</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32559477</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2006 Dec 14;444(7121):860-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17167474</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Heart J. 2020 Jun 7;41(22):2058-2066</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32498076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2006 Feb 15;295(7):850</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16478914</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Mar 26;382(13):1194-1196</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32074416</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jun 25;382(26):2534-2543</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32459916</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care. 2020 Jun 16;24(1):353</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32546188</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Epidemiol. 2009;24(11):659-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19504049</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Apr 28;323(16):1574-1581</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32250385</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32334646</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Endocrinol. 2020 Jul;16(7):341-342</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32327737</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32031570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cardiovasc Res. 2020 Aug 1;116(10):1688-1699</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32293003</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):430-436</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32640463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 2018 May 15;137(20):2166-2178</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29760227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2019 Aug;19(8):517-532</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30992524</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 May 22;369:m1966</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32444366</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Thromb Thrombolysis. 2020 Jul;50(1):54-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32415579</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Epidemiol. 2019 Apr;34(4):423-437</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30929112</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Diabetes Endocrinol. 2020 Oct;8(10):813-822</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32798472</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 May 2;395(10234):1421-1422</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32330427</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33596958</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Print">1742-4933</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>18</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>17</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Immunity &amp; ageing : I &amp; A</Title>
                <ISOAbbreviation>Immun Ageing</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Unanticipated efficacy of SARS-CoV-2 vaccination in older adults.</ArticleTitle>
            <Pagination>
                <MedlinePgn>7</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12979-021-00219-y</ELocationID>
            <Abstract>
                <AbstractText>The rapidity with which vaccines against COVID-19 have been developed and tested is unprecedented. As classically the case with randomized clinical trials, many studies excluded older adults. However, given the early realisation that senior citizens were most highly susceptible to COVID, older individuals have been included in licensing trials under these unusual conditions. The recently published results from the Comirnaty Vaccine (BNT162b) trial unexpectedly documented that vaccine efficacy was equally exceptionally high in older and younger adults. These extremely encouraging trial results with a neoantigen vaccine may suggest the beginning of a paradigm shift in our view of the impact of immunosenescence on vaccination against novel infectious diseases.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pawelec</LastName>
                    <ForeName>Graham</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3600-0163</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology, University of T..bingen, T..bingen, Germany. graham.pawelec@uni-tuebingen.de.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Health Sciences North Research Institute, Sudbury, Ontario, Canada. graham.pawelec@uni-tuebingen.de.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McElhaney</LastName>
                    <ForeName>Janet</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Sciences North Research Institute, Sudbury, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016421">Editorial</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Immun Ageing</MedlineTA>
            <NlmUniqueID>101235427</NlmUniqueID>
            <ISSNLinking>1742-4933</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Immunosenescence</Keyword>
            <Keyword MajorTopicYN="N">Paradigm shift</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">Vaccination</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>18</Day>
                <Hour>5</Hour>
                <Minute>46</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33596958</ArticleId>
            <ArticleId IdType="doi">10.1186/s12979-021-00219-y</ArticleId>
            <ArticleId IdType="pii">10.1186/s12979-021-00219-y</ArticleId>
            <ArticleId IdType="pmc">PMC7886644</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2020 Dec 11;370(6522):1339-1343</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33159009</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2016 Jan 20;34(4):540-546</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26667611</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):594-599</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32998157</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Open Forum Infect Dis. 2020 Apr 24;7(5):ofaa148</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32500087</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immun Ageing. 2019 Sep 13;16:25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31528180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2019 Nov 1;366(6465):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31672865</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2015 May 1;194(9):4073-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25888703</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Vaccines. 2017 Jul;16(7):1-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28562111</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13139-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25157137</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Transl Med. 2016 Jun 1;8(341):341ra77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27252176</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Jun 25;181(7):1489-1501.e15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32473127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2015 Nov 15;195(10):4699-711</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26459351</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mech Ageing Dev. 2020 Dec;192:111357</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32949594</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2016 Dec;1(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28361127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2004 Mar 1;172(5):2731-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14978070</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2018 Jul 24;9:1618</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30087674</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2015 May 28;372(22):2087-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25916341</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2017 Jul 13;547(7662):222-226</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28678784</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Anat. 2010 May;216(5):556-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20345860</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immun Ageing. 2020 Sep 4;17:26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32944053</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Nov;587(7833):270-274</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32726801</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Oct 2;370(6512):89-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32753554</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2005 Jun 1;174(11):7446-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15905594</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 31;383(27):2603-2615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2017 Aug 15;216(4):405-414</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28931244</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 17;383(25):2439-2450</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33053279</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33596800</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>18</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1875-5607</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Mini reviews in medicinal chemistry</Title>
                <ISOAbbreviation>Mini Rev Med Chem</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A review on Remdesivir: A broad-spectrum antiviral molecule for possible COVID-19 treatment.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.2174/1389557521666210217093004</ELocationID>
            <Abstract>
                <AbstractText>Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel coronavirus strain and the causative agent of COVID-19 was identified to have emerged in Wuhan, China, in December 2019 [1]. This pandemic situation and magnitude of suffering has led to global effort to find out effective measures for discovery of new specific drugs and vaccines to combat this deadly disease. In addition to many initiatives to develop vaccines for protective immunity against SARS-CoV-2, some of which are at various stages of clinical trials researchers worldwide are currently using available conventional therapeutic drugs with potential to combat the disease effectively in other viral infections and it is believed that these antiviral drugs could act as a promising immediate alternative. Remdesivir (RDV), a broad-spectrum anti-viral agent, initially developed for the treatment of Ebola virus (EBOV) and known to show promising efficiency in in vitro and in vivo studies against SARS and MERS coronaviruses, is now being investigated against SARS-CoV-2. On May 1, 2020, The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for RDV to treat COVID-19 patients [2]. A number of multicentre clinical trials are on-going to check the safety and efficacy of RDV for the treatment of COVID-19. Results of published double blind, and placebo-controlled trial on RDV against SARS-CoV-2, showed that RDV administration led to faster clinical improvement in severe COVID-19 patients compared to placebo. This review highlights the available knowledge about RDV as a therapeutic drug for coronaviruses and its preclinical and clinical trials against COVID-19.</AbstractText>
                <CopyrightInformation>Copyright.. Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Khazir</LastName>
                    <ForeName>Jabeena</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, Govt. Degree College (Boys) Pulwama, Kashmir-192301, J&amp;K. India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maqbool</LastName>
                    <ForeName>Tariq</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Nanotechnology, University of Kashmir, Srinagar-190006, J&amp;K. India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mir</LastName>
                    <ForeName>Bilal Ahmad</ForeName>
                    <Initials>BA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Botany, Kargil Campus, University of Kashmir (Kargil), J&amp;K. India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Mini Rev Med Chem</MedlineTA>
            <NlmUniqueID>101094212</NlmUniqueID>
            <ISSNLinking>1389-5575</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Coronavirus</Keyword>
            <Keyword MajorTopicYN="N">Drug re-purposing</Keyword>
            <Keyword MajorTopicYN="N">Remdesivir</Keyword>
            <Keyword MajorTopicYN="N">Therapeutic molecules</Keyword>
            <Keyword MajorTopicYN="N">therapeutics</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>18</Day>
                <Hour>5</Hour>
                <Minute>44</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33596800</ArticleId>
            <ArticleId IdType="pii">MRMC-EPUB-114279</ArticleId>
            <ArticleId IdType="doi">10.2174/1389557521666210217093004</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33596363</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>23</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1533-4406</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>384</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The New England journal of medicine</Title>
                <ISOAbbreviation>N Engl J Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Audio Interview: Viral Variants and Covid-19.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e38</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMe2102882</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rubin</LastName>
                    <ForeName>Eric J</ForeName>
                    <Initials>EJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baden</LastName>
                    <ForeName>Lindsey R</ForeName>
                    <Initials>LR</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Farrar</LastName>
                    <ForeName>Jeremy J</ForeName>
                    <Initials>JJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morrissey</LastName>
                    <ForeName>Stephen</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016421">Editorial</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>N Engl J Med</MedlineTA>
            <NlmUniqueID>0255562</NlmUniqueID>
            <ISSNLinking>0028-4793</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000600" MajorTopicYN="N">supply &amp; distribution</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
                <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004189" MajorTopicYN="N">Disaster Planning</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004197" MajorTopicYN="N">Disease Reservoirs</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019143" MajorTopicYN="Y">Evolution, Molecular</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014644" MajorTopicYN="Y">Genetic Variation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007391" MajorTopicYN="Y">International Cooperation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015980" MajorTopicYN="Y">Public Health Practice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>17</Day>
                <Hour>17</Hour>
                <Minute>11</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33596363</ArticleId>
            <ArticleId IdType="doi">10.1056/NEJMe2102882</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33596144</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>22</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>22</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1945-0257</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>25</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Genetic testing and molecular biomarkers</Title>
                <ISOAbbreviation>Genet Test Mol Biomarkers</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.</ArticleTitle>
            <Pagination>
                <MedlinePgn>85-101</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1089/gtmb.2020.0227</ELocationID>
            <Abstract>
                <AbstractText>Coronavirus disease 2019 (COVID-19) displays a broad spectrum of clinical presentations ranging from lack of symptoms to severe multiorgan system complications and death. Various laboratory assays have been employed in the diagnosis of COVID-19, including: nucleic acid-based tests; antigen tests; and serum testing for anti-severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies. The disease can also be diagnosed based on suggestive clinical features and radiological findings. Until now, remdesivir is the only medication approved for the treatment of COVID-19 by the U.S. Food and Drug Administration (FDA); however, it is anticipated that several anti-SARS-CoV-2 monoclonal antibodies will gain soon approval. Other methods of treatment include supportive care directed toward treating the symptoms. Nevertheless, many studies have recently emerged, showing controversial preliminary results with the off-label medication hydroxychloroquine. Given that all results are still preliminary, including those seen by remdesivir, additional evidence and research are required to identify effective medications that are broadly effective and well tolerated. Importantly, two RNA-based vaccines have recently gained approval from Pfizer and Moderna, with many others still in clinical trials. This article reviews various aspects of COVID-19, including its epidemiology; its evolution and mutational spectrum; and its clinical dynamics, symptoms and complications, diagnosis, and treatment.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Younis</LastName>
                    <ForeName>Nour K</ForeName>
                    <Initials>NK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zareef</LastName>
                    <ForeName>Rana O</ForeName>
                    <Initials>RO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maktabi</LastName>
                    <ForeName>Mohammad Ali N</ForeName>
                    <Initials>MAN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mahfouz</LastName>
                    <ForeName>Rami</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Genet Test Mol Biomarkers</MedlineTA>
            <NlmUniqueID>101494210</NlmUniqueID>
            <ISSNLinking>1945-0257</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>3QKI37EEHE</RegistryNumber>
                <NameOfSubstance UI="C000606551">remdesivir</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>415SHH325A</RegistryNumber>
                <NameOfSubstance UI="D000249">Adenosine Monophosphate</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>4QWG6N8QKH</RegistryNumber>
                <NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>OF5P57N2ZX</RegistryNumber>
                <NameOfSubstance UI="D000409">Alanine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <SupplMeshList>
            <SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000249" MajorTopicYN="N">Adenosine Monophosphate</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019143" MajorTopicYN="N">Evolution, Molecular</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000071219" MajorTopicYN="N">Global Burden of Disease</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056687" MajorTopicYN="N">Off-Label Use</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
                <QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">coronavirus</Keyword>
            <Keyword MajorTopicYN="N">review</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>17</Day>
                <Hour>17</Hour>
                <Minute>9</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33596144</ArticleId>
            <ArticleId IdType="doi">10.1089/gtmb.2020.0227</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33595410</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>16</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1744-8352</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>21</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Expert review of molecular diagnostics</Title>
                <ISOAbbreviation>Expert Rev Mol Diagn</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Are T cell repertoires useful as diagnostics for SARS- CoV- 2 infection?</ArticleTitle>
            <Pagination>
                <MedlinePgn>137-139</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/14737159.2021.1882852</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Harris</LastName>
                    <ForeName>Tim</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Repertoire Immune Medicines, Cambridge, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sauer</LastName>
                    <ForeName>Karsten</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Repertoire Immune Medicines, Cambridge, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016421">Editorial</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Expert Rev Mol Diagn</MedlineTA>
            <NlmUniqueID>101120777</NlmUniqueID>
            <ISSNLinking>1473-7159</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName>
                <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000067716" MajorTopicYN="N">Point-of-Care Testing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName>
                <QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">T cells</Keyword>
            <Keyword MajorTopicYN="Y">diagnostics</Keyword>
            <Keyword MajorTopicYN="Y">pathology of COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">vaccines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>4</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>17</Day>
                <Hour>12</Hour>
                <Minute>11</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33595410</ArticleId>
            <ArticleId IdType="doi">10.1080/14737159.2021.1882852</ArticleId>
            <ArticleId IdType="pmc">PMC7898294</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2021 Feb 18;184(4):861-880</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33497610</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Oct 1;183(1):158-168.e14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32979941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Sep;20(9):529-536</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32728222</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Oct 1;183(1):13-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32976799</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2021 Jan;27(1):78-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33184509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2008 Oct 15;181(8):5490-500</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18832706</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Nov;587(7833):270-274</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32726801</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2021 Feb 5;371(6529):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33408181</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):516-527</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32967006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>iScience. 2020 Aug 21;23(8):101406</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32771976</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2020 Sep 28;11:581807</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33117391</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2019 May;20(5):652-662</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30858620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 7;384(1):80-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33270381</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2020 Dec 1;33(9):108454</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33220791</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Dec 4;370(6521):1227-1230</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33115920</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33594794</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>31</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>31</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1099-1654</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>31</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>05</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Reviews in medical virology</Title>
                <ISOAbbreviation>Rev Med Virol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e2183</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/rmv.2183</ELocationID>
            <Abstract>
                <AbstractText>Coronavirus disease 2019 (Covid-19) is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) which is responsible for a global pandemic that started in late 2019 in Wuhan, China. To prevent the worldwide spread of this highly pathogenic virus, development of an effective and safe vaccine is urgently needed. The SARS-CoV-2 and SARS-CoV share a high degree of genetic and pathologic identity and share safety and immune-enhancement concerns regarding vaccine development. Prior animal studies with first generation (whole virus-based) preparations of SARS-CoV vaccines (inactivated and attenuated vaccine modalities) indicated the possibility of increased infectivity or eosinophilic infiltration by immunization. Therefore, development of second and third generation safer vaccines (by using modern vaccine platforms) is actively sought for this viral infection. The spike (S) protein of SARS-CoVs is the main determinant of cell entry and tropism and is responsible for facilitating zoonosis into humans and sustained person-to-person transmission. Furthermore, 'S' protein contains multiple neutralizing epitopes that play an essential role in the induction of neutralizing antibodies (nAbs) and protective immunity. Moreover, T-cell responses against the SARS-CoV-2 'S' protein have also been characterized that correlate to the IgG and IgA antibody titres in Covid-19 patients. Thus, S protein is an obvious candidate antigen for inclusion into vaccine platforms against SARS-CoV-2 viral infection. This manuscript reviews different characteristics of S protein, its potency and 'state of the art' of the vaccine development strategies and platforms using this antigen, for construction of a safe and effective SARS-CoV-2 vaccine.</AbstractText>
                <CopyrightInformation>.. 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Arashkia</LastName>
                    <ForeName>Arash</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jalilvand</LastName>
                    <ForeName>Somayeh</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">0000-0001-6390-8399</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mohajel</LastName>
                    <ForeName>Nasir</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Afchangi</LastName>
                    <ForeName>Atefeh</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Azadmanesh</LastName>
                    <ForeName>Kayhan</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Salehi-Vaziri</LastName>
                    <ForeName>Mostafa</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Arboviruses and Viral Hemorrhagic Fevers (National Ref Lab), Pasteur Institute of Iran, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fazlalipour</LastName>
                    <ForeName>Mehdi</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Arboviruses and Viral Hemorrhagic Fevers (National Ref Lab), Pasteur Institute of Iran, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pouriayevali</LastName>
                    <ForeName>Mohammad Hassan</ForeName>
                    <Initials>MH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Arboviruses and Viral Hemorrhagic Fevers (National Ref Lab), Pasteur Institute of Iran, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jalali</LastName>
                    <ForeName>Tahmineh</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Arboviruses and Viral Hemorrhagic Fevers (National Ref Lab), Pasteur Institute of Iran, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mousavi Nasab</LastName>
                    <ForeName>Seyed Dawood</ForeName>
                    <Initials>SD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Research and Development, Production and Research Complex, Pasteur Institute of Iran, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roohvand</LastName>
                    <ForeName>Farzin</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shoja</LastName>
                    <ForeName>Zabihollah</ForeName>
                    <Initials>Z</Initials>
                    <Identifier Source="ORCID">0000-0001-5617-5844</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>SARS CoV-2 Rapid Response Team of Pasteur Institute of Iran (PII)</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Rev Med Virol</MedlineTA>
            <NlmUniqueID>9112448</NlmUniqueID>
            <ISSNLinking>1052-9276</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D019444">Vaccines, DNA</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D022223">Vaccines, Subunit</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007115" MajorTopicYN="N">Immunization Schedule</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000071497" MajorTopicYN="N">Immunogenicity, Vaccine</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014613" MajorTopicYN="N">Vaccines, Attenuated</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019444" MajorTopicYN="N">Vaccines, DNA</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D022223" MajorTopicYN="N">Vaccines, Subunit</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">RBD</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">spike</Keyword>
            <Keyword MajorTopicYN="Y">vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>6</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>3</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33594794</ArticleId>
            <ArticleId IdType="doi">10.1002/rmv.2183</ArticleId>
            <ArticleId IdType="pmc">PMC7646037</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Title>REFERENCES</Title>
            <Reference>
                <Citation>Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418-423.</Citation>
            </Reference>
            <Reference>
                <Citation>de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl J Med. 2020;382:727-733.</Citation>
            </Reference>
            <Reference>
                <Citation>Peiris J, Guan Y, Yuen K. Severe acute respiratory syndrome. Nat Med. 2004;10(12):S88-S97.</Citation>
            </Reference>
            <Reference>
                <Citation>Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology. 2003;8:S9-S14.</Citation>
            </Reference>
            <Reference>
                <Citation>Lee J, Chowell G, Jung E. A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events. J Theor Biol. 2016;408:118-126.</Citation>
            </Reference>
            <Reference>
                <Citation>Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814-1820.</Citation>
            </Reference>
            <Reference>
                <Citation>Lee JY, Kim Y-J, Chung EH, et al. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect Dis. 2017;17(1):498.</Citation>
            </Reference>
            <Reference>
                <Citation>of the International CSG. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536-544.</Citation>
            </Reference>
            <Reference>
                <Citation>Tan W, Zhao X, Ma X, Wang W, Niu P, Xu W. A novel coronavirus genome identified in a cluster of pneumonia cases-Wuhan, China 2019...2020. China CDC Weekly. 2020;2(4):61-62.</Citation>
            </Reference>
            <Reference>
                <Citation>Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-574.</Citation>
            </Reference>
            <Reference>
                <Citation>Wong MC, Cregeen SJJ, Ajami NJ, Petrosino JF. Evidence of Recombination in Coronaviruses Implicating Pangolin Origins of NCoV-2019. 2020. https://doi.org/10.1101/2020.02.07.939207.</Citation>
            </Reference>
            <Reference>
                <Citation>Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812-827.</Citation>
            </Reference>
            <Reference>
                <Citation>Vabret N, Britton GJ, Gruber C, et al. Immunology of COVID-19: current state of the science. Immunity. 2020;52:910-941.</Citation>
            </Reference>
            <Reference>
                <Citation>Wu R, Wang L, Kuo H-CD, et al. An update on current therapeutic drugs treating COVID-19. Curr Pharmacol Rep. 2020;6:56-70.</Citation>
            </Reference>
            <Reference>
                <Citation>Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395:1569-1578.</Citation>
            </Reference>
            <Reference>
                <Citation>Hillaker E, Belfer JJ, Bondici A, Murad H, Dumkow LE. Delayed initiation of remdesivir in a COVID-19-positive patient. Pharmacotherapy. 2020;40:592-598.</Citation>
            </Reference>
            <Reference>
                <Citation>Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382(24):2327-2336.</Citation>
            </Reference>
            <Reference>
                <Citation>RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19 - preliminary report. N Engl J Med. 2020. https://doi.org/10.1056/nejmoa2021436.</Citation>
            </Reference>
            <Reference>
                <Citation>Wu A, Peng Y, Huang B, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27:325-328.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273.</Citation>
            </Reference>
            <Reference>
                <Citation>Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181-192.</Citation>
            </Reference>
            <Reference>
                <Citation>Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020;26(4):450-452.</Citation>
            </Reference>
            <Reference>
                <Citation>Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-269.</Citation>
            </Reference>
            <Reference>
                <Citation>Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281-292.</Citation>
            </Reference>
            <Reference>
                <Citation>Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271-280.</Citation>
            </Reference>
            <Reference>
                <Citation>Jiang S, Hillyer C, Du L. Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses. Trends Immunol. 2020;41:355-359.</Citation>
            </Reference>
            <Reference>
                <Citation>Wu F, Wang A, Liu M, et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. SSRN Electronic Journal. http://doi.org/10.2139/ssrn.3566211.</Citation>
            </Reference>
            <Reference>
                <Citation>Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181:1489-1501.</Citation>
            </Reference>
            <Reference>
                <Citation>Braun J, Loyal L, Frentsch M, et al. Presence of Sars-Cov-2 Reactive T cells in Covid-19 Patients and Healthy Donors. 2020. https://doi.org/10.1101/2020.04.17.20061440.</Citation>
            </Reference>
            <Reference>
                <Citation>Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3:237-261.</Citation>
            </Reference>
            <Reference>
                <Citation>Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260-1263.</Citation>
            </Reference>
            <Reference>
                <Citation>Pallesen J, Wang N, Corbett KS, et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci. 2017;114(35):E7348-E7357.</Citation>
            </Reference>
            <Reference>
                <Citation>Walls AC, Xiong X, Park Y-J, et al. Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell. 2019;176(5):1026-1039.</Citation>
            </Reference>
            <Reference>
                <Citation>Walls AC, Tortorici MA, Frenz B, et al. Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy. Nat Struct Mol Biol. 2016;23(10):899.</Citation>
            </Reference>
            <Reference>
                <Citation>Kirchdoerfer RN, Cottrell CA, Wang N, et al. Pre-fusion structure of a human coronavirus spike protein. Nature. 2016;531(7592):118-121.</Citation>
            </Reference>
            <Reference>
                <Citation>Tortorici MA, Veesler D. Structural insights into coronavirus entry. Adv virus Res. 2019;105:93-116.</Citation>
            </Reference>
            <Reference>
                <Citation>Li Z, Tomlinson AC, Wong AH, et al. The human coronavirus HCoV-229E S-protein structure and receptor binding. Elife. 2019;8:e51230.</Citation>
            </Reference>
            <Reference>
                <Citation>Wong AH, Tomlinson AC, Zhou D, et al. Receptor-binding loops in alphacoronavirus adaptation and evolution. Nat Commun. 2017;8(1):1-10.</Citation>
            </Reference>
            <Reference>
                <Citation>Wu K, Li W, Peng G, Li F. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proc Natl Acad Sci. 2009;106(47):19970-19974.</Citation>
            </Reference>
            <Reference>
                <Citation>Watanabe Y, Allen JD, Wrapp D, McLellan JS, Crispin M. Site-Specific Analysis of the SARS-CoV-2 Glycan Shield. 2020. https://doi.org/10.1101/2020.03.26.010322.</Citation>
            </Reference>
            <Reference>
                <Citation>Guo L, Ren L, Yang S, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020;71:778-785.</Citation>
            </Reference>
            <Reference>
                <Citation>Theel ES, Slev P, Wheeler S, Couturier MR, Wong SJ, Kadkhoda K. The role of antibody testing for SARS-CoV-2: is there one? J Clin Microbiol. 2020;58:e00797-20</Citation>
            </Reference>
            <Reference>
                <Citation>Guo C, Li B, Ma H, et al. Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm. Nat Commun. 2020;11(1). https://doi.org/10.1038/s41467-020-17834-w.</Citation>
            </Reference>
            <Reference>
                <Citation>Wen W, Su W, Tang H, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6(1):1-18.</Citation>
            </Reference>
            <Reference>
                <Citation>Ju B, Zhang Q, Ge J, et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature. 2020:1-8.</Citation>
            </Reference>
            <Reference>
                <Citation>Bao L, Deng W, Gao H, et al. Reinfection Could Not Occur in SARS-CoV-2 Infected Rhesus Macaques. 2020. https://doi.org/10.1101/2020.03.13.990226.</Citation>
            </Reference>
            <Reference>
                <Citation>Patel R, Babady E, Theel ES, et al. Report from the American Society for Microbiology COVID-19 international summit, 23 march 2020: value of diagnostic testing for SARS-CoV-2/COVID-19. Am Soc Microbiol. 2020;11:e00722-20</Citation>
            </Reference>
            <Reference>
                <Citation>Lu B, Huang Y, Huang L, et al. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice. Immunology. 2010;130(2):254-261.</Citation>
            </Reference>
            <Reference>
                <Citation>Shim B-S, Stadler K, Nguyen HH, et al. Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain. Virology J. 2012;9(1):1-9.</Citation>
            </Reference>
            <Reference>
                <Citation>To KK-W, Tsang OT-Y, Leung W-S, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20:565-574.</Citation>
            </Reference>
            <Reference>
                <Citation>Tian X, Li C, Huang A, et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 2020;9(1):382-385.</Citation>
            </Reference>
            <Reference>
                <Citation>Tai W, He L, Zhang X, et al. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol. 2020;17:613-620.</Citation>
            </Reference>
            <Reference>
                <Citation>Chen W-H, Hotez PJ, Bottazzi ME. Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19. Hum Vaccines Immunother. 2020;16:1239-1242.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhou Y, Yang Y, Huang J, Jiang S, Du L. Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain. Viruses. 2019;11(1):60.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhu Z, Chakraborti S, He Y, et al. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc Natl Acad Sci. 2007;104(29):12123-12128.</Citation>
            </Reference>
            <Reference>
                <Citation>Rockx B, Corti D, Donaldson E, et al. Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge. J virology. 2008;82(7):3220-3235.</Citation>
            </Reference>
            <Reference>
                <Citation>Sui J, Li W, Murakami A, et al. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci. 2004;101(8):2536-2541.</Citation>
            </Reference>
            <Reference>
                <Citation>He Y, Li J, Li W, Lustigman S, Farzan M, Jiang S. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein. J Immunol. 2006;176(10):6085-6092.</Citation>
            </Reference>
            <Reference>
                <Citation>Pinto D, Park Y-J, Beltramello M, et al. Structural and Functional Analysis of a Potent Sarbecovirus Neutralizing Antibody. 2020. https://doi.org/10.1101/2020.04.07.023903.</Citation>
            </Reference>
            <Reference>
                <Citation>Yuan M, Wu NC, Zhu X, et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science. 2020;368(6491):630-633.</Citation>
            </Reference>
            <Reference>
                <Citation>Chen X, Li R, Pan Z, et al. Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor. Cell Mol Immunol. 2020;17:647-649.</Citation>
            </Reference>
            <Reference>
                <Citation>W..lfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465-469.</Citation>
            </Reference>
            <Reference>
                <Citation>Wang C, Li W, Drabek D, et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun. 2020;11(1):1-6.</Citation>
            </Reference>
            <Reference>
                <Citation>Wu Y, Li C, Xia S, et al. Identification of human single-domain antibodies against SARS-CoV-2. Cell host microbe. 2020;27:891-898.</Citation>
            </Reference>
            <Reference>
                <Citation>Wrapp D, De Vlieger D, Corbett KS, et al. Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies. Cell. 2020;181:1004-1015.</Citation>
            </Reference>
            <Reference>
                <Citation>Lei C, Qian K, Li T, et al. Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig. Nat Commun. 2020;11(1):1-5.</Citation>
            </Reference>
            <Reference>
                <Citation>Li Y, Wang H, Tang X, et al. SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an improved ACE2-Ig. J Virol. 2020. https://doi.org/10.1128/jvi.01283-20.</Citation>
            </Reference>
            <Reference>
                <Citation>Okba NM, M..ller MA, Li W, et al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg Infect Dis. 2020;26(7):1478-1488.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062.</Citation>
            </Reference>
            <Reference>
                <Citation>Li K, Chen D, Chen S, et al. Radiographic Findings and Other Predictors in Adults with Covid-19. MedRxiv; 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhang L, Zhang F, Yu W, et al. Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J Med Virol. 2006;78(1):1-8.</Citation>
            </Reference>
            <Reference>
                <Citation>Liu L, Wei Q, Lin Q, et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 2019;4(4). https://doi.org/10.1172/jci.insight.123158.</Citation>
            </Reference>
            <Reference>
                <Citation>Wan Y, Shang J, Sun S, et al. Molecular mechanism for antibody-dependent enhancement of coronavirus entry. J Virol. 2019;94(5).http://doi.org/10.1128/jvi.02015-19.</Citation>
            </Reference>
            <Reference>
                <Citation>Lambert P-H, Ambrosino DM, Andersen SR, et al. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: assessment of risk of disease enhancement with Covid-19 vaccines. Vaccine. 2020;38:4783-4791.</Citation>
            </Reference>
            <Reference>
                <Citation>Padron-Regalado E. Vaccines for SARS-CoV-2: lessons from other coronavirus strains. Infect Dis Ther. 2020;9:255-274.</Citation>
            </Reference>
            <Reference>
                <Citation>Choi AH, Basu M, McNeal MM, Clements JD, Ward RL. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol. 1999;73(9):7574-7581.</Citation>
            </Reference>
            <Reference>
                <Citation>Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020;11:827.</Citation>
            </Reference>
            <Reference>
                <Citation>Wan S, Yi Q, Fan S, et al. Characteristics of Lymphocyte Subsets and Cytokines in Peripheral Blood of 123 Hospitalized Patients with 2019 Novel Coronavirus Pneumonia (NCP). 2020. https://doi.org/10.1101/2020.02.10.20021832.</Citation>
            </Reference>
            <Reference>
                <Citation>Sun D-w, Zhang D, Tian R-h, et al. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: a sentinel? Clin Chim Acta. 2020;508:122-129.</Citation>
            </Reference>
            <Reference>
                <Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. lancet. 2020;395(10223):497-506.</Citation>
            </Reference>
            <Reference>
                <Citation>Liu Y, Zhang C, Huang F, et al. Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury. Nat Sci Rev. 2020;7:1003-1011.</Citation>
            </Reference>
            <Reference>
                <Citation>Buonaguro FM, Ascierto PA, Morse GD, et al. Covid-19: time for a paradigm change. Rev Med Virol. 2020;30:e2134.</Citation>
            </Reference>
            <Reference>
                <Citation>Li CK-f, Wu H, Yan H, et al. T cell responses to whole SARS coronavirus in humans. J Immunol. 2008;181(8):5490-5500.</Citation>
            </Reference>
            <Reference>
                <Citation>Channappanavar R, Fett C, Zhao J, Meyerholz DK, Perlman S. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. J Virol. 2014;88(19):11034-11044.</Citation>
            </Reference>
            <Reference>
                <Citation>Tang F, Quan Y, Xin Z-T, et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J Immunol. 2011;186(12):7264-7268.</Citation>
            </Reference>
            <Reference>
                <Citation>Peng H, Yang L-t, Wang L-y, et al. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology. 2006;351(2):466-475.</Citation>
            </Reference>
            <Reference>
                <Citation>Fan Y-Y, Huang Z-T, Li L, et al. Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection. Arch Virol. 2009;154(7):1093-1099.</Citation>
            </Reference>
            <Reference>
                <Citation>Ahmed SF, Quadeer AA, McKay MR. Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses. 2020;12(3):254.</Citation>
            </Reference>
            <Reference>
                <Citation>Vashi Y, Jagrit V, Kumar S. Understanding the B and T cells Epitopes of Spike Protein of Severe Respiratory Syndrome Coronavirus-2: a Computational Way to Predict the Immunogens. 2020. https://doi.org/10.1101/2020.04.08.013516.</Citation>
            </Reference>
            <Reference>
                <Citation>Li J, Wang J, Kang AS, Sacitharan PK. Mapping the T cell response to COVID-19. Signal Transduct Target Ther. 2020;5(1):112.</Citation>
            </Reference>
            <Reference>
                <Citation>Ni L, Ye F, Cheng M-L, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52:971-977.</Citation>
            </Reference>
            <Reference>
                <Citation>Weiskopf D, Schmitz KS, Raadsen MP, et al. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol. 2020;5(48):eabd2071. http://doi.org/10.1126/sciimmunol.abd2071.</Citation>
            </Reference>
            <Reference>
                <Citation>Sekine T, Perez-Potti A, Rivera-Ballesteros O, et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell. 2020;183(1):158-168.e14. http://doi.org/10.1016/j.cell.2020.08.017.</Citation>
            </Reference>
            <Reference>
                <Citation>Tseng C-T, Sbrana E, Iwata-Yoshikawa N, et al. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS One. 2012;7(4):e35421.</Citation>
            </Reference>
            <Reference>
                <Citation>Bolles M, Deming D, Long K, et al. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J Virol. 2011;85(23):12201-12215.</Citation>
            </Reference>
            <Reference>
                <Citation>Agrawal AS, Tao X, Algaissi A, et al. Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus. Hum Vaccin Immunother. 2016;12(9):2351-2356.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhao J, Li K, Wohlford-Lenane C, et al. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci. 2014;111(13):4970-4975.</Citation>
            </Reference>
            <Reference>
                <Citation>Houser KV, Broadbent AJ, Gretebeck L, et al. Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody. PLoS Pathog. 2017;13(8):e1006565.</Citation>
            </Reference>
            <Reference>
                <Citation>Sun J, He W-T, Wang L, et al. COVID-19: epidemiology, evolution, and cross-disciplinary perspectives. Trends Mol Med. 2020;26:483-495.</Citation>
            </Reference>
            <Reference>
                <Citation>Ye T, Zhong Z, Garc..a-Sastre A, Schotsaert M, De Geest BG. Current status of COVID-19 (pre)clinical vaccine development. Angew Chem Int Ed. 2020. http://doi.org/10.1002/anie.202008319.</Citation>
            </Reference>
            <Reference>
                <Citation>Le TT, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305-306.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhao P, Ke J-S, Qin Z-L, et al. DNA vaccine of SARS-Cov S gene induces antibody response in mice. Acta Biochim Biophys Sin. 2004;36(1):37-41.</Citation>
            </Reference>
            <Reference>
                <Citation>Muthumani K, Falzarano D, Reuschel EL, et al. A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Sci Transl Med. 2015;7(301):301ra132.</Citation>
            </Reference>
            <Reference>
                <Citation>Bisht H, Roberts A, Vogel L, et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci. 2004;101(17):6641-6646.</Citation>
            </Reference>
            <Reference>
                <Citation>Chen Z, Zhang L, Qin C, et al. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J Virol. 2005;79(5):2678-2688.</Citation>
            </Reference>
            <Reference>
                <Citation>Bukreyev A, Lamirande EW, Buchholz UJ, et al. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet. 2004;363(9427):2122-2127.</Citation>
            </Reference>
            <Reference>
                <Citation>Kam YW, Kien F, Roberts A, et al. Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate Fc..RII-dependent entry into B cells in vitro. Vaccine. 2007;25(4):729-740.</Citation>
            </Reference>
            <Reference>
                <Citation>Vennema H, De Groot R, Harbour D, et al. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J Virol. 1990;64(3):1407-1409.</Citation>
            </Reference>
            <Reference>
                <Citation>Czub M, Weingartl H, Czub S, He R, Cao J. Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets. Vaccine. 2005;23(17-18):2273-2279.</Citation>
            </Reference>
            <Reference>
                <Citation>Weingartl H, Czub M, Czub S, et al. Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol. 2004;78(22):12672-12676.</Citation>
            </Reference>
            <Reference>
                <Citation>Honda-Okubo Y, Barnard D, Ong CH, Peng B-H, Tseng C-TK, Petrovsky N. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology. J Virol. 2015;89(6):2995-3007.</Citation>
            </Reference>
            <Reference>
                <Citation>Yang Z-y, Kong W-p, Huang Y, et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature. 2004;428(6982):561-564.</Citation>
            </Reference>
            <Reference>
                <Citation>He Y, Li J, Heck S, Lustigman S, Jiang S. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design. J Virol. 2006;80(12):5757-5767.</Citation>
            </Reference>
            <Reference>
                <Citation>Coleman CM, Liu YV, Mu H, et al. Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine. 2014;32(26):3169-3174.</Citation>
            </Reference>
            <Reference>
                <Citation>Draft landscape of COVID-19 candidate vaccines [updated 2020]. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.</Citation>
            </Reference>
            <Reference>
                <Citation>Folegatti PM, Ewer KJ, Aley PK, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396:467-478.</Citation>
            </Reference>
            <Reference>
                <Citation>van Doremalen N, Lambe T, Spencer A, et al. ChAdOx1 NCoV-19 Vaccination Prevents SARS-CoV-2 Pneumonia in Rhesus Macaques. 2020. https://doi.org/10.1101/2020.05.13.093195.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhu F-C, Li Y-H, Guan X-H, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020;395:1845-1854.</Citation>
            </Reference>
            <Reference>
                <Citation>Corbett KS, Edwards DK, Leist SR, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020. http://doi.org/10.1038/s41586-020-2622-0.</Citation>
            </Reference>
            <Reference>
                <Citation>Walsh EE, Frenck R, Falsey AR, et al. RNA-based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study. 2020. https://doi.org/10.1101/2020.08.17.20176651.</Citation>
            </Reference>
            <Reference>
                <Citation>Keech C, Albert G, Cho I, et al. Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine. N Engl Med. 2020. http://doi.org/10.1056/nejmoa2026920.</Citation>
            </Reference>
            <Reference>
                <Citation>Jackson LA., Anderson EJ, Rouphael NG, et al. An mRNA vaccine against SARS-CoV-2-preliminary report. N Engl J Med. 2020. http://doi.org/10.1056/nejmoa2022483.</Citation>
            </Reference>
            <Reference>
                <Citation>Vogel A, Kanevsky I, Che Y, et al. A Prefusion SARS-CoV-2 Spike RNA Vaccine is Highly Immunogenic and Prevents Lung Infection in Non-Human Primates. 2020. https://doi.org/10.1101/2020.09.08.280818.</Citation>
            </Reference>
            <Reference>
                <Citation>Tian J-H, Patel N, Haupt R, et al. SARS-CoV-2 Spike Glycoprotein Vaccine Candidate NVX-CoV2373 Elicits Immunogenicity in Baboons and Protection in Mice. 2020. https://doi.org/10.1101/2020.06.29.178509.</Citation>
            </Reference>
            <Reference>
                <Citation>Guebre-Xabier M, Patel N, Tian J-H, et al. NVX-CoV2373 Vaccine Protects Cynomolgus Macaque Upper and Lower Airways Against SARS-CoV-2 Challenge. 2020; https://doi.org/10.1101/2020.08.18.256578.</Citation>
            </Reference>
            <Reference>
                <Citation>Du L, He Y, Zhou Y, Liu S, Zheng B-J, Jiang S. The spike protein of SARS-CoV-a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7(3):226-236.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhu X, Liu Q, Du L, Lu L, Jiang S. Receptor-binding domain as a target for developing SARS vaccines. J Thorac Dis. 2013;5(suppl 2):S142.</Citation>
            </Reference>
            <Reference>
                <Citation>Lan J, Yao Y, Deng Y, et al. Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge. EBioMedicine. 2015;2(10):1438-1446.</Citation>
            </Reference>
            <Reference>
                <Citation>Jiang S, He Y, Liu S. SARS vaccine development. Emerg Infect Dis. 2005;11(7):1016.</Citation>
            </Reference>
            <Reference>
                <Citation>Yang Y, Deng Y, Wen B, et al. The amino acids 736-761 of the MERS-CoV spike protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents. Viral Immunol. 2014;27(10):543-550.</Citation>
            </Reference>
            <Reference>
                <Citation>Tai W, Wang Y, Fett CA, et al. Recombinant receptor-binding domains of multiple Middle East respiratory syndrome coronaviruses (MERS-CoVs) induce cross-neutralizing antibodies against divergent human and camel MERS-CoVs and antibody escape mutants. J Virol. 2017;91(1):e01651-16.</Citation>
            </Reference>
            <Reference>
                <Citation>He Y, Zhou Y, Siddiqui P, Jiang S. Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry. Biochem Biophys Res Commun. 2004;325(2):445-452.</Citation>
            </Reference>
            <Reference>
                <Citation>He Y, Zhu Q, Liu S, et al. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines. Virology. 2005;334(1):74-82.</Citation>
            </Reference>
            <Reference>
                <Citation>He Y, Zhou Y, Liu S, et al. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun. 2004;324(2):773-781.</Citation>
            </Reference>
            <Reference>
                <Citation>Du L, Zhao G, He Y, et al. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model. Vaccine. 2007;25(15):2832-2838.</Citation>
            </Reference>
            <Reference>
                <Citation>Nyon MP, Du L, Tseng C-TK, et al. Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen. Vaccine. 2018;36(14):1853-1862.</Citation>
            </Reference>
            <Reference>
                <Citation>Du L, Zhao G, Lin Y, et al. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Vaccine. 2008;26(13):1644-1651.</Citation>
            </Reference>
            <Reference>
                <Citation>Du L, He Y, Wang Y, et al. Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: implication for developing SARS vaccines. Virology. 2006;353(1):6-16.</Citation>
            </Reference>
            <Reference>
                <Citation>Du L, Zhao G, Lin Y, et al. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection. J Immunol. 2008;180(2):948-956.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhi Y, Kobinger GP, Jordan H, et al. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein. Virology. 2005;335(1):34-45.</Citation>
            </Reference>
            <Reference>
                <Citation>Sahin U, Muik A, Derhovanessian E, et al. Concurrent Human Antibody and TH1 type T-cell Responses Elicited by a COVID-19 RNA Vaccine. 2020; https://doi.org/10.1101/2020.07.17.20140533.</Citation>
            </Reference>
            <Reference>
                <Citation>Mulligan MJ, Lyke KE, Kitchin N, et al. Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report. 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Cheng Y, He B, Yang J, et al. Crystal structure of the S1 subunit N-terminal domain from DcCoV UAE-HKU23 spike protein. Virology. 2019;535:74-82.</Citation>
            </Reference>
            <Reference>
                <Citation>Qian Z, Ou X, G..es LGB, et al. Identification of the receptor-binding domain of the spike glycoprotein of human betacoronavirus HKU1. J Virol. 2015;89(17):8816-8827.</Citation>
            </Reference>
            <Reference>
                <Citation>Jiaming L, Yanfeng Y, Yao D, et al. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Vaccine. 2017;35(1):10-18.</Citation>
            </Reference>
            <Reference>
                <Citation>Chen Y, Lu S, Jia H, et al. A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein. Emerg microbes Infect. 2017;6(1):1-7.</Citation>
            </Reference>
            <Reference>
                <Citation>Adney DR, Wang L, van Doremalen N, et al. Efficacy of an adjuvanted Middle East respiratory syndrome coronavirus spike protein vaccine in dromedary camels and alpacas. Viruses. 2019;11(3):212.</Citation>
            </Reference>
            <Reference>
                <Citation>Liu R-Y, Wu L-Z, Huang B-J, et al. Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats. Virus Res. 2005;112(1-2):24-31.</Citation>
            </Reference>
            <Reference>
                <Citation>Wang Y, Tai W, Yang J, et al. Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection. Hum Vaccin Immunother. 2017;13(7):1615-1624.</Citation>
            </Reference>
            <Reference>
                <Citation>Kim E, Erdos G, Huang S, et al. Microneedle array delivered recombinant coronavirus vaccines: immunogenicity and rapid translational development. EBioMedicine. 2020;55:102743.</Citation>
            </Reference>
            <Reference>
                <Citation>Elshabrawy HA, Coughlin MM, Baker SC, Prabhakar BS. Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing. PLoS One. 2012;7(11):e50366. http://doi.org/10.1371/journal.pone.0050366.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhou Y, Jiang S, Du L. Prospects for a MERS-CoV spike vaccine. Expet Rev Vaccine. 2018;17(8):677-686.</Citation>
            </Reference>
            <Reference>
                <Citation>Shang W, Yang Y, Rao Y, Rao X. The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines. NPJ Vaccines. 2020;5(1):1-3.</Citation>
            </Reference>
            <Reference>
                <Citation>Chan JF-W, Kok K-H, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221-236.</Citation>
            </Reference>
            <Reference>
                <Citation>Wang N, Shang J, Jiang S, Du L. Subunit vaccines against emerging pathogenic human coronaviruses. Front Microbiol. 2020;11:298.</Citation>
            </Reference>
            <Reference>
                <Citation>Lu L, Liu Q, Zhu Y, et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun. 2014;5(1):1-12.</Citation>
            </Reference>
            <Reference>
                <Citation>Guo Y, Sun S, Wang K, Zhang S, Zhu W, Chen Z. Elicitation of immunity in mice after immunization with the S2 subunit of the severe acute respiratory syndrome coronavirus. DNA Cell Biol. 2005;24(8):510-515.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhang J, Zeng H, Gu J, Li H, Zheng L, Zou Q. Progress and prospects on vaccine development against SARS-CoV-2. Vaccines. 2020;8(2):153.</Citation>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33593976</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2150-7511</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>12</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>mBio</Title>
                <ISOAbbreviation>mBio</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">e02492-20</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/mBio.02492-20</ELocationID>
            <Abstract>
                <AbstractText>The global coronavirus disease 2019 (COVID-19) pandemic has mobilized efforts to develop vaccines and antibody-based therapeutics, including convalescent-phase plasma therapy, that inhibit viral entry by inducing or transferring neutralizing antibodies (nAbs) against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein (CoV2-S). However, rigorous efficacy testing requires extensive screening with live virus under onerous biosafety level 3 (BSL3) conditions, which limits high-throughput screening of patient and vaccine sera. Myriad BSL2-compatible surrogate virus neutralization assays (VNAs) have been developed to overcome this barrier. Yet, there is marked variability between VNAs and how their results are presented, making intergroup comparisons difficult. To address these limitations, we developed a standardized VNA using CoV2-S pseudotyped particles (CoV2pp) based on vesicular stomatitis virus bearing the <i>Renilla</i> luciferase gene in place of its G glycoprotein (VSV..G); this assay can be robustly produced at scale and generate accurate neutralizing titers within 18...h postinfection. Our standardized CoV2pp VNA showed a strong positive correlation with CoV2-S enzyme-linked immunosorbent assay (ELISA) results and live-virus neutralizations in confirmed convalescent-patient sera. Three independent groups subsequently validated our standardized CoV2pp VNA (<i>n</i>...&gt;...120). Our data (i) show that absolute 50% inhibitory concentration (absIC<sub>50</sub>), absIC<sub>80</sub>, and absIC<sub>90</sub> values can be legitimately compared across diverse cohorts, (ii) highlight the substantial but consistent variability in neutralization potency across these cohorts, and (iii) support the use of the absIC<sub>80</sub> as a more meaningful metric for assessing the neutralization potency of a vaccine or convalescent-phase sera. Lastly, we used our CoV2pp in a screen to identify ultrapermissive 293T clones that stably express ACE2 or ACE2 plus TMPRSS2. When these are used in combination with our CoV2pp, we can produce CoV2pp sufficient for 150,000 standardized VNAs/week.<b>IMPORTANCE</b> Vaccines and antibody-based therapeutics like convalescent-phase plasma therapy are premised upon inducing or transferring neutralizing antibodies that inhibit SARS-CoV-2 entry into cells. Virus neutralization assays (VNAs) for measuring neutralizing antibody titers (NATs) are an essential part of determining vaccine or therapeutic efficacy. However, such efficacy testing is limited by the inherent dangers of working with the live virus, which requires specialized high-level biocontainment facilities. We therefore developed a standardized replication-defective pseudotyped particle system that mimics the entry of live SARS-CoV-2. This tool allows for the safe and efficient measurement of NATs, determination of other forms of entry inhibition, and thorough investigation of virus entry mechanisms. Four independent labs across the globe validated our standardized VNA using diverse cohorts. We argue that a standardized and scalable assay is necessary for meaningful comparisons of the myriad of vaccines and antibody-based therapeutics becoming available. Our data provide generalizable metrics for assessing their efficacy.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 Oguntuyo et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Oguntuyo</LastName>
                    <ForeName>Kasopefoluwa Y</ForeName>
                    <Initials>KY</Initials>
                    <Identifier Source="ORCID">0000-0001-7824-2892</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Stevens</LastName>
                    <ForeName>Christian S</ForeName>
                    <Initials>CS</Initials>
                    <Identifier Source="ORCID">0000-0003-2472-6984</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hung</LastName>
                    <ForeName>Chuan Tien</ForeName>
                    <Initials>CT</Initials>
                    <Identifier Source="ORCID">0000-0001-6899-1312</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ikegame</LastName>
                    <ForeName>Satoshi</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Acklin</LastName>
                    <ForeName>Joshua A</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kowdle</LastName>
                    <ForeName>Shreyas S</ForeName>
                    <Initials>SS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carmichael</LastName>
                    <ForeName>Jillian C</ForeName>
                    <Initials>JC</Initials>
                    <Identifier Source="ORCID">0000-0001-5270-5916</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chiu</LastName>
                    <ForeName>Hsin-Ping</ForeName>
                    <Initials>HP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Azarm</LastName>
                    <ForeName>Kristopher D</ForeName>
                    <Initials>KD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haas</LastName>
                    <ForeName>Griffin D</ForeName>
                    <Initials>GD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Amanat</LastName>
                    <ForeName>Fatima</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Klingler</LastName>
                    <ForeName>J..romine</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>James J. Peters VA Medical Center, Bronx, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baine</LastName>
                    <ForeName>Ian</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arinsburg</LastName>
                    <ForeName>Suzanne</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bandres</LastName>
                    <ForeName>Juan C</ForeName>
                    <Initials>JC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>James J. Peters VA Medical Center, Bronx, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Siddiquey</LastName>
                    <ForeName>Mohammed N A</ForeName>
                    <Initials>MNA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Louisiana State University Health Science Center Shreveport, Shreveport, Louisiana, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schilke</LastName>
                    <ForeName>Robert M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Louisiana State University Health Science Center Shreveport, Shreveport, Louisiana, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Woolard</LastName>
                    <ForeName>Matthew D</ForeName>
                    <Initials>MD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Louisiana State University Health Science Center Shreveport, Shreveport, Louisiana, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Hongbo</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Louisiana State University Health Science Center Shreveport, Shreveport, Louisiana, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>COVIDAR Argentina Consortium</CollectiveName>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Duty</LastName>
                    <ForeName>Andrew J</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kraus</LastName>
                    <ForeName>Thomas A</ForeName>
                    <Initials>TA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moran</LastName>
                    <ForeName>Thomas M</ForeName>
                    <Initials>TM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tortorella</LastName>
                    <ForeName>Domenico</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lim</LastName>
                    <ForeName>Jean K</ForeName>
                    <Initials>JK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gamarnik</LastName>
                    <ForeName>Andrea V</ForeName>
                    <Initials>AV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>COVIDAR Argentina Consortium, Buenos Aires, Argentina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hioe</LastName>
                    <ForeName>Catarina E</ForeName>
                    <Initials>CE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>James J. Peters VA Medical Center, Bronx, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zolla-Pazner</LastName>
                    <ForeName>Susan</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">0000-0002-0750-2666</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ivanov</LastName>
                    <ForeName>Stanimir S</ForeName>
                    <Initials>SS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Louisiana State University Health Science Center Shreveport, Shreveport, Louisiana, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kamil</LastName>
                    <ForeName>Jeremy P</ForeName>
                    <Initials>JP</Initials>
                    <Identifier Source="ORCID">0000-0001-8422-7656</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Louisiana State University Health Science Center Shreveport, Shreveport, Louisiana, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krammer</LastName>
                    <ForeName>Florian</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">0000-0003-4121-776X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Benhur</ForeName>
                    <Initials>B</Initials>
                    <Identifier Source="ORCID">0000-0003-0760-1709</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA Benhur.Lee@mssm.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>T32 AI007647</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 AI139290</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>I01 BX003860</GrantID>
                    <Acronym>BX</Acronym>
                    <Agency>BLRD VA</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>HHSN272201400008C</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 AI123449</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R21 AI148033</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 AI143839</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>F31 AI154739</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 AI116851</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UL1 TR001433</GrantID>
                    <Acronym>TR</Acronym>
                    <Agency>NCATS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>mBio</MedlineTA>
            <NlmUniqueID>101519231</NlmUniqueID>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="UpdateOf">
                <RefSource>medRxiv. 2020 Aug 15;:</RefSource>
                <PMID Version="1">32817961</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">convalescent-phase plasma</Keyword>
            <Keyword MajorTopicYN="Y">neutralizing antibodies</Keyword>
            <Keyword MajorTopicYN="Y">viral neutralization assay</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>17</Day>
                <Hour>5</Hour>
                <Minute>44</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33593976</ArticleId>
            <ArticleId IdType="pii">mBio.02492-20</ArticleId>
            <ArticleId IdType="doi">10.1128/mBio.02492-20</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Rehman SU, Shafique L, Ihsan A, Liu Q. Evolutionary trajectory for the emergence of novel coronavirus SARS-CoV-2. Pathogens. 2020;9:240.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.3390/pathogens9030240</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Peiris JSM, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med. 2004;10:S88...S97.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/nm1143</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Revised U.S. surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases...United States and Worldwide, December 2003. 2003.</Citation>
            </Reference>
            <Reference>
                <Citation>Novel coronavirus (2019-nCoV): situation report, 19. 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Petherick A. Developing antibody tests for SARS-CoV-2. Lancet. 2020;395:1101...1102.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/S0140-6736(20)30788-1</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Schmidt F, Weisblum Y, Muecksch F, Hoffmann HH, Michailidis E, Lorenzi JCC, Mendoza P, Rutkowska M, Bednarski E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, Cipolla M, Caskey M, Robbiani DF, Nussenzweig MC, Rice CM, Hatziioannou T, Bieniasz PD. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J Exp Med. 2020;217:e20201181.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1084/jem.20201181</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dieterle ME. A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition. Cell Host Microbe. 2020;217:486...496.e6.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.chom.2020.06.020</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nie J, Li Q, Wu J, Zhao C, Hao H, Liu H, Zhang L, Nie L, Qin H, Wang M, Lu Q, Li X, Sun Q, Liu J, Fan C, Huang W, Xu M, Wang Y. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect. 2020;9:680...686.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1080/22221751.2020.1743767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Case JB, Rothlauf PW, Chen RE, Liu Z, Zhao H, Kim AS, Bloyet LM, Zeng Q, Tahan S, Droit L, Ilagan MXG, Tartell MA, Amarasinghe G, Henderson JP, Miersch S, Ustav M, Sidhu S, Virgin HW, Wang D, Ding S, Corti D, Theel ES, Fremont DH, Diamond MS, Whelan SPJ. Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2. bioRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.05.18.102038</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA II, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JHmRNA-1273 Study Group. An mRNA vaccine against SARS-CoV-2...preliminary report. N Engl J Med. 2020;383:1920...1931.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1056/NEJMoa2022483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA, Dold C, Faust SN, Finn A, Flaxman AL, Hallis B, Heath P, Jenkin D, Lazarus R, Makinson R, Minassian AM, Pollock KM, Ramasay M, Robinson H, Snape M, Tarrant R, Voysey M, Green C, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396:467...478.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/S0140-6736(20)31604-4</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhu F-C, Li Y-H, Guan X-H, Hou L-H, Wang W-J, Li J-X, Wu S-P, Wang B-S, Wang Z, Wang L, Jia S-Y, Jiang H-D, Wang L, Jiang T, Hu Y, Gou J-B, Xu S-B, Xu J-J, Wang X-W, Wang W, Chen W. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020;395:1845...1854.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/S0140-6736(20)31208-3</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mulligan MJ, Neuzil K, Raabe V, Bailey R, Kena A, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart SP, Neuzil K, Raabe V, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fonter-Garfias C, Shi P-Y, Tuereci O, Tompkins KR, Walsh EE, Frenck R, Falsey AR, Dormitzer PR, Gruber WC, Sahin U, Jansen KU. Phase 1/2 study to describe the safety and immunogenicity of a COVID-19 RNA vaccine candidate (BNT162b1) in adults 18 to 55 years of age: interim report. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.06.30.20142570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, Baum A, Pascal K, Quandt J, Maurus D, Brachtendorf S, Loerks VL, Sikorski J, Hilker R, Becker D, Eller A-K, Gruetzner J, Boesler C, Rosenbaum C, Kuehnle M-C, Luxemburger U, Kemmer-Brueck A, Langer D, Bexon M, Bolte S, Kariko K, Palanche T, Fischer B, Schultz A, Shi P-Y, Fontes-Garfias C, Perez JL, Swanson KA, Loschko J, Scully IL, Cutler M, Kalina W, Kyratsous CA, Cooper D, Dormitzer PR, Jansen KU, Tuereci O. Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.07.17.20140533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Keech C, Albert G, Reed P, Neal S, Plested JS, Zhu M, Cloney-Clark S, Zhou H, Patel N, Frieman MB, Haupt RE, Logue J, McGrath M, Weston S, Piedra PA, Cho I, Robertson A, Desai C, Callahan K, Lewis M, Price-Abbott P, Formica N, Shinde V, Fries L, Linkliter JD, Griffin P, Wilkinson B, Smith G, Glenn GM. First-in-human trial of a SARS CoV 2 recombinant spike protein nanoparticle vaccine. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.08.05.20168435</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020;117:9490...9496.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1073/pnas.2004168117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020;323:1582.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1001/jama.2020.4783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, Kong Y, Ren L, Wei Q, Mei H, Hu C, Tao C, Yang R, Wang J, Yu Y, Guo Y, Wu X, Xu Z, Zeng L, Xiong N, Chen L, Wang J, Man N, Liu Y, Xu H, Deng E, Zhang X, Li C, Wang C, Su S, Zhang L, Wang J, Wu Y, Liu Z. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19. JAMA. 2020;324:460.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1001/jama.2020.10044</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Joyner MJ, Wright RS, Fairweather D, Senefeld JW, Bruno KA, Klassen SA, Carter RE, Klompas AM, Wiggins CC, Shepherd JRA, Rea RF, Whelan ER, Clayburn AJ, Spiegel MR, Johnson PW, Lesser ER, Baker SE, Larson KF, Ripoll JG, Andersen KJ, Hodge DO, Kunze KL, Buras MR, Vogt MNP, Herasevich V, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, van Buskirk CM, Winters JL, Stubbs JR, Paneth NS, Verdun NC, Marks P, Casadevall A. Early safety indicators of COVID-19 convalescent plasma in 5,000 patients. J Clin Invest. 2020;130:4791...4797.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1172/JCI140200</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Joyner MJ, Klassen SA, Senefeld J, Johnson PW, Carter RE, Wiggins CC, Shoham S, Grossman BJ, Henderson JP, Musser JM, Salazar E, Hartman WR, Bouvier NM, Liu STH, Pirofski L, Baker SE, Van Helmond N, Wright RS, Fairweather D, Bruno KA, Paneth NS, Casadevall A. Evidence favouring the efficacy of convalescent plasma for COVID-19 therapy. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.07.29.20162917</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hartman W, Hess AS, Connor JP. Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.06.19.20135830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Jin C, Gu J, Yuan Y, Long Q, Zhang Q, Zhou H, Wu W, Zhang W. Treatment of six COVID-19 patients with convalescent plasma. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.05.21.20109512</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rasheed AM, Ftak DF, Hashim HA, Maulood MF, Kabah KK, Almusawi YA, Abdulamir AS. The therapeutic effectiveness of convalescent plasma therapy on treating COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.06.24.20121905</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gharbharan A, Jordans CCE, GeurtsvanKessel C, den Hollander JG, Karim F, Mollema FPN, Stalenhoef JE, Dofferhoff A, Ludwig I, Koster A, Hassing R-J, Bos JC, van Pottelberge GR, Vlasveld IN, Ammerlaan HSM, Segarceanu E, Miedema J, van der Eerden M, Papageorgiou G, te Broekhorst P, Swaneveld FH, Katsikis PD, Mueller Y, Okba NMA, Koopmans MPG, Haagmans BL, Rokx C, Rijnders B. Convalescent plasma for COVID-19. A randomized clinical trial. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.07.01.20139857</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Martinez-Resendez MF, Castilleja-Leal F, Torres-Quintanilla A, Rojas-Martinez A, Garcia-Rivas G, Ortiz-Lopez R, Trevino V, Lara-Medrano R, Villanueva-Lozano H, Ramirez-Elizondo T, Sanchez-Nava V, Moreno-Hoyos F, Martinez-Thomae A, Hernandez-Torre M, Diaz-Olachea C, Cardona-Huerta S, de la Rosa-Pacheco S, Diaz-Garza C, Reynoso-Lobo P, Marroquin-Escamilla AR, Herrera-Gamboa JG, Alvarado-Monroy FM, Aguayo-Millan CD, Villegas-Macedo FF, Flores-Osorio JE, Davila-Gonzalez D, Diaz-Sanchez ME, Torre-Amione G. Initial experience in Mexico with convalescent plasma in COVID-19 patients with severe respiratory failure, a retrospective case series. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.07.14.20144469</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhang B, Liu S, Tan T, Huang W, Dong Y, Chen L, Chen Q, Zhang L, Zhong Q, Zhang X, Zou Y, Zhang S. Treatment with convalescent plasma for critically ill patients with severe acute respiratory syndrome coronavirus 2 infection. Chest. 2020;158:e9...e13.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.chest.2020.03.039</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ahn JY, Sohn Y, Lee SH, Cho Y, Hyun JH, Baek YJ, Jeong SJ, Kim JH, Ku NS, Yeom J-S, Roh J, Ahn MY, Chin BS, Kim YS, Lee H, Yong D, Kim HO, Kim S, Choi JY. Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea. J Korean Med Sci. 2020;35:e149.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.3346/jkms.2020.35.e149</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pei S, Yuan X, Zhimin Zhang Z, Run Yao R, Xie Y, Minxue Shen M, Bijuan Li B, Chen X, Yin M. Convalescent plasma to treat COVID-19: Chinese strategy and experiences. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.04.07.20056440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ye M, Fu D, Ren Y, Wang F, Wang D, Zhang F, Xia X, Lv T. Treatment with convalescent plasma for COVID...19 patients in Wuhan, China. J Med Virol. 2020;92:1890...1901.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1002/jmv.25882</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zeng Q-L, Yu Z-J, Gou J-J, Li G-M, Ma S-H, Zhang G-F, Xu J-H, Lin W-B, Cui G-L, Zhang M-M, Li C, Wang Z-S, Zhang Z-H, Liu Z-S. Effect of convalescent plasma therapy on viral shedding and survival in patients with coronavirus disease 2019. J Infect Dis. 2020;222:38...43.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1093/infdis/jiaa228</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Salazar E, Perez KK, Ashraf M, Chen J, Castillo B, Christensen PA, Eubank T, Bernard DW, Eagar TN, Long SW, Subedi S, Olsen RJ, Leveque C, Schwartz MR, Dey M, Chavez-East C, Rogers J, Shehabeldin A, Joseph D, Williams G, Thomas K, Masud F, Talley C, Dlouhy KG, Lopez BV, Hampton C, Lavinder J, Gollihar JD, Maranhao AC, Ippolito GC, Saavedra MO, Cantu CC, Yerramilli P, Pruitt L, Musser JM. Treatment of coronavirus disease 2019 (COVID-19) patients with convalescent plasma. Am J Pathol. 2020;190:1680...1690.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.ajpath.2020.05.014</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>H Liu ST, Baine I, Dupper A, Zheng A, Altman DR, Chen BK, Krammer F, Rao Mendu D, Firpo-Betancourt A, Levin MA, Bagiella E, Arinsburg SA, Reich DL, Aberg JA, Bouvier NM. Convalescent plasma treatment of severe COVID-19: a matched control study. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.05.20.20102236</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Perotti C, Baldanti F, Bruno R, Fante C Del, Seminari E, Casari S, Percivalle E, Glingani C, Musella V, Belliato M, Garuti M, Meloni F, Frigato M, Sabatino A Di, Klersy C, De Donno G, Franchini M. Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter interventional trial. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.05.26.20113373</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ni L, Ye F, Cheng M-L, Feng Y, Deng Y-Q, Zhao H, Wei P, Ge J, Gou M, Li X, Sun L, Cao T, Wang P, Zhou C, Zhang R, Liang P, Guo H, Wang X, Qin C-F, Chen F, Dong C. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52:971...977.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.immuni.2020.04.023</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stadlbauer D, Tan J, Jiang K, Hernandez M, Fabre S, Amanat F, Teo C, Arunkumar GA, McMahon M, Jhang J, Nowak M, Simon V, Sordillo E, van Bakel H, Krammer F. Seroconversion of a city: longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.06.28.20142190</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bosch BJ, van der Zee R, de Haan CAM, Rottier PJM. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol. 2003;77:8801...8811.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1128/jvi.77.16.8801-8811.2003</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3:237...261.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1146/annurev-virology-110615-042301</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260...1263.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1126/science.abb2507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5:562...569.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41564-020-0688-y</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr..ger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, M..ller MA, Drosten C, P..hlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271...280.e8.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631...637.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1002/path.1570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Glowacka I, Bertram S, M..ller MA, Allen P, Soilleux E, Pfefferle S, Steffen I, Tsegaye TS, He Y, Gnirss K, Niemeyer D, Schneider H, Drosten C, P..hlmann S. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011;85:4122...4134.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1128/JVI.02232-10</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Menachery VD, Dinnon KH, Yount BL, McAnarney ET, Gralinski LE, Hale A, Graham RL, Scobey T, Anthony SJ, Wang L, Graham B, Randell SH, Lipkin WI, Baric RS. Trypsin treatment unlocks barrier for zoonotic bat coronavirus infection. J Virol. 2019;94:e01774-19.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1128/JVI.01774-19</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, Li F. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A. 2020;117:11727...11734.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1073/pnas.2003138117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol. 2010;84:12658...12664.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1128/JVI.01542-10</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Shulla A, Heald-Sargent T, Subramanya G, Zhao J, Perlman S, Gallagher T. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol. 2011;85:873...882.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1128/JVI.02062-10</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.jmii.2020.03.022</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gallagher TM, Buchmeier MJ. Coronavirus spike proteins in viral entry and pathogenesis. Virology. 2001;279:371...374.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1006/viro.2000.0757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Simmons G, Zmora P, Gierer S, Heurich A, P..hlmann S. Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antiviral Res. 2013;100:605...614.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.antiviral.2013.09.028</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tang T, Bidon M, Jaimes JA, Whittaker GR, Daniel S. Coronavirus membrane fusion mechanism offers a potential target for antiviral development. Antiviral Res. 2020;178:104792.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.antiviral.2020.104792</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, Nagata N, Sekizuka T, Katoh H, Kato F, Sakata M, Tahara M, Kutsuna S, Ohmagari N, Kuroda M, Suzuki T, Kageyama T, Takeda M. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A. 2020;117:7001...7003.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1073/pnas.2002589117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hofmann H, Hattermann K, Marzi A, Gramberg T, Geier M, Krumbiegel M, Kuate S, Uberla K, Niedrig M, P..hlmann S. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol. 2004;78:6134...6142.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1128/JVI.78.12.6134-6142.2004</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A. 2004;101:4240...4245.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1073/pnas.0306446101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Yang Z-Y, Huang Y, Ganesh L, Leung K, Kong W-P, Schwartz O, Subbarao K, Nabel GJ. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol. 2004;78:5642...5650.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1128/JVI.78.11.5642-5650.2004</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zheng M, Song L. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV. Cell Mol Immunol. 2020;17:536...538.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41423-020-0385-z</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Okba NMA, M..ller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, Yazdanpanah Y, Le Hingrat Q, Descamps D, Houhou-Fidouh N, Reusken CBEM, Bosch B-J, Drosten C, Koopmans MPG, Haagmans BL. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients. Emerg Infect Dis. 2020;26:1478...1488.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.3201/eid2607.200841</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Wang X, Yuan J, Li T, Li J, Qian S, Hong C, Wang F, Liu Y, Wang Z, He Q, Li Z, He B, Zhang T, Fu Y, Ge S, Liu L, Zhang J, Xia N, Zhang Z. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020;71:2027...2034.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1093/cid/ciaa344</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>W..lfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, M..ller MA, Niemeyer D, Jones TC, Vollmar P, Rothe C, Hoelscher M, Bleicker T, Br..nink S, Schneider J, Ehmann R, Zwirglmaier K, Drosten C, Wendtner C. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465...469.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41586-020-2196-x</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>To KK-W, Tsang OT-Y, Leung W-S, Tam AR, Wu T-C, Lung DC, Yip CC-Y, Cai J-P, Chan JM-C, Chik TS-H, Lau DP-L, Choi CY-C, Chen L-L, Chan W-M, Chan K-H, Ip JD, Ng AC-K, Poon RW-S, Luo C-T, Cheng VC-C, Chan JF-W, Hung IF-N, Chen Z, Chen H, Yuen K-Y. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20:565...574.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/S1473-3099(20)30196-1</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Wu L-P, Wang N-C, Chang Y-H, Tian X-Y, Na D-Y, Zhang L-Y, Zheng L, Lan T, Wang L-F, Liang G-D. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13:1562...1564.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.3201/eid1310.070576</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Xiao AT, Tong YX, Zhang S. False negative of RT...PCR and prolonged nucleic acid conversion in COVID...19: rather than recurrence. J Med Virol. 2020;92:1755...1756.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1002/jmv.25855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Xing Y, Mo P, Xiao Y, Zhao O, Zhang Y, Wang F. Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020. Eurosurveillance. 2020;25:2...5.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.10.2000191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bao L, Deng W, Gao H, Xiao C, Liu J, Xie J, Lv Q, Liu J, Yu P, Xu Y, Qi F, Qu Y, Li F, Xiang Z, Yu H, Gong S, Liu M, Wang G, Wang S, Song Z, Liu Y, Zhao W, Han Y, Chao L, Liu X, Wei Q, Qin C. Lack of reinfection in rhesus macaques infected with SARS-CoV-2. bioRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.03.13.990226</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chandrashekar A, Liu J, Martinot AJ, McMahan K, Mercado NB, Peter L, Tostanoski LH, Yu J, Maliga Z, Nekorchuk M, Busman-Sahay K, Terry M, Wrijil LM, Ducat S, Martinez DR, Atyeo C, Fischinger S, Burke JS, Slein MD, Pessaint L, Van Ry A, Greenhouse J, Taylor T, Blade K, Cook A, Finneyfrock B, Brown R, Teow E, Velasco J, Zahn R, Wegmann F, Abbink P, Bondzie EA, Dagotto G, Gebre MS, He X, Jacob-Dolan C, Kordana N, Li Z, Lifton MA, Mahrokhian SH, Maxfield LF, Nityanandam R, Nkolola JP, Schmidt AG, Miller AD, Baric RS, Alter G, Sorger PK, Estes JD. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;369:812...817.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1126/science.abc4776</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Holmes KV. SARS coronavirus: a new challenge for prevention and therapy. J Clin Invest. 2003;111:1605...1609.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1172/JCI18819</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cavanagh DZuckerman AJ, Banatvala JE, Pattison JR, Griffiths PD, Schoub BD. Principles and practice of clinical virology.. 2009;379...397.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1002/0470020970.ch10</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kellam P, Barclay W. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection. J Gen Virol. 2020;101:791...797.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1099/jgv.0.001439</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ibarrondo FJ, Fulcher JA, Goodman-Meza D, Elliott J, Hofmann C, Hausner MA, Ferbas KG, Tobin NH, Aldrovandi GM, Yang OO. Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild Covid-19. N Engl J Med. 2020;383:1085...1087.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1056/NEJMc2025179</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Wang K, Long Q-X, Deng H-J, Hu J, Gao Q-Z, Zhang G-J, He C-L, Huang L-Y, Jie-Li H, Chen J, Tang N, Huang A-L. Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.07.14.20151159</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Seow J, Graham C, Merrick B, Aors S, Steel KJ, Hemmings O, O'Bryne A, Kouphou N, Pickering S, Galao R, Betancor G, Wilson HD, Signell AW, Winstone H, Kerridge C, Temperton N, Snell L, Bisnauthsing K, Moore A, Green A, Martinez L, Stokes B, Honey J, Izquierdo-Barras A, Arbane G, Patel A, OConnell L, O Hara G, MacMahon E, Douthwaite S, Nebbia G, Batra R, Martinez-Nunez R, Edgeworth JD, Neil SJ, Malim MH, Doores K. Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.07.09.20148429</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Long Q-X, Tang X-J, Shi Q-L, Li Q, Deng H-J, Yuan J, Hu J-L, Xu W, Zhang Y, Lv F-J, Su K, Zhang F, Gong J, Wu B, Liu X-M, Li J-J, Qiu J-F, Chen J, Huang A-L. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200...1204.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41591-020-0965-6</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Liu W, Liu L, Kou G, Zheng Y, Ding Y, Ni W, Wang Q, Tan L, Wu W, Tang S, Xiong Z, Zheng S. Evaluation of nucleocapsid and spike protein-based enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2. J Clin Microbiol. 2020;58:e00461-20.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1128/JCM.00461-20</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Amanat F, Stadlbauer D, Strohmeier S, Nguyen THO, Chromikova V, McMahon M, Jiang K, Arunkumar GA, Jurczyszak D, Polanco J, Bermudez-Gonzalez M, Kleiner G, Aydillo T, Miorin L, Fierer DS, Lugo LA, Kojic EM, Stoever J, Liu STH, Cunningham-Rundles C, Felgner PL, Moran T, Garc..a-Sastre A, Caplivski D, Cheng AC, Kedzierska K, Vapalahti O, Hepojoki JM, Simon V, Krammer F. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020;26:1033...1036.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41591-020-0913-5</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Liu W, Liu L, Kou G, Zheng Y, Ding Y, Ni W, Wang Q, Tan L, Wu W, Tang S, Xiong Z, Zheng S. Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results. Clin Microbiol Infect. 2020;26:1178...1182.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.cmi.2020.06.019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rogers TF, Zhao F, Huang D, Beutler N, Burns A, He W, Limbo O, Smith C, Song G, Woehl J, Yang L, Abbott RK, Callaghan S, Garcia E, Hurtado J, Parren M, Peng L, Ramirez S, Ricketts J, Ricciardi MJ, Rawlings SA, Wu NC, Yuan M, Smith DM, Nemazee D, Teijaro JR, Voss JE, Wilson IA, Andrabi R, Briney B, Landais E, Sok D, Jardine JG, Burton DR. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science. 2020;369:956...963.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1126/science.abc7520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Seydoux E, Homad LJ, MacCamy AJ, Parks KR, Hurlburt NK, Jennewein MF, Akins NR, Stuart AB, Wan Y-H, Feng J, Whaley RE, Singh S, Boeckh M, Cohen KW, McElrath MJ, Englund JA, Chu HY, Pancera M, McGuire AT, Stamatatos L. Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation. Immunity. 2020;53:98...105.e5.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.immuni.2020.06.001</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Wu Y, Li C, Xia S, Tian X, Kong Y, Wang Z, Gu C, Zhang R, Tu C, Xie Y, Yang Z, Lu L, Jiang S, Ying T. Identification of human single-domain antibodies against SARS-CoV-2. Cell Host Microbe. 2020;27:891...898.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.chom.2020.04.023</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Wec AZ, Wrapp D, Herbert AS, Maurer DP, Haslwanter D, Sakharkar M, Jangra RK, Dieterle ME, Lilov A, Huang D, Tse LV, Johnson NV, Hsieh C-L, Wang N, Nett JH, Champney E, Burnina I, Brown M, Lin S, Sinclair M, Johnson C, Pudi S, Bortz R, Wirchnianski AS, Laudermilch E, Florez C, Fels JM, O'Brien CM, Graham BS, Nemazee D, Burton DR, Baric RS, Voss JE, Chandran K, Dye JM, McLellan JS, Walker LM. Broad neutralization of SARS-related viruses by human monoclonal antibodies. Science. 2020;369:731...736.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1126/science.abc7424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Manenti A, Maggetti M, Casa E, Martinuzzi D, Torelli A, Trombetta CM, Marchi S, Montomoli E. Evaluation of SARS...CoV...2 neutralizing antibodies using a CPE...based colorimetric live virus micro...neutralization assay in human serum samples. J Med Virol. 2020;92:2096...2104.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1002/jmv.25986</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Perera RA, Mok CK, Tsang OT, Lv H, Ko RL, Wu NC, Yuan M, Leung WS, Chan JM, Chik TS, Choi CYC, Leung K, Chan KH, Chan KCK, Li K-C, Wu JT, Wilson IA, Monto AS, Poon LL, Peiris M. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Euro Surveill. 2020;25:2000421.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.16.2000421</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bohn MK, Lippi G, Horvath A, Sethi S, Koch D, Ferrari M, Wang C-B, Mancini N, Steele S, Adeli K. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin Chem Lab Med. 2020;58:1037...1052.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1515/cclm-2020-0722</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>..z....r..mez MK, Ambrosch A, Frey O, Haselmann V, Holdenrieder S, Kiehntopf M, Neumaier M, Walter M, Wenzel F, W..lfel R, Renz HCOVID-19 Task Force of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL). SARS-CoV-2 antibody testing...questions to be asked. J Allergy Clin Immunol. 2020;146:35...43.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.jaci.2020.05.020</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tan CW, Chia WN, Chen MI-C, Hu Z, Young BE, Tan Y-J, Yi Y, Lye DC, Anderson DE, Want L-F. A SARS-CoV-2 surrogate virus neutralization test (sVNT) based on antibody-mediated blockage of ACE2-spike (RBD) protein-protein interaction. Res Sq. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.21203/rs.3.rs-24574/v1</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Liu L, Wang P, Nair MS, Yu J, Rapp M, Wang Q, Luo Y, Chan JF-W, Sahi V, Figueroa A, Guo XV, Cerutti G, Bimela J, Gorman J, Zhou T, Chen Z, Yuen K-Y, Kwong PD, Sodroski JG, Yin MT, Sheng Z, Huang Y, Shapiro L, Ho DD. Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike. Nature. 2020;584:450...456.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41586-020-2571-7</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chi X, Yan R, Zhang J, Zhang G, Zhang Y, Hao M, Zhang Z, Fan P, Dong Y, Yang Y, Chen Z, Guo Y, Zhang J, Li Y, Song X, Chen Y, Xia L, Fu L, Hou L, Xu J, Yu C, Li J, Zhou Q, Chen W. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science. 2020;369:650...655.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1126/science.abc6952</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gorse GJ, Donovan MM, Patel GB. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses. J Med Virol. 2020;92:512...517.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1002/jmv.25715</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Takada A, Robison C, Goto H, Sanchez A, Murti KG, Whitt MA, Kawaoka Y. A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A. 1997;94:14764...14769.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1073/pnas.94.26.14764</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, Lee B. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature. 2005;436:401...405.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/nature03838</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Avanzato VA, Oguntuyo KY, Escalera-Zamudio M, Gutierrez B, Golden M, Kosakovsky Pond SL, Pryce R, Walter TS, Seow J, Doores KJ, Pybus OG, Munster VJ, Lee B, Bowden TA. A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex. Proc Natl Acad Sci U S A. 2019;116:25057...25067.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1073/pnas.1912503116</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zettl F, Meister TL, Vollmer T, Fischer B, Steinmann J, Krawczyk A, V...kovski P, Todt D, Steinmann E, Pfaender S, Zimmer G. Rapid quantification of SARS-CoV-2-neutralizing antibodies using propagation-defective vesicular stomatitis virus pseudotypes. Vaccines. 2020;8:386.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.3390/vaccines8030386</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Shirato K, Kawase M, Matsuyama S. Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry. Virology. 2018;517:9...15.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.virol.2017.11.012</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Wang C. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun. 2020;11:2251.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41467-020-16256-y</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Johnson MC, Lyddon TD, Suarez R, Salcedo B, LePique M, Graham M, Ricana C, Robinson C, Ritter DG. Optimized pseudotyping conditions for the SARS-COV2 Spike glycoprotein 2. bioRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.05.28.122671</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aguilar HC, Anderson WF, Cannon PM. Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R peptide. J Virol. 2003;77:1281...1291.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1128/jvi.77.2.1281-1291.2003</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bosch BJ, de Haan CAM, Smits SL, Rottier PJM. Spike protein assembly into the coronavirion: exploring the limits of its sequence requirements. Virology. 2005;334:306...318.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.virol.2005.02.001</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Shulla A, Gallagher T. Role of spike protein endodomains in regulating coronavirus entry. J Biol Chem. 2009;284:32725...32734.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1074/jbc.M109.043547</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>McBride CE, Machamer CE. Palmitoylation of SARS-CoV S protein is necessary for partitioning into detergent-resistant membranes and cell-cell fusion but not interaction with M protein. Virology. 2010;405:139...148.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.virol.2010.05.031</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lin H-X, Feng Y, Tu X, Zhao X, Hsieh C-H, Griffin L, Junop M, Zhang C. Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry. Virus Res. 2011;160:283...293.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.virusres.2011.06.029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Wyss S, Dimitrov AS, Baribaud F, Edwards TG, Blumenthal R, Hoxie JA. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J Virol. 2005;79:12231...12241.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1128/JVI.79.19.12231-12241.2005</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Edwards TG, Wyss S, Reeves JD, Zolla-Pazner S, Hoxie JA, Doms RW, Baribaud F. Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein. J Virol. 2002;76:2683...2691.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1128/jvi.76.6.2683-2691.2002</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Waning DL, Russell CJ, Jardetzky TS, Lamb RA. Activation of a paramyxovirus fusion protein is modulated by inside-out signaling from the cytoplasmic tail. Proc Natl Acad Sci U S A. 2004;101:9217...9222.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1073/pnas.0403339101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>da Silva E, Mulinge M, Bercoff D. The frantic play of the concealed HIV envelope cytoplasmic tail. Retrovirology. 2013;10:54.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1186/1742-4690-10-54</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aguilar HC, Matreyek KA, Choi DY, Filone CM, Young S, Lee B. Polybasic KKR motif in the cytoplasmic tail of Nipah virus fusion protein modulates membrane fusion by inside-out signaling. J Virol. 2007;81:4520...4532.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1128/JVI.02205-06</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Negrete OA, Wolf MC, Aguilar HC, Enterlein S, Wang W, M..hlberger E, Su SV, Bertolotti-Ciarlet A, Flick R, Lee B. Two key residues in EphrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog. 2006;2:e7.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1371/journal.ppat.0020007</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oguntuyo KY, Stevens CS, Siddiquey MN, Schilke RM, Woolard MD, Zhang H, Acklin JA, Ikegame S, Huang C-T, Lim JK, Cross RW, Geisbert TW, Ivanov SS, Kamil JP, Lee B. In plain sight: the role of alpha-1-antitrypsin in COVID-19 pathogenesis and therapeutics. bioRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.08.14.248880</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stadlbauer D, Amanat F, Chromikova V, Jiang K, Strohmeier S, Arunkumar GA, Tan J, Bhavsar D, Capuano C, Kirkpatrick E, Meade P, Brito RN, Teo C, McMahon M, Simon V, Krammer F. SARS...CoV...2 seroconversion in humans: a detailed protocol for a serological assay, antigen production, and test setup. Curr Protoc Microbiol. 2020;57:e100.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1002/cpmc.100</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, P..hlmann S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2014;88:1293...1307.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1128/JVI.02202-13</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Afar DE, Vivanco I, Hubert RS, Kuo J, Chen E, Saffran DC, Raitano AB, Jakobovits A. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Cancer Res. 2001;61:1686...1692.</Citation>
            </Reference>
            <Reference>
                <Citation>Webb NE, Montefiori DC, Lee B. Dose-response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodies. Nat Commun. 2015;6:8443.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/ncomms9443</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Wagh K, Bhattacharya T, Williamson C, Robles A, Bayne M, Garrity J, Rist M, Rademeyer C, Yoon H, Lapedes A, Gao H, Greene K, Louder MK, Kong R, Karim SA, Burton DR, Barouch DH, Nussenzweig MC, Mascola JR, Morris L, Montefiori DC, Korber B, Seaman MS. Optimal combinations of broadly neutralizing antibodies for prevention and treatment of HIV-1 clade C infection. PLoS Pathog. 2016;12:e1005520.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1371/journal.ppat.1005520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>.</Citation>
            </Reference>
            <Reference>
                <Citation>Muruato AE, Fontes-Garfias CR, Ren P, Garcia-Blanco MA, Menachery VD, Xie X, Shi P-Y. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. bioRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.05.21.109546</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crawford KHD, Eguia R, Dingens AS, Loes AN, Malone KD, Wolf CR, Chu HY, Tortorici MA, Veesler D, Murphy M, Pettie D, King NP, Balazs AB, Bloom JD. Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays. Viruses. 2020;12:513.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.3390/v12050513</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ritz C, Baty F, Streibig JC, Gerhard D. Dose-response analysis using R. PLoS One. 2015;10:e0146021.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1371/journal.pone.0146021</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sebaugh JL. Guidelines for accurate EC50/IC50 estimation. Pharm Stat. 2011;10:128...134.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1002/pst.426</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Figar S, Pagotto V, Luna L, Salto J, Manslau MW, Mistchenko A, Gamarnik A, Gomez Saldano AM, Quiros F. Community-level SARS-CoV-2 seroprevalence survey in urban slum dwellers of Buenos Aires City, Argentina: a participatory research. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.07.14.20153858</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">33592338</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>21</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-3511</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>105</Volume>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Apr</Month>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title>
                <ISOAbbreviation>Int J Infect Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies.</ArticleTitle>
            <Pagination>
                <MedlinePgn>307-311</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1201-9712(21)00124-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2021.02.038</ELocationID>
            <Abstract>
                <AbstractText>The design of human challenge studies balances scientific validity, efficiency and study safety. This Perspective explores some advantages and disadvantages of 'low-dosage' challenge studies, in the setting of testing second-generation vaccines against COVID-19. Compared with a conventional vaccine challenge, a low-dosage vaccine challenge would be more likely to start, and start earlier. A low-dosage challenge would also be less likely to rule out a vaccine candidate that would have potentially been effective, particularly in certain target uses. A key ethical advantage of a low-dosage challenge over a conventional challenge is that both it and its dose escalation process are safer for each participant. Low-dosage studies would require larger numbers of participants than conventional challenges, but this and other potential disadvantages are less serious than they may initially appear. Overall, low-dosage challenges should be considered for certain roles such as prioritizing between second-generation vaccines against COVID-19.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Steuwer</LastName>
                    <ForeName>Bastian</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Population-Level Bioethics, Rutgers University, New Brunswick, NJ, USA; Rutgers Biomedical and Health Sciences, Newark, NJ, USA. Electronic address: steuwer@cplb.rutgers.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jamrozik</LastName>
                    <ForeName>Euzebiusz</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ethox Centre and Wellcome Centre for Ethics and Humanities, University of Oxford, Oxford, UK; Monash Bioethics Centre, Monash University, Melbourne, Australia; Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia. Electronic address: zeb.jamrozik@monash.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eyal</LastName>
                    <ForeName>Nir</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Population-Level Bioethics, Rutgers University, New Brunswick, NJ, USA; Department of Philosophy, Rutgers University, New Brunswick, NJ, USA; Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, NJ, USA. Electronic address: neyal@cplb.rutgers.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Canada</Country>
            <MedlineTA>Int J Infect Dis</MedlineTA>
            <NlmUniqueID>9610933</NlmUniqueID>
            <ISSNLinking>1201-9712</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012107" MajorTopicYN="Y">Research Design</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Coronavirus</Keyword>
            <Keyword MajorTopicYN="N">Ethics</Keyword>
            <Keyword MajorTopicYN="N">Human challenge studies</Keyword>
            <Keyword MajorTopicYN="N">Research design</Keyword>
            <Keyword MajorTopicYN="N">Vaccines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>5</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>16</Day>
                <Hour>20</Hour>
                <Minute>10</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33592338</ArticleId>
            <ArticleId IdType="pii">S1201-9712(21)00124-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ijid.2021.02.038</ArticleId>
            <ArticleId IdType="pmc">PMC7881292</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Infect Dis. 2021 Feb 16;72(4):598-603</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32594121</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kennedy Inst Ethics J. 2011 Jun;21(2):141-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21696094</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Oct 29;383(18):e101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32897661</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Dec;20(12):715-716</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33087904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2004 May 1;189 Suppl 1:S4-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15106083</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 29;368(6494):948-950</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32393526</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2021 Feb 16;72(4):604-610</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32726405</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2021 Feb;103:37-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33227512</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2020 Nov 17;117(46):28538-28542</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33122444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(6):e38434</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22701640</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 22;368(6493):832-834</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32381590</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Ethics. 2009 Jul;35(7):445-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19567696</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Infect. 2021 Mar;27(3):372-377</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33421580</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2015 Mar 1;60(5):693-702</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25416753</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Aug 28;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32857836</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 14;395(10227):e47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32113505</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Sep 3;383(10):e63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32610006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Theor Med Bioeth. 2012 Apr;33(2):137-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22198413</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 1974 Jan;129(1):45-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4809112</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Monash Bioeth Rev. 2014 Mar-Jun;32(1-2):63-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25434065</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Seton Hall Law Rev. 2009;39(4):1173-202</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20718134</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Aug;20(8):e198-e203</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32479747</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2005 Dec;11(12):1882-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16485474</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2019 Mar 1;9(1):3203</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30824732</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32571934</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Transl Med. 2020 Dec 9;12(573):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33229462</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med J Aust. 2021 Mar;214(4):150-152.e1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33550606</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8218-8221</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32229574</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):714-721</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32525850</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7831):651-652</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33082550</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">33591649</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>18</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>19</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0869-866X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>29</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny</Title>
                <ISOAbbreviation>Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[The organizational aspects of security support of participants of clinical testing of vaccine &quot;Gam-COVID-Vac&quot;].</ArticleTitle>
            <Pagination>
                <MedlinePgn>5-13</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.32687/0869-866X-2021-29-1-5-13</ELocationID>
            <Abstract>
                <AbstractText>The COVID-19 pandemic resulted in many aftermaths, economic crisis and extra charging of health care. The development of vaccine against SARS-nCoV-2 agent turned out as the priority task of world and Russian medicine and pharmaceutics. The investigation of efficiency and safety of vaccines can be prolonged for many years that can aggravate the observed crisis. Having regard to the global scope and speed of pandemic spreading, the vaccine &quot;Gam-COVID-Vac&quot; was registered with special procedure by the Decree of the Government of the Russian Federation No. 441 of 03.04.2020 for accelerated access to civic turn-over. To monitor safety of vaccine on the basis of international experience, the decision was made to organize the independent Committee of monitoring data concerning efficacy and safety of vaccines applied to prevent COVID-19. The article presents rationale for necessity to create independent committee and to implement such a practice.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Naygovzina</LastName>
                    <ForeName>N B</ForeName>
                    <Initials>NB</Initials>
                    <AffiliationInfo>
                        <Affiliation>The State Budget Educational Institution of Higher Professional Education ..The A. E. Evdokimov Moscow State University of Medicine and Dentistry.., 127473, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Khabriev</LastName>
                    <ForeName>R U</ForeName>
                    <Initials>RU</Initials>
                    <AffiliationInfo>
                        <Affiliation>N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krasheninnikov</LastName>
                    <ForeName>A E</ForeName>
                    <Initials>AE</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Federal State Budget Educational Institution of Higher Education ..N. I. Pirogov Russian National Research Medical University.. Minzdrav of Russia, 117997, Moscow, Russia, anatoly.krasheninnikov@drugsafety.ru.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matveev</LastName>
                    <ForeName>A V</ForeName>
                    <Initials>AV</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Federal State Budget Educational Institution of Additional Professional Education &quot;The Russian Medical Academy of Continuous Professional Education&quot; of Minzdrav of Russia, 125445, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>The Autonomous Nonprofit Organization &quot;The National Scientific Center of the Pharmakonadzor&quot; 127051, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>rus</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Russia (Federation)</Country>
            <MedlineTA>Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med</MedlineTA>
            <NlmUniqueID>101270373</NlmUniqueID>
            <ISSNLinking>0869-866X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016903" MajorTopicYN="N">Drug Monitoring</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012426" MajorTopicYN="N" Type="Geographic">Russia</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID</Keyword>
            <Keyword MajorTopicYN="N">Pharmakonadzor</Keyword>
            <Keyword MajorTopicYN="N">clinical trial</Keyword>
            <Keyword MajorTopicYN="N">independent committee</Keyword>
            <Keyword MajorTopicYN="N">monitoring</Keyword>
            <Keyword MajorTopicYN="N">safety</Keyword>
            <Keyword MajorTopicYN="N">vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>16</Day>
                <Hour>12</Hour>
                <Minute>15</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33591649</ArticleId>
            <ArticleId IdType="doi">10.32687/0869-866X-2021-29-1-5-13</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33591423</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>16</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">0070-217X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>17</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Current topics in microbiology and immunology</Title>
                <ISOAbbreviation>Curr Top Microbiol Immunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>mRNA-Based Vaccines and Mode of Action.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/82_2020_230</ELocationID>
            <Abstract>
                <AbstractText>In the past 20 years, the mRNA vaccine technology has evolved from the first proof of concept to the first licensed vaccine against emerging pandemics such as SARS-CoV-2. Two mRNA vaccines targeting SARS-CoV-2 have received emergency use authorization by US FDA, conditional marketing authorization by EMA, as well as multiple additional national regulatory authorities. The simple composition of an mRNA encoding the antigen formulated in a lipid nanoparticle enables a fast adaptation to new emerging pathogens. This can speed up vaccine development in pandemics from antigen and sequence selection to clinical trial to only a few months. mRNA vaccines are well tolerated and efficacious in animal models for multiple pathogens and will further contribute to the development of vaccines for other unaddressed diseases. Here, we give an overview of the mRNA vaccine design and factors for further optimization of this new promising technology and discuss current knowledge on the mode of action of mRNA vaccines interacting with the innate and adaptive immune system.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gergen</LastName>
                    <ForeName>Janina</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>CureVac AG, T..bingen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Petsch</LastName>
                    <ForeName>Benjamin</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>CureVac AG, T..bingen, Germany. benjamin.petsch@curevac.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Curr Top Microbiol Immunol</MedlineTA>
            <NlmUniqueID>0110513</NlmUniqueID>
            <ISSNLinking>0070-217X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>16</Day>
                <Hour>12</Hour>
                <Minute>11</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33591423</ArticleId>
            <ArticleId IdType="doi">10.1007/82_2020_230</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Ahmed F, Benedito VA, Zhao PX (2011) Mining functional elements in messenger RNAs: overview, challenges, and perspectives. Front Plant Sci 2</Citation>
            </Reference>
            <Reference>
                <Citation>Alberer M et al (2017) Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. Lancet</Citation>
            </Reference>
            <Reference>
                <Citation>Allen IC et al (2009) The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30(4):556...565</Citation>
            </Reference>
            <Reference>
                <Citation>Anderson BR et al (2010) Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res 38(17):5884...5892</Citation>
            </Reference>
            <Reference>
                <Citation>Anderson BR, Muramatsu H, Jha BK, Silverman RH, Weissman D, Karik.. K (2011) Nucleoside modifications in RNA limit activation of 2..-5..-oligoadenylate synthetase and increase resistance to cleavage by RNase L. Nucleic Acids Res 39(21):9329...9338</Citation>
            </Reference>
            <Reference>
                <Citation>Andries O et al (2013) Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells. J Control Release 167(2):157...166</Citation>
            </Reference>
            <Reference>
                <Citation>Andries O, Mc Cafferty S, De Smedt SC, Weiss R, Sanders NN, Kitada T (2015) N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. J Control Release 217:337...344</Citation>
            </Reference>
            <Reference>
                <Citation>Bahl K et al (2017) Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Mol Ther 25(6):1316...1327</Citation>
            </Reference>
            <Reference>
                <Citation>Baiersd..rfer M et al (2019) A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA. Mol Ther Nucleic Acids 15:26...35</Citation>
            </Reference>
            <Reference>
                <Citation>Banerjee AK (1980) 5...-terminal cap structure in eucaryotic messenger ribonucleic acids. Microbiol Rev 44(2):175...205</Citation>
            </Reference>
            <Reference>
                <Citation>Beddows S et al (2006) Construction and characterization of soluble, cleaved, and stabilized trimeric env proteins Based on HIV type 1 env subtype A. AIDS Res Hum Retroviruses 22(6):569...579</Citation>
            </Reference>
            <Reference>
                <Citation>Ben-Asouli Y, Banai Y, Pel-Or Y, Shir A, Kaempfer R (2002) Human interferon-.. mRNA autoregulates its translation through a Pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 108(2):221...232</Citation>
            </Reference>
            <Reference>
                <Citation>Berkovits BD, Mayr C (2015) Alternative 3.. UTRs act as scaffolds to regulate membrane protein localization. Nature 522(7556):363...367</Citation>
            </Reference>
            <Reference>
                <Citation>Bernstein P, Peltz SW, Ross J (1989) The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol. Cell. Biol. 9(2):659...670</Citation>
            </Reference>
            <Reference>
                <Citation>Beverley PCL (2002) Immunology of vaccination. Br Med Bull 62(1):15...28</Citation>
            </Reference>
            <Reference>
                <Citation>Beverly M, Hagen C, Slack O (2018) Poly A tail length analysis of in vitro transcribed mRNA by LC-MS. Anal Bioanal Chem 410(6):1667...1677</Citation>
            </Reference>
            <Reference>
                <Citation>Borg FA, Isenberg DA (2007) Syndromes and complications of interferon therapy. Curr Opin Rheumatol 19(1):61...66</Citation>
            </Reference>
            <Reference>
                <Citation>Bourhy H et al (2007) ...Annex 2 Recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs. World Heal Organ Tech Rep Ser 941:83...132</Citation>
            </Reference>
            <Reference>
                <Citation>Brisse M, Ly H (2019) Comparative structure and function analysis of the RIG-I-like receptors: RIG-I and MDA5. Front Immunol 10</Citation>
            </Reference>
            <Reference>
                <Citation>Broos K et al (2016) Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon. Mol. Ther. - Nucleic Acids 5:e326</Citation>
            </Reference>
            <Reference>
                <Citation>Burns CC, Diop OM, Sutter RW, Kew OM (2014) Vaccine-derived polioviruses. J Infect Dis 210(suppl 1):S283...S293</Citation>
            </Reference>
            <Reference>
                <Citation>Burton DR, Hangartner L (2016) Broadly neutralizing antibodies to HIV and their role in vaccine design. Annu Rev Immunol 34:635...659</Citation>
            </Reference>
            <Reference>
                <Citation>Carr MW, Roth SJ, Luther E, Rose SS, Springer TA (1994) Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 91(9):3652</Citation>
            </Reference>
            <Reference>
                <Citation>Carralot JP et al (2004) Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines. Cell Mol Life Sci 61(18):2418...2424</Citation>
            </Reference>
            <Reference>
                <Citation>Chumakov K, Elzinga N, Wood DJ (2002) Annex 2 Recommendations for the production and control of poliomyelitis vaccine ( inactivated) 1. World Heal Organ Tech Rep Ser (910)</Citation>
            </Reference>
            <Reference>
                <Citation>Clarke TF IV, Clark PL (2010) Increased incidence of rare codon clusters at 5.. and 3.. gene termini: implications for function. BMC Genomics 11:118</Citation>
            </Reference>
            <Reference>
                <Citation>Crouse J, Kalinke U, Oxenius A (2015) Regulation of antiviral T cell responses by type I interferons. Nat Rev Immunol 15(4):231...242</Citation>
            </Reference>
            <Reference>
                <Citation>De Beuckelaer A et al (2016) Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses. Mol Ther 24(11):2012...2020</Citation>
            </Reference>
            <Reference>
                <Citation>De Beuckelaer A, Grooten J, De Koker S (2017) Type I interferons modulate CD8<sup>+</sup> T cell immunity to mRNA vaccines. Trends Mol Med 23(3):216...226</Citation>
            </Reference>
            <Reference>
                <Citation>Devarkar SC et al (2016) Structural basis for m7G recognition and 2...-O-methyl discrimination in capped RNAs by the innate immune receptor RIG-I. Proc Natl Acad Sci USA 113(3):596</Citation>
            </Reference>
            <Reference>
                <Citation>Devoldere J, Dewitte H, De Smedt SC, Remaut K (2016) Evading innate immunity in nonviral mRNA delivery: don...t shoot the messenger. Drug Discov Today 21(1):11...25</Citation>
            </Reference>
            <Reference>
                <Citation>Ding Y, Tang Y, Kwok CK, Zhang Y, Bevilacqua PC, Assmann SM (2014) In vivo genome-wide profiling of RNA secondary structure reveals novel regulatory features. Nature 505(7485):696...700</Citation>
            </Reference>
            <Reference>
                <Citation>Durbin AF, Wang C, Marcotrigiano J, Gehrke L (2016) RNAs containing modified nucleotides fail to trigger RIG-I conformational changes for innate immune signaling. MBio 7(5)</Citation>
            </Reference>
            <Reference>
                <Citation>Edwards et al DK (2017) Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response. J Transl Med 15(1):1</Citation>
            </Reference>
            <Reference>
                <Citation>Elango N, Elango S, Shivshankar P, Katz MS (2005) Optimized transfection of mRNA transcribed from a d(A/T)100 tail-containing vector. Biochem Biophys Res Commun 330(3):958...966</Citation>
            </Reference>
            <Reference>
                <Citation>Elfakess R, Sinvani H, Haimov O, Svitkin Y, Sonenberg N, Dikstein R (2011) Unique translation initiation of mRNAs-containing TISU element. Nucleic Acids Res 39(17):7598...7609</Citation>
            </Reference>
            <Reference>
                <Citation>Fensterl V, Sen GC (2015) Interferon-induced Ifit proteins: their role in viral pathogenesis. J Virol 89(5):2462</Citation>
            </Reference>
            <Reference>
                <Citation>Ford LP, Bagga PS, Wilusz J (1997) The poly(A) tail inhibits the assembly of a 3..-to-5.. exonuclease in an in vitro RNA stability system. Mol Cell Biol 17(1):398...406</Citation>
            </Reference>
            <Reference>
                <Citation>Fotin-Mleczek M et al (2011) Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity. J Immunother 34(1):1...15</Citation>
            </Reference>
            <Reference>
                <Citation>Galloway A, Cowling VH (2019) mRNA cap regulation in mammalian cell function and fate. Biochim Biophys Acta Gene Regul Mech 1862(3):270</Citation>
            </Reference>
            <Reference>
                <Citation>Geall AJ et al (2012) Nonviral delivery of self-amplifying RNA vaccines. Proc Natl Acad Sci 109(36):14604...14609</Citation>
            </Reference>
            <Reference>
                <Citation>Georg P, Sander LE (2019) Innate sensors that regulate vaccine responses. Curr Opin Immunol 59:31...41</Citation>
            </Reference>
            <Reference>
                <Citation>Grier AE et al (2016) pEVL: a linear plasmid for generating mRNA IVT templates with extended encoded poly(A) sequences. Mol Ther Nucleic Acids 5(4):e306</Citation>
            </Reference>
            <Reference>
                <Citation>Groom JR, Luster AD (2011) CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89(2)</Citation>
            </Reference>
            <Reference>
                <Citation>Grudzien-Nogalska E, Jemielity J, Kowalska J, Darzynkiewicz E, Rhoads RE (2007) Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells. RNA 13(10):1745...1755</Citation>
            </Reference>
            <Reference>
                <Citation>Gruys E, Toussaint MJM, Niewold TA, Koopmans SJ (2005) Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 6(11):1045...1056</Citation>
            </Reference>
            <Reference>
                <Citation>Gustafsson C, Govindarajan S, Minshull J (2004) Codon bias and heterologous protein expression. Trends Biotechnol 22(7):346...353</Citation>
            </Reference>
            <Reference>
                <Citation>Haralambieva IH, Kennedy RB, Ovsyannikova IG, Schaid DJ, Poland GA (2019) Current perspectives in assessing humoral immunity after measles vaccination. Expert Rev Vaccines 18(1):75</Citation>
            </Reference>
            <Reference>
                <Citation>Hesseling A et al (2009) Disseminated bacille Calmette-Gu..rin disease in HIV-infected South African infants. Bull World Health Organ 87(7):505</Citation>
            </Reference>
            <Reference>
                <Citation>Hickling J, Jones K, Friede M, Zehrung D, Chen D, Kristensen D (2011) Intradermal delivery of vaccines: potential benefits and current challenges. Bull World Health Organ 89(3):221</Citation>
            </Reference>
            <Reference>
                <Citation>Hoerr I, Obst R, Rammensee HG, Jung G (2000) In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur J Immunol 30(1):1...7</Citation>
            </Reference>
            <Reference>
                <Citation>Holtkamp S et al (2006) Modification of antigen-encoding RNA increases stability, translational efficacy and T-cell stimularoy capacity of dendritic cells. Blood 108(13)</Citation>
            </Reference>
            <Reference>
                <Citation>https://www.who.int/news-room/feature-stories/detail/two-out-of-three-wild-poliovirus-strains-eradicated</Citation>
            </Reference>
            <Reference>
                <Citation>Iavarone C, O...hagan DT, Yu D, Delahaye NF, Ulmer JB (2017) Mechanism of action of mRNA-based vaccines. Expert Rev Vaccines 16(9):871...881</Citation>
            </Reference>
            <Reference>
                <Citation>Innis BL et al (1994) Protection against hepatitis A by an inactivated vaccine. JAMA J Am Med Assoc 271(17):1328</Citation>
            </Reference>
            <Reference>
                <Citation>Jackson LA et al (2020) An mRNA vaccine against SARS-CoV-2...preliminary report. N Engl J Med</Citation>
            </Reference>
            <Reference>
                <Citation>Jan CH, Friedman RC, Ruby JG, Bartel DP (2011) Formation, regulation and evolution of Caenorhabditis elegans 3... UTRs. Nature 469(7328):97...101</Citation>
            </Reference>
            <Reference>
                <Citation>Jemielity J et al (2003) Novel ...anti-reverse... cap analogs with superior translational properties. RNA 9(9):1108...1122</Citation>
            </Reference>
            <Reference>
                <Citation>Jia J, Yao P, Arif A, Fox PL (2013) Regulation and dysregulation of 3.. UTR-mediated translational control. Curr Opin Genet Dev 23(1):29...34</Citation>
            </Reference>
            <Reference>
                <Citation>John S et al (2018) Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity. Vaccine 36(12):1689...1699</Citation>
            </Reference>
            <Reference>
                <Citation>Juskewitch JE, Tapia CJ, Windebank AJ (2010) Lessons from the Salk polio vaccine: methods for and risks of rapid translation. Clin Transl Sci 3(4):182...185</Citation>
            </Reference>
            <Reference>
                <Citation>Karik.. K, Buckstein M, Ni H, Weissman D (2005) Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23(2):165...175</Citation>
            </Reference>
            <Reference>
                <Citation>Karik.. K et al (2008) Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther 16(11):1833...1840</Citation>
            </Reference>
            <Reference>
                <Citation>Karik.. K, Muramatsu H, Ludwig J, Weissman D (2011) Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res 39(21):e142</Citation>
            </Reference>
            <Reference>
                <Citation>Karik.. K, Muramatsu H, Keller JM, Weissman D (2012) Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin. Mol Ther 20(5):948...953</Citation>
            </Reference>
            <Reference>
                <Citation>Kato H et al (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205(7):1601...1610</Citation>
            </Reference>
            <Reference>
                <Citation>Kauffman KJ et al (2016) Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo. Biomaterials 109:78...87</Citation>
            </Reference>
            <Reference>
                <Citation>Kaygun H, Marzluff WF (2005) Translation termination is involved in histone mRNA degradation when DNA replication is inhibited. Mol Cell Biol 25(16):6879...6888</Citation>
            </Reference>
            <Reference>
                <Citation>Kierzek E, Kierzek R (2003) The thermodynamic stability of RNA duplexes and hairpins containing N6-alkyladenosines and 2-methylthio-N6-alkyladenosines. Nucleic Acids Res 31(15):4472...4480</Citation>
            </Reference>
            <Reference>
                <Citation>Kocmik I et al (2018) Modified ARCA analgos providing enhanced properties of capped mRNAs. Cell Cycle 17(13):71...75</Citation>
            </Reference>
            <Reference>
                <Citation>Koh WS, Porter JR, Batchelor E (2019) Tuning of mRNA stability through altering 3...-UTR sequences generates distinct output expression in a synthetic circuit driven by p53 oscillations. Sci Rep 9(1):5976</Citation>
            </Reference>
            <Reference>
                <Citation>Kore AR, Charles I (2010) Synthesis and evaluation of 2......O...allyl substituted dinucleotide cap analog for mRNA translation. Bioorganic Med Chem 18(22):8061...8065</Citation>
            </Reference>
            <Reference>
                <Citation>Kore AR, Shanmugasundaram M, Charles I, Vlassov AV, Barta TJ (2009) Locked nucleic acid (LNA)-modified dinucleotide mRNA cap analogue: synthesis, enzymatic incorporation, and utilization. J Am Chem Soc 131(18):6364...6365</Citation>
            </Reference>
            <Reference>
                <Citation>Kormann MSD et al (2011) Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol 29(2):110...112</Citation>
            </Reference>
            <Reference>
                <Citation>Kowalczyk A et al (2016) Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity. Vaccine 34(33):3882...3893</Citation>
            </Reference>
            <Reference>
                <Citation>Kozak M (2005) Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 361(1...2):13...37</Citation>
            </Reference>
            <Reference>
                <Citation>Kozak M (1991a) A short leader sequence impairs the fidelity of initiation by eukaryotic ribosomes. Gene Expr 1(2):111...115</Citation>
            </Reference>
            <Reference>
                <Citation>Kozak M (1991b) Effects of long 5.. leader sequences on initiation by eukaryotic ribosomes in vitro. Gene Expr 1(2):117...125</Citation>
            </Reference>
            <Reference>
                <Citation>Kranz LM et al (2016) Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 534</Citation>
            </Reference>
            <Reference>
                <Citation>Kuhn AN et al (2010) Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo. Gene Ther 17(8):961...971</Citation>
            </Reference>
            <Reference>
                <Citation>Kuhn AN, Diken M, Kreiter S, Vallazza B, T..reci .., Sahin U (2011) Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics. RNA Biol 8(1):35...43</Citation>
            </Reference>
            <Reference>
                <Citation>L..ssig C, Hopfner K-P (2017) Discrimination of cytosolic self and non-self RNA by RIG-I-like receptors. J Biol Chem 292(22):9000...9009</Citation>
            </Reference>
            <Reference>
                <Citation>Lawrence JB, Singer RH (1986) Intracellular localization of messenger RNAs for cytoskeletal proteins. Cell 45(3):407...415</Citation>
            </Reference>
            <Reference>
                <Citation>Le Bon A et al (2014) Direct stimulation of T cells by type I IFN enhances the CD8<sup>+</sup> T cell response during cross-priming. J Immunol 176(8):4682...4689</Citation>
            </Reference>
            <Reference>
                <Citation>Lee J, Arun Kumar S, Jhan YY, Bishop CJ (2018) Engineering DNA vaccines against infectious diseases. Acta Biomater 80:31...47</Citation>
            </Reference>
            <Reference>
                <Citation>Lemckert AAC et al (2005) Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-Ad5 immunity. J Virol 79(15):9694...9701</Citation>
            </Reference>
            <Reference>
                <Citation>Leppek K, Das R, Barna M (2018) Functional 5... UTR mRNA structures in eukaryotic translation regulation and how to find them. Nat Rev Mol Cell Biol 19(3):158...174</Citation>
            </Reference>
            <Reference>
                <Citation>Liang F et al (2017) Efficient targeting and activation of antigen-presenting cells in vivo after modified mRNA vaccine administration in rhesus macaques. Mol Ther 25(12):2635...2647</Citation>
            </Reference>
            <Reference>
                <Citation>Lindgren G et al (2017) Induction of robust B cell responses after influenza mRNA vaccination is accompanied by circulating hemagglutinin-specific ICOS+ PD-1+ CXCR3+ T follicular helper cells. Front Immunol 8:1539</Citation>
            </Reference>
            <Reference>
                <Citation>Loomis KH et al (2018) In vitro transcribed mRNA vaccines with programmable stimulation of innate immunity. Bioconjug Chem 29(9):3072...3083</Citation>
            </Reference>
            <Reference>
                <Citation>Lutz J et al (2017) Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines. NPJ Vaccines 2(1):1...9</Citation>
            </Reference>
            <Reference>
                <Citation>Mannironi C, Bonner WM, Hatch CL (1989) H2A.X. a histone isoprotein with a conserved C-terminal sequence, is encoded by a novel mRNA with both DNA replication type and polyA 3.. processing signals. Nucleic Acids Res 17(22):9113</Citation>
            </Reference>
            <Reference>
                <Citation>Mariner JC et al (2012) Rinderpest eradication: appropriate technology and social innovations. Science (80...) 337 (6100):1309...1312</Citation>
            </Reference>
            <Reference>
                <Citation>Martinon F et al (1993) Induction of virus-specific cytotoxic T lymphocytesin vivo by liposome-entrapped mRNA. Eur J Immunol 23(7):1719...1722</Citation>
            </Reference>
            <Reference>
                <Citation>Marzluff WF (1992) Histone 3.. ends: essential and regulatory functions. Gene Expr 2(2)</Citation>
            </Reference>
            <Reference>
                <Citation>Mauger DM et al (2019) mRNA structure regulates protein expression through changes in functional half-life. Proc Natl Acad Sci USA 116(48):24075...24083</Citation>
            </Reference>
            <Reference>
                <Citation>Mayr C (2008) Regualtion by 3..-untranslated regions. Postgrad Med J 67(791):862...862</Citation>
            </Reference>
            <Reference>
                <Citation>McHeyzer-Williams LJ, Pelletier N, Mark L, Fazilleau N, McHeyzer-Williams MG (2009) Follicular helper T cells as cognate regulators of B cell immunity. Curr Opin Immunol 21(3):266...273</Citation>
            </Reference>
            <Reference>
                <Citation>McNab F, Mayer-Barber K, Sher A, Wack A, O...Garra A (2015) Type I interferons in infectious disease. Nat Rev Immunol 15(2):87...103</Citation>
            </Reference>
            <Reference>
                <Citation>Meis R, Meis JE, Biotechnologies E (2006) Achieve 100 % capping efficiency with the NEW ScriptCap<sup>TM</sup> m 7 G capping system improve the translation efficiency of any 5..-capped mRNA with the NEW ScriptCap<sup>TM</sup> 2.....O...Methyltransferase. System 13(4):5...6</Citation>
            </Reference>
            <Reference>
                <Citation>Meis JE, Meis R, Biotechnologies E (2016) The new mScript TM mRNA production system...efficient mRNA transcription, capping and tailing for the highest yields of active protein. Epic Biotechnol Forum 14(1):4...5</Citation>
            </Reference>
            <Reference>
                <Citation>Mockey M, Gon..alves C, Dupuy FP, Lemoine FM, Pichon C, Midoux P (2006) mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level. Biochem Biophys Res Commun 340(4):1062...1068</Citation>
            </Reference>
            <Reference>
                <Citation>Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22(2):240</Citation>
            </Reference>
            <Reference>
                <Citation>Mu X, Greenwald E, Ahmad S, Hur S (2018) An origin of the immunogenicity of in vitro transcribed RNA. Nucleic Acids Res 46(10):5239...5249</Citation>
            </Reference>
            <Reference>
                <Citation>Muckenthaler MU, Rivella S, Hentze MW, Galy B (2017) A red carpet for iron metabolism. Cell 168(3):344</Citation>
            </Reference>
            <Reference>
                <Citation>Mulligan MJ et al (2020) Phase 1/2 study to describe the safety and immunogenicity of a COVID-19 RNA vaccine candidate (BNT162b1) in adults 18 to 55 years of age: interim report. medRxiv https://doi.org/10.1101/2020.06.30.20142570</Citation>
            </Reference>
            <Reference>
                <Citation>Ndhlovu ZM et al (2015) The breadth of expandable memory CD8<sup>+</sup> T cells inversely correlates with residual viral loads in HIV elite controllers. J Virol 89(21):10735...10747</Citation>
            </Reference>
            <Reference>
                <Citation>Nigg AJ, Walker PL (2009) Overview, prevention, and treatment of rabies. Pharmacotherapy 29(10):1182...1195</Citation>
            </Reference>
            <Reference>
                <Citation>Novoa EM, Ribas de Pouplana L (2012) Speeding with control: codon usage, tRNAs, and ribosomes. Trends Genet 28(11):574...581</Citation>
            </Reference>
            <Reference>
                <Citation>Orlandini von Niessen AG et al (2019) Improving mRNA-based therapeutic gene delivery by expression-augmenting 3.. UTRs identified by cellular library screening. Mol Ther 27(4):824...836</Citation>
            </Reference>
            <Reference>
                <Citation>Ozawa S et al (2017) Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001...2020. Bull World Health Organ 95(9):629</Citation>
            </Reference>
            <Reference>
                <Citation>Padilla-Quirarte HO, Lopez-Guerrero DV, Gutierrez-Xicotencatl L, Esquivel-Guadarrama F (2019) Protective antibodies against influenza proteins. Front Immunol 10</Citation>
            </Reference>
            <Reference>
                <Citation>Pardi N et al (2017a) Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat Commun 8:14630</Citation>
            </Reference>
            <Reference>
                <Citation>Pardi N et al (2017b) Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature 543(7644):248...251</Citation>
            </Reference>
            <Reference>
                <Citation>Pardi N et al (2018) Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies. Nat Commun 9(1):3361</Citation>
            </Reference>
            <Reference>
                <Citation>Pardi N et al (2018) Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J Exp Med 215(6):1571...1588</Citation>
            </Reference>
            <Reference>
                <Citation>Pardi N et al (2019) Characterization of HIV-1 nucleoside-modified mRNA vaccines in rabbits and rhesus macaques. Mol Ther Nucleic Acids 15:36...47</Citation>
            </Reference>
            <Reference>
                <Citation>Pasquinelli A, Dahlberg J, Elsebet L (1995) Reverse 5... caps in RNAs made in vitro by phage RNA polymerases. RNA 1(957):110...117</Citation>
            </Reference>
            <Reference>
                <Citation>Patinote C et al (2020) Agonist and antagonist ligands of toll-like receptors 7 and 8: ingenious tools for therapeutic purposes. Eur J Med Chem 193:112238</Citation>
            </Reference>
            <Reference>
                <Citation>Petrovsky N (2015) Comparative safety of vaccine adjuvants: a summary of current evidence and future needs. Drug Saf 38(11):1059...1074</Citation>
            </Reference>
            <Reference>
                <Citation>Petsch B et al (2012) Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection. Nat Biotechnol 30(12):1210...1216</Citation>
            </Reference>
            <Reference>
                <Citation>Plotkin S (2014) History of vaccination. Proc Natl Acad Sci USA 111(34):12283</Citation>
            </Reference>
            <Reference>
                <Citation>Pollard C et al (2013) Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines. Mol Ther 21(1):251...259</Citation>
            </Reference>
            <Reference>
                <Citation>Rabani M, Pieper L, Chew GL, Schier AF (2017) A massively parallel reporter assay of 3... UTR sequences identifies in vivo rules for mRNA degradation. Mol Cell 68(6):1083-1094.e5</Citation>
            </Reference>
            <Reference>
                <Citation>Rajan JV, Warren SE, Miao EA, Aderem A (2010) Activation of the NLRP3 inflammasome by intracellular poly I:C. FEBS Lett 584(22):4627...4632</Citation>
            </Reference>
            <Reference>
                <Citation>Rauch S, Jasny E, Schmidt KE, Petsch B (2018) New vaccine technologies to combat outbreak situations. Front Immunol 9:1963</Citation>
            </Reference>
            <Reference>
                <Citation>Richner JM et al (2017) Modified mRNA vaccines protect against Zika virus infection. Cell 168(6):1114-1125.e10</Citation>
            </Reference>
            <Reference>
                <Citation>R..nnblom LE (1991) Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 115(3):178</Citation>
            </Reference>
            <Reference>
                <Citation>Rossey I, McLellan JS, Saelens X, Schepens B (2018) Clinical potential of prefusion RSV F-specific antibodies. Trends Microbiol 26(3):209...219</Citation>
            </Reference>
            <Reference>
                <Citation>Rydzik AM et al (2017) mRNA cap analogues substituted in the tetraphosphate chain with CX2: identification of O-to-CCl2 as the first bridging modification that confers resistance to decapping without impairing translation. Nucleic Acids Res 45(15):8661...8675</Citation>
            </Reference>
            <Reference>
                <Citation>Sadler AJ, Williams BRG (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8(7):559...568</Citation>
            </Reference>
            <Reference>
                <Citation>Sample PJ et al (2019) Human 5... UTR design and variant effect prediction from a massively parallel translation assay. Nat Biotechnol 37(7):803</Citation>
            </Reference>
            <Reference>
                <Citation>Sanders RW, Moore JP (2017) Native-like env trimers as a platform for HIV-1 vaccine design. Immunol Rev 275(1):161</Citation>
            </Reference>
            <Reference>
                <Citation>Scheel B et al (2004) Immunostimulating capacities of stabilized RNA molecules. Eur J Immunol 34(2):537...547</Citation>
            </Reference>
            <Reference>
                <Citation>Schlake T, Thess A, Fotin-mleczek M, Kallen K (2012) Developing mRNA-vaccine technologies. RNA Biol 9(November):1...12</Citation>
            </Reference>
            <Reference>
                <Citation>Schlake T, Thess A, Thran M, Jordan I (2019) mRNA as novel technology for passive immunotherapy. Cell Mol Life Sci 76(2):301...328</Citation>
            </Reference>
            <Reference>
                <Citation>Schmidt A et al (2009) 5...-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci USA 106(29):12067</Citation>
            </Reference>
            <Reference>
                <Citation>Schnee M et al (2016) An mRNA vaccine encoding rabies virus glycoprotein induces protection against lethal infection in mice and correlates of protection in adult and newborn pigs. PLoS Negl Trop Dis 10(6):e0004746</Citation>
            </Reference>
            <Reference>
                <Citation>Schnierle BS, Gershon PD, Moss B (1992) Cap-specific mRNA (nucleoside-O2..-)-methyltransferase and poly(A) polymerase stimulatory activities of vaccinia virus are mediated by a single protein. Proc Natl Acad Sci USA 89(7):2897...2901</Citation>
            </Reference>
            <Reference>
                <Citation>Shanmugasundaram M, Charles I, Kore AR (2016) Design, synthesis and biological evaluation of dinucleotide mRNA cap analog containing propargyl moiety. Bioorganic Med Chem 24(6):1204...1208</Citation>
            </Reference>
            <Reference>
                <Citation>Skowronski DM et al (2014) Low 2012...13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS ONE 9(3):e92153</Citation>
            </Reference>
            <Reference>
                <Citation>Spenkuch F, Motorin Y, Helm M (2014) Pseudouridine: still mysterious, but never a fake (uridine)! RNA Biol 11(12):1540</Citation>
            </Reference>
            <Reference>
                <Citation>Stepinski J, Waddell C, Stolarski R, Darzynkiewicz E, Rhoads RE (2001) Synthesis and properties of mRNAs containing the novel ...anti-reverse... cap analogs 7-methyl(3...-O-methyl)GpppG and 7-methyl (3...-deoxy)GpppG. RNA 7(10):1486...1495</Citation>
            </Reference>
            <Reference>
                <Citation>Stewart M (2019) Polyadenylation and nuclear export of mRNAs. J Biol Chem 294(9):2977...2987</Citation>
            </Reference>
            <Reference>
                <Citation>Stitz L et al (2017) A thermostable messenger RNA based vaccine against rabies. PLoS Negl Trop Dis 11(12):1...10</Citation>
            </Reference>
            <Reference>
                <Citation>Svitkin YV, Cheng YM, Chakraborty T, Presnyak V, John M, Sonenberg N (2017) N1-methyl-pseudouridine in mRNA enhances translation through eIF2..-dependent and independent mechanisms by increasing ribosome density. Nucleic Acids Res 45(10):6023...6036</Citation>
            </Reference>
            <Reference>
                <Citation>Swiecki M, Wang Y, Vermi W, Gilfillan S, Schreiber RD, Colonna M (2011) Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo. J Exp Med 208(12):2367...2374</Citation>
            </Reference>
            <Reference>
                <Citation>Tannenbaum CS, Tubbs R, Armstrong D, Finke JH, Bukowski RM, Hamilton TA (1998) The CXC Chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol 153(10):4625...4635</Citation>
            </Reference>
            <Reference>
                <Citation>Thess A et al (2015) Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals. Mol Ther 23(9):1456...1464</Citation>
            </Reference>
            <Reference>
                <Citation>Trepotec Z, Aneja MK, Geiger J, Hasenpusch G, Plank C, Rudolph C (2018) Maximizing the translational yield of mRNA therapeutics by minimizing 5...-UTRs. Tissue Eng Part A 25(1...2):69...79</Citation>
            </Reference>
            <Reference>
                <Citation>Trepotec Z, Geiger J, Plank C, Aneja MK, Rudolph C (2019) Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life. RNA 25(4):507...518</Citation>
            </Reference>
            <Reference>
                <Citation>Tuller T, Zur H (2015) Multiple roles of the coding sequence 5... end in gene expression regulation. Nucleic Acids Res 43(1):13</Citation>
            </Reference>
            <Reference>
                <Citation>Tusup M, French LE, Guenova E, Kundig T, Pascolo S (2018) Optimizing the functionality of in vitro-transcribed mRNA. Biomed J Sci Tech Res 7(2):5845...5850</Citation>
            </Reference>
            <Reference>
                <Citation>Uchida S, Kataoka K, Itaka K (2015) Screening of mRNA chemical modification to maximize protein expression with reduced immunogenicity. Pharmaceutics 7(3):137...151</Citation>
            </Reference>
            <Reference>
                <Citation>Vaidyanathan S et al (2018) Uridine depletion and chemical modification increase Cas9 mRNA activity and reduce immunogenicity without HPLC purification. Mol Ther Nucleic Acids 12:530</Citation>
            </Reference>
            <Reference>
                <Citation>Vanblargan LA et al (2018) An mRNA vaccine protects mice against multiple article an mRNA vaccine protects mice against multiple tick-transmitted flavivirus infections, pp. 3382...3392</Citation>
            </Reference>
            <Reference>
                <Citation>Venkatesan S, Gershowitz A, Moss B (1980) Modification of the 5.. end of mRNA. J Biol Chem 255(3):903...908</Citation>
            </Reference>
            <Reference>
                <Citation>Vivinus S et al (2001) An element within the 5... untranslated region of human Hsp70 mRNA which acts as a general enhancer of mRNA translation. Eur J Biochem 268(7):1908...1917</Citation>
            </Reference>
            <Reference>
                <Citation>Wang Z, Day N, Trifillis P, Kiledjian M (1999) An mRNA stability complex functions with poly(A)-binding protein to stabilize mRNA in vitro. Mol Cell Biol 19(7):4552...4560</Citation>
            </Reference>
            <Reference>
                <Citation>Wills RJ, Dennis S, Spiegel HE, Gibson DM, Nadler PI (1984) Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection. Clin Pharmacol Ther 35(5):722...727</Citation>
            </Reference>
            <Reference>
                <Citation>Wolff JA et al (1990) Direct gene transfer into mouse muscle in vivo. Science 247(4949 Pt 1):1465...1468</Citation>
            </Reference>
            <Reference>
                <Citation>Wolpe SD, Cerami A (1989) Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J 3(14)</Citation>
            </Reference>
            <Reference>
                <Citation>World Health Organization (1980) World Health Assembly, 33. Declaration of global eradication of smallpox</Citation>
            </Reference>
            <Reference>
                <Citation>www.cleancapmrna.com</Citation>
            </Reference>
            <Reference>
                <Citation>Zhang L, Wang W, Wang S (2015) Effect of vaccine administration modality on immunogenicity and efficacy. Expert Rev Vaccines 14(11):1509...1523</Citation>
            </Reference>
            <Reference>
                <Citation>Zost SJ et al (2017) Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci USA 114(47):12578...12583</Citation>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33590417</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>18</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1386-9620</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Health care management science</Title>
                <ISOAbbreviation>Health Care Manag Sci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>From predictions to prescriptions: A data-driven response to COVID-19.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10729-020-09542-0</ELocationID>
            <Abstract>
                <AbstractText>The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at a steep economic price. We design analytical tools to support these decisions and combat the pandemic. Specifically, we propose a comprehensive data-driven approach to understand the clinical characteristics of COVID-19, predict its mortality, forecast its evolution, and ultimately alleviate its impact. By leveraging cohort-level clinical data, patient-level hospital data, and census-level epidemiological data, we develop an integrated four-step approach, combining descriptive, predictive and prescriptive analytics. First, we aggregate hundreds of clinical studies into the most comprehensive database on COVID-19 to paint a new macroscopic picture of the disease. Second, we build personalized calculators to predict the risk of infection and mortality as a function of demographics, symptoms, comorbidities, and lab values. Third, we develop a novel epidemiological model to project the pandemic's spread and inform social distancing policies. Fourth, we propose an optimization model to re-allocate ventilators and alleviate shortages. Our results have been used at the clinical level by several hospitals to triage patients, guide care management, plan ICU capacity, and re-distribute ventilators. At the policy level, they are currently supporting safe back-to-work policies at a major institution and vaccine trial location planning at Janssen Pharmaceuticals, and have been integrated into the US Center for Disease Control's pandemic forecast.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bertsimas</LastName>
                    <ForeName>Dimitris</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1985-1003</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. dbertsim@mit.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. dbertsim@mit.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boussioux</LastName>
                    <ForeName>Leonard</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cory-Wright</LastName>
                    <ForeName>Ryan</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Delarue</LastName>
                    <ForeName>Arthur</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Digalakis</LastName>
                    <ForeName>Vassilis</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jacquillat</LastName>
                    <ForeName>Alexandre</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kitane</LastName>
                    <ForeName>Driss Lahlou</ForeName>
                    <Initials>DL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lukin</LastName>
                    <ForeName>Galit</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mingardi</LastName>
                    <ForeName>Luca</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nohadani</LastName>
                    <ForeName>Omid</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Benefits Science Technologies, Boston, MA 02110, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Orfanoudaki</LastName>
                    <ForeName>Agni</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Papalexopoulos</LastName>
                    <ForeName>Theodore</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paskov</LastName>
                    <ForeName>Ivan</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pauphilet</LastName>
                    <ForeName>Jean</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>London Business School, London, NW1 4SA, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lami</LastName>
                    <ForeName>Omar Skali</ForeName>
                    <Initials>OS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stellato</LastName>
                    <ForeName>Bartolomeo</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research and Financial EngineeringPrinceton University, Princeton, NJ, 08544, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bouardi</LastName>
                    <ForeName>Hamza Tazi</ForeName>
                    <Initials>HT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carballo</LastName>
                    <ForeName>Kimberly Villalobos</ForeName>
                    <Initials>KV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wiberg</LastName>
                    <ForeName>Holly</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zeng</LastName>
                    <ForeName>Cynthia</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>#174530</GrantID>
                    <Agency>National Science Foundation</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>#174530</GrantID>
                    <Agency>National Science Foundation</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Health Care Manag Sci</MedlineTA>
            <NlmUniqueID>9815649</NlmUniqueID>
            <ISSNLinking>1386-9620</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Epidemiological modeling</Keyword>
            <Keyword MajorTopicYN="N">Machine learning</Keyword>
            <Keyword MajorTopicYN="N">Optimization</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>16</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33590417</ArticleId>
            <ArticleId IdType="doi">10.1007/s10729-020-09542-0</ArticleId>
            <ArticleId IdType="pii">10.1007/s10729-020-09542-0</ArticleId>
            <ArticleId IdType="pmc">PMC7883965</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Bioinformatics. 2001 Jun;17(6):520-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11395428</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2020 Jul;81(1):e6-e12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32283162</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Am Thorac Soc. 2020 Oct 13;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33049156</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Mar 26;368:m1198</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32217618</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Apr 30;382(18):e41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32212516</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2020 Jul;39(7):1247-1252</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32352846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 22;368(6493):860-868</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32291278</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2020 Jul 1;94(14):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32357959</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hosp Infect. 2020 Jun 17;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32563551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Death Differ. 2020 May;27(5):1451-1454</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32205856</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Jun;92(6):568-576</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32134116</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2020 Jul;26(7):1470-1477</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32255761</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Mach Intell. 2020 Jan;2(1):56-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32607472</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Emerg Med. 2020 Oct;38(10):2243.e5-2243.e6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32471783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ Open. 2020 Aug 11;10(8):e039849</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32784264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32298251</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32109013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Radiology. 2020 Aug;296(2):E79-E85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32243238</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intensive Care Med. 2016 May;42(5):699-711</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27040102</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 21;395(10228):931-934</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32164834</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32171076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9241-9243</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32269081</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2020 May;97(5):829-838</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32247631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trop Med Int Health. 2020 Mar;25(3):278-280</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32052514</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Mal Infect. 2020 Jun;50(4):332-334</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32243911</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2013 Aug 15;188(4):440-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23348974</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2017 Jun;23(6):914-921</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28518041</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anesthesiology. 2020 Jun;132(6):1317-1332</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32195705</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc. 2020 Jun;95(6):1138-1147</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32376101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Sep 9;370:m3339</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32907855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Apr 21;323(15):1502-1503</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32105304</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33585808</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2590-0536</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>3</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Apr</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biosafety and health</Title>
                <ISOAbbreviation>Biosaf Health</ISOAbbreviation>
            </Journal>
            <ArticleTitle>An update to monoclonal antibody as therapeutic option against COVID-19.</ArticleTitle>
            <Pagination>
                <MedlinePgn>87-91</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bsheal.2021.02.001</ELocationID>
            <Abstract>
                <AbstractText>With the number of Coronavirus Disease 2019 (COVID-19) cases soaring worldwide and limited vaccine availability for the general population in most countries, the monoclonal antibody (mAb) remains a viable therapeutic option to treat COVID-19 disease and its complications, especially in the elderly individuals. More than 50 monoclonal antibody-related clinical trials are being conducted in different countries around the world, with few of them nearing the completion of the third and fourth phase clinical trial. In view of recent emergency use authorization (EUA) from the FDA (Food and Drug Administration) of casirivimab and imdevimab, it is of importance that mAbs, already used to treat diseases such as Ebola and respiratory syncytial virus (RSV) infection, are discussed in scientific communities. This brief review discusses the mechanism of action and updates to clinical trials of different monoclonal antibodies used to treat COVID-19, with special attention paid to SARS-CoV-2 immune response in host cells, target viral structures, and justification of developing mAbs following the approval and administration of potential effective vaccine among vulnerable populations in different countries.</AbstractText>
                <CopyrightInformation>.. 2021 Chinese Medical Association Publishing House. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Deb</LastName>
                    <ForeName>Paroma</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Virology, Dhaka Medical College, Dhaka 1000, Bangladesh.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Molla</LastName>
                    <ForeName>Md Maruf Ahmed</ForeName>
                    <Initials>MMA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Virology, National Institute of Laboratory Medicine and Referral Center, Dhaka 1207, Bangladesh.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Saif-Ur-Rahman</LastName>
                    <ForeName>K M</ForeName>
                    <Initials>KM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Systems and Population Studies Division, icddr,b, Dhaka 1000, Bangladesh.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Biosaf Health</MedlineTA>
            <NlmUniqueID>101768009</NlmUniqueID>
            <ISSNLinking>2590-0536</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antibody therapy</Keyword>
            <Keyword MajorTopicYN="N">Coronavirus</Keyword>
            <Keyword MajorTopicYN="N">Monoclonal antibody</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">mAb</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>12</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33585808</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bsheal.2021.02.001</ArticleId>
            <ArticleId IdType="pii">S2590-0536(21)00019-7</ArticleId>
            <ArticleId IdType="pmc">PMC7872849</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2020 Jul;583(7815):290-295</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32422645</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 May 4;11(1):2251</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32366817</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Immunol. 2020 Dec;41(12):1100-1115</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33132005</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Pharmacol. 2020 Aug 27;11:1327</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32973534</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 21;384(3):238-251</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33332778</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EBioMedicine. 2020 Aug;58:102887</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32736307</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2020 Aug 03;21(15):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32756480</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol Methods. 2005 Sep;128(1-2):21-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15885812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pathogens. 2020 May 29;9(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32485970</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2019 Dec 12;381(24):2365-2366</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31774948</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Microbes Infect. 2020 Dec;9(1):382-385</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32065055</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Lett. 2005 Sep 15;100(2):177-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15893826</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2021 Jan;21(1):52-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33058797</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 11;384(6):497-511</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33264556</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2021 Feb;103:25-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33186704</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Autoimmun Rev. 2020 Jul;19(7):102568</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32376398</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Microbes Infect. 2020 Dec;9(1):727-732</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32196410</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2020 Apr;8(4):420-422</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32085846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2007 Dec;25(12):1421-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18066039</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 21;384(3):229-237</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33113295</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Asian Pac J Allergy Immunol. 2020 Mar;38(1):10-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32134278</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Rheumatol. 2020 Oct;2(10):e603-e612</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32838323</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Hematol. 2015 Nov;22(6):521-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26457963</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jul 14;324(2):131-132</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32539093</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):333-334</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32782402</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Rheumatol. 2020 Aug;2(8):e474-e484</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32835257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2018 Apr 19;378(16):1469-1472</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29513615</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Microbiol. 2020 Jul 03;11:1576</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32719672</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2013 Mar 15;31(12):1553-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23370150</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2020 Nov;38(11):1242-1252</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33087898</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Pharmacol. 2009 May;157(2):220-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19459844</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Life Sci. 2020 Sep 15;257:118102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32687918</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc. 2020 Nov;95(11):2382-2394</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33153629</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Pharmacol. 2020 Oct;180:114169</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32710969</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33582489</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>08</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-7603</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>144</Volume>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>04</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of reproductive immunology</Title>
                <ISOAbbreviation>J Reprod Immunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery.</ArticleTitle>
            <Pagination>
                <MedlinePgn>103285</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0165-0378(21)00015-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jri.2021.103285</ELocationID>
            <Abstract>
                <AbstractText>We report herein the longest-lasting study of SARS-CoV-2 antibody profile in pregnancy, from first trimester-infection to delivery. Seventeen out of 164 pregnant women tested positive for COVID-19. Throughout pregnancy, the neutralizing antibody titer remained stable, whilst a significant decline in the non-neutralizing antibodies was observed after 16 weeks of gestation. All the newborns of women who developed IgG antibodies showed the presence of the same antibodies in arterial cord blood. Knowledge on the longevity and type of SARS-CoV-2 antibody response may help to guide vaccination strategies in pregnancy.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cosma</LastName>
                    <ForeName>Stefano</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carosso</LastName>
                    <ForeName>Andrea Roberto</ForeName>
                    <Initials>AR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy. Electronic address: andrea88.carosso@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Corcione</LastName>
                    <ForeName>Silvia</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy; Tufts University School of Medicine, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cusato</LastName>
                    <ForeName>Jessica</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Clinical Pharmacology and Pharmacogenetics, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Borella</LastName>
                    <ForeName>Fulvio</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Antonucci</LastName>
                    <ForeName>Miriam</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Clinical Pharmacology and Pharmacogenetics, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marozio</LastName>
                    <ForeName>Luca</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Revelli</LastName>
                    <ForeName>Alberto</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Preti</LastName>
                    <ForeName>Mario</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ghisetti</LastName>
                    <ForeName>Valeria</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Microbiology and Virology, Amedeo di Savoia Hospital, ASL 'Citt.. di Torino', Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Di Perri</LastName>
                    <ForeName>Giovanni</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Infectious Diseases, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Benedetto</LastName>
                    <ForeName>Chiara</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016430">Clinical Trial</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>02</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Ireland</Country>
            <MedlineTA>J Reprod Immunol</MedlineTA>
            <NlmUniqueID>8001906</NlmUniqueID>
            <ISSNLinking>0165-0378</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Antibodies</Keyword>
            <Keyword MajorTopicYN="Y">COVID-19 immunology</Keyword>
            <Keyword MajorTopicYN="Y">COVID-19 vaccines</Keyword>
            <Keyword MajorTopicYN="Y">Pregnancy</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>14</Day>
                <Hour>20</Hour>
                <Minute>31</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33582489</ArticleId>
            <ArticleId IdType="pii">S0165-0378(21)00015-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jri.2021.103285</ArticleId>
            <ArticleId IdType="pmc">PMC7973007</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:375-376</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31088698</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Netw Open. 2020 Dec 1;3(12):e2030455</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33351086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Aug;26(8):1200-1204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32555424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Microbiol. 2020 Dec;5(12):1598-1607</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33106674</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2021 Jan;93(1):537-540</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32633869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 31;383(27):2603-2615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Obstet Gynecol. 2020 Oct 8;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33039396</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Oct 1;183(1):158-168.e14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32979941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2021 Mar;27(3):928-931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33350923</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Obstet Gynecol Reprod Biol. 2020 Jul;250:246-249</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32418711</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">33582237</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>21</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1569-8041</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>32</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>05</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of oncology : official journal of the European Society for Medical Oncology</Title>
                <ISOAbbreviation>Ann Oncol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate.</ArticleTitle>
            <Pagination>
                <MedlinePgn>579-581</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0923-7534(21)00096-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.annonc.2021.01.068</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Garassino</LastName>
                    <ForeName>M C</ForeName>
                    <Initials>MC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Thoracic Oncology, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: Marina.Garassino@istitutotumori.mi.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vyas</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>European Society for Medical Oncology, Lugano, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Vries</LastName>
                    <ForeName>E G E</ForeName>
                    <Initials>EGE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kanesvaran</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Medical Oncology, National Cancer Centre Singapore, Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Giuliani</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Clatterbridge Cancer Centre, Liverpool, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peters</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>European Society for Medical Oncology</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016421">Editorial</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Ann Oncol</MedlineTA>
            <NlmUniqueID>9007735</NlmUniqueID>
            <ISSNLinking>0923-7534</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName>
                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <CoiStatement>Disclosures MCG reports grants and personal fees from Eli Lilly, Otsuka Pharma, Astra Zeneca, Novartis, BMS, Roche, Pfizer, Celgene, Incyte, Bayer, MSD, GlaxoSmithKline S.p.A., Sanofi-Aventis, Spectrum Pharmaceuticals, and Blueprint Medicine; personal fees from Boehringer Ingelheim, Inivata, Takeda, Seattle Genetics, Daiichi Sankyo, Janssen, and Mirati Therapeutics, Regeneron Pharmaceuticals; grants from Tiziana Sciences, Clovis, Merck Serono, United Therapeutics Corporation, Merck KGaA, Turning Point, Ipsen, MedImmune, Exelixis, Pfizer, and BMS &amp; Celgene; nonfinancial support from MSD and Eli-Lilly. MV reports being an employee of the European Society for Medical Oncology. EdV reports institutional financial support for her advisory/consultancy role from Daiichi Sankyo, NSABP, and Crescendo Biologics, and institutional financial support for clinical trials or contracted research from Amgen, Bayer, CytomX Therapeutics, G1 Therapeutics, Genentech, Regeneron, Roche, Servier, and Synthon, all outside the submitted work. RK reports advisory board/speaker/received honoraria from J&amp;J, Astellas, MSD, BMS, Amgen, Pfizer, Ipsen, AstraZeneca, and Eisai. RG reports being a core member of the European Medicines Agency Scientific Advisory Group-Oncology, an expert evaluator for the EU Commission on the topic ...Global Alliance for Chronic Diseases (GACD) 2 ... Prevention and/or early diagnosis of cancer...; provides consultation/lectures (no remuneration) for Novartis, Mylan, Roche, Lilly, and Apogen; and institutional financial support (clinical trials, Italy) from MSD and Novartis. SP reports education grants, provided consultation, attended advisory boards, and/or provided lectures for the following organisations, from which she has received honoraria: AbbVie, Amgen, AstraZeneca, Bayer, BeiGene, Biocartis, Boehringer Ingelheim, Bristol-Myers Squibb, Clovis, Daiichi Sankyo, Debiopharm, Eli Lilly, F. Hoffmann-La Roche, Foundation Medicine, Illumina, Incyte, Janssen, Medscape, Merck Sharp and Dohme, Merck Serono, Merrimack, Novartis, Pharma Mar, Phosphoplatin Therapeutics, Pfizer, Regeneron, Sanofi, Seattle Genetics, and Takeda (Consultation/advisory role); AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, F. Hoffmann-La Roche, Illumina, Medscape, Merck Sharp and Dohme, Novartis, Pfizer, Prime, Sanofi, and Takeda (Talk in a company's organised public event); receipt of grants/research supports/(sub)investigator in trials (institutional financial support for clinical trials) sponsored by Amgen, AstraZeneca, Biodesix, Boehringer Ingelheim, Bristol-Myers Squibb, Clovis, F. Hoffmann-La Roche, GSK, Illumina, Lilly, Merck Sharp and Dohme, Merck Serono, Mirati, Novartis, Pfizer, and Phoshoplatin Therapeutics.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>4</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>14</Day>
                <Hour>20</Hour>
                <Minute>27</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33582237</ArticleId>
            <ArticleId IdType="pii">S0923-7534(21)00096-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.annonc.2021.01.068</ArticleId>
            <ArticleId IdType="pmc">PMC7879154</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA Oncol. 2021 Mar 1;7(3):458-460</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33443549</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2021 May;32(5):579-581</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33582237</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33580113</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>26</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>26</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Spatio-temporal distribution characteristics and influencing factors of COVID-19 in China.</ArticleTitle>
            <Pagination>
                <MedlinePgn>3717</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-83166-4</ELocationID>
            <Abstract>
                <AbstractText>In December 2019, corona virus disease 2019 (COVID-19) has broken out in China. Understanding the distribution of disease at the national level contributes to the formulation of public health policies. There are several studies that investigating the influencing factors on distribution of COVID-19 in China. However, more influencing factors need to be considered to improve our understanding about the current epidemic. Moreover, in the absence of effective medicine or vaccine, the Chinese government introduced a series of non-pharmaceutical interventions (NPIs). However, assessing and predicting the effectiveness of these interventions requires further study. In this paper, we used statistical techniques, correlation analysis and GIS mapping expression method to analyze the spatial and temporal distribution characteristics and the influencing factors of the COVID-19 in mainland China. The results showed that the spread of outbreaks in China's non-Hubei provinces can be divided into five stages. Stage I is the initial phase of the COVID-19 outbreak; in stage II the new peak of the epidemic was observed; in stage III the outbreak was contained and new cases decreased; there was a rebound in stage IV, and stage V led to level off. Moreover, the cumulative confirmed cases were mainly concentrated in the southeastern part of China, and the epidemic in the cities with large population flows from Wuhan was more serious. In addition, statistically significant correlations were found between the prevalence of the epidemic and the temperature, rainfall and relative humidity. To evaluate the NPIs, we simulated the prevalence of the COVID-19 based on an improved SIR model and under different prevention intensity. It was found that our simulation results were compatible with the observed values and the parameter of the time function in the improved SIR model for China is a...=...-..0.0058. The findings and methods of this study can be effective for predicting and managing the epidemics and can be used as an aid for decision makers to control the current and future epidemics.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Youliang</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Civil and Surveying and Mapping Engineering, Jiangxi University of Science and Technology, Ganzhou, China. 9120010023@jxust.edu.cn.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Geosciences and Info Physics, Central South University, Changsha, China. 9120010023@jxust.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Qun</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Civil and Surveying and Mapping Engineering, Jiangxi University of Science and Technology, Ganzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karimian</LastName>
                    <ForeName>Hamed</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Civil and Surveying and Mapping Engineering, Jiangxi University of Science and Technology, Ganzhou, China. hamedk@pku.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Xunjun</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Information Engineering, Jiangxi University of Science and Technology, Ganzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Xiaoming</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Spinal Surgery, Ganzhou People's Hospital Jiangxi, Ganzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011790" MajorTopicYN="N">Quarantine</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D062211" MajorTopicYN="Y">Spatio-Temporal Analysis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014505" MajorTopicYN="N">Urban Population</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014887" MajorTopicYN="N">Weather</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>13</Day>
                <Hour>5</Hour>
                <Minute>47</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33580113</ArticleId>
            <ArticleId IdType="doi">10.1038/s41598-021-83166-4</ArticleId>
            <ArticleId IdType="pii">10.1038/s41598-021-83166-4</ArticleId>
            <ArticleId IdType="pmc">PMC7881146</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Biosci Trends. 2020 Mar 16;14(1):64-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32037389</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ACS Cent Sci. 2020 Mar 25;6(3):315-331</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32226821</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Pediatr. 2020 Apr;87(4):281-286</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32166607</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Environ Res Public Health. 2020 May 31;17(11):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32486403</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2013 Mar;9(3):e1003194</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23505366</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Total Environ. 2020 Jul 10;725:138436</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32298883</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Microbes Infect. 2020 Dec;9(1):1537-1545</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32573353</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Total Environ. 2021 Jan 20;753:142272</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33207446</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Total Environ. 2020 Oct 1;737:139659</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32492607</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Euro Surveill. 2020 Feb;25(5):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32046819</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):514-523</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986261</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2011 May 3;108(18):7460-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21502510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Total Environ. 2020 Aug 1;728:138884</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32335404</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Total Environ. 2020 Jul 1;724:138201</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32408450</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Mar 26;382(13):1199-1207</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31995857</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 8;368(6491):638-642</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32234804</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2020 Apr;8(4):420-422</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32085846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Sep 1;324(9):859-870</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32745200</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Influenza Other Respir Viruses. 2020 Jan;14(1):11-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31631558</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Apr;92(4):401-402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31950516</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2020 Oct 1;10(1):16213</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33004925</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Total Environ. 2020 Aug 1;728:138811</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32361118</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 Jun;95:301-303</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32360939</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Total Environ. 2020 Jul 1;724:138226</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32408453</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Environ Res Public Health. 2020 Aug 14;17(16):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32824030</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 May;94:96-102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32251789</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 May;94:133-138</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32247826</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Total Environ. 2020 Nov 20;744:140929</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32687995</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2021 Jan;102:247-253</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33129965</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Apr;20(4):400-402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32113509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Mar 5;382(10):970-971</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32003551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Total Environ. 2020 Jul 15;726:138513</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32304942</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Apr 24;368(6489):395-400</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32144116</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">33579547</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-114X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>43</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical therapeutics</Title>
                <ISOAbbreviation>Clin Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?</ArticleTitle>
            <Pagination>
                <MedlinePgn>549-556</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0149-2918(21)00018-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clinthera.2021.01.014</ELocationID>
            <Abstract>
                <AbstractText>In December 2020, the US Food and Drug Administration issued emergency use authorizations for two mRNA vaccines against coronavirus disease 2019. These vaccines represent an incredible scientific achievement and a major step in efforts to bring the global pandemic to a close. However, these vaccines create many logistical challenges that limit just how far-reaching their impact can be. This commentary reviews how these vaccines offer immunity, summarizes the Phase III trial results, and offers a discussion of the challenges that remain after these vaccines are introduced for widespread use.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jhaveri</LastName>
                    <ForeName>Ravi</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Infectious Diseases, Ann &amp; Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: ravi.jhaveri@northwestern.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Clin Ther</MedlineTA>
            <NlmUniqueID>7706726</NlmUniqueID>
            <ISSNLinking>0149-2918</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">SARS CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">Spike protein</Keyword>
            <Keyword MajorTopicYN="Y">mRNA vaccines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>5</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>13</Day>
                <Hour>5</Hour>
                <Minute>38</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33579547</ArticleId>
            <ArticleId IdType="pii">S0149-2918(21)00018-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.clinthera.2021.01.014</ArticleId>
            <ArticleId IdType="pmc">PMC7825996</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33578506</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2191-0286</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>32</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Dec</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of basic and clinical physiology and pharmacology</Title>
                <ISOAbbreviation>J Basic Clin Physiol Pharmacol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Therapeutic clinical trials to combat COVID-19 pandemic in India: analysis from trial registry.</ArticleTitle>
            <Pagination>
                <MedlinePgn>267-278</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1515/jbcpp-2020-0208</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">With the emergence of Novel corona virus, hunt for finding a preventive and therapeutic treatment options has already begun at a rapid pace with faster clinical development programs. The present study was carried out to give an insight of therapeutic interventional trials registered under clinical trial registry of India (CTRI) for COVID-19 pandemic.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">All trials registered under CTRI were evaluated using keyword &quot;COVID&quot; from its inception till 9th June 2020. Out of which, therapeutic interventional studies were chosen for further analysis. Following information was collected for each trial: type of therapeutic intervention (preventive/therapeutic), treatment given, no. of centers (single center/multicentric), type of institution (government/private), study design (randomized/single-blinded/double-blinded) and sponsors (Government/private). Microsoft Office Excel 2007 was used for tabulation and analysis.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The search yielded total of 205 trials, out of which, 127 (62%) trials were interventional trials. Out of these, 71 (56%) were AYUSH interventions, 36 (28.3%) tested drugs, 9 (7%) tested a nondrug intervention, rest were nutraceuticals and vaccines. About 66 (56%) were therapeutic trials. Majority were single-centered trials, i.e. 87 (73.7%). Trials were government funded in 57 (48.3%) studies. Majority were randomized controlled trials, i.e. 67 (56.8%). AYUSH preparations included AYUSH-64, Arsenic Album, SamshamaniVati etc.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The number of therapeutic interventional clinical trials was fair in India. A clear-cut need exists for an increase in both quantity and quality of clinical trials for COVID-19. Drug repurposing approach in all systems of medicine can facilitate prompt clinical decisions at lower costs than <i>de novo</i> drug development.</AbstractText>
                <CopyrightInformation>.. 2020 Walter de Gruyter GmbH, Berlin/Boston.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Batta</LastName>
                    <ForeName>Angelika</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Faculty of Medical &amp; Health Sciences, SGT Medical College, Hospital and Research Institute, SGT University, Gurugram, Haryana, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Khirasaria</LastName>
                    <ForeName>Raj</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Affairs, Sanofi Genzyme India, Saket District Center, Saket, New Delhi 110017, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kapoor</LastName>
                    <ForeName>Vinod</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Faculty of Medical &amp; Health Sciences, SGT Medical College, Hospital and Research Institute, SGT University, Gurugram, Haryana, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Varshney</LastName>
                    <ForeName>Deepansh</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medical &amp; Health Sciences, SGT Medical College, Hospital and Research Institute, SGT University, Gurugram, Haryana, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>J Basic Clin Physiol Pharmacol</MedlineTA>
            <NlmUniqueID>9101750</NlmUniqueID>
            <ISSNLinking>0792-6855</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058492" MajorTopicYN="N">Drug Repositioning</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">AYUSH</Keyword>
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">CTRI</Keyword>
            <Keyword MajorTopicYN="N">India</Keyword>
            <Keyword MajorTopicYN="N">clinical trials</Keyword>
            <Keyword MajorTopicYN="N">corona virus</Keyword>
            <Keyword MajorTopicYN="N">therapeutic interventions</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>5</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>12</Day>
                <Hour>20</Hour>
                <Minute>23</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33578506</ArticleId>
            <ArticleId IdType="pii">jbcpp-2020-0208</ArticleId>
            <ArticleId IdType="doi">10.1515/jbcpp-2020-0208</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Title>References</Title>
            <Reference>
                <Citation>Lumbreras-Marquez, MI, Campos-Zamora, M, Lizaola-Diaz de Leon, H, Farber, MK. Maternal mortality from COVID-19 in Mexico [published online ahead of print, 2020 May 30]. Int J Gynaecol Obstet 2020. https://doi.org/10.1002/ijgo.13250.</Citation>
            </Reference>
            <Reference>
                <Citation>Sohrabi, C, Alsafi, Z, O...Neill, N, Khan, M, Kerwan, A, Al-Jabir, A, et al.. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>WHO coronavirus disease (COVID-19) dashboard. Available from: https://covid19.who.int/ [Accessed 2 Jul 2020].</Citation>
            </Reference>
            <Reference>
                <Citation>Iyer, M, Jayaramayya, K, Subramaniam, MD, Lee, SB, Dayem, AA, Cho, SG, et al.. COVID-19: an update on diagnostic and therapeutic approaches. BMB Rep 2020;53:191...205.</Citation>
            </Reference>
            <Reference>
                <Citation>COVID-19 INDIA. Available from: https://www.mohfw.gov.in/ [Accessed 2 Jul 2020].</Citation>
            </Reference>
            <Reference>
                <Citation>Gowri, S, Kannan, S. Clinical trials in dentistry in India: analysis from trial registry. Perspect Clin Res 2017;8:95.</Citation>
            </Reference>
            <Reference>
                <Citation>Clinical Management Protocol. COVID-19. Available from: https://www.mohfw.gov.in/pdf/ClinicalManagementProtocolforCOVID19.pdf [Accessed 2 Jul 2020].</Citation>
            </Reference>
            <Reference>
                <Citation>Karekar, SR, Pooja, SG, Marathe, PA. A review of clinical studies involving pregnant women registered in the Clinical Trials Registry of India. Perspect Clin Res 2020;11:8.</Citation>
            </Reference>
            <Reference>
                <Citation>COVID-19: Developing Drugs and Biological Products for Treatment or Prevention Guidance for Industry. Available from: https://www.fda.gov/media/137926/download [Accessed 2 Jul 2020].</Citation>
            </Reference>
            <Reference>
                <Citation>A pilot study to assess the efficacy of ayush-64 in covid-19 cases. Available from: https://mahayush.gov.in/DOA/COVID19_Research/Protocols%20for%20Clinical%20Studies%20and%20Survey%20Studies/Clinical%20protocols/PILOT%20STUDY.pdf [Accessed 2 Jul 2020].</Citation>
            </Reference>
            <Reference>
                <Citation>Chaturvedi, S, Kumar, N, Tillu, G, Deshpande, S, Patwardhan, B. Ayush, modern medicine and the covid-19 pandemic. Indian J Med Ethics 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Maurya, DK. Evaluation of yashtimadhu (Glycyrrhiza glabra) active phytochemicals against novel coronavirus. SARS-CoV-2.</Citation>
            </Reference>
            <Reference>
                <Citation>Kaur, R, Kaur, H, Dhindsa, AS. Glycyrrhiza glabra: a phytopharmacological review. Int J Pharma Sci Res 2013;4:2470...7. https://doi.org/10.13040/IJPSR.0975-8232.4(7).2470-77.</Citation>
            </Reference>
            <Reference>
                <Citation>Sharma, R, Martins, N, Kuca, K, Chaudhary, A, Kabra, A, Rao, MM, et al.. Chyawanprash: a traditional Indian bioactive health supplement. Published. Biomolecules 20192019;9:161. https://doi.org/10.3390/biom9050161.</Citation>
            </Reference>
            <Reference>
                <Citation>Gupta, A, Kumar, S, Dole, S, Deshpande, S, Deshpande, V, Singh, S, et al.. Evaluation of cyavanapr....a on health and immunity related parameters in healthy children: a two arm, randomized, open labeled, prospective, multicenter, clinical study. Ancient Sci Life 2017;36:141...50. https://doi.org/10.4103/asl.ASL_8_17.</Citation>
            </Reference>
            <Reference>
                <Citation>Guidelines for Ayurveda Practitioners for COVID 19. Available from: https://www.ayush.gov.in/docs/125.pdf [Accessed on 2 July 2020].</Citation>
            </Reference>
            <Reference>
                <Citation>Keyaerts, E, Vijgen, L, Maes, P, Neyts, J, Van Ranst, M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun 2004;323:264...8.</Citation>
            </Reference>
            <Reference>
                <Citation>Keyaerts, E, Li, S, Vijgen, L, Rysman, E, Verbeeck, J, Van Ranst, M, et al.. Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice. Antimicrob Agents Chemother 2009;58:3416...21.</Citation>
            </Reference>
            <Reference>
                <Citation>Gautret, P, Lagier, JC, Parola, P, Meddeb, L, Mailhe, M, Doudier, B, et al.. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020:105949.</Citation>
            </Reference>
            <Reference>
                <Citation>Liu, J, Cao, R, Xu, M, Wang, X, Zhang, H, Hu, H, et al.. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov [Internet]; 2020, 6:16 p. Available from: https://doi.org/10.1038/s41421-020-0156-0.</Citation>
            </Reference>
            <Reference>
                <Citation>Wang, M, Cao, R, Zhang, L, Yang, X, Liu, J, Xu, M, et al.. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020:10...0282.</Citation>
            </Reference>
            <Reference>
                <Citation>Chen, Z, Hu, J, Zhang, Z, Jiang, S, Han, S, Yan, D, et al.. Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial medRxiv;2020, 03:20040758 p. Preprint. https://doi.org/10.1101/2020.03.22.20040758.Version 2.</Citation>
            </Reference>
            <Reference>
                <Citation>Yao, X, Ye, F, Zhang, M, Cui, C, Huang, B, Niu, P, et al.. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020. pii: ciaa237. https://doi.org/10.1093/cid/ciaa237.</Citation>
            </Reference>
            <Reference>
                <Citation>Lenzer, J. Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence. BMJ 2020;369. m1335. https://doi.org/10.1136/bmj.m1335.32238355.</Citation>
            </Reference>
            <Reference>
                <Citation>Indian Council for Medical Research. Recommendation for empiric use of hydroxychloroquine for prophylaxis of SARS-CoV-2 infection. Available from: https://icmr.nic.in/sites/default/files/upload_documents/HCQ_Recommendation_22March_final_MM_V2.pdf [Accessed 3 Apr 2020].</Citation>
            </Reference>
            <Reference>
                <Citation>Gautret, P, Lagier, JC, Parola, P, Meddeb, L, Sevestre, J, Mailhe, M, et al.. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study. Trav Med Infect Dis 2020;34:101663.</Citation>
            </Reference>
            <Reference>
                <Citation>International clinical trial registry platform. Available from: https://apps.who.int/trialsearch/Trial2.aspx?TrialID=PER-010-20 [Accessed 2 Jul 2020].</Citation>
            </Reference>
            <Reference>
                <Citation>Recommendations for investigational COVID-19 convalescent plasma. Available from: https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma [Accessed 2 Jul 2020].</Citation>
            </Reference>
            <Reference>
                <Citation>Shen, C, Wang, Z, Zhao, F, Yang, Y, Li, J, Yuan, J, et al.. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. J Am Med Assoc 2020;323:1582...9. https://doi.org/10.1001/jama.2020.4783.</Citation>
            </Reference>
            <Reference>
                <Citation>Li, L, Zhang, W, Hu, Y, Tong, X, Zheng, S, Yang, J, et al.. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. J Am Med Assoc 2020: e2010044. https://doi.org/10.1001/jama.2020.10044.</Citation>
            </Reference>
            <Reference>
                <Citation>Caly, L, Druce, JD, Catton, MG, Jans, DA, Wagstaff, KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivir Res 2020;178:104787. https://doi.org/10.1016/j.antiviral.2020.104787.</Citation>
            </Reference>
            <Reference>
                <Citation>Miyasaka, M. Is BCG vaccination causally related to reduced COVID-19 mortality? EMBO Mol Med 2020;12:e12661. https://doi.org/10.15252/emmm.202012661.</Citation>
            </Reference>
            <Reference>
                <Citation>Sehgal, IS, Bhalla, A, Puri, GD, Yaddanapudi, LN, Singh, M, Malhotra, P, et al.. Safety of an immunomodulator Mycobacterium w in COVID-19. Lung India 2020;37:279...81.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhang, B, Swamy, S, Balijepalli, S, Panicker, S, Mooliyil, J, Sherman, MA, et al.. Direct pulmonary delivery of solubilized curcumin reduces severity of lethal pneumonia. Faseb J 2019;33:13294...309. https://doi.org/10.1096/fj.201901047RR.</Citation>
            </Reference>
            <Reference>
                <Citation>Wen, CC, Kuo, YH, Jan, JT, Liang, PH, Wang, SY, Liu, HG, et al.. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem 2007;50:4087...95.</Citation>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">33578007</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>12</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>18</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-3511</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>105</Volume>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Apr</Month>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title>
                <ISOAbbreviation>Int J Infect Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010-20.</ArticleTitle>
            <Pagination>
                <MedlinePgn>91-104</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1201-9712(21)00097-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2021.02.011</ELocationID>
            <Abstract>
                <AbstractText>To evaluate the effects of probiotics on respiratory tract infection (RTI) a systematic review of randomized controlled trials (RCTs) from January 2010 to January 2020 was conducted. The PubMed, Google Scholar, Embase, Scopus, Clinicaltrials.gov, and International Clinical Trials Registry Platform databases were systematically searched for the following keywords: respiratory tract infection, probiotics, viral infection, COVID-19, and clinical trial. A total of 27 clinical trials conducted on 9433 patients with RTI plus 10 ongoing clinical studies of probiotics intervention in Coronavirus disease 2019 (COVID-19) were reviewed. The review looked at the potency of probiotics for the hindrance and/or treatment of RTI diseases, this may also apply to COVID-19. The review found that probiotics could significantly increase the plasma levels of cytokines, the effect of influenza vaccine and quality of life, as well as reducing the titer of viruses and the incidence and duration of respiratory infections. These antiviral and immune-modulating activities and their ability to stimulate interferon production recommend the use of probiotics as an adjunctive therapy to prevent COVID-19. Based on this extensive review of RCTs we suggest that probiotics are a rational complementary treatment for RTI diseases and a viable option to support faster recovery.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Darbandi</LastName>
                    <ForeName>Atieh</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran; Microbial Biotechnology Research Centre, Iran University of Medical Sciences, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Asadi</LastName>
                    <ForeName>Arezoo</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran; Microbial Biotechnology Research Centre, Iran University of Medical Sciences, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ghanavati</LastName>
                    <ForeName>Roya</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Behbahan Faculty of Medical Sciences, Behbahan, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Afifirad</LastName>
                    <ForeName>Roghayeh</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Darb Emamie</LastName>
                    <ForeName>Amir</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kakanj</LastName>
                    <ForeName>Maryam</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Food and Drug Laboratory Research Center, Food and Drug Administation, MOH&amp;ME, Tehran, Iran. Electronic address: maryam_kakanj@yahoo.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Talebi</LastName>
                    <ForeName>Malihe</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran; Microbial Biotechnology Research Centre, Iran University of Medical Sciences, Tehran, Iran. Electronic address: talebi_25@yahoo.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D000078182">Systematic Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Canada</Country>
            <MedlineTA>Int J Infect Dis</MedlineTA>
            <NlmUniqueID>9610933</NlmUniqueID>
            <ISSNLinking>1201-9712</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019936" MajorTopicYN="N">Probiotics</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Influenza vaccines</Keyword>
            <Keyword MajorTopicYN="N">Probiotic</Keyword>
            <Keyword MajorTopicYN="N">Randomized controlled trials</Keyword>
            <Keyword MajorTopicYN="N">Respiratory tract infection</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>5</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>12</Day>
                <Hour>20</Hour>
                <Minute>12</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33578007</ArticleId>
            <ArticleId IdType="pii">S1201-9712(21)00097-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ijid.2021.02.011</ArticleId>
            <ArticleId IdType="pmc">PMC7871912</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Nutr. 2007 Mar;137(3 Suppl 2):773S-80S</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17311974</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunopharmacol Immunotoxicol. 2012 Dec;34(6):937-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22468623</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2014 Feb;133(2):405-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24131826</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Pharmacol Sci. 2020 Jun;41(6):363-382</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32291112</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Int. 2012 Oct;54(5):682-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22507276</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2010 Aug 13;5(8):e12164</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20730056</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2015 May 21;21(19):5985-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26019464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jun 11;382(24):2327-2336</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32275812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lett Appl Microbiol. 2010 Jul;51(1):6-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20438618</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 1999 Mar 10;281(10):908-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10078487</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Nutr. 2010 Jul;64(7):669-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20485304</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aliment Pharmacol Ther. 2006 Jun 1;23(11):1567-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16696804</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Implement Sci. 2007 Aug 03;2:26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17683558</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2019 Sep 5;178(6):1313-1328.e13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31491384</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1306-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26884164</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Food Sci Nutr. 2016;67(1):67-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26708938</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 Jun 9;:1-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32475223</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biosci Biotechnol Biochem. 2010;74(5):939-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20460726</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Nutr. 2015 Feb 14;113(3):426-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25604727</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nutrition. 2007 Mar;23(3):254-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17352961</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trop Anim Health Prod. 2010 Dec;42(8):1855-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20623187</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Appl Physiol. 2016 Aug;116(8):1555-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27294502</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Clin Nutr. 2015 Jun;101(6):1188-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25926507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2012 Mar;86(6):2900-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22258243</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Clin Nutr. 2011 Jun;93(6):1305-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21525194</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2006 Apr 21;312(5772):399</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16556800</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Nutr. 2006 Dec;136(12):3069-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17116721</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2015 Aug;15(8):471-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26160613</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Cell Infect Microbiol. 2019 Jul 18;9:256</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31380299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Nutr. 2015 Sep 14;114(5):727-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26234407</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Nutr. 2014 Jul 14;112(1):41-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24780623</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Sports Med. 2010 Mar;44(4):222-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18272539</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Microbiol. 2009;63:269-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19575569</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Geriatr Gerontol Int. 2016 Feb;16(2):205-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25613751</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Nutr. 2010 Jan;103(1):58-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19747410</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2014 Jul 14;20(26):8709-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25024629</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Immunopharmacol. 2011 Dec;11(12):2246-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21986509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Inflamm Allergy Drug Targets. 2012 Apr;11(2):79-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22280243</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20689501</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Geriatr Soc. 2018 Jul;66(7):1346-1352</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29741754</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lett Appl Microbiol. 2010 Jun 1;50(6):597-602</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20438620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2011 May 27;34(5):637-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21616434</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2012 Jul 27;37(1):158-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22705104</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chin Med J (Engl). 2014;127(7):1344-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24709192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Ther. 2014 Jan;141(1):32-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23969226</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Nutr. 2021 Jan 4;151(1):214-222</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33296464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Nutr. 2011 Apr;65(4):501-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21285968</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Nutr. 2020 Aug;39(8):2358-2367</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31831184</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Nutr. 2010 Oct;104(7):998-1006</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20487575</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2016 Dec 23;7:633</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28066442</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Sport Nutr Exerc Metab. 2012 Aug;22(4):235-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22645171</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 1999 Jul 14;282(2):137-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10411194</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2011 Oct 15;184(8):957-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21680950</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Dairy Sci. 1995 Mar;78(3):491-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7782506</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2015 Feb 03;(2):CD006895</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25927096</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Dairy Sci. 2019 Jun;102(6):4783-4797</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30954261</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Nutr. 2019 Feb;58(1):83-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29124387</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2010 May 15;50 Suppl 3:S201-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20397949</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2009 Jul 21;339:b2535</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19622551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Res. 2006 Aug;60(2):221-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16864708</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Nutr. 2005 Aug;24(4):481-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16054520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Nutr. 2018 Apr;37(2):443-451</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28215759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomed Pharmacother. 2021 Jan;133:110947</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33197765</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Nutr. 2011 Apr;50(3):203-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20803023</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Benef Microbes. 2017 Apr 26;8(2):207-215</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28343401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Food Funct. 2019 Dec 11;10(12):8129-8136</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31738351</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods. 2007 Jan;41(1):31-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17161300</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2014 Jul;60(3):276-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24793963</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lett Appl Microbiol. 2014 Dec;59(6):565-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25294223</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Nutr. 2013 May 28;109(10):1856-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22947249</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Benef Microbes. 2015;6(5):631-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26322544</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2009 Sep 18;27(41):5677-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19615959</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Clin Nutr. 2012 May;95(5):1165-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22440853</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Nutr. 2012 Mar;107(6):876-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21899798</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Microbiol. 2017 Sep;199(7):953-961</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28634691</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2018 May 22;9:1091</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29872432</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Immunol. 2013 May;172(2):321-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23574328</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33577086</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1527-3350</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Hepatology (Baltimore, Md.)</Title>
                <ISOAbbreviation>Hepatology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>AASLD Expert Panel Consensus Statement: Vaccines to Prevent COVID-19 Infection in Patients with Liver Disease.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/hep.31751</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND AND RATIONALE" NlmCategory="OBJECTIVE">The aim of this document is to provide a concise scientific review of the currently available COVID-19 vaccines and those in development, including mRNA, adenoviral vectors, and recombinant protein approaches. The anticipated use of COVID-19 vaccines in patients with chronic liver disease and liver transplant recipients is reviewed and practical guidance is provided for health care providers involved in the care of patients with liver disease and liver transplantation about vaccine prioritization and administration.</AbstractText>
                <AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">The Pfizer and Moderna mRNA COVID-19 vaccines are associated with a 94%-95% vaccine efficacy compared to placebo against COVID-19. Local site reactions of pain and tenderness were reported in 70%-90% of clinical trial participants, and systemic reactions of fever and fatigue were reported in 40%-70% of participants, but these reactions were generally mild and self-limited and occurred more frequently in younger individuals. Severe hypersensitivity reactions related to the mRNA COVID-19 vaccines are rare and more commonly seen in women and individuals with a history of prior drug reactions for unclear reasons. Because patients with advanced liver disease and immunosuppressed patients were excluded from the vaccine licensing trials, additional data regarding the safety and efficacy of COVID-19 vaccines are eagerly awaited in these and other subgroups CONCLUSIONS: Remarkably safe and highly effective mRNA COVID-19 vaccines are now available for widespread use and should be given to all adult patients with chronic liver disease and liver transplant recipients. The online companion document located at https://www.aasld.org/about-aasld/covid-19-resources will be updated as additional data become available regarding the safety and efficacy of..other COVID-19 vaccines in development.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fix</LastName>
                    <ForeName>Oren K</ForeName>
                    <Initials>OK</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-8570-9646</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Elson S. Floyd College of Medicine, Washington State University, Spokane, WA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Blumberg</LastName>
                    <ForeName>Emily A</ForeName>
                    <Initials>EA</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Pennsylvania, Philadelphia, PA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chang</LastName>
                    <ForeName>Kyong-Mi</ForeName>
                    <Initials>KM</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Pennsylvania, Philadelphia, PA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>The Corporal Michael J. Crescenz VAMC.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chu</LastName>
                    <ForeName>Jaime</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Icahn School of Medicine at Mt Sinai, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chung</LastName>
                    <ForeName>Raymond T</ForeName>
                    <Initials>RT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Massachusetts General Hospital, Boston, MA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goacher</LastName>
                    <ForeName>Elizabeth K</ForeName>
                    <Initials>EK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Duke University, Durham, NC.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hameed</LastName>
                    <ForeName>Bilal</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of California, San Francisco, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaul</LastName>
                    <ForeName>Daniel R</ForeName>
                    <Initials>DR</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Michigan, Ann Arbor, MI.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kulik</LastName>
                    <ForeName>Laura M</ForeName>
                    <Initials>LM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Northwestern Medicine, Chicago, IL.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kwok</LastName>
                    <ForeName>Ryan M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Uniformed Services University, Bethesda, MD.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McGuire</LastName>
                    <ForeName>Brendan M</ForeName>
                    <Initials>BM</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Alabama, Birmingham, AL.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mulligan</LastName>
                    <ForeName>David C</ForeName>
                    <Initials>DC</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0901-2617</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Yale University, New Haven, CT.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Price</LastName>
                    <ForeName>Jennifer C</ForeName>
                    <Initials>JC</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of California, San Francisco, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reau</LastName>
                    <ForeName>Nancy S</ForeName>
                    <Initials>NS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rush University, Chicago, IL.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reddy</LastName>
                    <ForeName>K Rajender</ForeName>
                    <Initials>KR</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Pennsylvania, Philadelphia, PA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reynolds</LastName>
                    <ForeName>Andrew</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>San Francisco AIDS Foundation, San Francisco, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rosen</LastName>
                    <ForeName>Hugo R</ForeName>
                    <Initials>HR</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1110-6914</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Keck Medicine of USC, Los Angeles, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Russo</LastName>
                    <ForeName>Mark W</ForeName>
                    <Initials>MW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Atrium Health, Carolinas Medical Center, Charlotte, NC.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schilsky</LastName>
                    <ForeName>Michael L</ForeName>
                    <Initials>ML</Initials>
                    <AffiliationInfo>
                        <Affiliation>Yale University, New Haven, CT.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Verna</LastName>
                    <ForeName>Elizabeth C</ForeName>
                    <Initials>EC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Columbia University, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ward</LastName>
                    <ForeName>John W</ForeName>
                    <Initials>JW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Coalition for Global Hepatitis Elimination.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fontana</LastName>
                    <ForeName>Robert J</ForeName>
                    <Initials>RJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Michigan, Ann Arbor, MI.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>AASLD COVID-19 Vaccine Working Group</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Hepatology</MedlineTA>
            <NlmUniqueID>8302946</NlmUniqueID>
            <ISSNLinking>0270-9139</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">cirrhosis</Keyword>
            <Keyword MajorTopicYN="N">coronavirus</Keyword>
            <Keyword MajorTopicYN="N">immunosuppression</Keyword>
            <Keyword MajorTopicYN="N">transplantation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>12</Day>
                <Hour>12</Hour>
                <Minute>13</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33577086</ArticleId>
            <ArticleId IdType="doi">10.1002/hep.31751</ArticleId>
            <ArticleId IdType="pmc">PMC8014184</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33576498</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>05</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1531-4995</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>131</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>04</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The Laryngoscope</Title>
                <ISOAbbreviation>Laryngoscope</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Violation of the Laryngoscope and the Resultant Injury It Has Caused to Human Beings.</ArticleTitle>
            <Pagination>
                <MedlinePgn>701-702</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.29450</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Selesnick</LastName>
                    <ForeName>Samuel H</ForeName>
                    <Initials>SH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Weill Cornell Medical College, New York, NY, U.S.A.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pensak</LastName>
                    <ForeName>Myles L</ForeName>
                    <Initials>ML</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Cincinnati, Cincinnati, OH, U.S.A.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016421">Editorial</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Laryngoscope</MedlineTA>
            <NlmUniqueID>8607378</NlmUniqueID>
            <ISSNLinking>0023-852X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014612">Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D020330" MajorTopicYN="N">Bell Palsy</DescriptorName>
                <QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018156" MajorTopicYN="N">Journalism, Medical</DescriptorName>
                <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017594" MajorTopicYN="N">Publication Bias</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014612" MajorTopicYN="N">Vaccines</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>4</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>12</Day>
                <Hour>8</Hour>
                <Minute>40</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33576498</ArticleId>
            <ArticleId IdType="doi">10.1002/lary.29450</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33574597</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>19</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1476-4687</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>590</Volume>
                    <Issue>7846</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Nature</Title>
                <ISOAbbreviation>Nature</ISOAbbreviation>
            </Journal>
            <ArticleTitle>This COVID-vaccine designer is tackling vaccine hesitancy - in churches and on Twitter.</ArticleTitle>
            <Pagination>
                <MedlinePgn>377</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/d41586-021-00338-y</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Subbaraman</LastName>
                    <ForeName>Nidhi</ForeName>
                    <Initials>N</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D017203">Interview</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nature</MedlineTA>
            <NlmUniqueID>0410462</NlmUniqueID>
            <ISSNLinking>0028-0836</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014614">Vaccines, Synthetic</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C000711953">mRNA Vaccine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D044383" MajorTopicYN="N">African Continental Ancestry Group</DescriptorName>
                <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086562" MajorTopicYN="N">American Natives</DescriptorName>
                <QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName>
                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
                <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005239" MajorTopicYN="Y">Fear</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006266" MajorTopicYN="Y">Health Education</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000069576" MajorTopicYN="Y">Health Equity</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D054625" MajorTopicYN="N">Healthcare Disparities</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006630" MajorTopicYN="N">Hispanic Americans</DescriptorName>
                <QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName>
                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012067" MajorTopicYN="Y">Religion</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012108" MajorTopicYN="N">Research Personnel</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D061108" MajorTopicYN="Y">Social Media</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D035502" MajorTopicYN="N">Trust</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014614" MajorTopicYN="N">Vaccines, Synthetic</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014838" MajorTopicYN="N">Volunteers</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Health care</Keyword>
            <Keyword MajorTopicYN="Y">Human behaviour</Keyword>
            <Keyword MajorTopicYN="Y">Public health</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">Society</Keyword>
            <Keyword MajorTopicYN="Y">Vaccines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>2</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33574597</ArticleId>
            <ArticleId IdType="doi">10.1038/d41586-021-00338-y</ArticleId>
            <ArticleId IdType="pii">10.1038/d41586-021-00338-y</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33571468</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>15</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1474-5488</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>22</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The Lancet. Oncology</Title>
                <ISOAbbreviation>Lancet Oncol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>SARS-CoV-2 vaccination and phase 1 cancer clinical trials.</ArticleTitle>
            <Pagination>
                <MedlinePgn>298-301</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1470-2045(21)00017-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S1470-2045(21)00017-6</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yap</LastName>
                    <ForeName>Timothy A</ForeName>
                    <Initials>TA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Investigational Cancer Therapeutics (Phase I Program), University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: tyap@mdanderson.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Siu</LastName>
                    <ForeName>Lillian L</ForeName>
                    <Initials>LL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Calvo</LastName>
                    <ForeName>Emiliano</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Early Phase Clinical Drug Development in Oncology, START Madrid-CIOCC, Centro Integral Oncol..gico Clara Campal, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lolkema</LastName>
                    <ForeName>Martijn P</ForeName>
                    <Initials>MP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>LoRusso</LastName>
                    <ForeName>Patricia M</ForeName>
                    <Initials>PM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Early Phase Clinical Trials Program, Yale University Medical Center, New Haven, CT, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soria</LastName>
                    <ForeName>Jean-Charles</ForeName>
                    <Initials>JC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Drug Development, Gustave Roussy Cancer Institute, University Paris Saclay, Villejuif, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Plummer</LastName>
                    <ForeName>Ruth</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Northern Institute for Cancer Care, Freeman Hospital and Newcastle University, Newcastle upon Tyne, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Bono</LastName>
                    <ForeName>Johann S</ForeName>
                    <Initials>JS</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tabernero</LastName>
                    <ForeName>Josep</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Universitat Aut..noma de Barcelona, Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Banerji</LastName>
                    <ForeName>Udai</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>P30 CA016672</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 CA180964</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <Acronym>DH_</Acronym>
                    <Agency>Department of Health</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Lancet Oncol</MedlineTA>
            <NlmUniqueID>100957246</NlmUniqueID>
            <ISSNLinking>1470-2045</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017321" MajorTopicYN="Y">Clinical Trials, Phase I as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>11</Day>
                <Hour>20</Hour>
                <Minute>10</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33571468</ArticleId>
            <ArticleId IdType="pii">S1470-2045(21)00017-6</ArticleId>
            <ArticleId IdType="doi">10.1016/S1470-2045(21)00017-6</ArticleId>
            <ArticleId IdType="pmc">PMC7906739</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33569389</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>12</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2296-889X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>7</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in molecular biosciences</Title>
                <ISOAbbreviation>Front Mol Biosci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic.</ArticleTitle>
            <Pagination>
                <MedlinePgn>585899</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fmolb.2020.585899</ELocationID>
            <Abstract>
                <AbstractText>A new strain of coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the coronavirus disease 2019 (COVID-19) pandemic was first detected in the city of Wuhan in Hubei province, China in late December 2019. To date, more than 1 million deaths and nearly 57 million confirmed cases have been recorded across 220 countries due to COVID-19, which is the greatest threat to global public health in our time. Although SARS-CoV-2 is genetically similar to other coronaviruses, i.e., SARS and Middle East respiratory syndrome coronavirus (MERS<i>-</i>CoV), no confirmed therapeutics are yet available against COVID-19, and governments, scientists, and pharmaceutical companies worldwide are working together in search for effective drugs and vaccines. Repurposing of relevant therapies, developing vaccines, and using bioinformatics to identify potential drug targets are strongly in focus to combat COVID-19. This review deals with the pathogenesis of COVID-19 and its clinical symptoms in humans including the most recent updates on candidate drugs and vaccines. Potential drugs (remdesivir, hydroxychloroquine, azithromycin, dexamethasone) and vaccines [mRNA-1273; measles, mumps and rubella (MMR), bacille Calmette-Gu..rin (BCG)] in human clinical trials are discussed with their composition, dosage, mode of action, and possible release dates according to the trial register of US National Library of Medicines (clinicaltrials.gov), European Union (clinicaltrialsregister.eu), and Chinese Clinical Trial Registry (chictr.org.cn) website. Moreover, recent reports on <i>in silico</i> approaches like molecular docking, molecular dynamics simulations, network-based identification, and homology modeling are included, toward repurposing strategies for the use of already approved drugs against newly emerged pathogens. Limitations of effectiveness, side effects, and safety issues of each approach are also highlighted. This review should be useful for the researchers working to find out an effective strategy for defeating SARS-CoV-2.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 Sumon, Hussain, Hasan, Hasan, Jang, Bhuiya, Chowdhury, Sharifuzzaman, Brown, Kwon and Lee.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sumon</LastName>
                    <ForeName>Tofael Ahmed</ForeName>
                    <Initials>TA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Fish Health Management, Sylhet Agricultural University, Sylhet, Bangladesh.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hussain</LastName>
                    <ForeName>Md Ashraf</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Fisheries Technology and Quality Control, Sylhet Agricultural University, Sylhet, Bangladesh.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hasan</LastName>
                    <ForeName>Md Tawheed</ForeName>
                    <Initials>MT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Aquaculture, Sylhet Agricultural University, Sylhet, Bangladesh.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hasan</LastName>
                    <ForeName>Mahmudul</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceuticals and Industrial Biotechnology, Sylhet Agricultural University, Sylhet, Bangladesh.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jang</LastName>
                    <ForeName>Won Je</ForeName>
                    <Initials>WJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, Pukyong National University, Busan, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bhuiya</LastName>
                    <ForeName>Eleus Hussain</ForeName>
                    <Initials>EH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Analytical Development, Globe Biotech Limited, Dhaka, Bangladesh.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chowdhury</LastName>
                    <ForeName>Abdullah Al Mamun</ForeName>
                    <Initials>AAM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, Rangamati General Hospital, Rangamati, Bangladesh.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sharifuzzaman</LastName>
                    <ForeName>S M</ForeName>
                    <Initials>SM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Marine Sciences, University of Chittagong, Chittagong, Bangladesh.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brown</LastName>
                    <ForeName>Christopher Lyon</ForeName>
                    <Initials>CL</Initials>
                    <AffiliationInfo>
                        <Affiliation>World Fisheries University Pilot Programme, Pukyong National University, Busan, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kwon</LastName>
                    <ForeName>Hyun-Ju</ForeName>
                    <Initials>HJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biopharmaceutical Engineering Major, Division of Applied Bioengineering, Dong-Eui University, Busan, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Eun-Woo</ForeName>
                    <Initials>EW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biopharmaceutical Engineering Major, Division of Applied Bioengineering, Dong-Eui University, Busan, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Mol Biosci</MedlineTA>
            <NlmUniqueID>101653173</NlmUniqueID>
            <ISSNLinking>2296-889X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">drugs</Keyword>
            <Keyword MajorTopicYN="N">in silico approaches</Keyword>
            <Keyword MajorTopicYN="N">vaccines</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>11</Day>
                <Hour>5</Hour>
                <Minute>55</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33569389</ArticleId>
            <ArticleId IdType="doi">10.3389/fmolb.2020.585899</ArticleId>
            <ArticleId IdType="pmc">PMC7868442</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Infect Dis. 2018 May 2;66(10):1501-1503</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29315362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virusdisease. 2020 May 2;:1-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32363219</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 May 12;323(18):1824-1836</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32282022</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 Jul 17;:1-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32677533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Nov 19;71(16):2027-2034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32221519</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32075877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2020 May 10;12(5):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32397688</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2005 Apr 15;171(8):850-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15657466</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2020 Jun;178:104786</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32251767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 May 14;:1-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32362217</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 May 30;395(10238):1695-1704</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32401715</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2020 Apr;8(4):420-422</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32085846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Discov Ther. 2020;14(1):58-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32147628</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mil Med Res. 2020 Mar 13;7(1):11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32169119</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Microbes Infect. 2020 Dec;9(1):221-236</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31987001</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):467-478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Chem Inf Model. 2007 May-Jun;47(3):1258-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17447753</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Life Sci. 2020 Jul 1;252:117652</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32278693</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2016 Feb 23;315(8):801-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26903338</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31978945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Biochem Anal. 2003;44:509-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12647402</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32031570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32020029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Med Res Pract. 2020 Mar-Apr;10(2):54-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32363221</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 May 13;:1-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32345124</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 12;383(20):1920-1931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32663912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Dis Poverty. 2020 Sep 16;9(1):132</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32938504</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioanalysis. 2018 Feb;10(3):163-180</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29333863</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Asian Pac J Allergy Immunol. 2020 Mar;38(1):10-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32134278</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32109013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ACS Cent Sci. 2020 Mar 25;6(3):315-331</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32226821</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Med. 2006 Sep;3(9):e343</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16968120</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2020 May 21;64(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32205349</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Discov Today. 2002 Jun 1;7(11):S83-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12047885</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Dev Res. 2020 Jul 6;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32632960</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Engineering (Beijing). 2020 Oct;6(10):1192-1198</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32346491</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Pharmacol Rep. 2020 May 11;:1-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32395418</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharm Anal. 2020 Apr;10(2):102-108</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32282863</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2014 May;105:17-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24583123</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacotherapy. 2020 Jun;40(6):592-598</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32281114</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32492293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 Apr 26;:1-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32306862</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Inform. 2021 Jan;40(1):e2000115</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32722864</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Med Sci. 2020 Apr 25;16(3):490-496</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32399094</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 May 6;:1-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32306822</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chemphyschem. 2020 Jul 17;21(14):1486-1514</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32452115</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Genet Evol. 2020 Sep;83:104327</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32320825</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 Jul 22;:1-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32698689</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 May 2;:1-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32295479</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>F1000Res. 2020 Feb 21;9:129</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32194944</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Proteome Res. 2020 Nov 6;19(11):4567-4575</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32786890</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2007 Oct;30(4):297-308</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17629679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pathogens. 2020 Mar 04;9(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32143502</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Travel Med Infect Dis. 2020 May - Jun;35:101646</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32294562</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2020 May;19(5):305-306</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32273591</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Mar 5;382(10):929-936</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32004427</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Recognit. 2011 Mar-Apr;24(2):149-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21360606</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 May 6;:1-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32338164</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virus Res. 2008 Apr;133(1):13-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17374415</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2020 Apr 16;55(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32269085</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microbes Infect. 2020 Mar;22(2):74-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32017984</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Pharmacol. 2017 May 23;8:298</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28588497</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Trop Med Rep. 2020 Mar 3;:1-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32219057</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Discov. 2020 Mar 16;6:14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32194980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2004 Nov;78(22):12672-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15507655</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2020 Jun 2;172(11):754-755</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32232419</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Inf Med. 2008;47(4):283-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18690362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Molecules. 2020 Aug 23;25(17):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32842509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharm Anal. 2020 Aug;10(4):313-319</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32296570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Cell Biol. 2020 May 18;12(4):322-325</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32236562</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>F1000Res. 2015 May 01;4:104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26167272</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biophys Rev. 2014 Mar;6(1):75-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28509958</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2019 Dec 12;381(24):2293-2303</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31774950</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Emerg Physicians Open. 2020 Apr 19;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32838367</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EXCLI J. 2020 Mar 17;19:400-409</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32210741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Travel Med Infect Dis. 2020 May - Jun;35:101738</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32387409</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Pharmacol. 2020 Sep 15;883:173348</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32634438</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Clin Microbiol Antimicrob. 2020 Sep 2;19(1):40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32878641</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Turk J Biol. 2020 Jun 21;44(3):228-241</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32595359</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Integr Med. 2020 Mar;18(2):152-158</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32113846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Apr;580(7805):576-577</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32346146</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2009 Nov 17;4(11):e7870</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19924243</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2020 May;38(5):523-532</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32203293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2011 Jan;85(2):873-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21068237</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 29;368(6494):1012-1015</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32303590</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioorg Chem. 2021 Jan;106:104490</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33261845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 May 18;:1-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32266867</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 Apr 15;:1-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32238078</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Panam Salud Publica. 2020 Mar 20;44:e40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32256547</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2020 Jun;80(6):607-613</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32283152</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32350134</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mem Inst Oswaldo Cruz. 2020;115:e200179</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32490889</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>New Microbes New Infect. 2020 Apr 20;35:100682</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32313660</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(4):e35421</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22536382</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2020 Mar 27;12(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32230900</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Comput Biol Med. 2020 Apr;119:103670</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32209231</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Oct;92(10):2087-2095</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32374457</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2020 Jun 2;16(6):1232-1238</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32186952</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2020 Jul 28;11:1784</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32849643</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2020 May;80(5):554-562</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32169481</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Pharmacol. 2007 Sep;152(1):21-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17549046</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 5;383(19):1813-1826</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32445440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32007143</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Clin Microbiol Antimicrob. 2020 May 30;19(1):23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32473642</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jun 11;382(24):2327-2336</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32275812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32142651</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Microbes Infect. 2020 Dec;9(1):386-389</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32065057</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Discov Today. 2014 Apr;19(4):433-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24183925</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Med Virol. 2020 Sep;30(5):e2123</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32648313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 Jul;96:500-502</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32470602</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Microbiol Immunol Infect. 2020 Mar 31;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32265180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Public Health. 2020 Sep;13(9):1210-1223</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32561274</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2006 Feb;6(2):67-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16439323</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 May 20;:1-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32396769</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32205204</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2020 Apr 14;52(4):583-589</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32259480</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Apr 3;368(6486):14-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32241928</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2020 May;158(6):1831-1833.e3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32142773</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Mar;579(7798):265-269</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32015508</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33566088</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>23</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1538-3598</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>325</Volume>
                    <Issue>11</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Mar</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JAMA</Title>
                <ISOAbbreviation>JAMA</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1041-1042</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2021.1865</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bianchi</LastName>
                    <ForeName>Diana W</ForeName>
                    <Initials>DW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaeser</LastName>
                    <ForeName>Lisa</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cernich</LastName>
                    <ForeName>Alison N</ForeName>
                    <Initials>AN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>JAMA</MedlineTA>
            <NlmUniqueID>7501160</NlmUniqueID>
            <ISSNLinking>0098-7484</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
                <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
                <QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D033161" MajorTopicYN="N">Government Regulation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007774" MajorTopicYN="N">Lactation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D036302" MajorTopicYN="N">Therapeutic Human Experimentation</DescriptorName>
                <QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>10</Day>
                <Hour>12</Hour>
                <Minute>10</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33566088</ArticleId>
            <ArticleId IdType="pii">2776540</ArticleId>
            <ArticleId IdType="doi">10.1001/jama.2021.1865</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33563499</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>01</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1600-0641</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>74</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>04</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of hepatology</Title>
                <ISOAbbreviation>J Hepatol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.</ArticleTitle>
            <Pagination>
                <MedlinePgn>944-951</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0168-8278(21)00081-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jhep.2021.01.032</ELocationID>
            <Abstract>
                <AbstractText>According to a recent World Health Organization estimate, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, which originated in China in 2019, has spread globally, infecting nearly 100 million people worldwide by January 2021. Patients with chronic liver diseases (CLD), particularly cirrhosis, hepatobiliary malignancies, candidates for liver transplantation, and immunosuppressed individuals after liver transplantation appear to be at increased risk of infections in general, which in turn translates into increased mortality. This is also the case for SARS-CoV-2 infection, where patients with cirrhosis, in particular, are at high risk of a severe COVID-19 course. Therefore, vaccination against various pathogens including SARS-CoV-2, administered as early as possible in patients with CLD, is an important protective measure. However, due to impaired immune responses in these patients, the immediate and long-term protective response through immunisation may be incomplete. The current SARS-CoV-2 pandemic has led to the exceptionally fast development of several vaccine candidates. A small number of these SARS-CoV-2 vaccine candidates have already undergone phase III, placebo-controlled, clinical trials in healthy individuals with proof of short-term safety, immunogenicity and efficacy. However, although regulatory agencies in the US and Europe have already approved some of these vaccines for clinical use, information on immunogenicity, duration of protection and long-term safety in patients with CLD, cirrhosis, hepatobiliary cancer and liver transplant recipients has yet to be generated. This review summarises the data on vaccine safety, immunogenicity, and efficacy in this patient population in general and discusses the implications of this knowledge on the introduction of the new SARS-CoV-2 vaccines.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cornberg</LastName>
                    <ForeName>Markus</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; Centre for Individualised Infection Medicine (CiiM), a joint venture of Helmholtz Centre for Infection Research and Hannover Medical School, Hannover, Germany; German Center for Infection Research (DZIF), Partner-Site Hannover-Braunschweig, Hannover, Germany. Electronic address: cornberg.markus@mh-hannover.de.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Buti</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Liver Unit. Hospital Universitario Valle Hebron and Ciber-ehd del Instituto Carlos III, Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eberhardt</LastName>
                    <ForeName>Christiane S</ForeName>
                    <Initials>CS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Vaccinology, University Hospitals of Geneva and Faculty of Medicine, University of Geneva, Switzerland and Emory Vaccine Center, Emory University, Atlanta, GA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grossi</LastName>
                    <ForeName>Paolo Antonio</ForeName>
                    <Initials>PA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Infectious and Tropical Diseases Unit, Department of Medicine and Surgery University of Insubria and ASST-Sette Laghi, Varese, Italy; Italian National Center for Transplantation, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shouval</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Liver Unit, Department of Medicine, Hadassah-Hebrew University Hospital, Jerusalem, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>J Hepatol</MedlineTA>
            <NlmUniqueID>8503886</NlmUniqueID>
            <ISSNLinking>0168-8278</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D001661" MajorTopicYN="Y">Biliary Tract Neoplasms</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016867" MajorTopicYN="N">Immunocompromised Host</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008107" MajorTopicYN="Y">Liver Diseases</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020379" MajorTopicYN="N">Risk Adjustment</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">Cirrhosis</Keyword>
            <Keyword MajorTopicYN="Y">Influenza</Keyword>
            <Keyword MajorTopicYN="Y">Liver transplantation</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">Vaccine</Keyword>
        </KeywordList>
        <CoiStatement>Conflict of interest MC reports personal fees from Abbvie, personal fees from Gilead Sciences, personal fees from Merck Sharp &amp; Dohme (MSD), personal fees from GlaxoSmithKline (GSK), personal fees from Janssen-Cilag, personal fees from Spring Bank Pharmaceuticals, personal fees from Novartis, from Swedish Orphan Biovitrum (SOBI), personal fees from Falk Foundation, grants and personal fees from Roche, outside the submitted work. PAG reports personal fees from Merck, Sharp &amp; Dohme, personal fees from Biotest, personal fees from Angelini, personal fees from Nordic Pharma, personal fees from Vertex, personal fees from Gilead, personal fees from Astellas, outside the submitted work. MB, CSE and DS have nothing to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>4</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>10</Day>
                <Hour>5</Hour>
                <Minute>39</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33563499</ArticleId>
            <ArticleId IdType="pii">S0168-8278(21)00081-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jhep.2021.01.032</ArticleId>
            <ArticleId IdType="pmc">PMC7867401</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Gastroenterol Hepatol. 2021 Mar;6(3):156-158</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33444545</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2021 Jan 9;397(10269):99-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33306989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dig Dis Sci. 2020 Jul 2;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32617767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2018 Sep 11;36(38):5796-5802</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30100071</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2017 Mar 1;35(9):1216-1226</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28162821</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2012 Oct;206(8):1250-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22904335</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JCO Oncol Pract. 2020 Jul;16(7):e573-e580</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32048920</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Saudi J Kidney Dis Transpl. 2015 Sep;26(5):877-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26354557</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Sep;585(7823):107-112</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32728218</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2013 Jun;144(7):1426-37, 1437.e1-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23474284</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2018 May 17;66(11):1802-1811</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29253095</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2014 Jun;60(6):1310-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24530646</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Travel Med Infect Dis. 2019 Sep 12;:101479</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31521804</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Microbiol Immunol. 2015 Feb;204(1):57-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25557605</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2021 Jan 19;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33460347</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2018 Jul;24(7):1267-1274</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29912696</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2021 Mar;74(3):567-577</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33035628</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2018 Aug;69(2):406-460</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29653741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Gastroenterol Rep. 2013 Jan;15(1):300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23250700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheum. 2011 Jun;63(6):1486-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21384334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccines (Basel). 2021 Jan 11;9(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33440895</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2002 Dec 20;20 Suppl 5:B33-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12477416</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Infect. 2021 Jan 20;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33482352</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ Open. 2019 Sep 6;9(9):e031070</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31494620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Gastroenterol Hepatol. 2020 Jul;5(7):643-644</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32339474</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Heart Lung Transplant. 2018 Jul;37(7):844-852</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29609844</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2001 Jul;34(1):28-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11431730</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vet Clin North Am Small Anim Pract. 2018 Mar;48(2):279-290</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29195924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2020 Nov 20;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33227350</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med. 1990 May;88(5):460-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2140010</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 4;384(5):403-416</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33378609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Transplant. 2017 Apr;17(4):856-879</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28117944</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Transplant. 2019 Sep;33(9):e13563</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31002409</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Discov Med. 2010 Feb;9(45):90-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20193633</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2014 May;60(5):1075-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24384327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2014 Dec;61(6):1385-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25135860</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Res. 2018 Feb;48(2):119-126</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29197147</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2001 Feb 1;344(5):319-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11172162</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2003;39 Suppl 1:S70-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14708681</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Liver Transpl. 2000 Jul;6(4):440-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10915165</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dig Dis Sci. 1988 Mar;33(3):263-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2856849</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2016 Nov;12(11):2909-2915</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27392026</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):516-527</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32967006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2018 Feb 01;2:CD008983</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29388675</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Can J Gastroenterol. 2000 Jul-Aug;14 Suppl B:59B-62B</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10938507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Prev Med Hyg. 2018 Sep 28;59(3):E194-E199</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30397675</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Transplantation. 2018 Feb;102(2S Suppl 2):S72-S80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29381581</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2000 Feb;181(2):757-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10669371</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013;8(2):e56974</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23451126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JHEP Rep. 2020 Oct;2(5):100169</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32835190</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunother Cancer. 2018 May 22;6(1):40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29789020</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Microbiol Immunol. 2015 Feb;204(1):69-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25523196</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Jan 2;70(2):193-199</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30874791</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Autoimmun Rev. 2015 Oct;14(10):880-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26031899</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 Sep 11;38(40):6205-6214</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32788132</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 31;383(27):2603-2615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2020 Nov 06;11:589833</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33240278</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 2008 Jan;103(1):138-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17970833</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">33563270</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>22</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1741-7015</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>19</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC medicine</Title>
                <ISOAbbreviation>BMC Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Who should be prioritized for COVID-19 vaccination in China? A descriptive study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>45</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12916-021-01923-8</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">All countries are facing decisions about which population groups to prioritize for access to COVID-19 vaccination after the first vaccine products have been licensed, at which time supply shortages are inevitable. Our objective is to define the key target populations, their size, and priority for a COVID-19 vaccination program in the context of China.</AbstractText>
                <AbstractText Label="METHODS">On the basis of utilitarian and egalitarian principles, we define and estimate the size of tiered target population groups for a phased introduction of COVID-19 vaccination, considering evolving goals as vaccine supplies increase, detailed information on the risk of illness and transmission, and past experience with vaccination during the 2009 influenza pandemic. Using publicly available data, we estimated the size of target population groups, and the number of days needed to vaccinate 70% of the target population. Sensitivity analyses considered higher vaccine coverages and scaled up vaccine delivery relative to the 2009 pandemic.</AbstractText>
                <AbstractText Label="RESULTS">Essential workers, including staff in the healthcare, law enforcement, security, nursing homes, social welfare institutes, community services, energy, food and transportation sectors, and overseas workers/students (49.7 million) could be prioritized for vaccination to maintain essential services in the early phase of a vaccination program. Subsequently, older adults, individuals with underlying health conditions and pregnant women (563.6 million) could be targeted for vaccination to reduce the number of individuals with severe COVID-19 outcomes, including hospitalizations, critical care admissions, and deaths. In later stages, the vaccination program could be further extended to target adults without underlying health conditions and children (784.8 million), in order to reduce symptomatic infections and/or to stop virus transmission. Given 10 million doses administered per day, and a two-dose vaccination schedule, it would take 1..week to vaccinate essential workers but likely up to 7...months to vaccinate 70% of the overall population.</AbstractText>
                <AbstractText Label="CONCLUSIONS">The proposed framework is general but could assist Chinese policy-makers in the design of a vaccination program. Additionally, this exercise could be generalized to inform other national and regional strategies for use of COVID-19 vaccines, especially in low- and middle-income countries.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Juan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zheng</LastName>
                    <ForeName>Wen</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Huilin</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yan</LastName>
                    <ForeName>Xuemei</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dong</LastName>
                    <ForeName>Kaige</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>You</LastName>
                    <ForeName>Qian</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhong</LastName>
                    <ForeName>Guangjie</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gong</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Zhiyuan</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jit</LastName>
                    <ForeName>Mark</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Special Administrative Region, Hong Kong, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Viboud</LastName>
                    <ForeName>Cecile</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ajelli</LastName>
                    <ForeName>Marco</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Hongjie</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China. yhj@fudan.edu.cn.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China. yhj@fudan.edu.cn.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of infectious diseases, Huashan Hospital, Fudan University, Shanghai, China. yhj@fudan.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>81525023</GrantID>
                    <Agency>National Science Fund for Distinguished Young Scholars</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2018ZX10201001-010</GrantID>
                    <Agency>National Major Science and Technology Projects of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2018ZX10713001-007</GrantID>
                    <Agency>National Major Science and Technology Projects of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2017ZX10103009-005</GrantID>
                    <Agency>National Major Science and Technology Projects of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>no. 16/137/109</GrantID>
                    <Agency>National Institute for Health Research</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMC Med</MedlineTA>
            <NlmUniqueID>101190723</NlmUniqueID>
            <ISSNLinking>1741-7015</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D028663" MajorTopicYN="N">Ethical Theory</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019649" MajorTopicYN="N">Food Industry</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006282" MajorTopicYN="Y">Health Personnel</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006292" MajorTopicYN="N">Health Priorities</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
                <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009735" MajorTopicYN="N">Nursing Homes</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018579" MajorTopicYN="Y">Patient Selection</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016495" MajorTopicYN="Y">Police</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011050" MajorTopicYN="N">Policy Making</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014186" MajorTopicYN="N">Transportation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">China</Keyword>
            <Keyword MajorTopicYN="Y">Novel coronavirus disease 2019</Keyword>
            <Keyword MajorTopicYN="Y">Target population</Keyword>
            <Keyword MajorTopicYN="Y">Vaccination</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>10</Day>
                <Hour>5</Hour>
                <Minute>36</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33563270</ArticleId>
            <ArticleId IdType="doi">10.1186/s12916-021-01923-8</ArticleId>
            <ArticleId IdType="pii">10.1186/s12916-021-01923-8</ArticleId>
            <ArticleId IdType="pmc">PMC7872877</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Infect Dis. 2011 Apr 1;52(7):911-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21427399</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Infect. 2020 Jun;26(6):767-772</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32304745</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Mar 26;382(13):1199-1207</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31995857</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2013 Jan;19(1):85-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23260039</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Int. 2020 Sep;14(5):612-620</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32725453</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Jun 26;368(6498):1481-1486</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32350060</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aging (Albany NY). 2020 Jul 13;12(13):12493-12503</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32658868</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Jul 4;396(10243):63-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32505220</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Acad Emerg Med. 2020 Mar 23;8(1):e34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32232217</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 May 30;395(10238):1715-1725</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32405103</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 May;94:91-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32173574</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Apr 20;369:m1548</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32312785</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 Oct;99:47-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32721533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2016 Apr;45:103-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26972042</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Obes Metab. 2020 Oct;22(10):1915-1924</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32573903</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Glob Health. 2020 Aug;8(8):e1003-e1017</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32553130</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 1;396(10247):313-319</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32534626</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2011 Feb 11;29(8):1605-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21211593</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2019 Oct 22;9(1):15141</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31641189</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):430-436</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32640463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Open Forum Infect Dis. 2020 Aug 13;7(9):ofaa350</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32929403</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2018 Oct 4;18(1):502</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30286735</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32240128</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Jun 6;395(10239):1771-1778</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32410760</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Aug 07;69(31):1023-1025</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32759921</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2007 Mar 1;25(11):2019-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17258359</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Epidemiol Serv Saude. 2020 Apr 06;29(2):e2020119</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32267300</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Apr;26(4):506-510</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32284616</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 May 19;323(19):1915-1923</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32275295</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 22;396(10250):535-544</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32645347</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32555134</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33562619</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>16</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Print">2076-393X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>9</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccines</Title>
                <ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Why It Is Important to Develop an Effective and Safe Pediatric COVID-19 Vaccine.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">127</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines9020127</ELocationID>
            <Abstract>
                <AbstractText>The need to cope with the medical, social, and economic storm due to the new coronavirus 2019 (COVID-19) pandemic as quickly as possible has led to the very rapid development of a huge number of vaccines. All these vaccines have been mainly developed in healthy adults and, in some cases, in the elderly. Children were marginally involved as, according to the clinical trial registry Clinical Trials.gov, only very few studies have included children among subjects to enroll, although just a few weeks after the pandemic declaration, the US Food and Drug Administration had highlighted the importance of vaccine evaluation in pediatrics. Availability of an effective and safe pediatric COVID-19 vaccine appears mandatory for several clinical and epidemiological reasons. However, as the development of an effective and safe pediatric vaccine seems far from easy, strong cooperation among governments, researchers, and pharmaceutical companies is highly desirable.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Principi</LastName>
                    <ForeName>Nicola</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">0000-0002-3468-5568</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Universit.. degli Studi di Milano, 20122 Milan, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Esposito</LastName>
                    <ForeName>Susanna</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pediatric Clinic, Pietro Barilla Children's Hospital, University of Parma, 43126 Parma, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Vaccines (Basel)</MedlineTA>
            <NlmUniqueID>101629355</NlmUniqueID>
            <ISSNLinking>2076-393X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">children</Keyword>
            <Keyword MajorTopicYN="N">pediatric infectious diseases</Keyword>
            <Keyword MajorTopicYN="N">vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>10</Day>
                <Hour>1</Hour>
                <Minute>2</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33562619</ArticleId>
            <ArticleId IdType="pii">vaccines9020127</ArticleId>
            <ArticleId IdType="doi">10.3390/vaccines9020127</ArticleId>
            <ArticleId IdType="pmc">PMC7914736</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA. 2020 Sep 8;324(10):951-960</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32789505</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Future Microbiol. 2015;10(10):1599-607</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26439470</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2018 Aug 28;36(36):5391-5396</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28928077</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Biol Sci. 2015 Dec 22;282(1821):20143085</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26702035</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Jun 03;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32492123</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2020 Dec;146(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32973121</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Pediatr. 2021 Feb 1;175(2):143-156</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32975552</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Future Microbiol. 2020 Sep;15:1201-1206</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32878481</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Infect Dis. 2019 Oct;32(5):435-444</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31305493</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Epidemiol. 1969 Apr;89(4):405-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4305197</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccines (Basel). 2020 Jun 17;8(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32560340</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2020 Oct;26(10):2465-2468</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32673193</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Netw Open. 2020 Sep 1;3(9):e2020495</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32897374</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33559733</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-069X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Archives of dermatological research</Title>
                <ISOAbbreviation>Arch Dermatol Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>&quot;COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment&quot;.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00403-021-02190-6</ELocationID>
            <Abstract>
                <AbstractText>We present the first reported cases of delayed inflammatory reactions (DIR) to hyaluronic acid (HA) dermal fillers after exposure to the COVID-19 spike protein. DIR to HA is reported to occur in the different scenarios including: secondary to poor injection technique, following dental cleaning procedures, following bacterial/viral illness, and after vaccination. In this report of 4 cases with distinct clinical histories and presentations: one case occured following a community acquired COVID-19 infection, one case occured in a study subject in the mRNA-1273 clinical phase III trial, one case occurred following the first dose of publically available mRNA-1273 vaccine (Moderna, Cambridge MA), and the last case occurred after the second dose of BNT162b2 vaccine (Pfizer, New York, NY). Injectable HA dermal fillers are prevalent in aesthetic medicine for facial rejuvenation. Structural modifications in the crosslinking of HA fillers have enhanced the products' resistance to enzymatic breakdown and thus increased injected product longevity, however, have also led to a rise in DIR. Previous, DIR to HA dermal fillers can present clinically as edema with symptomatic and inflammatory erythematous papules and nodules. The mechanism of action for the delayed reaction to HA fillers is unknown and is likely to be multifactorial in nature. A potential mechanism of DIR to HA fillers in COVID-19 related cases is binding and blockade of angiotensin 2 converting enzyme receptors (ACE2), which are targeted by the SARS-CoV-2 virus spike protein to gain entry into the cell. Spike protein interaction with dermal ACE2 receptors favors a pro-inflammatory, loco-regional TH1 cascade, promoting a CD8+T cell mediated reaction to incipient granulomas, which previously formed around residual HA particles. Management to suppress the inflammatory response in the native COVID-19 case required high-dose corticosteroids (CS) to suppress inflammatory pathways, with concurrent ACE2 upregulation, along with high-dose intralesional hyaluronidase to dissolve the inciting HA filler. With regards to the two vaccine related cases; in the mRNA-1273 case, a low dose angiotensin converting enzyme inhibitor (ACE-I) was utilized for treatment, to reduce pro-inflammatory Angiotensin II. Whereas, in the BNT162b2 case the filler reaction was suppressed with oral corticosteroids. Regarding final disposition of the cases; the vaccine-related cases returned to baseline appearance within 3..days, whereas the native COVID-19 case continued to have migratory, evanescent, periorbital edema for weeks which ultimately subsided.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Munavalli</LastName>
                    <ForeName>Girish Gilly</ForeName>
                    <Initials>GG</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5061-8314</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Dermatology, Laser, and Vein Specialists of the Carolinas, PLLC, Charlotte, NC, USA. gmunavalli@carolinaskin.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, Wake Forest School of Medicine, Winston Salem, NC, USA. gmunavalli@carolinaskin.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guthridge</LastName>
                    <ForeName>Rachel</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dermatology, Laser, and Vein Specialists of the Carolinas, PLLC, Charlotte, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Knutsen-Larson</LastName>
                    <ForeName>Siri</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>South Dakota Sanford School of Medicine, Vermillion, SD, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brodsky</LastName>
                    <ForeName>Amy</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Derm-Glenview, Glenview, IL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matthew</LastName>
                    <ForeName>Ethan</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>South Dakota Sanford School of Medicine, Vermillion, SD, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Landau</LastName>
                    <ForeName>Marina</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Arena Dermatology, Herzliya, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Arch Dermatol Res</MedlineTA>
            <NlmUniqueID>8000462</NlmUniqueID>
            <ISSNLinking>0340-3696</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ACE receptor</Keyword>
            <Keyword MajorTopicYN="N">ACE receptor inhibitor</Keyword>
            <Keyword MajorTopicYN="N">ACE2</Keyword>
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Delayed inflammatory reaction</Keyword>
            <Keyword MajorTopicYN="N">Hyaluronic acid fillers</Keyword>
            <Keyword MajorTopicYN="N">mRNA vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>8</Hour>
                <Minute>45</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33559733</ArticleId>
            <ArticleId IdType="doi">10.1007/s00403-021-02190-6</ArticleId>
            <ArticleId IdType="pii">10.1007/s00403-021-02190-6</ArticleId>
            <ArticleId IdType="pmc">PMC7871141</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Dermatol Surg. 2020 Jul;46(7):958-961</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31592917</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Biol Sci. 2020 Jun 27;16(13):2382-2391</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32760206</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dermatol Ther. 2020 Sep;33(5):e13549</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32390279</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dermatol Surg. 2019 Aug;45(8):1085-1094</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30789508</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cosmet Investig Dermatol. 2020 May 18;13:371-378</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32547150</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cosmet Dermatol. 2012 Sep;11(3):237-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22938010</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Sep 22;324(12):1125-1127</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32880613</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Arthritis Rheum. 2013 Oct;43(2):241-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23642806</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dermatol Surg. 2016 Jan;42(1):31-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26655699</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Acad Dermatol. 2020 Jul;83(1):86-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32035107</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Dis Poverty. 2020 Apr 28;9(1):45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32345362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care. 2020 Jul 13;24(1):422</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32660650</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Intern Med. 2020 Jun;76:14-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32336612</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Plast Reconstr Surg. 2021 Jan 1;147(1):50e-53e</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33002985</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2021 Jan 9;397(10269):99-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33306989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2003 Apr 1;170(7):3866-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12646655</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 12;383(20):1920-1931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32663912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Rev Allergy Immunol. 2013 Aug;45(1):97-108</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23361999</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Plast Reconstr Surg. 2018 Jul;142(1):112-121</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29952893</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2505-2510</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32594572</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Plast Reconstr Surg Glob Open. 2017 Dec 22;5(12):e1532</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29632758</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cosmet Investig Dermatol. 2019 Apr 29;12:277-283</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31118731</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Pathol. 2020 Dec;106:106-116</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33058948</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dermatol Surg. 2015 Aug;41(8):929-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26166260</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):589-593</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32785213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Hypertens. 2020 Jul 15;26:14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32685191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 4;384(5):403-416</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33378609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cutan Aesthet Surg. 2010 Jan;3(1):16-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20606987</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2021 Dec 19;396(10267):1979-1993</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33220855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 17;383(25):2439-2450</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33053279</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2018 Apr 10;9(1):1366</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29636450</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33558856</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>16</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2468-0427</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>6</Volume>
                    <PubDate>
                        <Year>2021</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Infectious Disease Modelling</Title>
                <ISOAbbreviation>Infect Dis Model</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A metapopulation network model for the spreading of SARS-CoV-2: Case study for Ireland.</ArticleTitle>
            <Pagination>
                <MedlinePgn>420-437</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.idm.2021.01.004</ELocationID>
            <Abstract>
                <AbstractText>We present preliminary results on an all-Ireland network modelling approach to simulate the spreading the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2), commonly known as the <i>coronavirus</i>. In the model, nodes correspond to locations or communities that are connected by links indicating travel and commuting between different locations. While this proposed modelling framework can be applied on all levels of spatial granularity and different countries, we consider Ireland as a case study. The network comprises 3440 <i>electoral divisions</i> (EDs) of the Republic of Ireland and 890 <i>superoutput areas</i> (SOAs) for Northern Ireland, which corresponds to local administrative units below the NUTS 3 regions. The local dynamics within each node follows a phenomenological SIRX compartmental model including classes of Susceptibles, Infected, Recovered and Quarantined (X) inspired from Science <b>368</b>, 742 (2020). For better comparison to empirical data, we extended that model by a class of Deaths. We consider various scenarios including the 5-phase roadmap for Ireland. In addition, as proof of concept, we investigate the effect of dynamic interventions that aim to keep the number of infected below a given threshold. This is achieved by dynamically adjusting containment measures on a national scale, which could also be implemented at a regional (county) or local (ED/SOA) level. We find that - in principle - dynamic interventions are capable to limit the impact of future waves of outbreaks, but on the downside, in the absence of a vaccine, such a strategy can last several years until herd immunity is reached.</AbstractText>
                <CopyrightInformation>.. 2021 The Authors.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Humphries</LastName>
                    <ForeName>Rory</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Mathematical Sciences, University College Cork, Western Road, Cork, T12XF64, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Spillane</LastName>
                    <ForeName>Mary</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Mathematical Sciences, University College Cork, Western Road, Cork, T12XF64, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mulchrone</LastName>
                    <ForeName>Kieran</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Mathematical Sciences, University College Cork, Western Road, Cork, T12XF64, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wieczorek</LastName>
                    <ForeName>Sebastian</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Mathematical Sciences, University College Cork, Western Road, Cork, T12XF64, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>O'Riordain</LastName>
                    <ForeName>Micheal</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Mathematical Sciences, University College Cork, Western Road, Cork, T12XF64, Ireland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, Mercy University Hospital, Grenville Place, Cork, T12WE28, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>H..vel</LastName>
                    <ForeName>Philipp</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Mathematical Sciences, University College Cork, Western Road, Cork, T12XF64, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Infect Dis Model</MedlineTA>
            <NlmUniqueID>101692406</NlmUniqueID>
            <ISSNLinking>2468-0427</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Compartmental model</Keyword>
            <Keyword MajorTopicYN="N">Coronavirus</Keyword>
            <Keyword MajorTopicYN="N">Network model</Keyword>
            <Keyword MajorTopicYN="N">Non-pharmaceutical containment strategies</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>35</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33558856</ArticleId>
            <ArticleId IdType="doi">10.1016/j.idm.2021.01.004</ArticleId>
            <ArticleId IdType="pii">S2468-0427(21)00007-5</ArticleId>
            <ArticleId IdType="pmc">PMC7859709</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2020 May 15;368(6492):742-746</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32269067</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Digit Health. 2020 Dec;2(12):e638-e649</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33163951</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2017 Apr 26;7:46677</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28443647</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Apr 27;369:m1557</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32341002</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Med. 2020 Jul 17;17(7):e1003193</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32678827</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Math Biosci. 2002 Nov-Dec;180:29-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12387915</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Public Health. 2020 May;5(5):e261-e270</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32220655</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2006 Jan 26;439(7075):462-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16437114</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Theor Biol. 2021 Mar 21;513:110587</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33450286</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Oct 31;396(10260):e71-e72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33069277</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2020 Dec 29;117(52):32883-32890</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33273120</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Dis Model. 2020 Jul 03;5:442-458</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32691016</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Dis Model. 2020;5:766-771</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33015424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2012 Feb 26;484(7392):96-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22367540</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Dis Model. 2020 Apr 28;5:323-337</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32346664</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 22;368(6493):860-868</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32291278</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 May;20(5):533-534</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32087114</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2010 Feb 19;327(5968):1018-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20167789</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Epidemiol. 2020 May;35(5):389-399</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32430840</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2020 Nov 12;10(1):19662</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33184338</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32007143</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33558296</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Electronic-Print">
            <Journal>
                <ISSN IssnType="Electronic">1098-6596</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>65</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Antimicrobial agents and chemotherapy</Title>
                <ISOAbbreviation>Antimicrob Agents Chemother</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Plitidepsin: a Repurposed Drug for the Treatment of COVID-19.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">e00200-21</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/AAC.00200-21</ELocationID>
            <Abstract>
                <AbstractText>Finding antivirals to reduce coronavirus disease 2019 (COVID-19) morbidity and mortality has been challenging. Large randomized clinical trials that aimed to test four repurposed drugs, hydroxychloroquine, lopinavir-ritonavir, interferon beta 1a, and remdesivir, have shown that these compounds lack an impact on the COVID-19 course. Although the phase III COVID-19 vaccine trial results are encouraging, the search for effective COVID-19 therapeutics should not stop. Recently, plitidepsin (aplidin) demonstrated highly effective preclinical activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Its antiviral activity was 27.5-fold more potent than that of remdesivir (K. M. White, R. Rosales, S. Yildiz, T. Kehrer, et al., Science, 2021, https://science.sciencemag.org/content/early/2021/01/22/science.abf4058). Plitidepsin, a repurposed drug developed for the treatment of multiple myeloma, targets the host translation cofactor eEF1A. Plitidepsin has shown efficacy in animal models and phase I/II human trials. Although plitidepsin is administered intravenously and its toxicity profile remains to be fully characterized, this compound may be a promising alternative COVID-19 therapeutic.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 American Society for Microbiology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Martinez</LastName>
                    <ForeName>Miguel Angel</ForeName>
                    <Initials>MA</Initials>
                    <Identifier Source="ORCID">0000-0002-6681-4950</Identifier>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Universitat Aut..noma de Barcelona (UAB), Badalona, Spain mmartinez@irsicaixa.es.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>03</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Antimicrob Agents Chemother</MedlineTA>
            <NlmUniqueID>0315061</NlmUniqueID>
            <ISSNLinking>0066-4804</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D047630">Depsipeptides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010456">Peptides, Cyclic</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>Y76ID234HW</RegistryNumber>
                <NameOfSubstance UI="C098980">plitidepsin</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017321" MajorTopicYN="N">Clinical Trials, Phase I as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017322" MajorTopicYN="N">Clinical Trials, Phase II as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D047630" MajorTopicYN="N">Depsipeptides</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010456" MajorTopicYN="N">Peptides, Cyclic</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">experimental therapeutics</Keyword>
            <Keyword MajorTopicYN="Y">plitidepsin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>4</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>8</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33558296</ArticleId>
            <ArticleId IdType="pii">AAC.00200-21</ArticleId>
            <ArticleId IdType="doi">10.1128/AAC.00200-21</ArticleId>
            <ArticleId IdType="pmc">PMC8097422</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 25;384(8):693-704</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32678530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Oct 19;371:m4057</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33077424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Future Oncol. 2019 Jan;15(2):109-120</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30111169</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2021 Feb 26;371(6532):926-931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33495306</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):516-527</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32967006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2020 Aug 20;64(9):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32631826</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2008 Jul 1;68(13):5216-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18593922</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2021 Feb;27(2):205-211</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33469205</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Jul;583(7816):459-468</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32353859</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2020 Apr 21;64(5):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32152082</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2020 Dec 16;65(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33139290</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33554155</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2666-6340</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Mar</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Med (New York, N.Y.)</Title>
                <ISOAbbreviation>Med (N Y)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Stable neutralizing antibody levels 6..months after mild and severe COVID-19 episodes.</ArticleTitle>
            <Pagination>
                <MedlinePgn>313-320.e4</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medj.2021.01.005</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Understanding mid-term kinetics of immunity to SARS-CoV-2 is the cornerstone for public health control of the pandemic and vaccine development. However, current evidence is rather based on limited measurements, losing sight of the temporal pattern of these changes.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">We conducted a longitudinal analysis on a prospective cohort of COVID-19 patients followed up for &gt;6..months. Neutralizing activity was evaluated using HIV reporter pseudoviruses expressing SARS-CoV-2..S protein. IgG antibody titer was evaluated by ELISA against the S2 subunit, the receptor binding domain (RBD), and the nucleoprotein (NP). Statistical analyses were carried out using mixed-effects models.</AbstractText>
                <AbstractText Label="Findings" NlmCategory="UNASSIGNED">We found that individuals with mild or asymptomatic infection experienced an insignificant decay in neutralizing activity, which persisted 6..months after symptom onset or diagnosis. Hospitalized individuals showed higher neutralizing titers, which decreased following a 2-phase pattern, with an initial rapid decline that significantly slowed after day 80. Despite this initial decay, neutralizing activity at 6..months remained higher among hospitalized individuals compared to mild symptomatic. The slow decline in neutralizing activity at mid-term contrasted with the steep slope of anti-RBD, S2, or NP antibody titers, all of them showing a constant decline over the follow-up period.</AbstractText>
                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Our results reinforce the hypothesis that the quality of the neutralizing immune response against SARS-CoV-2 evolves over the post-convalescent stage.</AbstractText>
                <CopyrightInformation>.. 2021 Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pradenas</LastName>
                    <ForeName>Edwards</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trinit..</LastName>
                    <ForeName>Benjamin</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Urrea</LastName>
                    <ForeName>V..ctor</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marfil</LastName>
                    <ForeName>Silvia</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>..vila-Nieto</LastName>
                    <ForeName>Carlos</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rodr..guez de la Concepci..n</LastName>
                    <ForeName>Mar..a Luisa</ForeName>
                    <Initials>ML</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tarr..s-Freixas</LastName>
                    <ForeName>Ferran</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>P..rez-Yanes</LastName>
                    <ForeName>Silvia</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratorio de Inmunolog..a Celular y Viral, Unidad de Farmacolog..a, Secci..n de Medicina, Facultad de Ciencias de la Salud, Universidad de La Laguna (ULL), La Laguna 38071, Tenerife, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rovirosa</LastName>
                    <ForeName>Carla</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ainsua-Enrich</LastName>
                    <ForeName>Erola</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rodon</LastName>
                    <ForeName>Jordi</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>IRTA Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la UAB, 08193 Bellaterra, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vergara-Alert</LastName>
                    <ForeName>J..lia</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>IRTA Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la UAB, 08193 Bellaterra, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Segal..s</LastName>
                    <ForeName>Joaquim</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>UAB, Centre de Recerca en Sanitat Animal (IRTA-UAB), Campus de la UAB, 08193 Bellaterra, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Departament de Sanitat i Anatomia Animals, Facultat de Veterin..ria, UAB, 08193 Bellaterra, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guallar</LastName>
                    <ForeName>Victor</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Barcelona Supercomputing Center, 08034 Barcelona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Catalan Institution for Research and Advanced Studies (ICREA), 08010 Barcelona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Valencia</LastName>
                    <ForeName>Alfonso</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Barcelona Supercomputing Center, 08034 Barcelona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Catalan Institution for Research and Advanced Studies (ICREA), 08010 Barcelona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Izquierdo-Useros</LastName>
                    <ForeName>Nuria</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paredes</LastName>
                    <ForeName>Roger</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Infectious Diseases Department, Fight against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mateu</LastName>
                    <ForeName>Lourdes</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Infectious Diseases Department, Fight against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chamorro</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Infectious Diseases Department, Fight against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Massanella</LastName>
                    <ForeName>Marta</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carrillo</LastName>
                    <ForeName>Jorge</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Clotet</LastName>
                    <ForeName>Bonaventura</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Infectious Diseases Department, Fight against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Blanco</LastName>
                    <ForeName>Juli..</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Catalonia, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Med (N Y)</MedlineTA>
            <NlmUniqueID>101769215</NlmUniqueID>
            <ISSNLinking>2666-6340</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">disease severity</Keyword>
            <Keyword MajorTopicYN="N">durability</Keyword>
            <Keyword MajorTopicYN="N">humoral response</Keyword>
            <Keyword MajorTopicYN="N">neutralization</Keyword>
            <Keyword MajorTopicYN="N">pseudovirus</Keyword>
        </KeywordList>
        <CoiStatement>J.B. and J.C. are founders of and shareholders in AlbaJuna Therapeutics; B.C. is a founder of and shareholder in AlbaJuna Therapeutics and AELIX Therapeutics (all unrelated to the present work). The other authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>5</Hour>
                <Minute>58</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33554155</ArticleId>
            <ArticleId IdType="doi">10.1016/j.medj.2021.01.005</ArticleId>
            <ArticleId IdType="pii">S2666-6340(21)00035-0</ArticleId>
            <ArticleId IdType="pmc">PMC7847406</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>Cell Rep Med. 2020 Jun 23;1(3):100040</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32835303</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Dec 11;370(6522):1339-1343</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33159009</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2020 Oct 21;58(11):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32826322</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Aug 03;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32745196</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 1995 Feb 1;206(2):935-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7531918</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Aug;20(8):e192-e197</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32539990</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2021 Feb 5;371(6529):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33408181</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Dec 17;71(10):2688-2694</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32497196</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Nov 27;371:m4509</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33246972</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Mar 27;11(1):1620</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32221306</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 7;369(6504):643-650</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32540902</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Sep 10;383(11):1085-1087</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32706954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2007 Oct;13(10):1562-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18258008</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Nov 19;71(16):2027-2034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32221519</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2020 Jul;81(1):147-178</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32209385</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Aug;26(8):1200-1204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32555424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2011 Jul 18;29(32):5250-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21609746</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Epidemiol Infect. 1990 Oct;105(2):435-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2170159</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2021 Jan 28;11(1):2608</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33510275</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2021 Mar;591(7851):639-644</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33461210</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Dec 4;370(6521):1227-1230</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33115920</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33553091</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2296-2565</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <PubDate>
                        <MedlineDate>2020</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in public health</Title>
                <ISOAbbreviation>Front Public Health</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19 and Italian Healthcare Workers From the Initial Sacrifice to the mRNA Vaccine: Pandemic Chrono-History, Epidemiological Data, Ethical Dilemmas, and Future Challenges.</ArticleTitle>
            <Pagination>
                <MedlinePgn>591900</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2020.591900</ELocationID>
            <Abstract>
                <AbstractText>On March 11, 2020, the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) outbreak a pandemic. Simultaneously, in Italy, in which the first case had occurred on February 18, the rigid phase of the lockdown began. The country has attracted worldwide attention, becoming at the same time a field of study both concerning the spread of the pandemic and advanced assessments of the effectiveness of political, public health, and therapeutic measures. The protagonists of the Italian crisis were the healthcare workers (HCWs) who were exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) without having any perception of what they were facing, courageously contributing to the containment of the epidemic to be defined by the media as &quot;heroes.&quot; However, in the first phase of the pandemic (March-May 2020), the price that the Italian Public Health System had to pay both in terms of the number of positive virus cases and deaths among the HCWs was beyond and represented a peculiarity compared to what happened in other countries. In the current study, after a summary of the evolution of the pandemic in Italy, we offer an analysis of the statistical data concerning contagions and deaths among healthcare workers (physicians in particular). In conclusion, we describe the critical issues that still need to be resolved and the future challenges facing healthcare workers and the general population.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 Nioi, Napoli, Lobina, Fossarello and d'Aloja.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nioi</LastName>
                    <ForeName>Matteo</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences and Public Health, Forensic Medicine Unit, University of Cagliari, Cagliari, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Napoli</LastName>
                    <ForeName>Pietro Emanuele</ForeName>
                    <Initials>PE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgical Science, Eye Clinic, University of Cagliari, Cagliari, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lobina</LastName>
                    <ForeName>Jessica</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences and Public Health, Forensic Medicine Unit, University of Cagliari, Cagliari, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fossarello</LastName>
                    <ForeName>Maurizio</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgical Science, Eye Clinic, University of Cagliari, Cagliari, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>d'Aloja</LastName>
                    <ForeName>Ernesto</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences and Public Health, Forensic Medicine Unit, University of Cagliari, Cagliari, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Public Health</MedlineTA>
            <NlmUniqueID>101616579</NlmUniqueID>
            <ISSNLinking>2296-2565</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>H</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003140" MajorTopicYN="Y">Communicable Disease Control</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName>
                <QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000067393" MajorTopicYN="N">Personal Protective Equipment</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012333" MajorTopicYN="Y">RNA, Messenger</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">COVID-19 HCWs deaths</Keyword>
            <Keyword MajorTopicYN="N">COVID-19 Italian physician's positivities and deaths</Keyword>
            <Keyword MajorTopicYN="N">COVID-19 ethical dilemmas</Keyword>
            <Keyword MajorTopicYN="N">COVID-19 future challenges</Keyword>
            <Keyword MajorTopicYN="N">COVID-19 healthcare workers</Keyword>
            <Keyword MajorTopicYN="N">COVID-19 mRNA vaccine</Keyword>
            <Keyword MajorTopicYN="N">COVID-19: specialties of dead doctors</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>5</Hour>
                <Minute>45</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33553091</ArticleId>
            <ArticleId IdType="doi">10.3389/fpubh.2020.591900</ArticleId>
            <ArticleId IdType="pmc">PMC7859528</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect. 2020 Aug;81(2):e106-e107</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32445726</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2020 Sep;26(9):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32568661</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Med. 2020 May 09;9(5):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32397530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Minerva Anestesiol. 2016 Dec;82(12):1259-1266</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27270072</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care. 2020 Apr 22;24(1):165</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32321562</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2020 Aug 18;173(4):268-277</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32374815</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Occup Med (Lond). 2020 Jul 17;70(5):370-374</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32409839</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biosaf Health. 2020 Jun;2(2):57-59</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32835209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Forensic Sci Med Pathol. 2020 Sep 21;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32955718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Psychiatry. 2017 Dec 01;8:256</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29249992</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EClinicalMedicine. 2020 Jul 24;25:100470</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32734174</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 2021 Jan;80(1):e7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32571868</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Feb 28;368:bmj.m799</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32111645</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Med. 2020 Apr 28;9(5):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32353982</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Bone Joint Surg Am. 2020 Jul 15;102(14):1205-1212</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32675662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Med. 2020 Apr 16;9(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32316118</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Control Hosp Epidemiol. 2020 May 15;:1-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32408922</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Community Health. 2020 Aug;45(4):675-683</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32440724</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2021 Jan;102:239-241</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33130210</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mod Pathol. 2020 Nov;33(11):2156-2168</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32879413</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 May;20(5):e102-e107</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32145768</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Aug 12;370:m3158</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32788196</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Apr 14;323(14):1406-1407</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32083643</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2020 May;19(5):305-306</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32273591</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2019 May 17;365:l2160</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31101646</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2018 Mar 22;360:k1253</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29567639</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Gastroenterol Hepatol. 2020 May;17(5):259</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32214231</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2016 Sep 26;354:i5165</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27671895</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Public Health. 2020 Nov 09;8:595405</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33240836</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2019 Apr 15;365:l1717</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30987982</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Psychiatry. 2020 Sep 03;11:572245</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33101086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Med. 2020 Jul 30;9(8):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32751615</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33553084</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2296-2565</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in public health</Title>
                <ISOAbbreviation>Front Public Health</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Influence of Empathy Disposition and Risk Perception on the Psychological Impact of Lockdown During the Coronavirus Disease Pandemic Outbreak.</ArticleTitle>
            <Pagination>
                <MedlinePgn>567337</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2020.567337</ELocationID>
            <Abstract>
                <AbstractText>During the current COVID-19 pandemic, and especially in the absence of availability of an effective treatment or a vaccine, the main health measure is neither chemical nor biological, but behavioral. To reduce the exponential growth of infections due to the new coronavirus (SARS-CoV-2) and the resulting overburdening of the healthcare system, many European Countries, parts of the US and Switzerland gradually implemented measures of quarantine and isolation defined as lockdown. This consideration leads to the need to understand how individuals are motivated to protect themselves and others. Recent research suggested that prosocial mental dispositions, such as empathy, might promote adherence to social norms of distancing. Other research conducted during the COVID-19 outbreak indicates, however, that empathy levels might fluctuate according to anxiety linked to the risk of death, and this negatively predicted prosocial willingness. The present protocol proposes a study on whether people's empathic dispositions, interacting with the levels of risk, influence the psychological impact of lockdown. The rationale is that emphatic dispositions, encouraging the acceptance of the lockdown, determine a better psychological adaptation and less distress. One retrospective study will be developed in Switzerland and, if the pandemic conditions force a new wave of lockdown on the population, one prospective study as well. A total of 120 participants will be involved, distinguished by their level of objective risk: (1) high objective risk (COVID-19 positive patients, hospitalized in isolation in post-acute phase); (2) moderate objective risk (COVID-19 positive patients, isolated at home); (3) minimum objective risk (non-positive adults, in lockdown). Measures of perceived risk of being contagious for third parties, empathic dispositions and acceptance of lockdown will be collected. The expected results provide important answers related to the immediate impact of empathic dispositions, effective risk and risk perception on the psychological impact of lockdown during a pandemic outbreak. Data gathered from this study could inform policy makers and public health managers about the best communication strategies that will take into account the various stages of health risk and, in particular, to modulate messages to the population aimed at inducing self-isolation behaviors.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 Grignoli, Petrocchi, Bernardi, Massari, Traber, Malacrida and Gabutti.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Grignoli</LastName>
                    <ForeName>Nicola</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Consultation-Liaison Psychiatry Service, Organizzazione Sociopsichiatrica Cantonale, Mendrisio, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine and Nephrology, Regional Hospital of Bellinzona and Valli, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Petrocchi</LastName>
                    <ForeName>Serena</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Communication and Health, Universit.. della Svizzera Italiana, Lugano, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bernardi</LastName>
                    <ForeName>Sheila</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sasso Corbaro Medical Humanities Foundation, Bellinzona, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Massari</LastName>
                    <ForeName>Ilaria</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Consultation-Liaison Psychiatry Service, Organizzazione Sociopsichiatrica Cantonale, Mendrisio, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Traber</LastName>
                    <ForeName>Rafael</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Consultation-Liaison Psychiatry Service, Organizzazione Sociopsichiatrica Cantonale, Mendrisio, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Malacrida</LastName>
                    <ForeName>Roberto</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sasso Corbaro Medical Humanities Foundation, Bellinzona, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gabutti</LastName>
                    <ForeName>Luca</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine and Nephrology, Regional Hospital of Bellinzona and Valli, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Public Health</MedlineTA>
            <NlmUniqueID>101616579</NlmUniqueID>
            <ISSNLinking>2296-2565</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>H</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000223" MajorTopicYN="Y">Adaptation, Psychological</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004645" MajorTopicYN="Y">Empathy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010465" MajorTopicYN="Y">Perception</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000079225" MajorTopicYN="N">Psychological Distress</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011790" MajorTopicYN="Y">Quarantine</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D040242" MajorTopicYN="N">Risk Reduction Behavior</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">empathy</Keyword>
            <Keyword MajorTopicYN="Y">ethics</Keyword>
            <Keyword MajorTopicYN="Y">isolation</Keyword>
            <Keyword MajorTopicYN="Y">lockdown</Keyword>
            <Keyword MajorTopicYN="Y">prosocial</Keyword>
            <Keyword MajorTopicYN="Y">psychological distress</Keyword>
            <Keyword MajorTopicYN="Y">risk</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>5</Hour>
                <Minute>45</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33553084</ArticleId>
            <ArticleId IdType="doi">10.3389/fpubh.2020.567337</ArticleId>
            <ArticleId IdType="pmc">PMC7855966</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Infect Dis. 2020 Aug 17;20(1):607</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32807087</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Environ Res Public Health. 2020 May 02;17(9):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32370116</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Soc Sci Med. 2020 Nov;265:113478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33162198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Can J Public Health. 2021 Feb;112(1):17-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33464556</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Bioeth. 2007 Feb;7(2):1-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17366181</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Ethics. 2020 Aug;46(8):495-498</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32522813</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Psychiatry. 2020 Jun 05;11:533</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32581895</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2020 Nov 5;15(11):e0240204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33152030</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Intern Med. 2006 May 22;166(10):1092-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16717171</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Hum Behav. 2020 May;4(5):438</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32221514</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pers Individ Dif. 2021 Feb 15;170:110420</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33082614</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Patient Educ Couns. 2020 May;103(5):873-876</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32336348</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychol Sci. 2020 Nov;31(11):1363-1373</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32993455</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Public Health. 2011 Jul 19;11:575</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21771296</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychooncology. 2014 Mar;23(3):241-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25160838</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>QJM. 2020 Jun 22;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32569360</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Asian Bioeth Rev. 2020 Aug 18;:1-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32837564</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2020 Oct 7;15(10):e0240349</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33027308</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2020 May;19(5):305-306</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32273591</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Public Health. 2020 Nov 19;8:587833</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33330330</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2006 Dec 1;43(11):1379-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17083008</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Arch Psychiatry Clin Neurosci. 2020 Oct 6;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33025099</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Med Suisse. 2020 Mar 18;16(686):564-565</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32186807</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Apr;20(4):398-400</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32113510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pers Individ Dif. 2021 Jan 1;168:110399</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32982001</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>R Soc Open Sci. 2020 Sep 16;7(9):200742</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33047037</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Compr Psychiatry. 2012 Jan;53(1):15-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21489421</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Epidemiol Health. 2020;42:e2020038</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32512661</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Public Health. 2009 Dec 16;9:470</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20015400</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Educ Behav. 2020 Aug;47(4):531-535</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32527161</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Appl Psychol Health Well Being. 2020 Dec;12(4):1205-1223</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33010119</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2010 Oct 14;10:296</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20946662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 14;395(10227):912-920</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32112714</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Camb Q Healthc Ethics. 2021 Jan;30(1):114-122</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32349824</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Psychiatry. 2020 Sep 28;63(1):e87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32981568</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Can J Psychiatry. 2009 May;54(5):302-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19497162</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Med. 2020 Jun 10;9(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32531884</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Intern Med. 2001 Sep;16(9):606-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11556941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Aug 6;383(6):510-512</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32283003</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33552839</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">2195-9595</ISSN>
                <JournalIssue CitedMedium="Print">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Current hepatology reports</Title>
                <ISOAbbreviation>Curr Hepatol Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-11</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11901-021-00560-2</ELocationID>
            <Abstract>
                <AbstractText Label="Purpose of Review" NlmCategory="UNASSIGNED">This paper aims to summarize the data of recently completed and key ongoing clinical trials of systemic agents for advanced hepatocellular carcinoma (aHCC). In particular, the review focuses on ongoing checkpoint inhibitor combination trials and promising studies combining tyrosine kinase inhibitors with checkpoint inhibitors.</AbstractText>
                <AbstractText Label="Recent Findings" NlmCategory="UNASSIGNED">The recently approved combination of atezolizumab and bevacizumab based on the IMbrave150 trial has shown the most potential with the highest overall survival of any systemic agent in HCC to date, surpassing sorafenib. Despite COVID-19 delays, other promising trials that involve combining VEGF-directed therapy and checkpoint inhibition, cancer vaccines, phosphatidylserine, YIV-906, and oncolytic and immunotherapeutic vaccinia virus are actively recruiting patients.</AbstractText>
                <AbstractText Label="Summary" NlmCategory="UNASSIGNED">After almost a 10-year dormancy, the list of potential systemic treatment options for aHCC is growing rapidly. Given the promising data from the IMbrave150 trial, the combination of atezolizumab and bevacizumab is now the new first-line therapy. We discuss the change in landscape, the new second- and third-line systemic treatments in aHCC, and the ongoing clinical trials for newer agents including combination therapies.</AbstractText>
                <CopyrightInformation>.. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2021.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Aitcheson</LastName>
                    <ForeName>Gabriella</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Jackson Memorial Hospital, Miami, FL USA.</Affiliation>
                        <Identifier Source="GRID">grid.414905.d</Identifier>
                        <Identifier Source="ISNI">0000 0000 8525 5459</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pillai</LastName>
                    <ForeName>Anjana</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gastroenterology, University of Chicago, Chicago, IL USA.</Affiliation>
                        <Identifier Source="GRID">grid.170205.1</Identifier>
                        <Identifier Source="ISNI">0000 0004 1936 7822</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dahman</LastName>
                    <ForeName>Bassam</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Behavior and Policy, Virginia Commonwealth University, Richmond, VA USA.</Affiliation>
                        <Identifier Source="GRID">grid.224260.0</Identifier>
                        <Identifier Source="ISNI">0000 0004 0458 8737</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>John</LastName>
                    <ForeName>Binu V</ForeName>
                    <Initials>BV</Initials>
                    <Identifier Source="ORCID">0000-0002-2002-9682</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Hepatology, Bruce W Carter VA Medical Center, Miami, FL 33125 USA.</Affiliation>
                        <Identifier Source="GRID">grid.484420.e</Identifier>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Curr Hepatol Rep</MedlineTA>
            <NlmUniqueID>101631871</NlmUniqueID>
            <ISSNLinking>2195-9595</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Atezolizumab</Keyword>
            <Keyword MajorTopicYN="N">Bevacizumab</Keyword>
            <Keyword MajorTopicYN="N">Clinical trials</Keyword>
            <Keyword MajorTopicYN="N">Immunotherapy</Keyword>
            <Keyword MajorTopicYN="N">Tyrosine kinase inhibitors</Keyword>
        </KeywordList>
        <CoiStatement>Conflict of InterestDr. Gabriella Aitcheson declares no conflict of interest. Dr. Anjana Pillai declares the following conflicts of interest: Medical Advisory Board for Exelixis, Genentetch, Eisai Inc and Speaker...s Bureau for Simply Speaking Hepatitis CME series. Dr. Bassam Dachman declares no conflict of interest. Dr. Binu John declares the following conflicts of interest: grants from BMS, H3B biosciences, Exelixis, Bayer, Exact Sciences, Glycotest therapeutics, Inc.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>5</Hour>
                <Minute>42</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33552839</ArticleId>
            <ArticleId IdType="doi">10.1007/s11901-021-00560-2</ArticleId>
            <ArticleId IdType="pii">560</ArticleId>
            <ArticleId IdType="pmc">PMC7848044</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2008 Jul 24;359(4):378-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18650514</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Oncol. 2019 Feb;20(2):282-296</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30665869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Oncol. 2009 Jan;10(1):25-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19095497</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2017 Jun 24;389(10088):2492-2502</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28434648</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Liver Dis (Hoboken). 2019 Feb 21;13(1):13-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31168360</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Int. 2019 Mar;13(2):125-137</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30600478</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancers (Basel). 2019 Jun 18;11(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31216701</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2018 Mar 24;391(10126):1163-1173</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29433850</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 May 14;382(20):1894-1905</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32402160</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2017 Jan 7;389(10064):56-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27932229</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 May 14;382(20):1953-1955</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32402168</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2018 Aug;69(2):353-358</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29704513</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Death Differ. 2016 Jun;23(6):962-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26915293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Future Oncol. 2019 Jun;15(16):1811-1822</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30969136</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2008 Feb;134(2):379</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18242200</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Oncol. 2015 Jul;16(7):859-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26095784</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am Soc Clin Oncol Educ Book. 2019 Jan;39:248-260</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31099615</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncol Lett. 2020 Nov;20(5):268</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32989402</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncology (Williston Park). 2018 Feb 15;32(2):e20-e27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29492950</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2020 Jan;69(1):168-176</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30878947</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Oncol. 2018 Jul;19(7):940-952</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29875066</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Mol Biol. 2015;1317:343-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26072416</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CA Cancer J Clin. 2020 Jan;70(1):7-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31912902</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2020 Jan 20;38(3):193-202</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31790344</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2018 Jul 05;379(1):54-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29972759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2019 Apr 11;380(15):1450-1462</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30970190</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33552508</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2050-0068</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>10</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical &amp; translational immunology</Title>
                <ISOAbbreviation>Clin Transl Immunology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Pattern of circulating SARS-CoV-2-specific antibody-secreting and memory B-cell generation in patients with acute COVID-19.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e1245</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/cti2.1245</ELocationID>
            <Abstract>
                <AbstractText Label="Objectives" NlmCategory="UNASSIGNED">To predict the spread of coronavirus disease (COVID-19), information regarding the immunological memory for disease-specific antigens is necessary. The possibility of reinfection, as well as the efficacy of vaccines for COVID-19 that are currently under development, will largely depend on the quality and longevity of immunological memory in patients. To elucidate the process of humoral immunity development, we analysed the generation of plasmablasts and virus receptor-binding domain (RBD)-specific memory B (Bmem) cells in patients during the acute phase of COVID-19.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">The frequencies of RBD-binding plasmablasts and RBD-specific antibody-secreting cells (ASCs) in the peripheral blood samples collected from patients with COVID-19 were measured using flow cytometry and the ELISpot assay.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The acute phase of COVID-19 was characterised by the transient appearance of total as well as RBD-binding plasmablasts. ELISpot analysis indicated that most patients exhibited a spontaneous secretion of RBD-specific ASCs in the circulation with good correlation between the IgG and IgM subsets. IL-21/CD40L stimulation of purified B cells induced the activation and proliferation of Bmem cells, which led to the generation of plasmablast phenotypic cells as well as RBD-specific ASCs. No correlation was observed between the frequency of Bmem cell-derived and spontaneous ASCs, suggesting that the two types of ASCs were weakly associated with each other.</AbstractText>
                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Our findings reveal that SARS-CoV-2-specific Bmem cells are generated during the acute phase of COVID-19. These findings can serve as a basis for further studies on the longevity of SARS-CoV-2-specific B-cell memory.</AbstractText>
                <CopyrightInformation>.. 2021 The Authors. Clinical &amp; Translational Immunology published by John Wiley &amp; Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Byazrova</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Research Center Institute of Immunology of Federal Medical Biological Agency of Russia Moscow Russia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology Faculty of Biology Lomonosov Moscow State University Moscow Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yusubalieva</LastName>
                    <ForeName>Gaukhar</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal Research and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the FMBA of Russia Moscow Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Spiridonova</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Research Center Institute of Immunology of Federal Medical Biological Agency of Russia Moscow Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Efimov</LastName>
                    <ForeName>Grigory</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Research Center for Hematology Moscow Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mazurov</LastName>
                    <ForeName>Dmitriy</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Gene Biology Russian Academy of Sciences Center for Precision Genome Editing and Genetic Technologies for Biomedicine Moscow Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baranov</LastName>
                    <ForeName>Konstantin</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Molecular and Cellular Biology SB RAS Lomonosov Moscow State University Novosibirsk Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baklaushev</LastName>
                    <ForeName>Vladimir</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal Research and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the FMBA of Russia Moscow Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Filatov</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-6460-9427</Identifier>
                    <AffiliationInfo>
                        <Affiliation>National Research Center Institute of Immunology of Federal Medical Biological Agency of Russia Moscow Russia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology Faculty of Biology Lomonosov Moscow State University Moscow Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Australia</Country>
            <MedlineTA>Clin Transl Immunology</MedlineTA>
            <NlmUniqueID>101638268</NlmUniqueID>
            <ISSNLinking>2050-0068</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">SARS...CoV...2</Keyword>
            <Keyword MajorTopicYN="N">antibody...secreting cell</Keyword>
            <Keyword MajorTopicYN="N">memory B cell</Keyword>
            <Keyword MajorTopicYN="N">plasmablast</Keyword>
            <Keyword MajorTopicYN="N">virus...neutralising antibodies</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>5</Hour>
                <Minute>38</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33552508</ArticleId>
            <ArticleId IdType="doi">10.1002/cti2.1245</ArticleId>
            <ArticleId IdType="pii">CTI21245</ArticleId>
            <ArticleId IdType="pmc">PMC7848539</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Microbes Infect. 2018 Feb 16;7(1):16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29449582</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Sep;26(9):1422-1427</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32651581</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2019 Jul 24;10:1694</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31396218</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytometry B Clin Cytom. 2010;78 Suppl 1:S69-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20839340</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol Methods. 2013 Aug 30;394(1-2):84-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23707324</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 Dec 22;5(54):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33443036</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):437-442</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32555388</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Sep;26(9):1428-1434</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32661393</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):457-462</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32668444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Transl Immunology. 2020 Oct 16;9(10):e1199</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33088507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2011 Jun 15;186(12):7264-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21576510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2012 Apr 17;3:78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22566959</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Jul;583(7815):290-295</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32422645</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2010 Jan;16(1):123-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20023635</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4719-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25775592</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2012 Mar;86(6):2911-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22238318</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 May 4;11(1):2251</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32366817</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2015 Jul 27;5:12573</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26212756</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioconjug Chem. 2011 Nov 16;22(11):2263-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21950520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Microbiol Immunol Infect. 2020 Oct;53(5):821-822</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32249185</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Nov 12;183(4):996-1012.e19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33010815</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):450-456</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32698192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Med. 2011 Jan 17;208(1):181-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21220454</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Apr 16;181(2):281-292.e6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32155444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2021 Jan 7;184(1):169-183.e17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33296701</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Oct 1;183(1):143-157.e13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32877699</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2016 Dec 07;7:13600</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27924814</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2020 Dec;21(12):1506-1516</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33028979</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods. 2014 Jan 1;65(1):38-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23867338</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Immunol. 2017 Nov;321:18-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28735813</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Immunol. 2014 May-Jun;152(1-2):77-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24589749</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2016 May 27;90(12):5574-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27030262</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2007 Sep 13;357(11):1162-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17855683</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7819):115-119</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32454513</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Transl Immunology. 2015 Oct 09;4(10):e44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26682052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EBioMedicine. 2016 Oct;12:178-188</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27628668</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2010 Dec 1;202(11):1659-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20979459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Sep 4;369(6508):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32669297</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2009 Sep 1;183(5):3177-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19675172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 21;369(6506):956-963</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32540903</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2020 Jul 21;32(3):107918</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32668215</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2011 Jun 1;186(11):6173-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21531891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2020 Jul;179:104820</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32405117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 Jul 15;5(49):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32669287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol Methods. 2007 Jan 30;319(1-2):21-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17098248</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Immunol. 2020 Sep;50(9):1283-1294</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32910469</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2010 Apr 30;28(20):3582-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20298818</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2011;6(12):e29430</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22216280</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2020 Jul 14;53(1):98-105.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32561270</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2014 May 1;209(9):1354-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24415790</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2018 Dec 29;11(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30597938</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2020 Aug 07;11:1949</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32849654</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Med. 2012 Sep 24;209(10):1797-812</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22927551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32142651</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2016 Oct;17(10):1226-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27525369</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33550983</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>17</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>17</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1757-2215</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of ovarian research</Title>
                <ISOAbbreviation>J Ovarian Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?</ArticleTitle>
            <Pagination>
                <MedlinePgn>28</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13048-021-00772-6</ELocationID>
            <Abstract>
                <AbstractText>Improving early diagnosis along with timely and effective treatment of COVID-19 are urgently needed. However, at present, the mechanisms underlying disease spread and development, defined prognosis, and immune status of patients with COVID-19 remain to be determined. Patients with severe disease state exhibit a hyperinflammatory response associated with cytokine storm syndrome, hypercoagulability, and depressed cell-mediated immunity. These clinical manifestations, sharing similar pathogenesis, have been well-studied in patients with advanced ovarian cancer. The present review suggests treatment approaches for COVID-19 based on strategies used against ovarian cancer, which shares similar immunopathology and associated coagulation disorders.The chronicization of the hyperinflammatory cytokine storm in patients with severe COVID-19 highlights a defective resistance phase that leads to aspecific chronic inflammation, associated with oxidative stress, which impairs specific T-cell response, induces tissue and endothelial damage, and thrombosis associated with systemic effects that lead to severe multi-organ failure and death. These events are similar to those observed in advanced ovarian cancer which share similar pathogenesis mediated primarily by Interleukin-6, which is, as well demonstrated in ovarian cancer, the key cytokine driving the immunopathology, related systemic symptoms, and patient prognosis.Consistent with findings in other disease models with similar immunopathology, such as advanced ovarian cancer, treatment of severe COVID-19 infection should target inflammation, oxidative stress, coagulation disorders, and immunodepression to improve patient outcome. Correctly identifying disease stages, based on available laboratory data, and developing a specific protocol for each phase is essential for effective treatment.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Macci..</LastName>
                    <ForeName>Antonio</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecologic Oncology, Businco Hospital, &quot;Azienda di Rilievo Nazionale ad Alta Specializzazione G. Brotzu&quot;, Via Jenner, 09100, Cagliari, Italy. antoniomaccio56@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oppi</LastName>
                    <ForeName>Sara</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hematology and Transplant Center, Businco Hospital, &quot;Azienda di Rilievo Nazionale ad Alta Specializzazione G. Brotzu&quot;, Cagliari, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Madeddu</LastName>
                    <ForeName>Clelia</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Ovarian Res</MedlineTA>
            <NlmUniqueID>101474849</NlmUniqueID>
            <ISSNLinking>1757-2215</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C508600">IL6 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>R16CO5Y76E</RegistryNumber>
                <NameOfSubstance UI="D001241">Aspirin</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <SupplMeshList>
            <SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
            <SupplMeshName Type="Protocol" UI="C000705128">COVID-19 serotherapy</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000080424" MajorTopicYN="N">Cytokine Release Syndrome</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007116" MajorTopicYN="N">Immunization, Passive</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009336" MajorTopicYN="N">Necrosis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010051" MajorTopicYN="N">Ovarian Neoplasms</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Corticosteroids</Keyword>
            <Keyword MajorTopicYN="N">Immunopathology</Keyword>
            <Keyword MajorTopicYN="N">Interleukin-6</Keyword>
            <Keyword MajorTopicYN="N">Ovarian cancer</Keyword>
            <Keyword MajorTopicYN="N">Oxidative stress</Keyword>
            <Keyword MajorTopicYN="N">Resistance</Keyword>
            <Keyword MajorTopicYN="N">Tolerance</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>5</Hour>
                <Minute>24</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33550983</ArticleId>
            <ArticleId IdType="doi">10.1186/s13048-021-00772-6</ArticleId>
            <ArticleId IdType="pii">10.1186/s13048-021-00772-6</ArticleId>
            <ArticleId IdType="pmc">PMC7868172</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Mol Med (Berl). 2013 Dec;91(12):1355-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24057813</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Epidemiol. 2020 Aug;35(8):763-773</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32816244</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 1980 Jun;64(6):1307-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6246299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gynecol Oncol. 1998 Jun;69(3):248-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9648596</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gynecol Oncol. 2017 Oct;147(1):181-187</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28698008</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytokine. 2012 Nov;60(2):575-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22854263</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cachexia Sarcopenia Muscle. 2020 Dec 31;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33382211</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 2000 Jun 15;86(6):842-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10842199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Netw Open. 2020 Oct 1;3(10):e2023934</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33125498</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Neurobiol. 2019 Dec;56(12):8035-8051</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31165973</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Med. 2000;51:245-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10774463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Rev. 2011 Sep;243(1):136-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21884173</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drugs. 2001;61(4):499-514</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11324680</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2008 Oct 10;26(29):4820-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18779606</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2020 Jul;81(1):e6-e12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32283162</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2021 Jan 9;397(10269):99-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33306989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem J. 1990 Feb 1;265(3):621-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1689567</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Nov;26(11):1708-1713</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32934372</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Oncol. 2018 Aug 1;4(8):1134</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29902292</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Immunol. 2019 Aug;197(2):161-169</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30868561</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31978945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Oct;92(10):1733-1734</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32242950</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MAbs. 2020 Jan-Dec;12(1):1854149</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33319649</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Behav Immun. 2012 Oct;26(7):1037-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22543257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Integr Cancer Ther. 2010 Sep;9(3):270-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20702499</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Mol Med. 2009 Sep;13(9B):3951-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18624749</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Res. 2011 Jan;21(1):103-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21187859</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Immunol Res. 2020 Mar;8(3):383-395</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31924656</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Cell. 2020 Nov 9;38(5):598-601</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33038939</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2017 May;18(5):530-540</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28288101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Intern Med. 2021 Jan 1;181(1):41-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33080002</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncologist. 2010;15(8):894-902</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20647390</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Intern Med. 2021 Jan 1;181(1):24-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33080005</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anemia. 2012;2012:563251</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23091709</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Behav Immun. 2013 Mar;30 Suppl:S126-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22884960</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Pharmacother. 2012 Dec;13(17):2453-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23072481</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Res. 2009 Aug;29(8):2875-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19661290</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 May 26;323(20):2052-2059</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32320003</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytokine. 2012 May;58(2):133-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22349527</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32171076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 2020 Oct 1;147(7):1768-1777</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32208517</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Free Radic Res. 2003 Feb;37(2):213-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12653210</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Apr 16;181(2):250-269</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32302569</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Jul 28;71(15):762-768</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32161940</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Cell Infect Microbiol. 2016 Sep 30;6:112</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27747195</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem J. 2015 Mar 1;466(2):401-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25697096</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Leukemia. 2020 Jul;34(7):1805-1815</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32518419</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aging Cell. 2007 Jun;6(3):361-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17517043</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BioDrugs. 2020 Aug;34(4):415-422</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32557214</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Thromb Haemost. 2020 Apr;18(4):844-847</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32073213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancers (Basel). 2019 Jun 12;11(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31212816</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Immunol. 2017 Jan;187(1):16-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27711979</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Death Dis. 2013 Apr 18;4:e592</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23598404</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Physiol Biochem. 2017;41(6):2411-2418</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28467978</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Mol Med. 2002 Oct-Dec;6(4):570-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12611641</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Hematol. 2020 Jul;95(7):834-847</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32282949</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gynecol Oncol. 2010 May;117(2):366-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20144842</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2020 Jan 10;15(1):e0227081</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31923221</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2005 Jul 15;175(2):1197-205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16002723</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):685-700</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30009406</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Haematol. 1993 Mar;83(3):433-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8485049</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Oct 6;324(13):1330-1341</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32876694</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Pharmacother. 2009 Mar;10(4):693-703</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19239402</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Immunol Immunother. 1984;17(3):190-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6332671</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Mar 27;367(6485):1412-1413</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32217705</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Transl Med. 2020 May 20;18(1):206</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32434518</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncol Lett. 2020 Nov;20(5):162</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32934730</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Virus Res. 2016;96:219-243</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27712625</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2016 Sep 8;166(6):1512-1525.e12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27610573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2020 Apr 8;10(1):6096</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32269279</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 2002 Mar 1;98(1):84-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11857390</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Immunol. 2019 Apr 26;37:405-437</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30673535</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Haematologica. 2018 Sep;103(9):e388-e391</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29674498</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Future Oncol. 2015 Oct;11(19):2697-2710</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26376740</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2018 Oct;562(7727):423-428</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30305738</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 1991 Apr 15;146(8):2873-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2016530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2011 Jan 15;71(2):424-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21123455</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Pharmacother. 2015;16(14):2163-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26330024</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Rev Oncol Hematol. 2017 Aug;116:134-146</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28693795</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2010 Jul;10(7):514-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20577268</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2012 Feb 16;366(7):610-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22335738</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Mar 27;367(6485):1434</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32198292</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Obstet Gynecol. 1991 Apr;164(4):1038-42; discussion 1042-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2014824</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Jun;582(7813):469</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32546811</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Immunopathol. 2017 Jul;39(5):529-539</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28466096</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1030-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16702388</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Apr 14;323(14):1335</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32181795</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2005 Dec;5(12):917-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16322745</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2017 May 4;169(4):570-586</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28475890</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2018 Apr 17;48(4):812-830.e14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29628290</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2019 Jan 15;202(2):484-493</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30530483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2008 Jul 24;454(7203):436-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18650914</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2016 Oct 3;126(10):3699-3707</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27571407</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 1981 Aug 15;28(2):143-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6172388</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunology. 2020 Apr;159(4):357-364</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31821533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Res. 2014 Jun;34(6):2811-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24922644</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Cancer. 2011 May 30;11:210</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21619709</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gynecol Oncol. 2012 Mar;124(3):417-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22198049</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2011 Sep 15;17(18):6083-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21795409</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2017 Sep 28;130(13):1499-1506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28807983</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2014 Jul 17;41(1):14-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25035950</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2008 Nov;8(11):889-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18927577</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2009 Jul;119(7):1745-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19587449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2018 Jul 31;9:1777</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30108592</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Thromb Haemost. 2020 Apr;18(4):786-787</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32212240</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2006 Apr 15;176(8):5023-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16585599</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 1990 Nov 1;50(21):6959-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2208162</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Physiol. 2019 Mar;234(3):2143-2151</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30146782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 1989 Nov 15;44(5):795-801</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2583859</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Intern Med. 2021 Jan 1;181(1):12-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33079980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2770-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19196953</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 1991 Nov 15;78(10):2505-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1824247</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2020 May 01;11:827</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32425950</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 11;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33306283</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Behav Immun. 2011 Mar;25(3):555-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21182930</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9069-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19451634</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Intern Med. 2021 Jan 1;181(1):32-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33080017</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Z Naturforsch B. 1958 Aug;13B(8):515-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">13593654</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Pharmacol. 2021 Mar 5;894:173817</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33345849</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Medicine (Baltimore). 2019 Nov;98(45):e17475</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31702609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Intern Med. 2020 Jul 1;180(7):934-943</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32167524</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Oncol. 2020 Oct 22;10:566511</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33194645</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Treat Rev. 2017 Jul;58:1-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28602879</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virol Sin. 2016 Feb;31(1):12-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26786772</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Sep 12;71(6):1400-1409</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32270184</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vascul Pharmacol. 2018 Jan;100:1-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28579545</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gynecol Oncol. 2019 Feb;152(2):259-264</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30558974</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 5;383(19):1813-1826</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32445440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32192578</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Immunol. 2014 Jul;177(1):253-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24580121</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Endocrinol Metab. 2013 May 15;304(10):E1042-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23531613</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann N Y Acad Sci. 2000 Jun;908:244-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10911963</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32172226</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmunol. 2001 Jul 2;117(1-2):87-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11431008</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Cell. 2020 Nov 9;38(5):594-597</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33086031</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2005 Jul 1;106(1):362-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15774616</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Ovarian Res. 2020 May 15;13(1):59</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32414391</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jul 17;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32678530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2010 May 6;115(18):3810-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20081092</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Res. 2007 Jan-Feb;27(1A):267-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17352242</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pain Symptom Manage. 2015 Aug;50(2):e1-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26004402</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS J. 2013 Sep;280(17):4131-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23663276</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2012 Feb 24;335(6071):936-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22363001</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32105090</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2014 Oct 17;5:514</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25368618</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Apr;26(4):506-510</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32284616</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Med (Berl). 2003 Oct;81(10):664-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12928788</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 31;383(27):2603-2615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 7;384(1):20-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33332779</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 1994 Jan;69(1):200-1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8286207</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 2020 Aug;135:62-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32544799</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2007 Jun 15;67(12):5708-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17575137</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Immunol. 2020 Aug;17(8):878-880</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32587367</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 Dec;101:29-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33007455</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Haematologica. 2015 Jan;100(1):124-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25239265</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Pathol. 2000 Aug;157(2):411-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10934146</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ageing Res Rev. 2004 Nov;3(4):431-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15541710</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1999 Apr 30;284(5415):825-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10221919</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33550776</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2508-4909</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>25</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Mar</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of geriatric medicine and research</Title>
                <ISOAbbreviation>Ann Geriatr Med Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Review of COVID-19 Vaccines and Their Evidence in Older Adults.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.4235/agmr.21.0011</ELocationID>
            <Abstract>
                <AbstractText>Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in a global pandemic and significant loss of life. Older people are vulnerable to SARS-CoV-2 infections and complications; thus, they are a priority group to receive COVID-19 vaccines. This review discusses considerations for COVID-19 vaccines for older adults. The general concepts of vaccine effectiveness in older adults are described, particularly immune senescence and vaccine development approaches to improve immunogenicity. The types of COVID-19 vaccine platforms are also described before reviewing the available, although limited, evidence from phase 3 COVID-19 vaccine trials relevant to older adults. The BNT162b2 vaccine by Pfizer-BioNTech and mRNA-1273 vaccine from Moderna demonstrated high efficacy and immunogenicity, which were also observed in older people. While the ChAdOx1 nCoV-19 vaccine (AZD1222) by AstraZeneca demonstrated some efficacy in older people, the vaccine dose requires clarification through further studies. Finally, the Ad26.COV2.S vaccine by Janssen Pharmaceuticals shows promise as a single-dose vaccine with a potential durability of response.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Teo</LastName>
                    <ForeName>Shyh Poh</ForeName>
                    <Initials>SP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Raja Isteri Pengiran Anak Saleha (RIPAS) Hospital, Brunei Darussalam.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>Ann Geriatr Med Res</MedlineTA>
            <NlmUniqueID>101701105</NlmUniqueID>
            <ISSNLinking>2508-4798</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Aged</Keyword>
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Older adults</Keyword>
            <Keyword MajorTopicYN="N">Vaccines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>2</Hour>
                <Minute>47</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33550776</ArticleId>
            <ArticleId IdType="pii">agmr.21.0011</ArticleId>
            <ArticleId IdType="doi">10.4235/agmr.21.0011</ArticleId>
            <ArticleId IdType="pmc">PMC8024166</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccines (Basel). 2019 Apr 24;7(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31022829</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Vaccines. 2013 Jul;12(7):759-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23885821</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2021 Jan 9;397(10269):99-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33306989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 12;383(20):1920-1931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32663912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccines (Basel). 2020 Dec 06;8(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33291245</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Intern Med. 2010 Feb;267(2):220-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20175868</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Oct;20(10):615-632</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32887954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 4;384(5):403-416</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33378609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 13;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33440088</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 31;383(27):2603-2615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Ther Methods Clin Dev. 2016 Apr 27;3:16030</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27162933</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2018 Jul 5;36(29):4207-4214</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29885773</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2016 Feb 25;7:41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26941738</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2019 Apr 19;219(10):1525-1535</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30551178</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Sep 12;396(10253):741-743</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32861315</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 17;383(25):2427-2438</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32991794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2008 Apr 1;46(7):1078-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18444828</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2021 Dec 19;396(10267):1979-1993</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33220855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AAPS PharmSciTech. 2020 Aug 5;21(6):225</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32761294</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2006 May 15;176(10):6333-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16670345</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33550606</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>09</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1326-5377</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>214</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The Medical journal of Australia</Title>
                <ISOAbbreviation>Med J Aust</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Not in my backyard: COVID-19 vaccine development requires someone to be infected somewhere.</ArticleTitle>
            <Pagination>
                <MedlinePgn>150-152.e1</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.5694/mja2.50930</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Heriot</LastName>
                    <ForeName>George S</ForeName>
                    <Initials>GS</Initials>
                    <Identifier Source="ORCID">0000-0002-5337-5944</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Monash University, Melbourne, VIC.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jamrozik</LastName>
                    <ForeName>Euzebiusz</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Monash Bioethics Centre, Monash University, Melbourne, VIC.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Wellcome Centre for Ethics and the Humanities, Ethox Centre, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Australia</Country>
            <MedlineTA>Med J Aust</MedlineTA>
            <NlmUniqueID>0400714</NlmUniqueID>
            <ISSNLinking>0025-729X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000076722" MajorTopicYN="N">Drug Development</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
                <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">Clinical trials as topic</Keyword>
            <Keyword MajorTopicYN="Y">Infectious diseases</Keyword>
            <Keyword MajorTopicYN="Y">Respiratory tract infections</Keyword>
            <Keyword MajorTopicYN="Y">Vaccines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>20</Hour>
                <Minute>53</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33550606</ArticleId>
            <ArticleId IdType="doi">10.5694/mja2.50930</ArticleId>
            <ArticleId IdType="pmc">PMC8014116</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2019 Feb 4;37(6):863-868</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30639461</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2020 May;19(5):305-306</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32273591</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Value Health. 2012 Jan;15(1):158-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22264984</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Aug;20(8):e198-e203</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32479747</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2012 Jan;12(1):36-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22032844</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Sep 12;396(10253):741-743</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32861315</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 Jan 16;38(3):460-469</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31732326</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33550050</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>02</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>137</Volume>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>May</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed Pharmacother</ISOAbbreviation>
            </Journal>
            <ArticleTitle>SARS-CoV-2: From the pathogenesis to potential anti-viral treatments.</ArticleTitle>
            <Pagination>
                <MedlinePgn>111352</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(21)00137-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2021.111352</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The world is witnessing the spread of one of the members of Coronaviruses (CoVs) family, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the 21st century. Considering the short time spent after its prevalence, limited information is known about the effect of the virus mechanism on different organs of the body; meanwhile the lack of specific treatment and vaccine for this virus has exposed millions of people to a big challenge.</AbstractText>
                <AbstractText Label="AREAS COVERED" NlmCategory="UNASSIGNED">The review article aims to describe the general and particular characteristics of CoVs, their classification, genome structure, host cell infection, cytokine storm, anti-viral treatments, and inhibition of COVID-19-related ER-mitochondrial stress. In addition, it refers to drugs such as Chloroquine/Hydroxychloroquine, Lopinavir/Ritonavir, darunavir, ribavirin, remdesivir, and favipiravir, which have undergone clinical trials for coronavirus disease 2019 (COVID-19) treatment. This analysis was derived from an extensive scientific literature search including Pubmed, ScienceDirect, and Google Scholar performed.</AbstractText>
                <AbstractText Label="EXPERT OPINION" NlmCategory="UNASSIGNED">The effectiveness rate and complications of these drugs can reveal new insights into the potential therapeutic goals for the disease. Moreover, lifestyle change can effectively prevent SARS-CoV-2 infection.</AbstractText>
                <CopyrightInformation>Copyright .. 2021. Published by Elsevier Masson SAS.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zarandi</LastName>
                    <ForeName>Peyman Kheirandish</ForeName>
                    <Initials>PK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran; Cancer Biology Signaling Pathway Interest Group (CBSPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zinatizadeh</LastName>
                    <ForeName>Mohammad Reza</ForeName>
                    <Initials>MR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran; Cancer Biology Signaling Pathway Interest Group (CBSPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran. Electronic address: mr.zinatizadeh@srbiau.ac.ir.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zinatizadeh</LastName>
                    <ForeName>Maryam</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anesthesiology, Semnan Branch, Islamic Azad University, Shahrood, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yousefi</LastName>
                    <ForeName>Mohammad Hadi</ForeName>
                    <Initials>MH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran; Department of Mycobacteriology and Pulmonary Research, Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rezaei</LastName>
                    <ForeName>Nima</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. Electronic address: rezaei_nima@tums.ac.ir.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>02</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Anti-viral treatments</Keyword>
            <Keyword MajorTopicYN="N">Cytokine storm</Keyword>
            <Keyword MajorTopicYN="N">MERS</Keyword>
            <Keyword MajorTopicYN="N">Pathogenesis</Keyword>
            <Keyword MajorTopicYN="N">SARS</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>4</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>20</Hour>
                <Minute>40</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33550050</ArticleId>
            <ArticleId IdType="pii">S0753-3322(21)00137-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2021.111352</ArticleId>
            <ArticleId IdType="pmc">PMC7969672</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33550049</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>02</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>137</Volume>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>May</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed Pharmacother</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Targets and strategies for vaccine development against SARS-CoV-2.</ArticleTitle>
            <Pagination>
                <MedlinePgn>111254</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(21)00039-1</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2021.111254</ELocationID>
            <Abstract>
                <AbstractText>The SARS-CoV-2, previously called a novel coronavirus, that broke out in the Wuhan city of China caused a significant number of morbidity and mortality in the world. It is spreading at peak levels since the first case reported and the need for vaccines is in immense demand globally. Numerous treatment and vaccination strategies that were previously employed for other pathogens including coronaviruses are now being been adopted to guide the formulation of new SARS-CoV-2 vaccines. Several vaccine targets can be utilized for the development of the SARS-CoV-2 vaccine. In this review, we highlighted the potential of various antigenic targets and other modes for formulating an effective vaccine against SARS-CoV-2. There are a varying number of challenges encountered during developing the most effective vaccines, and measures for tackling such challenges will assist in fast pace development of vaccines. This review will give a concise overview of various aspects of the vaccine development process against SARS-CoV-2, including 1) potential antigen targets 2) different vaccination strategies from conventional to novel platforms, 3) ongoing clinical trials, 4) varying challenges encountered during developing the most effective vaccine and the futuristic approaches.</AbstractText>
                <CopyrightInformation>Copyright .. 2021. Published by Elsevier Masson SAS.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Malik</LastName>
                    <ForeName>Jonaid Ahmad</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Guwahati, Assam, India; Department of Biomedical Engineering, Indian Institute of Technology (IIT), Ropar, Punjab, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mulla</LastName>
                    <ForeName>Almas Hanif</ForeName>
                    <Initials>AH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Goa College of Pharmacy, Goa, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Farooqi</LastName>
                    <ForeName>Tahmeena</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Toxicology National Institute of Pharmaceutical Education and Research, Hyderabad Telangana, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pottoo</LastName>
                    <ForeName>Faheem Hyder</ForeName>
                    <Initials>FH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P.O.BOX 1982, Dammam, 31441, Saudi Arabia. Electronic address: fhpottoo@iau.edu.sa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Anwar</LastName>
                    <ForeName>Sirajudheen</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail, 81442, Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rengasamy</LastName>
                    <ForeName>Kannan R R</ForeName>
                    <Initials>KRR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Research and Development, Duy Tan University, Da Nang, 550000, Viet Nam; Faculty of Environment and Chemical Engineering, Duy Tan University, Da Nang, 550000, Viet Nam; Indigenous Knowledge Systems Centre, Faculty of Natural and Agricultural Sciences, North-West University, Private Bag X2046, Mmabatho, 2745, North West Province, South Africa. Electronic address: rengasamyrrajakannan@duytan.edu.vn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000076722" MajorTopicYN="N">Drug Development</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antigen targets</Keyword>
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Clinical trials</Keyword>
            <Keyword MajorTopicYN="N">Pandemic</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2 vaccine</Keyword>
            <Keyword MajorTopicYN="N">Vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>4</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>20</Hour>
                <Minute>40</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33550049</ArticleId>
            <ArticleId IdType="pii">S0753-3322(21)00039-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2021.111254</ArticleId>
            <ArticleId IdType="pmc">PMC7843096</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33549712</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>08</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-0038</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>777</Volume>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Apr</Month>
                        <Day>20</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Gene</Title>
                <ISOAbbreviation>Gene</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The use of mesenchymal stem cells in the process of treatment and tissue regeneration after recovery in patients with Covid-19.</ArticleTitle>
            <Pagination>
                <MedlinePgn>145471</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0378-1119(21)00065-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gene.2021.145471</ELocationID>
            <Abstract>
                <AbstractText>In addition to causing health concerns, the new coronavirus has been considered in the world with its unknown mechanism of physiopathogenesis and long-term effects after patient recovery. Pulmonary, renal, hepatic and cardiac complications have been reported so far. Beside the researchers' focus on finding vaccines and using conventional therapies, cell-based therapy might be an effective therapeutic strategy. The use of mesenchymal stem cells (MSCs) is one of the options due to their immunomodulatory properties and their proven effects in the treatment of many diseases. As MSCs are not infected with covid-19, there is evidence that it modulates the immune system and prevents the virus from clotting. Despite the beginning of numerous clinical trials in the use of mesenchymal stem cells, it is necessary to set a practical guideline that specifies items such as cell origin, number of cells, frequency of injection, injection site, etc.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Saburi</LastName>
                    <ForeName>Ehsan</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Genetics and Molecular Medicine Department, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Abazari</LastName>
                    <ForeName>Mohammad Foad</ForeName>
                    <Initials>MF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hassannia</LastName>
                    <ForeName>Hadi</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Immunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. Amol Faculty of Paramedical Sciences, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mansour</LastName>
                    <ForeName>Reyhaneh Nassiri</ForeName>
                    <Initials>RN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eshaghi-Gorji</LastName>
                    <ForeName>Reza</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gheibi</LastName>
                    <ForeName>Mobina</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rahmati</LastName>
                    <ForeName>Mohammad</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Biotechnology, Faculty of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Enderami</LastName>
                    <ForeName>Seyed Ehsan</ForeName>
                    <Initials>SE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Immunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Department of Medical Biotechnology, Faculty of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: ehsan.enderami@strc.ac.ir.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Gene</MedlineTA>
            <NlmUniqueID>7706761</NlmUniqueID>
            <ISSNLinking>0378-1119</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056747" MajorTopicYN="Y">Immunomodulation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D045164" MajorTopicYN="Y">Mesenchymal Stem Cell Transplantation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059630" MajorTopicYN="N">Mesenchymal Stem Cells</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Covid 19</Keyword>
            <Keyword MajorTopicYN="N">Mesenchymal stem cells</Keyword>
            <Keyword MajorTopicYN="N">Tissue regeneration</Keyword>
            <Keyword MajorTopicYN="N">Treatment</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>20</Hour>
                <Minute>34</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33549712</ArticleId>
            <ArticleId IdType="pii">S0378-1119(21)00065-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.gene.2021.145471</ArticleId>
            <ArticleId IdType="pmc">PMC7860931</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33549288</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1558-1357</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>56</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The Nursing clinics of North America</Title>
                <ISOAbbreviation>Nurs Clin North Am</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Herbal Medication to Enhance or Modulate Viral Infections.</ArticleTitle>
            <Pagination>
                <MedlinePgn>79-89</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0029-6465(20)30085-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cnur.2020.10.007</ELocationID>
            <Abstract>
                <AbstractText>Viral infections and their emergence continue to pose a threat to human lives. Up to the present, there are limited numbers of vaccines that effectively work and few antivirals licensed for use in clinical practice. Added to this is the increase in antiviral resistance, meaning that drugs that do work are at risk of reduced efficacy. The recent global pandemic of coronavirus 2019 has provided evidence for the risk of a preventative vaccination and effective treatment of viruses' subsequent consequences. The aim of this article is to review traditional and herbal treatments for infections, specifically addressing gastrointestinal and respiratory viral infections.</AbstractText>
                <CopyrightInformation>Copyright .. 2020 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tahmasbi</LastName>
                    <ForeName>Sherin F</ForeName>
                    <Initials>SF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Tennessee State University, School of Nursing, 3500 John A. Merritt Boulevard, Campus Box 9590, Nashville, TN 37209, USA. Electronic address: stahmasb@tnstate.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Revell</LastName>
                    <ForeName>Maria A</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Tennessee State University, School of Nursing, 3500 John A. Merritt Boulevard, Campus Box 9590, Nashville, TN 37209, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tahmasebi</LastName>
                    <ForeName>Natasha</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Kings College University, Guys Campus, Great maze pond, London SE1 1UL, England.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Nurs Clin North Am</MedlineTA>
            <NlmUniqueID>0042033</NlmUniqueID>
            <ISSNLinking>0029-6465</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <CitationSubset>N</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D057179" MajorTopicYN="N">Advanced Practice Nursing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024802" MajorTopicYN="N">Nurse's Role</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008517" MajorTopicYN="Y">Phytotherapy</DescriptorName>
                <QualifierName UI="Q000451" MajorTopicYN="N">nursing</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000451" MajorTopicYN="N">nursing</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">Gastrointestinal</Keyword>
            <Keyword MajorTopicYN="Y">Herbs</Keyword>
            <Keyword MajorTopicYN="Y">Immune</Keyword>
            <Keyword MajorTopicYN="Y">Respiratory</Keyword>
            <Keyword MajorTopicYN="Y">Viral</Keyword>
        </KeywordList>
        <CoiStatement>Disclosure The authors have nothing to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>20</Hour>
                <Minute>29</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33549288</ArticleId>
            <ArticleId IdType="pii">S0029-6465(20)30085-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cnur.2020.10.007</ArticleId>
            <ArticleId IdType="pmc">PMC7699023</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Tradit Complement Med. 2014 Jan;4(1):24-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24872930</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Res. 2018 Jun 22;19(1):123</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29929556</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Can Fam Physician. 2013 Aug;59(8):e372-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23946044</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Influenza Other Respir Viruses. 2009 Jan;3(1):37-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19453440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunopharmacol Immunotoxicol. 2012 Feb;34(1):66-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21561325</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2014 Mar 7;63(9):194-200</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24598596</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Vaccines. 2015;14(10):1299-301</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26104835</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Pharmacol. 2011 Sep;164(2):344-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21418188</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Ther Res Clin Exp. 2015 Apr 20;77:66-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26265958</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1995 Apr;69(4):2306-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7884876</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Complement Ther Med. 2013 Apr;21 Suppl 1:S34-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23578916</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncol Lett. 2018 Apr;15(4):4821-4826</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29552121</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Scientifica (Cairo). 2014;2014:430629</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24800107</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2010 Jun 10;362(23):2175-2184</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20558368</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2017 Jun;139(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28562281</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2018 Mar 27;319(12):1248-1260</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29584843</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2013 Sep;444(1-2):301-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23876457</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Bone Miner Res. 2007 Oct;22(10):1640-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17576165</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2013 Sep;99(3):371-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23820269</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2012 Jan;4(1):117-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22355455</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Ethnopharmacol. 2020 May 10;253:112671</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32081739</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Virol. 2012 Apr;2(2):168-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22445964</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2015 May 05;10(5):e0125357</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25942440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Thorac Dis. 2012 Feb;4(1):10-1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22295159</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Patient Exp. 2017 Sep;4(3):108-113</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28959715</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Evid Based Complementary Altern Med. 2017 Jan;22(1):166-174</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27055821</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2012 Jun;4(6):1011-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22816037</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microbes Infect. 2011 May;13(5):516-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21276872</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2011 Aug 16;155(4):217-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21844547</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2013 Feb 11;13:81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23398722</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2019 Jul 17;9(1):10338</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31316146</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Chemother. 2012 Aug;18(4):534-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22350323</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Molecules. 2016 Oct 20;21(10):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27775614</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2013 Jun;98(3):386-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23588232</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Microbes Infect. 2012 Dec;1(12):e46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26038413</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Evid Based Complement Alternat Med. 2017;2017:1062065</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28904550</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2017 Jul 26;7(1):6548</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28747714</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Transl Med. 2016 Jul 6;8(346):346ra91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27384347</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Tradit Chin Med. 2018 Feb;38(1):107-116</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32185959</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Pharmacol. 2014 Jan 10;4:177</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24454289</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33549263</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1942-5546</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>96</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Mayo Clinic proceedings</Title>
                <ISOAbbreviation>Mayo Clin Proc</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine.</ArticleTitle>
            <Pagination>
                <MedlinePgn>446-463</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0025-6196(20)31384-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mayocp.2020.11.024</ELocationID>
            <Abstract>
                <AbstractText>Coronavirus disease 2019 (COVID-19) is characterized by heterogeneity in susceptibility to the disease and severity of illness. Understanding inter-individual variation has important implications for not only allocation of resources but also targeting patients for escalation of care, inclusion in clinical trials, and individualized medical therapy including vaccination. In addition to geographic location and social vulnerability, there are clear biological differences such as age, sex, race, presence of comorbidities, underlying genetic variation, and differential immune response that contribute to variability in disease manifestation. These differences may have implications for precision medicine. Specific examples include the observation that androgens regulate the expression of the enzyme transmembrane protease, serine 2 which facilitates severe acute respiratory syndrome coronavirus 2 viral entry into the cell; therefore, androgen deprivation therapy is being explored as a treatment option in males infected with COVID-19. An immunophenotyping study of COVID-19 patients has shown that a subset develop T cytopenia which has prompted a clinical trial that is testing the efficacy of interleukin-7 in these patients. Predicting which COVID-19 patients will develop progressive disease that will require hospitalization has important implications for clinical trials that target outpatients. Enrollment of patients at low risk for progression of disease and hospitalization would likely not result in such therapy demonstrating efficacy. There are efforts to use artificial intelligence to integrate digital data from smartwatch applications or digital monitoring systems and biological data to enable identification of the high risk COVID-19 patient. The ultimate goal of precision medicine using such modern technology is to recognize individual differences to improve health for all.</AbstractText>
                <CopyrightInformation>Copyright .. 2020 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pereira</LastName>
                    <ForeName>Naveen L</ForeName>
                    <Initials>NL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN. Electronic address: pereira.naveen@mayo.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ahmad</LastName>
                    <ForeName>Ferhaan</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Cardiovascular Medicine, University of Iowa Carver College of Medicine Iowa City, IA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Byku</LastName>
                    <ForeName>Mirnela</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cummins</LastName>
                    <ForeName>Nathan W</ForeName>
                    <Initials>NW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Mayo Clinic, Rochester, MN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morris</LastName>
                    <ForeName>Alanna A</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cardiology, Emory University, Atlanta, GA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Owens</LastName>
                    <ForeName>Anjali</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, University of Pennsylvania, Philadelphia, PA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tuteja</LastName>
                    <ForeName>Sony</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Translational Medicine and Human Genetics, Department of Medicine, University of Pennsylvania, Philadelphia, PA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cresci</LastName>
                    <ForeName>Sharon</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine and Genetics, Washington University, St Louis, MO.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>K23 HL143161</GrantID>
                    <Acronym>HL</Acronym>
                    <Agency>NHLBI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Mayo Clin Proc</MedlineTA>
            <NlmUniqueID>0405543</NlmUniqueID>
            <ISSNLinking>0025-6196</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000073537" MajorTopicYN="Y">Biological Variation, Population</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057285" MajorTopicYN="Y">Precision Medicine</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>20</Hour>
                <Minute>29</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33549263</ArticleId>
            <ArticleId IdType="pii">S0025-6196(20)31384-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.mayocp.2020.11.024</ArticleId>
            <ArticleId IdType="pmc">PMC7713605</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2020 Sep;26(9):1978-1986</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32544053</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):467-478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2020 Jul;26(7):1478-1488</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32267220</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Nov 19;71(16):2027-2034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32221519</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Apr 7;323(13):1239-1242</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32091533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32075877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Res. 2020 Sep;159:104951</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32464327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Clin Pathol. 2020 Jun 8;154(1):1-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32412044</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jun 25;382(26):2534-2543</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32459916</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Infect. 2020 Jun;26(6):767-772</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32304745</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jul 23;383(4):334-346</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32598831</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Sep 8;324(10):951-960</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32789505</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jul 21;324(3):259-269</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32511692</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 25;384(8):693-704</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32678530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2020 Jun 29;222(2):206-213</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32427334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Epidemiol. 2020 Jul;47:37-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32419766</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Immunol. 2010 Aug;40(8):2112-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20853496</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Oct 15;383(16):1522-1534</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32558485</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2018 Jan 26;3(19):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29374079</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Discov. 2020 Feb 24;6:11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32133153</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32031570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2020 Jun 23;20(1):445</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32576139</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Jun;582(7812):389-394</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32349120</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 Jun 11;5(48):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32527802</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 12;383(20):1920-1931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32663912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32150618</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Aug;26(8):1200-1204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32555424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tob Induc Dis. 2020 Jul 03;18:58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32641924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 21;395(10228):931-934</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32164834</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 May 26;323(20):2052-2059</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32320003</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cosmet Dermatol. 2020 Jul;19(7):1545-1547</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32301221</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>mBio. 2015 May 26;6(3):e00638-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26015500</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jun 16;323(23):2386-2387</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32432681</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2017 May 15;198(10):4046-4053</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28373583</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32271728</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Res Cardiol. 2020 May;109(5):531-538</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32161990</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2019 Sep;169:104541</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31233808</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immun Ageing. 2019 Sep 13;16:25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31528180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Virol. 2016 Sep 29;3(1):237-261</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27578435</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2009 Aug 27;114(9):1794-802</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19553637</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Wellcome Open Res. 2020 Jun 11;5:139</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33748431</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 Jun 1;:1-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32410502</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32492293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Aug 20;182(4):812-827.e19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32697968</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>G3 (Bethesda). 2017 Jun 7;7(6):1653-1663</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28592648</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jul 24;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32706371</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Jul 28;71(15):778-785</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32198501</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2020 Aug;26(8):1842-1845</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32459984</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Nov 13;11(1):5761</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33188185</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 May 28;181(5):1016-1035.e19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32413319</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Heart J. 2020 May 14;41(19):1810-1817</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32388565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Oct 30;11(1):5503</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33127911</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jun 9;323(22):2340-2341</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32401274</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chim Acta. 2020 Oct;509:117-125</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32505774</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Hypotheses. 2020 Nov;144:110155</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33254482</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Nov 27;370(6520):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32994364</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Apr 14;323(14):1406-1407</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32083643</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>HLA. 2020 Sep;96(3):277-298</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32475052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):869-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24367114</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jun 18;382(25):e102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32356626</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Immunol. 2012;272(2):214-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22078320</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Nov;587(7835):610-612</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32998156</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EClinicalMedicine. 2020 Jun 03;23:100404</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32632416</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2009 Aug;83(15):7411-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19439480</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Heart. 2020 Aug;106(15):1154-1159</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32354798</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lab Chip. 2020 Jun 21;20(12):2075-2085</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32490853</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pathogens. 2020 Oct 10;9(10):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33050463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2020 Apr 28;16(4):e1008520</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32343745</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2014 May 09;348:g2943</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24816731</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Microbes Infect. 2020 Dec;9(1):833-836</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32306864</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Sep 4;369(6508):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32669297</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chem Lab Med. 2020 Jun 25;58(7):1125-1126</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32286246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2020 Aug 27;56(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32430429</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Jun;20(6):375-388</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32132681</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jun 2;323(21):2192-2195</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32347898</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am Heart J. 2021 Feb;232:84-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33129990</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Metab Syndr. 2020 May - Jun;14(3):247-250</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32247212</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Oct;26(10):1623-1635</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32807934</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Mar 19;382(12):1177-1179</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32074444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Nov 30;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33252659</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 10;383(24):2320-2332</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32877576</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32240128</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Aug 04;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32750119</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2006 Apr 20;354(16):1671-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16625008</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2007 Apr;131(4):954-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17426195</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertens Res. 2020 Jul;43(7):729-730</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32355222</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Dec 17;71(10):2688-2694</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32497196</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2015 May 15;29(8):889-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25784441</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Jul;20(7):442-447</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32528136</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chem Lab Med. 2020 Jun 25;58(7):1144-1145</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32386187</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 29;396(10251):603-611</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32822564</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc. 2020 Aug;95(8):1710-1714</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32753145</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2020 Nov 3;33(5):108352</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33113345</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2004 Mar 5;303(5663):1529-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14976261</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jul 23;383(4):347-358</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32598830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 May 08;69(18):545-550</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32379729</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Jun 27;395(10242):1955-1957</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32539937</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Mar 27;11(1):1620</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32221306</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc. 2020 Aug;95(8):1613-1620</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32753136</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chim Acta. 2020 Jun;505:192-193</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32220422</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2020 Jul 1;130(7):3350-3352</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32392184</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO Mol Med. 2020 Jun 8;12(6):e12661</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32379923</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2020 Nov 18;15(11):e0242534</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33206719</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 5;383(19):1813-1826</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32445440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32007143</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 Jun 26;38(31):4783-4791</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32507409</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc. 2020 Oct;95(10):2172-2188</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33012348</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc. 2020 Oct;95(10):2189-2203</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33012349</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Transl Med. 2020 Jun 3;12(546):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32493791</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 Apr 30;:1-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32306836</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32142651</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chem Lab Med. 2020 Jun 25;58(7):1127-1128</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32386188</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2019 Jul;18(7):553-566</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30967658</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 2020 Aug 4;142(5):429-436</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32418446</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Hum Genet. 2020 Nov;28(11):1602-1614</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32681121</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Public Health. 2020 Apr 29;8:152</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32411652</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Mar 18;368:m1090</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32188598</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aging (Albany NY). 2020 Jun 5;12(11):10087-10098</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32501810</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">33548194</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>06</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1474-4457</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>21</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>06</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The Lancet. Infectious diseases</Title>
                <ISOAbbreviation>Lancet Infect Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.</ArticleTitle>
            <Pagination>
                <MedlinePgn>803-812</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1473-3099(20)30987-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S1473-3099(20)30987-7</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">A vaccine against COVID-19 is urgently needed for older adults, in whom morbidity and mortality due to the disease are increased. We aimed to assess the safety, tolerability, and immunogenicity of a candidate COVID-19 vaccine, CoronaVac, containing inactivated SARS-CoV-2, in adults aged 60 years and older.</AbstractText>
                <AbstractText Label="METHODS">We did a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial of CoronaVac in healthy adults aged 60 years and older in Renqiu (Hebei, China). Vaccine or placebo was given by intramuscular injection in two doses (days 0 and 28). Phase 1 comprised a dose-escalation study, in which participants were allocated to two blocks: block 1 (3 ..g inactivated virus in 0..5 mL of aluminium hydroxide solution per injection) and block 2 (6 ..g per injection). Within each block, participants were randomly assigned (2:1) using block randomisation to receive CoronaVac or placebo (aluminium hydroxide solution only). In phase 2, participants were randomly assigned (2:2:2:1) using block randomisation to receive either CoronaVac at 1..5 ..g, 3 ..g, or 6 ..g per dose, or placebo. All participants, investigators, and laboratory staff were masked to treatment allocation. The primary safety endpoint was adverse reactions within 28 days after each injection in all participants who received at least one dose. The primary immunogenicity endpoint was seroconversion rate at 28 days after the second injection (which was assessed in all participants who had received the two doses of vaccine according to their random assignment, had antibody results available, and did not violate the trial protocol). Seroconversion was defined as a change from seronegative at baseline to seropositive for neutralising antibodies to live SARS-CoV-2 (positive cutoff titre 1/8), or a four-fold titre increase if the participant was seropositive at baseline. This study is ongoing and is registered with ClinicalTrials.gov (NCT04383574).</AbstractText>
                <AbstractText Label="FINDINGS">Between May 22 and June 1, 2020, 72 participants (24 in each intervention group and 24 in the placebo group; mean age 65..8 years [SD 4..8]) were enrolled in phase 1, and between June 12 and June 15, 2020, 350 participants were enrolled in phase 2 (100 in each intervention group and 50 in the placebo group; mean age 66..6 years [SD 4..7] in 349 participants). In the safety populations from both phases, any adverse reaction within 28 days after injection occurred in 20 (20%) of 100 participants in the 1..5 ..g group, 25 (20%) of 125 in the 3 ..g group, 27 (22%) of 123 in the 6 ..g group, and 15 (21%) of 73 in the placebo group. All adverse reactions were mild or moderate in severity and injection site pain (39 [9%] of 421 participants) was the most frequently reported event. As of Aug 28, 2020, eight serious adverse events, considered unrelated to vaccination, have been reported by seven (2%) participants. In phase 1, seroconversion after the second dose was observed in 24 of 24 participants (100..0% [95% CI 85..8-100..0]) in the 3 ..g group and 22 of 23 (95..7% [78..1-99..9]) in the 6 ..g group. In phase 2, seroconversion was seen in 88 of 97 participants in the 1..5 ..g group (90..7% [83..1-95..7]), 96 of 98 in the 3 ..g group (98..0% [92..8-99..8]), and 97 of 98 (99..0% [94..5-100..0]) in the 6 ..g group. There were no detectable antibody responses in the placebo groups.</AbstractText>
                <AbstractText Label="INTERPRETATION">CoronaVac is safe and well tolerated in older adults. Neutralising antibody titres induced by the 3 ..g dose were similar to those of the 6 ..g dose, and higher than those of the 1..5 ..g dose, supporting the use of the 3 ..g dose CoronaVac in phase 3 trials to assess protection against COVID-19.</AbstractText>
                <AbstractText Label="FUNDING">Chinese National Key Research and Development Program and Beijing Science and Technology Program.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Zhiwei</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Yaling</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sinovac Biotech, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Miao</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Institutes for Food and Drug Control, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Zhen</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Institutes for Food and Drug Control, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Wanqi</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sinovac Biotech, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Zhiwei</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Beijing Key Tech Statistics Technology, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Minjie</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jin</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Renqiu City Center for Disease Control and Prevention, Renqiu, Hebei, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cui</LastName>
                    <ForeName>Guoliang</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sinovac Life Sciences, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Panpan</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Renqiu City Center for Disease Control and Prevention, Renqiu, Hebei, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sinovac Biotech, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Guoqing</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Beijing Key Tech Statistics Technology, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ding</LastName>
                    <ForeName>Yuzhu</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Renqiu City Center for Disease Control and Prevention, Renqiu, Hebei, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Yuliang</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China. Electronic address: yuliang_zh1@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yin</LastName>
                    <ForeName>Weidong</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sinovac Biotech, Beijing, China. Electronic address: yinwd@sinovac.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NCT04383574</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Lancet Infect Dis</MedlineTA>
            <NlmUniqueID>101130150</NlmUniqueID>
            <ISSNLinking>1473-3099</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>Lancet Infect Dis. 2021 Jun;21(6):746-748</RefSource>
                <PMID Version="1">33548196</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>6</Day>
                <Hour>20</Hour>
                <Minute>9</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33548194</ArticleId>
            <ArticleId IdType="pii">S1473-3099(20)30987-7</ArticleId>
            <ArticleId IdType="doi">10.1016/S1473-3099(20)30987-7</ArticleId>
            <ArticleId IdType="pmc">PMC7906628</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33547453</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>01</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2397-3374</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Nature human behaviour</Title>
                <ISOAbbreviation>Nat Hum Behav</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA.</ArticleTitle>
            <Pagination>
                <MedlinePgn>337-348</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41562-021-01056-1</ELocationID>
            <Abstract>
                <AbstractText>Widespread acceptance of a vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will be the next major step in fighting the coronavirus disease 2019 (COVID-19) pandemic, but achieving high uptake will be a challenge and may be impeded by online misinformation. To inform successful vaccination campaigns, we conducted a randomized controlled trial in the UK and the USA to quantify how exposure to online misinformation around COVID-19 vaccines affects intent to vaccinate to protect oneself or others. Here we show that in both countries-as of September 2020-fewer people would 'definitely' take a vaccine than is likely required for herd immunity, and that, relative to factual information, recent misinformation induced a decline in intent of 6.2 percentage points (95th percentile interval 3.9 to 8.5) in the UK and 6.4 percentage points (95th percentile interval 4.0 to 8.8) in the USA among those who stated that they would definitely accept a vaccine. We also find that some sociodemographic groups are differentially impacted by exposure to misinformation. Finally, we show that scientific-sounding misinformation is more strongly associated with declines in vaccination intent.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Loomba</LastName>
                    <ForeName>Sahil</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5043-9746</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Mathematics, Imperial College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>de Figueiredo</LastName>
                    <ForeName>Alexandre</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7751-0645</Identifier>
                    <AffiliationInfo>
                        <Affiliation>The Vaccine Confidence Project, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. alex.defigueiredo@lshtm.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Piatek</LastName>
                    <ForeName>Simon J</ForeName>
                    <Initials>SJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Vaccine Confidence Project, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Graaf</LastName>
                    <ForeName>Kristen</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Vaccine Confidence Project, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Larson</LastName>
                    <ForeName>Heidi J</ForeName>
                    <Initials>HJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8477-7583</Identifier>
                    <AffiliationInfo>
                        <Affiliation>The Vaccine Confidence Project, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. heidi.larson@lshtm.ac.uk.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Metrics and Evaluation, University of Washington, Seattle, WA, USA. heidi.larson@lshtm.ac.uk.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. heidi.larson@lshtm.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Hum Behav</MedlineTA>
            <NlmUniqueID>101697750</NlmUniqueID>
            <ISSNLinking>2397-3374</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="ErratumIn">
                <RefSource>Nat Hum Behav. 2021 Mar 8;:</RefSource>
                <PMID Version="1">33686205</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003142" MajorTopicYN="Y">Communication</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015438" MajorTopicYN="Y">Health Behavior</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D032521" MajorTopicYN="N">Immunity, Herd</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D033182" MajorTopicYN="Y">Intention</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020407" MajorTopicYN="Y">Internet</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>4</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>6</Day>
                <Hour>5</Hour>
                <Minute>43</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33547453</ArticleId>
            <ArticleId IdType="doi">10.1038/s41562-021-01056-1</ArticleId>
            <ArticleId IdType="pii">10.1038/s41562-021-01056-1</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C. &amp; Garry, R. F. The proximal origin of SARS-CoV-2. Nat. Med. 26, 450...452 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41591-020-0820-9</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270...273 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World Health Organization. WHO Director-General...s opening remarks at the media briefing on COVID-19...11 March 2020 https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Jackson, L. A. et al. An mRNA vaccine against SARS-CoV-2...preliminary report. N. Engl. J. Med. 383, 1920...1931 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1056/NEJMoa2022483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mulligan, M. J. et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586, 589...593 (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Folegatti, P. M. et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet 396, 467...478 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/S0140-6736(20)31604-4</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pfizer. Pfizer and BioNTech conclude phase 3 study of COVID-19 vaccine candidate, meeting all primary efficacy endpoints https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>US National Institute of Allergy and Infectious Diseases. Promising interim results from clinical trial of NIH-Moderna COVID-19 vaccine https://www.nih.gov/news-events/news-releases/promising-interim-results-clinical-trial-nih-moderna-covid-19-vaccine (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet https://doi.org/10.1016/S0140-6736(20)32661-1 (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>US Food and Drug Administration. FDA takes key action in fight against COVID-19 By issuing emergency use authorization for first COVID-19 vaccine https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19 (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>US Food and Drug Administration. FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>UK Medicines and Healthcare products Regulatory Agency. UK medicines regulator gives approval for first UK COVID-19 vaccine https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>UK Department of Health and Social Care. Oxford University/AstraZeneca vaccine authorised by UK medicines regulator https://www.gov.uk/government/news/oxford-universityastrazeneca-vaccine-authorised-by-uk-medicines-regulator (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>European Medicines Agency. EMA recommends first COVID-19 vaccine for authorisation in the EU https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Kwok, K. O., Lai, F., Wei, W. I., Wong, S. Y. S. &amp; Tang, J. W. T. Herd immunity...estimating the level required to halt the COVID-19 epidemics in affected countries. J. Infect. 80, e32...e33 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.jinf.2020.03.027</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sanche, S. et al. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg. Infect. Dis. 26, 1470...1477 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.3201/eid2607.200282</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>de Figueiredo, A., Simas, C., Karafillakis, E., Paterson, P. &amp; Larson, H. J. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet 396, 898...908 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/S0140-6736(20)31558-0</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bellaby, P. Communication and miscommunication of risk: understanding UK parents... attitudes to combined MMR vaccination. BMJ 327, 725...728 (2003).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1136/bmj.327.7417.725</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Burki, T. Vaccine misinformation and social media. Lancet Digit. Health 1, E258...E259 (2019).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/S2589-7500(19)30136-0</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lo, N. C. &amp; Hotez, P. J. Public health and economic consequences of vaccine hesitancy for measles in the United States. JAMA Pediatr. 171, 887...892 (2017).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1001/jamapediatrics.2017.1695</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Megget, K. Even COVID-19 can...t kill the anti-vaccination movement. BMJ 369, m2184 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1136/bmj.m2184</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Geldsetzer, P. Knowledge and perceptions of COVID-19 among the general public in the United States and the United Kingdom: a cross-sectional online survey. Ann. Intern. Med. 173, 157...160 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.7326/M20-0912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pennycook, G., McPhetres, J., Zhang, Y., Lu, J. G. &amp; Rand, D. G. Fighting COVID-19 misinformation on social media: experimental evidence for a scalable accuracy-nudge intervention. Psychol. Sci. 31, 770...780 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1177/0956797620939054</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Salath.., M. &amp; Bonhoeffer, S. The effect of opinion clustering on disease outbreaks. J. R. Soc. Interface 5, 1505...1508 (2008).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1098/rsif.2008.0271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>McAndrew, S. &amp; Allington, D. Mode and frequency of COVID-19 information updates, political values, and future covid-19 vaccine attitudes. Preprint https://doi.org/10.31234/osf.io/j7srx (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Tyson, A., Johnson, C. &amp; Funk, C. U.S. public now divided over whether to get COVID-19 vaccine. Pew Research Center https://www.pewresearch.org/science/2020/09/17/u-s-public-now-divided-over-whether-to-get-covid-19-vaccine/ (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Peretti-Watel, P. et al. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect. Dis. 20, 769...770 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/S1473-3099(20)30426-6</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Galv..o, J. COVID-19: the deadly threat of misinformation. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(20)30721-0 (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Altmann, D. M., Douek, D. C. &amp; Boyton, R. J. What policy makers need to know about COVID-19 protective immunity. Lancet 395, 1527...1529 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/S0140-6736(20)30985-5</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zarocostas, J. How to fight an infodemic. Lancet 395, 676 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/S0140-6736(20)30461-X</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Islam, M. S. et al. COVID-19...related infodemic and its impact on public health: a global social media analysis. Am. J. Trop. Med. Hyg. 103, 1621...1629 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.4269/ajtmh.20-0812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kim, H. K., Ahn, J., Atkinson, L. &amp; Kahlor, L. A. Effects of COVID-19 misinformation on information seeking, avoidance, and processing: a multicountry comparative study. Sci Commun 42, https://doi.org/10.1177/1075547020959670 (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Kreps, S. E. &amp; Kriner, D. Medical misinformation in the COVID-19 pandemic. SSRN https://doi.org/10.2139/ssrn.3624510 (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Murphy, J., Valli..res, F. &amp; Bentall, R.P. et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat. Commun. 12, 29 (2021).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41467-020-20226-9</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Roozenbeek, J. et al. Susceptibility to misinformation about COVID-19 around the world. R. Soc. Open Sci. 7, 201199 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1098/rsos.201199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Romer, D. &amp; Jamieson, K. H. Conspiracy theories as barriers to controlling the spread of COVID-19 in the U.S. Soc. Sci. Med. 263, 113356 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.socscimed.2020.113356</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ernala, S. K., Burke, M., Leavitt, A. &amp; Ellison, N. B. How well do people report time spent on Facebook? In Proc. 2020 CHI Conference on Human Factors in Computing Systems (ACM, 2020); https://doi.org/10.1145/3313831.3376435</Citation>
            </Reference>
            <Reference>
                <Citation>National Health Service England. Protect your loved ones https://www.nhs.uk/apps-library/nhs-covid-19/ (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>National Health Service England. We must keep on protecting each other https://coronavirusresources.phe.gov.uk/Hands-Face-Space-/resources/co-branded-posters/ (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>US Centers for Disease Control and Prevention. Do it for yourself and your friends. https://www.cdc.gov/coronavirus/2019-ncov/downloads/Young-Mitigation-recommendations-resources-toolkit-COL.pdf (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>US Centers for Disease Control and Prevention. Wear a mask to protect you and your friends. https://www.cdc.gov/coronavirus/2019-ncov/downloads/Young-Mitigation-recommendations-resources-toolkit.pdf (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Lazer, D. M. J. et al. The science of fake news. Science 359, 1094...1096 (2018).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1126/science.aao2998</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vraga, E. K. &amp; Bode, L. Defining misinformation and understanding its bounded nature: Using expertise and evidence for describing misinformation. Political Commun. 37, 136...144 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1080/10584609.2020.1716500</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Graham, M. &amp; Coppock, A. Asking about attitude change. Public Opinion Quarterly (in the press).</Citation>
            </Reference>
            <Reference>
                <Citation>Zhu, B. et al. Brief exposure to misinformation can lead to long-term false memories. Appl. Cogn. Psychol. 26, 301...307 (2012).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1002/acp.1825</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Paul, E., Steptoe, A. &amp; Fancourt, D. Attitudes towards vaccines and intention to vaccinate against COVID-19: implications for public health communications. Lancet Reg. Health Eur. https://doi.org/10.1016/j.lanepe.2020.100012 (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Malik, A. A., McFadden, S. M., Elharake, J. &amp; Omer, S. B. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine 26, 100495 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.eclinm.2020.100495</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>de Figueiredo, A. Sub-national forecasts of COVID-19 vaccine acceptance across the UK: a large-scale cross-sectional spatial modelling study. Preprint at medRxiv https://doi.org/10.1101/2020.12.17.20248382 (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Callaghan, T. et al. Correlates and disparities of COVID-19 vaccine hesitancy. SSRN https://doi.org/10.2139/ssrn.3667971 (2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Motta, M., Callaghan, T. &amp; Sylvester, S. Knowing less but presuming more: Dunning...Kruger effects and the endorsement of anti-vaccine policy attitudes. Soc. Sci. Med. 211, 274...281 (2018).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.socscimed.2018.06.032</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bakshy, E., Messing, S. &amp; Adamic, L. A. Exposure to ideologically diverse news and opinion on Facebook. Science 348, 1130...1132 (2015).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1126/science.aaa1160</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Del Vicario, M. et al. The spreading of misinformation online. Proc. Natl Acad. Sci. USA 113, 554...559 (2016).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1073/pnas.1517441113</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Del Vicario, M., Quattrociocchi, F., Scala, S. &amp; Zollo, F. Polarization and fake news: early warning of potential misinformation targets. ACM Trans. Web 13, 10 (2019).</Citation>
            </Reference>
            <Reference>
                <Citation>Schmidt, A. L., Zollo, F., Scala, A., Betsch, C. &amp; Quattrociocchi, W. Polarization of the vaccination debate on Facebook. Vaccine 36, 3606...3612 (2018).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.vaccine.2018.05.040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cossard, A. et al. Falling into the echo chamber: the Italian vaccination debate on Twitter. In Proc. 14th International AAAI Conference on Web and Social Media 130...140 (AAAI, 2020).</Citation>
            </Reference>
            <Reference>
                <Citation>Vosoughi, S., Roy, D. &amp; Aral, S. The spread of true and false news online. Science 359, 1146...1151 (2018).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1126/science.aap9559</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pluviano, S., Watt, C. &amp; della Sala, S. Misinformation lingers in memory: failure of three pro-vaccination strategies. PLOS ONE 12, e0181640 (2017).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1371/journal.pone.0181640</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cinelli, M. et al. The COVID-19 social media infodemic. Sci. Rep. 10, 16598 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41598-020-73510-5</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>US Census Bureau. Census regions and divisions of the United States. https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf (2010).</Citation>
            </Reference>
            <Reference>
                <Citation>An Overview of the 3 NUTS and 2 LAU Layers in the UK (UK Office for National Statistics, accessed September 2020); https://www.ons.gov.uk/methodology/geography/ukgeographies/eurostat</Citation>
            </Reference>
            <Reference>
                <Citation>Rubin, D. B. Estimating causal effects of treatments in randomized and nonrandomized studies. J. Educ. Psychol. 66, 688...701 (1974).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1037/h0037350</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Holland, P. W. Statistics and causal inference. J. Am. Stat. Assoc. 81, 945...960 (1986).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1080/01621459.1986.10478354</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>B..rkner, P. &amp; Charpentier, E. Modelling monotonic effects of ordinal predictors in Bayesian regression models. Br. J. Math. Stat. Psychol. 73, 42...451 (2020).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1111/bmsp.12195</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>McElreath, R. Statistical Rethinking: A Bayesian Course with Examples in R and STAN (CRC Press, 2020).</Citation>
            </Reference>
            <Reference>
                <Citation>McCullagh, P. Regression models for ordinal data. J. R. Stat. Soc. 42, 109...142 (1980).</Citation>
            </Reference>
            <Reference>
                <Citation>Wang, C., Dominici, F., Parmigiani, G. &amp; Zigler, C. M. Accounting for uncertainty in confounder and effect modifier selection when estimating average causal effects in generalized linear models. Biometrics 71, 654...6565 (2015).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1111/biom.12315</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Boes, S. Nonparametric analysis of treatment effects in ordered response models. Empir. Econ. 44, 81...109 (2013).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1007/s00181-010-0354-y</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Volfovsky, A., Airoldi, E. M. &amp; Rubin, D. B. Causal inference for ordinal outcomes. Preprint at arXiv https://arxiv.org/abs/1501.01234 (2015).</Citation>
            </Reference>
            <Reference>
                <Citation>PyStan: the Python Interface to Stan Version 2.17.1.0 (Stan Development Team, 2019).</Citation>
            </Reference>
            <Reference>
                <Citation>Gelman, A. &amp; Rubin, D. B. Inference from iterative simulation using multiple sequences. Stat. Sci. 7, 457...472 (1992).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1214/ss/1177011136</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vehtari, A., Gelman, A., Simpson, D., Carpenter, B. &amp; B..rkner, P.-C. Rank-normalization, folding, and localization: an improved .. for assessing convergence of MCMC. Bayesian Anal. https://doi.org/10.1214/20-BA1221 (2020).</Citation>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33547431</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>19</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1476-4687</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>590</Volume>
                    <Issue>7846</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Nature</Title>
                <ISOAbbreviation>Nature</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Could mixing COVID vaccines boost immune response?</ArticleTitle>
            <Pagination>
                <MedlinePgn>375-376</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/d41586-021-00315-5</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ledford</LastName>
                    <ForeName>Heidi</ForeName>
                    <Initials>H</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016433">News</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nature</MedlineTA>
            <NlmUniqueID>0410462</NlmUniqueID>
            <ISSNLinking>0028-0836</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014614">Vaccines, Synthetic</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C000711953">mRNA Vaccine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004345" MajorTopicYN="N">Drug Industry</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007117" MajorTopicYN="N">Immunization, Secondary</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014614" MajorTopicYN="N">Vaccines, Synthetic</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Immunology</Keyword>
            <Keyword MajorTopicYN="Y">Infection</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">Vaccines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>6</Day>
                <Hour>5</Hour>
                <Minute>42</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33547431</ArticleId>
            <ArticleId IdType="doi">10.1038/d41586-021-00315-5</ArticleId>
            <ArticleId IdType="pii">10.1038/d41586-021-00315-5</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Logunov, D. Y. et al. Lancet https://doi.org/10.1016/S0140-6736(21)00234-8 (2021).</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/S0140-6736(21)00234-8</ArticleId>
                    <ArticleId IdType="pubmed">33545094</ArticleId>
                    <ArticleId IdType="pmcid">7852454</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Spencer, A. J. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.01.28.428665 (2021).</Citation>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33545094</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>26</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1474-547X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>397</Volume>
                    <Issue>10275</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>20</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Lancet (London, England)</Title>
                <ISOAbbreviation>Lancet</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.</ArticleTitle>
            <Pagination>
                <MedlinePgn>671-681</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0140-6736(21)00234-8</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(21)00234-8</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), showed a good safety profile and induced strong humoral and cellular immune responses in participants in phase 1/2 clinical trials. Here, we report preliminary results on the efficacy and safety of Gam-COVID-Vac from the interim analysis of this phase 3 trial.</AbstractText>
                <AbstractText Label="METHODS">We did a randomised, double-blind, placebo-controlled, phase 3 trial at 25 hospitals and polyclinics in Moscow, Russia. We included participants aged at least 18 years, with negative SARS-CoV-2 PCR and IgG and IgM tests, no infectious diseases in the 14 days before enrolment, and no other vaccinations in the 30 days before enrolment. Participants were randomly assigned (3:1) to receive vaccine or placebo, with stratification by age group. Investigators, participants, and all study staff were masked to group assignment. The vaccine was administered (0..5 mL/dose) intramuscularly in a prime-boost regimen: a 21-day interval between the first dose (rAd26) and the second dose (rAd5), both vectors carrying the gene for the full-length SARS-CoV-2 glycoprotein S. The primary outcome was the proportion of participants with PCR-confirmed COVID-19 from day 21 after receiving the first dose. All analyses excluded participants with protocol violations: the primary outcome was assessed in participants who had received two doses of vaccine or placebo, serious adverse events were assessed in all participants who had received at least one dose at the time of database lock, and rare adverse events were assessed in all participants who had received two doses and for whom all available data were verified in the case report form at the time of database lock. The trial is registered at ClinicalTrials.gov (NCT04530396).</AbstractText>
                <AbstractText Label="FINDINGS">Between Sept 7 and Nov 24, 2020, 21...977 adults were randomly assigned to the vaccine group (n=16...501) or the placebo group (n=5476). 19...866 received two doses of vaccine or placebo and were included in the primary outcome analysis. From 21 days after the first dose of vaccine (the day of dose 2), 16 (0..1%) of 14...964 participants in the vaccine group and 62 (1..3%) of 4902 in the placebo group were confirmed to have COVID-19; vaccine efficacy was 91..6% (95% CI 85..6-95..2). Most reported adverse events were grade 1 (7485 [94..0%] of 7966 total events). 45 (0..3%) of 16...427 participants in the vaccine group and 23 (0..4%) of 5435 participants in the placebo group had serious adverse events; none were considered associated with vaccination, with confirmation from the independent data monitoring committee. Four deaths were reported during the study (three [&lt;0..1%] of 16 427 participants in the vaccine group and one [&lt;0..1%] of 5435 participants in the placebo group), none of which were considered related to the vaccine.</AbstractText>
                <AbstractText Label="INTERPRETATION">This interim analysis of the phase 3 trial of Gam-COVID-Vac showed 91..6% efficacy against COVID-19 and was well tolerated in a large cohort.</AbstractText>
                <AbstractText Label="FUNDING">Moscow City Health Department, Russian Direct Investment Fund, and Sberbank.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Logunov</LastName>
                    <ForeName>Denis Y</ForeName>
                    <Initials>DY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia. Electronic address: ldenisy@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dolzhikova</LastName>
                    <ForeName>Inna V</ForeName>
                    <Initials>IV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shcheblyakov</LastName>
                    <ForeName>Dmitry V</ForeName>
                    <Initials>DV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tukhvatulin</LastName>
                    <ForeName>Amir I</ForeName>
                    <Initials>AI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zubkova</LastName>
                    <ForeName>Olga V</ForeName>
                    <Initials>OV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dzharullaeva</LastName>
                    <ForeName>Alina S</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kovyrshina</LastName>
                    <ForeName>Anna V</ForeName>
                    <Initials>AV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lubenets</LastName>
                    <ForeName>Nadezhda L</ForeName>
                    <Initials>NL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grousova</LastName>
                    <ForeName>Daria M</ForeName>
                    <Initials>DM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Erokhova</LastName>
                    <ForeName>Alina S</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Botikov</LastName>
                    <ForeName>Andrei G</ForeName>
                    <Initials>AG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Izhaeva</LastName>
                    <ForeName>Fatima M</ForeName>
                    <Initials>FM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Popova</LastName>
                    <ForeName>Olga</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ozharovskaya</LastName>
                    <ForeName>Tatiana A</ForeName>
                    <Initials>TA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Esmagambetov</LastName>
                    <ForeName>Ilias B</ForeName>
                    <Initials>IB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Favorskaya</LastName>
                    <ForeName>Irina A</ForeName>
                    <Initials>IA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zrelkin</LastName>
                    <ForeName>Denis I</ForeName>
                    <Initials>DI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Voronina</LastName>
                    <ForeName>Daria V</ForeName>
                    <Initials>DV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shcherbinin</LastName>
                    <ForeName>Dmitry N</ForeName>
                    <Initials>DN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Semikhin</LastName>
                    <ForeName>Alexander S</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Simakova</LastName>
                    <ForeName>Yana V</ForeName>
                    <Initials>YV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tokarskaya</LastName>
                    <ForeName>Elizaveta A</ForeName>
                    <Initials>EA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Egorova</LastName>
                    <ForeName>Daria A</ForeName>
                    <Initials>DA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shmarov</LastName>
                    <ForeName>Maksim M</ForeName>
                    <Initials>MM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nikitenko</LastName>
                    <ForeName>Natalia A</ForeName>
                    <Initials>NA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gushchin</LastName>
                    <ForeName>Vladimir A</ForeName>
                    <Initials>VA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Smolyarchuk</LastName>
                    <ForeName>Elena A</ForeName>
                    <Initials>EA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Autonomous Educational Institution of Higher Education I M Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zyryanov</LastName>
                    <ForeName>Sergey K</ForeName>
                    <Initials>SK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Peoples' Friendship University of Russia (RUDN University), Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Borisevich</LastName>
                    <ForeName>Sergei V</ForeName>
                    <Initials>SV</Initials>
                    <AffiliationInfo>
                        <Affiliation>48 Central Research Institute of the Ministry of Defence of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Naroditsky</LastName>
                    <ForeName>Boris S</ForeName>
                    <Initials>BS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gintsburg</LastName>
                    <ForeName>Alexander L</ForeName>
                    <Initials>AL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal State Budget Institution &quot;National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya&quot; of the Ministry of Health of the Russian Federation, Moscow, Russia; Federal State Autonomous Educational Institution of Higher Education I M Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>Gam-COVID-Vac Vaccine Trial Group</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NCT04530396</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>02</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Lancet</MedlineTA>
            <NlmUniqueID>2985213R</NlmUniqueID>
            <ISSNLinking>0140-6736</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014614">Vaccines, Synthetic</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>Lancet. 2021 Feb 20;397(10275):642-643</RefSource>
                <PMID Version="1">33545098</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="ErratumIn">
                <RefSource>Lancet. 2021 Feb 20;397(10275):670</RefSource>
                <PMID Version="1">33610213</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>Lancet. 2021 Mar 13;397(10278):958</RefSource>
                <PMID Version="1">33714379</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>Lancet. 2021 May 22;397(10288):1883-1884</RefSource>
                <PMID Version="1">33991474</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007117" MajorTopicYN="N">Immunization, Secondary</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007273" MajorTopicYN="N">Injections, Intramuscular</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009031" MajorTopicYN="N" Type="Geographic">Moscow</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014614" MajorTopicYN="N">Vaccines, Synthetic</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>20</Hour>
                <Minute>9</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33545094</ArticleId>
            <ArticleId IdType="pii">S0140-6736(21)00234-8</ArticleId>
            <ArticleId IdType="doi">10.1016/S0140-6736(21)00234-8</ArticleId>
            <ArticleId IdType="pmc">PMC7852454</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33545014</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2164-554X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Human vaccines &amp; immunotherapeutics</Title>
                <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Coronavirus (SARS-CoV-2): a systematic review for potential vaccines.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-18</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2020.1865774</ELocationID>
            <Abstract>
                <AbstractText>COVID-19 is an international public health emergency in need of effective and safe vaccines for SARS-CoV-2. A systematic review has been done to analyze the availability, development and status of new COVID-19 vaccine candidates as well as the status of vaccines for other diseases that might be effective against SARS-CoV-2 infection. PubMed, MEDLINE, EMBASE, Science Direct, Google Scholar, Cochrane library, ClinicalTrials.gov, Web of Science and different trial registries were searched for currently available and probable future vaccines. Articles and ongoing clinical trials are included to ascertain the availability and developmental approaches of new vaccines that could limit the present and future outbreaks. Pharmaceutical companies and institutions are at different stages of developing new vaccines, and extensive studies and clinical trials are still required.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bhatta</LastName>
                    <ForeName>Mihir</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-8850-7604</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nandi</LastName>
                    <ForeName>Srijita</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dutta</LastName>
                    <ForeName>Shanta</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Saha</LastName>
                    <ForeName>Malay Kumar</ForeName>
                    <Initials>MK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Hum Vaccin Immunother</MedlineTA>
            <NlmUniqueID>101572652</NlmUniqueID>
            <ISSNLinking>2164-5515</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">clinical trial</Keyword>
            <Keyword MajorTopicYN="N">coronavirus</Keyword>
            <Keyword MajorTopicYN="N">covid-19</Keyword>
            <Keyword MajorTopicYN="N">vaccine candidates</Keyword>
            <Keyword MajorTopicYN="N">vaccine development</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>20</Hour>
                <Minute>8</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33545014</ArticleId>
            <ArticleId IdType="doi">10.1080/21645515.2020.1865774</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33544720</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1553-7358</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>17</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                    </PubDate>
                </JournalIssue>
                <Title>PLoS computational biology</Title>
                <ISOAbbreviation>PLoS Comput Biol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e1008686</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pcbi.1008686</ELocationID>
            <Abstract>
                <AbstractText>The novelty of new human coronavirus COVID-19/SARS-CoV-2 and the lack of effective drugs and vaccines gave rise to a wide variety of strategies employed to fight this worldwide pandemic. Many of these strategies rely on the repositioning of existing drugs that could shorten the time and reduce the cost compared to de novo drug discovery. In this study, we presented a new network-based algorithm for drug repositioning, called SAveRUNNER (Searching off-lAbel dRUg aNd NEtwoRk), which predicts drug-disease associations by quantifying the interplay between the drug targets and the disease-specific proteins in the human interactome via a novel network-based similarity measure that prioritizes associations between drugs and diseases locating in the same network neighborhoods. Specifically, we applied SAveRUNNER on a panel of 14 selected diseases with a consolidated knowledge about their disease-causing genes and that have been found to be related to COVID-19 for genetic similarity (i.e., SARS), comorbidity (e.g., cardiovascular diseases), or for their association to drugs tentatively repurposed to treat COVID-19 (e.g., malaria, HIV, rheumatoid arthritis). Focusing specifically on SARS subnetwork, we identified 282 repurposable drugs, including some the most rumored off-label drugs for COVID-19 treatments (e.g., chloroquine, hydroxychloroquine, tocilizumab, heparin), as well as a new combination therapy of 5 drugs (hydroxychloroquine, chloroquine, lopinavir, ritonavir, remdesivir), actually used in clinical practice. Furthermore, to maximize the efficiency of putative downstream validation experiments, we prioritized 24 potential anti-SARS-CoV repurposable drugs based on their network-based similarity values. These top-ranked drugs include ACE-inhibitors, monoclonal antibodies (e.g., anti-IFN.., anti-TNF.., anti-IL12, anti-IL1.., anti-IL6), and thrombin inhibitors. Finally, our findings were in-silico validated by performing a gene set enrichment analysis, which confirmed that most of the network-predicted repurposable drugs may have a potential treatment effect against human coronavirus infections.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fiscon</LastName>
                    <ForeName>Giulia</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">0000-0002-3354-8203</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Analysis and Computer Science &quot;Antonio Ruberti&quot;, National Research Council, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Fondazione per la Medicina Personalizzata, Genova, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Conte</LastName>
                    <ForeName>Federica</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">0000-0003-0427-1476</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Analysis and Computer Science &quot;Antonio Ruberti&quot;, National Research Council, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Farina</LastName>
                    <ForeName>Lorenzo</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Computer, Control and Management Engineering, Sapienza University of Rome, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paci</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">0000-0002-9393-2047</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Computer, Control and Management Engineering, Sapienza University of Rome, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D023362">Evaluation Study</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D023361">Validation Study</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS Comput Biol</MedlineTA>
            <NlmUniqueID>101238922</NlmUniqueID>
            <ISSNLinking>1553-734X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <SupplMeshList>
            <SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058492" MajorTopicYN="N">Drug Repositioning</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000076662" MajorTopicYN="N">Host Microbial Interactions</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D060066" MajorTopicYN="N">Protein Interaction Maps</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>17</Hour>
                <Minute>12</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33544720</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pcbi.1008686</ArticleId>
            <ArticleId IdType="pii">PCOMPBIOL-D-20-01120</ArticleId>
            <ArticleId IdType="pmc">PMC7891752</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Artif Intell Med. 2015 Jan;63(1):41-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25704113</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2018 Jul 12;9(1):2691</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30002366</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmgenomics Pers Med. 2020 Oct 23;13:531-542</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33122936</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L211-L217</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32519894</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2010 Jan 1;26(1):145-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19864262</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Netw Open. 2020 Apr 24;3(4):e208857</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32330277</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2020 Apr;55(4):105932</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32145363</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Thromb Haemost. 2020 May;18(5):1094-1099</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32220112</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29126136</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 11;384(6):497-511</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33264556</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Cardiol Rep. 2020 Apr 14;22(5):31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32291526</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32007145</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32187464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Wiley Interdiscip Rev Syst Biol Med. 2020 Nov;12(6):e1489</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32307915</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32031570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32020029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Thromb Haemost. 2020 May;18(5):1020-1022</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32239799</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2020 May;177:104762</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32147496</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2019 Nov 28;20(23):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31795299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Genet. 2011 Jan;12(1):56-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21164525</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 May 26;323(20):2052-2059</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32320003</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>OMICS. 2012 May;16(5):284-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22455463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jul 16;383(3):e11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32302075</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32074550</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 May 2;395(10234):1407-1409</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32278362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharm Anal. 2020 Apr;10(2):102-108</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32282863</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brief Bioinform. 2016 Jan;17(1):2-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25832646</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Dec;70(6 Pt 2):066111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15697438</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2004 Mar;59(3):252-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14985565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Discov. 2020 Mar 18;6:16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32194981</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2020 May;69(5):841-851</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31409604</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2004 Feb;10(2):317-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15030704</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2017 Nov 30;171(6):1437-1452.e17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29195078</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2019 Jan;18(1):41-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30310233</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virus Res. 2008 Apr;133(1):13-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17374415</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brief Bioinform. 2018 Sep 28;19(5):878-892</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28334136</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 16;43(0):E014</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32061198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Discov. 2020 Mar 16;6:14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32194980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2020 Jan 8;48(D1):D1031-D1041</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31691823</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stress. 2020 Mar 02;4(4):66-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32292881</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2016 Sep 1;32(17):2664-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27153662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Regul Homeost Agents. 2020 Mar 14;34(2):327-331</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32171193</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Apr;20(4):398-400</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32113510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Apr;20(4):400-402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32113509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Genet. 2008 Feb;40(2):124-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18227866</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 2012 Oct;92(4):414-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22992668</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Res. 2020 Jun;156:104803</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32289478</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2019 Nov 14;2019(11):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31742665</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microbiol Mol Biol Rev. 2012 Mar;76(1):16-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22390970</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105923</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32070753</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Comput Biol. 2012;8(5):e1002503</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22589709</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Contemp Clin Trials. 2020 Nov;98:106165</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33031955</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Microbiol. 2020 Apr;5(4):536-544</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32123347</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mil Med Res. 2020 Feb 6;7(1):4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32029004</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Pharmacol. 2020 Aug 21;11:1307</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32973526</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virus Res. 2007 Sep;128(1-2):1-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17532082</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32311448</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Heart Assoc. 2020 Apr 7;9(7):e016219</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32233755</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2015 Feb 20;347(6224):1257601</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25700523</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 May 12;323(18):1824-1836</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32282022</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immune Netw. 2018 Oct 17;18(5):e33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30402328</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2020 Apr;8(4):e21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32171062</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32192578</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prog Cardiovasc Dis. 2020 May - Jun;63(3):383-385</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32061635</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 5;383(19):1813-1826</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32445440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32007143</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pac Symp Biocomput. 2013;:53-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23424111</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jun 11;382(24):2327-2336</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32275812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32142651</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Biol Sci. 2018 Jul 13;14(10):1232-1244</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30123072</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Jul;583(7816):459-468</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32353859</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Immunol. 2020 May;214:108393</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32222466</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33544024</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2164-554X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Human vaccines &amp; immunotherapeutics</Title>
                <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-3</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2021.1872344</ELocationID>
            <Abstract>
                <AbstractText>Bacillus Calmette-Gu..rin (BCG) vaccine is known to have &quot;bystander benefits&quot; in protecting against heterologous infections; interim analysis of the &quot;ACTIVATE&quot; trial shows protection against respiratory infections in the elderly population. Epidemiologic studies suggest a potential benefit of BCG vaccination on COVID-19 outcomes. Differential past BCG vaccination policies between the former East and West German states provides a unique natural experiment to assess the potential effect of prior BCG vaccination on COVID-19. We estimated a 5% heterologous vaccine efficacy in the highly vaccinated former East Germany using the COVID-19 International Modeling (CoMo) Consortium model. A comparable BCG vaccination campaign undertaken prior to the pandemic in former West Germany, instituted along with known country-wide transmission reduction measures, is associated with a 37% decrease in projected mortality by mid-summer, 2020. These findings support a combined heterologous vaccine and non-pharmaceutical interventions (HVI+NPI) approach to mitigate the SARS-CoV-2 pandemic until SARS-CoV-2 specific vaccines are widely distributed.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mar..n-Hern..ndez</LastName>
                    <ForeName>Daniela</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-1362-6881</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, Belfer Research Building, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nixon</LastName>
                    <ForeName>Douglas F</ForeName>
                    <Initials>DF</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-2801-1786</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, Belfer Research Building, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hupert</LastName>
                    <ForeName>Nathaniel</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-7590-3680</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Hum Vaccin Immunother</MedlineTA>
            <NlmUniqueID>101572652</NlmUniqueID>
            <ISSNLinking>2164-5515</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">BCG</Keyword>
            <Keyword MajorTopicYN="N">CoMo model</Keyword>
            <Keyword MajorTopicYN="N">Heterologous effects</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">mathematical model</Keyword>
            <Keyword MajorTopicYN="N">model-based experiment</Keyword>
            <Keyword MajorTopicYN="N">non-pharmaceutical-interventions</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>12</Hour>
                <Minute>11</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33544024</ArticleId>
            <ArticleId IdType="doi">10.1080/21645515.2021.1872344</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33542114</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>23</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1095-9203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>371</Volume>
                    <Issue>6529</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Science (New York, N.Y.)</Title>
                <ISOAbbreviation>Science</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Two new vaccines deliver good and bad news for the pandemic.</ArticleTitle>
            <Pagination>
                <MedlinePgn>548-549</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1126/science.371.6529.548</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cohen</LastName>
                    <ForeName>Jon</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>With reporting by Meredith Wadman.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016433">News</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Science</MedlineTA>
            <NlmUniqueID>0404511</NlmUniqueID>
            <ISSNLinking>0036-8075</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <SupplMeshList>
            <SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D032541" MajorTopicYN="N">Mass Vaccination</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013019" MajorTopicYN="N" Type="Geographic">South Africa</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>5</Hour>
                <Minute>47</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33542114</ArticleId>
            <ArticleId IdType="pii">371/6529/548</ArticleId>
            <ArticleId IdType="doi">10.1126/science.371.6529.548</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33539825</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>05</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-6868</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>224</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>05</Month>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of obstetrics and gynecology</Title>
                <ISOAbbreviation>Am J Obstet Gynecol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients.</ArticleTitle>
            <Pagination>
                <MedlinePgn>470-478</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0002-9378(21)00082-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajog.2021.01.027</ELocationID>
            <Abstract>
                <AbstractText>The development of coronavirus disease 2019 vaccines in the current and planned clinical trials is essential for the success of a public health response. This paper focuses on how physicians should implement the results of these clinical trials when counseling patients who are pregnant, planning to become pregnant, breastfeeding or planning to breastfeed about vaccines with government authorization for clinical use. Determining the most effective approach to counsel patients about coronavirus disease 2019 vaccination is challenging. We address the professionally responsible counseling of 3 groups of patients-those who are pregnant, those planning to become pregnant, and those breastfeeding or planning to breastfeed. We begin with an evidence-based account of the following 5 major challenges: the limited evidence base, the documented increased risk for severe disease among pregnant coronavirus disease 2019-infected patients, conflicting guidance from government agencies and professional associations, false information about coronavirus disease 2019 vaccines, and maternal mistrust and vaccine hesitancy. We subsequently provide evidence-based, ethically justified, practical guidance for meeting these challenges in the professionally responsible counseling of patients about coronavirus disease 2019 vaccination. To guide the professionally responsible counseling of patients who are pregnant, planning to become pregnant, and breastfeeding or planning to breastfeed, we explain how obstetrician-gynecologists should evaluate the current clinical information, why a recommendation of coronavirus disease 2019 vaccination should be made, and how this assessment should be presented to patients during the informed consent process with the goal of empowering them to make informed decisions. We also present a proactive account of how to respond when patients refuse the recommended vaccination, including the elements of the legal obligation of informed refusal and the ethical obligation to ask patients to reconsider. During this process, the physician should be alert to vaccine hesitancy, ask patients to express their hesitation and reasons for it, and respectfully address them. In contrast to the conflicting guidance from government agencies and professional associations, evidence-based professional ethics in obstetrics and gynecology provides unequivocal and clear guidance: Physicians should recommend coronavirus disease 2019 vaccination to patients who are pregnant, planning to become pregnant, and breastfeeding or planning to breastfeed. To prevent widening of the health inequities, build trust in the health benefits of vaccination, and encourage coronavirus disease 2019 vaccine and treatment uptake, in addition to recommending coronavirus disease 2019 vaccinations, physicians should engage with communities to tailor strategies to overcome mistrust and deliver evidence-based information, robust educational campaigns, and novel approaches to immunization.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chervenak</LastName>
                    <ForeName>Frank A</ForeName>
                    <Initials>FA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Obstetrics and Gynecology, Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY. Electronic address: fchervenak@northwell.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McCullough</LastName>
                    <ForeName>Laurence B</ForeName>
                    <Initials>LB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Obstetrics and Gynecology, Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bornstein</LastName>
                    <ForeName>Eran</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Obstetrics and Gynecology, Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Johnson</LastName>
                    <ForeName>Lisa</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Obstetrics and Gynecology, Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Katz</LastName>
                    <ForeName>Adi</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Obstetrics and Gynecology, Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McLeod-Sordjan</LastName>
                    <ForeName>Renee</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, Hofstra/Northwell School of Nursing &amp; PA Studies Northwell Health, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nimaroff</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics &amp; Gynecology, Zucker School of Medicine at Hofstra/Northwell, North Shore University Hospital, Manhasset, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rochelson</LastName>
                    <ForeName>Burton L</ForeName>
                    <Initials>BL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics &amp; Gynecology, Zucker School of Medicine at Hofstra/Northwell, North Shore University Hospital, Manhasset, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tekbali</LastName>
                    <ForeName>Asma</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology, Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Warman</LastName>
                    <ForeName>Ashley</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Medical Ethics, Department of Medicine, Lenox Hill Hospital, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Williams</LastName>
                    <ForeName>Kim</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pediatrics/Neonatology, Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gr..nebaum</LastName>
                    <ForeName>Amos</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Obstetrics and Gynecology, Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Obstet Gynecol</MedlineTA>
            <NlmUniqueID>0370476</NlmUniqueID>
            <ISSNLinking>0002-9378</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D001942" MajorTopicYN="N">Breast Feeding</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003376" MajorTopicYN="Y">Counseling</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006176" MajorTopicYN="N">Gynecology</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007258" MajorTopicYN="N">Informed Consent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009774" MajorTopicYN="N">Obstetrics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
                <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">autonomy</Keyword>
            <Keyword MajorTopicYN="Y">becoming pregnant</Keyword>
            <Keyword MajorTopicYN="Y">beneficence</Keyword>
            <Keyword MajorTopicYN="Y">breastfeeding</Keyword>
            <Keyword MajorTopicYN="Y">clinical trials</Keyword>
            <Keyword MajorTopicYN="Y">counseling</Keyword>
            <Keyword MajorTopicYN="Y">informed consent</Keyword>
            <Keyword MajorTopicYN="Y">informed refusal</Keyword>
            <Keyword MajorTopicYN="Y">mRNA vaccines</Keyword>
            <Keyword MajorTopicYN="Y">pregnancy</Keyword>
            <Keyword MajorTopicYN="Y">professional ethics</Keyword>
            <Keyword MajorTopicYN="Y">shared decision-making</Keyword>
            <Keyword MajorTopicYN="Y">vaccination</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>5</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>20</Hour>
                <Minute>12</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33539825</ArticleId>
            <ArticleId IdType="pii">S0002-9378(21)00082-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ajog.2021.01.027</ArticleId>
            <ArticleId IdType="pmc">PMC7849424</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33539728</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1474-547X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>397</Volume>
                    <Issue>10274</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Lancet (London, England)</Title>
                <ISOAbbreviation>Lancet</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19 vaccine research and the trouble with clinical equipoise.</ArticleTitle>
            <Pagination>
                <MedlinePgn>576</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0140-6736(21)00198-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(21)00198-7</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Friesen</LastName>
                    <ForeName>Phoebe</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Ethics Unit, McGill University, Montreal, QC, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Caplan</LastName>
                    <ForeName>Arthur L</ForeName>
                    <Initials>AL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Medical Ethics, New York University, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Miller</LastName>
                    <ForeName>Jennifer E</ForeName>
                    <Initials>JE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Yale School of Medicine, Yale University, New Haven, CT 06520, USA; Bioethics International, New York, NY, USA. Electronic address: jennifer.e.miller@yale.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Lancet</MedlineTA>
            <NlmUniqueID>2985213R</NlmUniqueID>
            <ISSNLinking>0140-6736</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000076722" MajorTopicYN="N">Drug Development</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
                <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057212" MajorTopicYN="Y">Therapeutic Equipoise</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>20</Hour>
                <Minute>11</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33539728</ArticleId>
            <ArticleId IdType="pii">S0140-6736(21)00198-7</ArticleId>
            <ArticleId IdType="doi">10.1016/S0140-6736(21)00198-7</ArticleId>
            <ArticleId IdType="pmc">PMC7906638</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Bioethics. 2019 Mar;33(3):326-334</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30051635</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Nov 20;371:m4552</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33219049</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 14;384(2):e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33264543</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1987 Jul 16;317(3):141-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3600702</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33539333</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>05</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1545-861X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>70</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>MMWR. Morbidity and mortality weekly report</Title>
                <ISOAbbreviation>MMWR Morb Mortal Wkly Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program - United States, December 14, 2020-January 14, 2021.</ArticleTitle>
            <Pagination>
                <MedlinePgn>174-177</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.15585/mmwr.mm7005e1</ELocationID>
            <Abstract>
                <AbstractText>In December 2020, two COVID-19 vaccines (Pfizer-BioNTech and Moderna) were authorized for emergency use in the United States for the prevention of coronavirus disease 2019 (COVID-19).* Because of limited initial vaccine supply, the Advisory Committee on Immunization Practices (ACIP) prioritized vaccination of health care personnel<sup>...</sup> and residents and staff members of long-term care facilities (LTCF) during the first phase of the U.S. COVID-19 vaccination program (1). Both vaccines require 2 doses to complete the series. Data on vaccines administered during December 14, 2020-January 14, 2021, and reported to CDC by January 26, 2021, were analyzed to describe demographic characteristics, including sex, age, and race/ethnicity, of persons who received ...1 dose of COVID-19 vaccine (i.e., initiated vaccination). During this period, 12,928,749 persons in the United States in 64 jurisdictions and five federal entities<sup>..</sup> initiated COVID-19 vaccination. Data on sex were reported for 97.0%, age for 99.9%, and race/ethnicity for 51.9% of vaccine recipients. Among persons who received the first vaccine dose and had reported demographic data, 63.0% were women, 55.0% were aged ...50 years, and 60.4% were non-Hispanic White (White). More complete reporting of race and ethnicity data at the provider and jurisdictional levels is critical to ensure rapid detection of and response to potential disparities in COVID-19 vaccination. As the U.S. COVID-19 vaccination program expands, public health officials should ensure that vaccine is administered efficiently and equitably within each successive vaccination priority category, especially among those at highest risk for infection and severe adverse health outcomes, many of whom are non-Hispanic Black (Black), non-Hispanic American Indian/Alaska Native (AI/AN), and Hispanic persons (2,3).</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Painter</LastName>
                    <ForeName>Elizabeth M</ForeName>
                    <Initials>EM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ussery</LastName>
                    <ForeName>Emily N</ForeName>
                    <Initials>EN</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patel</LastName>
                    <ForeName>Anita</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hughes</LastName>
                    <ForeName>Michelle M</ForeName>
                    <Initials>MM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zell</LastName>
                    <ForeName>Elizabeth R</ForeName>
                    <Initials>ER</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moulia</LastName>
                    <ForeName>Danielle L</ForeName>
                    <Initials>DL</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Scharf</LastName>
                    <ForeName>Lynn Gibbs</ForeName>
                    <Initials>LG</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lynch</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ritchey</LastName>
                    <ForeName>Matthew D</ForeName>
                    <Initials>MD</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Toblin</LastName>
                    <ForeName>Robin L</ForeName>
                    <Initials>RL</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murthy</LastName>
                    <ForeName>Bhavini Patel</ForeName>
                    <Initials>BP</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Harris</LastName>
                    <ForeName>LaTreace Q</ForeName>
                    <Initials>LQ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wasley</LastName>
                    <ForeName>Annemarie</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rose</LastName>
                    <ForeName>Dale A</ForeName>
                    <Initials>DA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cohn</LastName>
                    <ForeName>Amanda</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Messonnier</LastName>
                    <ForeName>Nancy E</ForeName>
                    <Initials>NE</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>MMWR Morb Mortal Wkly Rep</MedlineTA>
            <NlmUniqueID>7802429</NlmUniqueID>
            <ISSNLinking>0149-2195</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D044469" MajorTopicYN="N">Continental Population Groups</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005006" MajorTopicYN="N">Ethnic Groups</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017589" MajorTopicYN="Y">Immunization Programs</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <CoiStatement>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>17</Hour>
                <Minute>16</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33539333</ArticleId>
            <ArticleId IdType="doi">10.15585/mmwr.mm7005e1</ArticleId>
            <ArticleId IdType="pmc">PMC7861480</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Health Aff (Millwood). 2020 Jul;39(7):1253-1262</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32437224</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Nov 27;69(47):1782-1786</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33237895</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1857-1859</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301429</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33539332</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>05</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1545-861X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>70</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>MMWR. Morbidity and mortality weekly report</Title>
                <ISOAbbreviation>MMWR Morb Mortal Wkly Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities Participating in the Pharmacy Partnership for Long-Term Care Program - United States, December 2020-January 2021.</ArticleTitle>
            <Pagination>
                <MedlinePgn>178-182</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.15585/mmwr.mm7005e2</ELocationID>
            <Abstract>
                <AbstractText>Residents and staff members of long-term care facilities (LTCFs), because they live and work in congregate settings, are at increased risk for infection with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19) (1,2). In particular, skilled nursing facilities (SNFs), LTCFs that provide skilled nursing care and rehabilitation services for persons with complex medical needs, have been documented settings of COVID-19 outbreaks (3). In addition, residents of LTCFs might be at increased risk for severe outcomes because of their advanced age or the presence of underlying chronic medical conditions (4). As a result, the Advisory Committee on Immunization Practices has recommended that residents and staff members of LTCFs be offered vaccination in the initial COVID-19 vaccine allocation phase (Phase 1a) in the United States (5). In December 2020, CDC launched the Pharmacy Partnership for Long-Term Care Program* to facilitate on-site vaccination of residents and staff members at enrolled LTCFs. To evaluate early receipt of vaccine during the first month of the program, the number of eligible residents and staff members in enrolled SNFs was estimated using resident census data from the National Healthcare Safety Network (NHSN<sup>...</sup>) and staffing data from the Centers for Medicare &amp; Medicaid Services (CMS) Payroll-Based Journal.<sup>..</sup> Among 11,460 SNFs with at least one vaccination clinic during the first month of the program (December 18, 2020-January 17, 2021), an estimated median of 77.8% of residents (interquartile range [IQR]..=..61.3%- 93.1%) and a median of 37.5% (IQR..=..23.2%- 56.8%) of staff members per facility received ...1 dose of COVID-19 vaccine through the Pharmacy Partnership for Long-Term Care Program. The program achieved moderately high coverage among residents; however, continued development and implementation of focused communication and outreach strategies are needed to improve vaccination coverage among staff members in SNFs and other long-term care settings.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gharpure</LastName>
                    <ForeName>Radhika</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guo</LastName>
                    <ForeName>Angela</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bishnoi</LastName>
                    <ForeName>Courtney Krier</ForeName>
                    <Initials>CK</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patel</LastName>
                    <ForeName>Urvi</ForeName>
                    <Initials>U</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gifford</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tippins</LastName>
                    <ForeName>Ashley</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jaffe</LastName>
                    <ForeName>Aaron</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shulman</LastName>
                    <ForeName>Evan</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stone</LastName>
                    <ForeName>Nimalie</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mungai</LastName>
                    <ForeName>Elisabeth</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bagchi</LastName>
                    <ForeName>Suparna</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bell</LastName>
                    <ForeName>Jeneita</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Srinivasan</LastName>
                    <ForeName>Arjun</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patel</LastName>
                    <ForeName>Anita</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Link-Gelles</LastName>
                    <ForeName>Ruth</ForeName>
                    <Initials>R</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>MMWR Morb Mortal Wkly Rep</MedlineTA>
            <NlmUniqueID>7802429</NlmUniqueID>
            <ISSNLinking>0149-2195</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002487" MajorTopicYN="N">Centers for Disease Control and Prevention, U.S.</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008134" MajorTopicYN="N">Long-Term Care</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010604" MajorTopicYN="N">Pharmacy</DescriptorName>
                <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055818" MajorTopicYN="Y">Public-Private Sector Partnerships</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012866" MajorTopicYN="N">Skilled Nursing Facilities</DescriptorName>
                <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <CoiStatement>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. David Gifford reports that his wife serves as the commissioner of public health in Connecticut, a jurisdiction involved in the Pharmacy Partnership for Long-Term Care Program partnership. Aaron Jaffe reports that his employer, Palantir Technologies, is in a paid engagement with the U.S. Department of Health and Human Services for providing software and configuration services. No other potential conflicts of interest were disclosed.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>17</Hour>
                <Minute>16</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33539332</ArticleId>
            <ArticleId IdType="doi">10.15585/mmwr.mm7005e2</ArticleId>
            <ArticleId IdType="pmc">PMC7861479</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1857-1859</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301429</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Geriatr Soc. 2020 Dec 28;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33370448</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 May 21;382(21):2005-2011</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32220208</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Med Dir Assoc. 2020 Oct;21(10):1390-1391</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32893137</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Nov 17;324(19):1928-1930</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33112395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2018 Sep 28;67(38):1050-1054</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30260944</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32214079</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):52-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33444301</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Infect Control. 2015 Feb;43(2):100-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25637113</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">33539309</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>07</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>04</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1438-8871</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>23</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>03</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of medical Internet research</Title>
                <ISOAbbreviation>J Med Internet Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Comparing Public Perceptions and Preventive Behaviors During the Early Phase of the COVID-19 Pandemic in Hong Kong and the United Kingdom: Cross-sectional Survey Study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e23231</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2196/23231</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">Given the public health responses to previous respiratory disease pandemics, and in the absence of treatments and vaccines, the mitigation of the COVID-19 pandemic relies on population engagement in nonpharmaceutical interventions. This engagement is largely driven by risk perception, anxiety levels, and knowledge, as well as by historical exposure to disease outbreaks, government responses, and cultural factors.</AbstractText>
                <AbstractText Label="OBJECTIVE">The aim of this study is to compare psychobehavioral responses in Hong Kong and the United Kingdom during the early phase of the COVID-19 pandemic.</AbstractText>
                <AbstractText Label="METHODS">Comparable cross-sectional surveys were administered to adults in Hong Kong and the United Kingdom during the early phase of the epidemic in each setting. Explanatory variables included demographics, risk perception, knowledge of COVID-19, anxiety level, and preventive behaviors. Responses were weighted according to census data. Logistic regression models, including effect modification to quantify setting differences, were used to assess the association between the explanatory variables and the adoption of social distancing measures.</AbstractText>
                <AbstractText Label="RESULTS">Data from 3431 complete responses (Hong Kong, 1663; United Kingdom, 1768) were analyzed. Perceived severity of symptoms differed by setting, with weighted percentages of 96.8% for Hong Kong (1621/1663) and 19.9% for the United Kingdom (366/1768). A large proportion of respondents were abnormally or borderline anxious (Hong Kong: 1077/1603, 60.0%; United Kingdom: 812/1768, 46.5%) and regarded direct contact with infected individuals as the transmission route of COVID-19 (Hong Kong: 94.0%-98.5%; United Kingdom: 69.2%-93.5%; all percentages weighted), with Hong Kong identifying additional routes. Hong Kong reported high levels of adoption of various social distancing measures (Hong Kong: 32.6%-93.7%; United Kingdom: 17.6%-59.0%) and mask-wearing (Hong Kong: 98.8% (1647/1663); United Kingdom: 3.1% (53/1768)). The impact of perceived severity of symptoms and perceived ease of transmission of COVID-19 on the adoption of social distancing measures varied by setting. In Hong Kong, these factors had no impact, whereas in the United Kingdom, those who perceived their symptom severity as &quot;high&quot; were more likely to adopt social distancing (adjusted odds ratios [aORs] 1.58-3.01), and those who perceived transmission as &quot;easy&quot; were prone to adopt both general social distancing (aOR 2.00, 95% CI 1.57-2.55) and contact avoidance (aOR 1.80, 95% CI 1.41-2.30). The impact of anxiety on adopting social distancing did not vary by setting.</AbstractText>
                <AbstractText Label="CONCLUSIONS">Our results suggest that health officials should ascertain baseline levels of risk perception and knowledge in populations, as well as prior sensitization to infectious disease outbreaks, during the development of mitigation strategies. Risk should be communicated through suitable media channels-and trust should be maintained-while early intervention remains the cornerstone of effective outbreak response.</AbstractText>
                <CopyrightInformation>..Leigh Bowman, Kin On Kwok, Rozlyn Redd, Yuanyuan Yi, Helen Ward, Wan In Wei, Christina Atchison, Samuel Yeung-Shan Wong. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 08.03.2021.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bowman</LastName>
                    <ForeName>Leigh</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">0000-0003-0657-7911</Identifier>
                    <AffiliationInfo>
                        <Affiliation>MRC Centre for Global Infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA), School of Public Health, Imperial College, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kwok</LastName>
                    <ForeName>Kin On</ForeName>
                    <Initials>KO</Initials>
                    <Identifier Source="ORCID">0000-0002-2804-5433</Identifier>
                    <AffiliationInfo>
                        <Affiliation>JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Redd</LastName>
                    <ForeName>Rozlyn</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">0000-0003-4776-2769</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Patient Experience Research Centre, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yi</LastName>
                    <ForeName>Yuanyuan</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">0000-0003-2594-8423</Identifier>
                    <AffiliationInfo>
                        <Affiliation>JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ward</LastName>
                    <ForeName>Helen</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">0000-0001-8238-5036</Identifier>
                    <AffiliationInfo>
                        <Affiliation>MRC Centre for Global Infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA), School of Public Health, Imperial College, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Patient Experience Research Centre, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wei</LastName>
                    <ForeName>Wan In</ForeName>
                    <Initials>WI</Initials>
                    <Identifier Source="ORCID">0000-0001-8083-3528</Identifier>
                    <AffiliationInfo>
                        <Affiliation>JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Atchison</LastName>
                    <ForeName>Christina</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">0000-0001-8304-7389</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Patient Experience Research Centre, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wong</LastName>
                    <ForeName>Samuel Yeung-Shan</ForeName>
                    <Initials>SY</Initials>
                    <Identifier Source="ORCID">0000-0003-0934-6385</Identifier>
                    <AffiliationInfo>
                        <Affiliation>JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <Acronym>WT_</Acronym>
                    <Agency>Wellcome Trust</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>03</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Canada</Country>
            <MedlineTA>J Med Internet Res</MedlineTA>
            <NlmUniqueID>100959882</NlmUniqueID>
            <ISSNLinking>1438-8871</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018562" MajorTopicYN="N">Disease Transmission, Infectious</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006723" MajorTopicYN="N" Type="Geographic">Hong Kong</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011639" MajorTopicYN="Y">Public Opinion</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">Hong Kong</Keyword>
            <Keyword MajorTopicYN="Y">United Kingdom</Keyword>
            <Keyword MajorTopicYN="Y">anxiety</Keyword>
            <Keyword MajorTopicYN="Y">behavioural response</Keyword>
            <Keyword MajorTopicYN="Y">comparative</Keyword>
            <Keyword MajorTopicYN="Y">novel coronavirus</Keyword>
            <Keyword MajorTopicYN="Y">pandemic</Keyword>
            <Keyword MajorTopicYN="Y">risk perceptions</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>4</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>17</Hour>
                <Minute>15</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33539309</ArticleId>
            <ArticleId IdType="pii">v23i3e23231</ArticleId>
            <ArticleId IdType="doi">10.2196/23231</ArticleId>
            <ArticleId IdType="pmc">PMC7942393</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Infect Dis. 2012 Nov;12(11):845-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23041199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Behav Med. 2009;16(1):30-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19125335</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Data Brief. 2020 May 08;30:105685</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32391411</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2020 Apr 17;15(4):e0231808</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32302370</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Internet Res. 2020 Sep 29;22(9):e19788</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32931446</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2020 Jul;26(7):1575-1579</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32298227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Disaster Med Public Health Prep. 2015 Apr;9(2):207-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25882127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Internet Res. 2020 May 15;22(5):e19370</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32392172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Qual Life Outcomes. 2003 Aug 01;1:29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12914662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Public Health. 2011 Jan 03;11:2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21199571</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2005 Jun 15;40(12):1713-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15909256</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hosp Infect. 2020 Sep;106(1):214-216</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32619456</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Health Psychol. 2010 Nov;15(Pt 4):797-824</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20109274</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J R Soc Interface. 2010 Sep 6;7(50):1247-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20504800</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Euro Surveill. 2020 Apr;25(13):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32265008</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JMIR Public Health Surveill. 2020 May 8;6(2):e19161</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32369759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2009 Dec 03;4(12):e8032</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19997505</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trop Med Int Health. 2006 Mar;11(3):258-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16553905</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Environ Res Public Health. 2020 Apr 27;17(9):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32349253</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CMAJ. 2020 May 11;192(19):E511-E515</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32332040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Data Brief. 2020 Apr 10;30:105530</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32322641</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33538178</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1744-8301</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>17</Volume>
                    <Issue>9</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Mar</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Future oncology (London, England)</Title>
                <ISOAbbreviation>Future Oncol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The right immune-modulation at the right time: thymosin ..1 for prevention of severe COVID-19 in cancer patients.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1097-1104</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2217/fon-2020-0754</ELocationID>
            <Abstract>
                <AbstractText>We presented the rationale for the use of thymosin ..1 as prophylaxis of severe COVID-19 in cancer patients undergoing active treatment, constituting the background for the PROTHYMOS study, a prospective, multicenter, open-label, Phase II randomized study, currently in its start-up phase..(Eudract no. 2020-006020-13). We aim to offer new hope for this incurable disease, especially to frail patient population, such as patients with cancer. The hypothesis of an effective prophylactic approach to COVID-19 would have immediate clinical relevance, especially given the lack of curative approaches. Moreover, in the 'COVID-19 vaccine race era' both clinical and biological results coming from the PROTHYMOS trials could even support the rationale for future combinatorial approaches, trying to rise vaccine efficacy in frail individuals.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bersanelli</LastName>
                    <ForeName>Melissa</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-6527-6281</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medicine &amp; Surgery Department, University of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Giannarelli</LastName>
                    <ForeName>Diana</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biostatistical Unit, Regina Elena National Cancer Institute, IRCCS, Via Elio Chianesi 53, Rome, 00144, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Leonetti</LastName>
                    <ForeName>Alessandro</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-5415-6703</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medicine &amp; Surgery Department, University of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Buti</LastName>
                    <ForeName>Sebastiano</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0876-0226</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medicine &amp; Surgery Department, University of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tiseo</LastName>
                    <ForeName>Marcello</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medicine &amp; Surgery Department, University of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nouvenne</LastName>
                    <ForeName>Antonio</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Geriatric Rehabilitation Medical Department, University Hospital of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ticinesi</LastName>
                    <ForeName>Andrea</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medicine &amp; Surgery Department, University of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Geriatric Rehabilitation Medical Department, University Hospital of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meschi</LastName>
                    <ForeName>Tiziana</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medicine &amp; Surgery Department, University of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Geriatric Rehabilitation Medical Department, University Hospital of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Procopio</LastName>
                    <ForeName>Giuseppe</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Genito-Urinary Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori of Milan, Via Giacomo Venezian, 1, Milano, 20133, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Danielli</LastName>
                    <ForeName>Riccardo</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Immuno-Oncology Unit, University Hospital of Siena, Viale Mario Bracci..16, Siena, 53100, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Future Oncol</MedlineTA>
            <NlmUniqueID>101256629</NlmUniqueID>
            <ISSNLinking>1479-6694</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>W0B22ISQ1C</RegistryNumber>
                <NameOfSubstance UI="D000077596">Thymalfasin</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <SupplMeshList>
            <SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017322" MajorTopicYN="N">Clinical Trials, Phase II as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000077596" MajorTopicYN="N">Thymalfasin</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">cancer</Keyword>
            <Keyword MajorTopicYN="N">cancer patients</Keyword>
            <Keyword MajorTopicYN="N">prevention</Keyword>
            <Keyword MajorTopicYN="N">prophylaxis</Keyword>
            <Keyword MajorTopicYN="N">vaccination</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>8</Hour>
                <Minute>37</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33538178</ArticleId>
            <ArticleId IdType="doi">10.2217/fon-2020-0754</ArticleId>
            <ArticleId IdType="pmc">PMC7874885</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33536319</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2044-6055</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>03</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMJ open</Title>
                <ISOAbbreviation>BMJ Open</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Country-level determinants of the severity of the first global wave of the COVID-19 pandemic: an ecological study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e042034</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2020-042034</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE">We aimed to identify the country-level determinants of the severity of the first wave of the COVID-19 pandemic.</AbstractText>
                <AbstractText Label="DESIGN">Ecological study of publicly available data. Countries reporting &gt;25 COVID-19 related deaths until 8 June 2020 were included. The outcome was log mean mortality rate from COVID-19, an estimate of the country-level daily increase in reported deaths during the ascending phase of the epidemic curve. Potential determinants assessed were most recently published demographic parameters (population and population density, percentage population living in urban areas, population &gt;65 years, average body mass index and smoking prevalence); economic parameters (gross domestic product per capita); environmental parameters (pollution levels and mean temperature (January-May); comorbidities (prevalence of diabetes, hypertension and cancer); health system parameters (WHO Health Index and hospital beds per 10...000 population); international arrivals; the stringency index, as a measure of country-level response to COVID-19; BCG vaccination coverage; UV radiation exposure; and testing capacity. Multivariable linear regression was used to analyse the data.</AbstractText>
                <AbstractText Label="PRIMARY OUTCOME">Country-level mean mortality rate: the mean slope of the COVID-19 mortality curve during its ascending phase.</AbstractText>
                <AbstractText Label="PARTICIPANTS">Thirty-seven countries were included: Algeria, Argentina, Austria, Belgium, Brazil, Canada, Chile, Colombia, the Dominican Republic, Ecuador, Egypt, Finland, France, Germany, Hungary, India, Indonesia, Ireland, Italy, Japan, Mexico, the Netherlands, Peru, the Philippines, Poland, Portugal, Romania, the Russian Federation, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, Ukraine, the UK and the USA.</AbstractText>
                <AbstractText Label="RESULTS">Of all country-level determinants included in the multivariable model, total number of international arrivals (beta 0.033 (95% CI 0.012 to 0.054)) and BCG vaccination coverage (-0.018 (95% CI -0.034 to -0.002)), were significantly associated with the natural logarithm of the mean death rate.</AbstractText>
                <AbstractText Label="CONCLUSIONS">International travel was directly associated with the mortality slope and thus potentially the spread of COVID-19. Very early restrictions on international travel should be considered to control COVID-19 outbreaks and prevent related deaths.</AbstractText>
                <CopyrightInformation>.. Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Pana</LastName>
                    <ForeName>Tiberiu A</ForeName>
                    <Initials>TA</Initials>
                    <Identifier Source="ORCID">0000-0002-1423-8111</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Applied Health Sciences, School of Medicine, Medical Sciences &amp; Nutrition, University of Aberdeen, Aberdeen, UK tiberiupana12@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Bhattacharya</LastName>
                    <ForeName>Sohinee</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">0000-0002-2358-5860</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Applied Health Sciences, School of Medicine, Medical Sciences &amp; Nutrition, University of Aberdeen, Aberdeen, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gamble</LastName>
                    <ForeName>David T</ForeName>
                    <Initials>DT</Initials>
                    <Identifier Source="ORCID">0000-0002-9723-5142</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Applied Health Sciences, School of Medicine, Medical Sciences &amp; Nutrition, University of Aberdeen, Aberdeen, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pasdar</LastName>
                    <ForeName>Zahra</ForeName>
                    <Initials>Z</Initials>
                    <Identifier Source="ORCID">0000-0001-7632-7171</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Applied Health Sciences, School of Medicine, Medical Sciences &amp; Nutrition, University of Aberdeen, Aberdeen, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Szlachetka</LastName>
                    <ForeName>Weronika A</ForeName>
                    <Initials>WA</Initials>
                    <Identifier Source="ORCID">0000-0002-2465-029X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Applied Health Sciences, School of Medicine, Medical Sciences &amp; Nutrition, University of Aberdeen, Aberdeen, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Perdomo-Lampignano</LastName>
                    <ForeName>Jesus A</ForeName>
                    <Initials>JA</Initials>
                    <Identifier Source="ORCID">0000-0002-7861-0584</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Applied Health Sciences, School of Medicine, Medical Sciences &amp; Nutrition, University of Aberdeen, Aberdeen, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ewers</LastName>
                    <ForeName>Kai D</ForeName>
                    <Initials>KD</Initials>
                    <Identifier Source="ORCID">0000-0003-1813-1925</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Applied Health Sciences, School of Medicine, Medical Sciences &amp; Nutrition, University of Aberdeen, Aberdeen, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McLernon</LastName>
                    <ForeName>David J</ForeName>
                    <Initials>DJ</Initials>
                    <Identifier Source="ORCID">0000-0001-8905-2429</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Applied Health Sciences, School of Medicine, Medical Sciences &amp; Nutrition, University of Aberdeen, Aberdeen, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Myint</LastName>
                    <ForeName>Phyo K</ForeName>
                    <Initials>PK</Initials>
                    <Identifier Source="ORCID">0000-0003-3852-6158</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Applied Health Sciences, School of Medicine, Medical Sciences &amp; Nutrition, University of Aberdeen, Aberdeen, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMJ Open</MedlineTA>
            <NlmUniqueID>101552874</NlmUniqueID>
            <ISSNLinking>2044-6055</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000397" MajorTopicYN="N">Air Pollution</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000569" MajorTopicYN="N" Type="Geographic">Americas</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011156" MajorTopicYN="N">Population Density</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D064890" MajorTopicYN="N">Social Determinants of Health</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014195" MajorTopicYN="N">Travel</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">epidemiology</Keyword>
            <Keyword MajorTopicYN="Y">infectious diseases</Keyword>
            <Keyword MajorTopicYN="Y">public health</Keyword>
        </KeywordList>
        <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>5</Hour>
                <Minute>41</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33536319</ArticleId>
            <ArticleId IdType="pii">bmjopen-2020-042034</ArticleId>
            <ArticleId IdType="doi">10.1136/bmjopen-2020-042034</ArticleId>
            <ArticleId IdType="pmc">PMC7868125</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2020 May 16;395(10236):1545-1546</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32359402</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Total Environ. 2020 Jul 15;726:138605</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32302812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2020 May 5;117(18):9696-9698</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32300018</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17720-17726</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32647056</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2020 May;8(5):440-442</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32247325</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2011 May 11;6(5):e19432</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21589928</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2020 May 14;55(5):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32217650</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tob Induc Dis. 2020 Mar 20;18:20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32206052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2009 Jul 9;361(2):212-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19564630</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Diabetes Endocrinol. 2020 Jun;8(6):474-475</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32359411</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bull World Health Organ. 2014 Dec 1;92(12):868-880D</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25552771</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Heart J. 2020 Jun 7;41(22):2058-2066</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32498076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2020 Jul;81(1):e98-e99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32305488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Glob Health. 2020 Apr;8(4):e480</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32109372</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chaos Solitons Fractals. 2020 Jun;135:109842</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32341627</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Med. 2009 Dec 10;7:76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20003249</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Med (Lausanne). 2020 Jul 14;7:402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32766267</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">33535811</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>06</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1740-7753</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>18</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>06</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical trials (London, England)</Title>
                <ISOAbbreviation>Clin Trials</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19 vaccine trials: The use of active controls and non-inferiority studies.</ArticleTitle>
            <Pagination>
                <MedlinePgn>335-342</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1177/1740774520988244</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">Recently emerging results from a few placebo-controlled randomized trials of COVID-19 vaccines revealed estimates of 62%-95% relative reductions in risk of virologically confirmed symptomatic COVID-19 disease, over approximately 2-month average follow-up period. Additional safe and effective COVID-19 vaccines are needed in a timely manner to adequately address the pandemic on an international scale. Such safe and effective vaccines would be especially appealing for international deployment if they also have favorable stability, supply, and potential for implementation in mass vaccination campaigns. Randomized trials provide particularly reliable insights about vaccine efficacy and safety. While enhanced efficiency and interpretability can be obtained from placebo-controlled trials, in settings where their conduct is no longer possible, randomized non-inferiority trials may enable obtaining reliable evaluations of experimental vaccines through direct comparison with active comparator vaccines established to have worthwhile efficacy.</AbstractText>
                <AbstractText Label="METHODS">The usual objective of non-inferiority trials is to reliably assess whether the efficacy of an experimental vaccine is not unacceptably worse than that of an active control vaccine previously established to be effective, likely in a placebo-controlled trial. This is formally achieved by ruling out a non-inferiority margin identified to be the minimum threshold for what would constitute an unacceptable loss of efficacy. This article not only investigates non-inferiority margins, denoted by <b>..</b>, that address the usual objective of determining whether the experimental vaccine is &quot;at least similarly effective to&quot; the active comparator vaccine in the non-inferiority trial, but also develops non-inferiority margins, denoted by <b>..<sub>o</sub></b>, intended to address the worldwide need for multiple safe and effective vaccines by satisfying the less stringent requirement that the experimental vaccine be &quot;at least similarly effective to&quot; an active comparator vaccine having efficacy that satisfies the widely accepted World Health Organization-Food and Drug Administration criteria for &quot;worthwhile&quot; vaccine efficacy.</AbstractText>
                <AbstractText Label="RESULTS">Using the margin <b>..</b> enables non-inferiority trials to reliably evaluate experimental vaccines that truly are similarly effective to an active comparator vaccine having any level of &quot;worthwhile&quot; efficacy. When active comparator vaccines have efficacy in the range of 50%-70%, non-inferiority trials designed to use the margin <b>..<sub>o</sub></b> have appealing properties, especially for experimental vaccines having true efficacy of approximately 60%.</AbstractText>
                <AbstractText Label="CONCLUSION">Non-inferiority trials using the proposed margins may enable reliable randomized evaluations of efficacy and safety of experimental COVID-19 vaccines. Such trials often require approximately two- to three-fold the person-years follow-up than a placebo-controlled trial. This could be achieved, without substantive increases in sample size, by increasing the average duration of follow-up from 2...months to approximately 4-6...months, assuming efficacy of the active comparator vaccine has been reliably evaluated over that longer duration.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fleming</LastName>
                    <ForeName>Thomas R</ForeName>
                    <Initials>TR</Initials>
                    <Identifier Source="ORCID">0000-0002-0420-5068</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Biostatistics, University of Washington, Seattle, WA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krause</LastName>
                    <ForeName>Philip R</ForeName>
                    <Initials>PR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Office of Vaccines Research and Review, FDA/CBER, Silver Spring, MD, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nason</LastName>
                    <ForeName>Martha</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Institute of Allergy and Infectious Diseases (NIAID/NIH), Bethesda, MD, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Longini</LastName>
                    <ForeName>Ira M</ForeName>
                    <Initials>IM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biostatistics, University of Florida, Gainesville, FL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Henao-Restrepo</LastName>
                    <ForeName>Ana-Maria M</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>World Health Organization, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>001</GrantID>
                    <Acronym>WHO_</Acronym>
                    <Agency>World Health Organization</Agency>
                    <Country>International</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 AI029168</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R37 AI029168</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Clin Trials</MedlineTA>
            <NlmUniqueID>101197451</NlmUniqueID>
            <ISSNLinking>1740-7745</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">active comparator</Keyword>
            <Keyword MajorTopicYN="Y">margin</Keyword>
            <Keyword MajorTopicYN="Y">non-inferiority</Keyword>
            <Keyword MajorTopicYN="Y">placebo-controlled</Keyword>
            <Keyword MajorTopicYN="Y">vaccines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>5</Hour>
                <Minute>31</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33535811</ArticleId>
            <ArticleId IdType="doi">10.1177/1740774520988244</ArticleId>
            <ArticleId IdType="pmc">PMC8172418</ArticleId>
            <ArticleId IdType="mid">NIHMS1658306</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Trials. 2011 Aug;8(4):432-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21835862</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2021 Jan 9;397(10269):99-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33306989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 14;384(2):e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33264543</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Apr 2;382(14):1366-1369</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32242365</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 4;384(5):403-416</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33378609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Med. 2008 Feb 10;27(3):317-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17340597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 31;383(27):2603-2615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Sep 12;396(10253):741-743</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32861315</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2021 Feb;174(2):221-228</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33090877</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33535239</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1537-6613</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>223</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>03</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of infectious diseases</Title>
                <ISOAbbreviation>J Infect Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Lessons From Bacille Calmette-Gu..rin for SARS-CoV-2 Vaccine Candidates.</ArticleTitle>
            <Pagination>
                <MedlinePgn>189-191</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiaa637</ELocationID>
            <Abstract>
                <AbstractText>Developers of severe acute respiratory syndrome coronavirus 2 vaccines should consider some of the lessons from a &quot;new&quot; vaccine introduced in 1921, namely bacille Calmette-Gu..rin.</AbstractText>
                <CopyrightInformation>.. The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Behr</LastName>
                    <ForeName>Marcel A</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, McGill University, Montreal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>McGill International TB Centre, Montreal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Infectious Diseases and Immunity in Global Health, McGill University Health Centre Research Institute, Montreal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>McGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Divangahi</LastName>
                    <ForeName>Maziar</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, McGill University, Montreal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>McGill International TB Centre, Montreal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>McGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Meakins-Christie Laboratories, Montreal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schurr</LastName>
                    <ForeName>Erwin</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, McGill University, Montreal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>McGill International TB Centre, Montreal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Infectious Diseases and Immunity in Global Health, McGill University Health Centre Research Institute, Montreal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>McGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Infect Dis</MedlineTA>
            <NlmUniqueID>0413675</NlmUniqueID>
            <ISSNLinking>0022-1899</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D001500">BCG Vaccine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001500" MajorTopicYN="N">BCG Vaccine</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014376" MajorTopicYN="N">Tuberculosis</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">BCG</Keyword>
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>3</Day>
                <Hour>20</Hour>
                <Minute>9</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33535239</ArticleId>
            <ArticleId IdType="pii">6012502</ArticleId>
            <ArticleId IdType="doi">10.1093/infdis/jiaa637</ArticleId>
            <ArticleId IdType="pmc">PMC7798939</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29324233</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Urol. 2017 May;197(5):1189-1199</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28027868</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Paediatr Scand. 1982 May;71(3):471-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6753476</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2019 Jan 29;219(4):624-632</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30239767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Rev. 2015 Mar;264(1):103-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25703555</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2014 Feb;58(4):470-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24336911</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tuberculosis (Edinb). 2011 Dec;91 Suppl 1:S11-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22079589</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am Rev Tuberc. 1948 Jan;57(1):96-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18917601</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Control Clin Trials. 1994 Aug;15(4):247-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7956266</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2016 Jan 21;12(1):e1005271</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26794678</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc R Soc Med. 1931 Sep;24(11):1481-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19988326</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1999 May 28;284(5419):1520-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10348738</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2012;8(5):e1002607</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22589713</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Oct 15;183(2):315-323.e9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32941801</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bull World Health Organ. 1979;57(5):819-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">396057</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Sep;585(7824):168-169</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32887957</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tubercle. 1948 Apr;29(4):84-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18909014</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33532780</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Jan</Month>
                        <Day>25</Day>
                    </PubDate>
                </JournalIssue>
                <Title>bioRxiv : the preprint server for biology</Title>
                <ISOAbbreviation>bioRxiv</ISOAbbreviation>
            </Journal>
            <ArticleTitle>mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challenge.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">2021.01.25.428136</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1101/2021.01.25.428136</ELocationID>
            <Abstract>
                <AbstractText>The mRNA-1273 vaccine was recently determined to be effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from interim Phase 3 results. Human studies, however, cannot provide the controlled response to infection and complex immunological insight that are only possible with preclinical studies. Hamsters are the only model that reliably exhibit more severe SARS-CoV-2 disease similar to hospitalized patients, making them pertinent for vaccine evaluation. We demonstrate that prime or prime-boost administration of mRNA-1273 in hamsters elicited robust neutralizing antibodies, ameliorated weight loss, suppressed SARS-CoV-2 replication in the airways, and better protected against disease at the highest prime-boost dose. Unlike in mice and non-human primates, mRNA-1273- mediated immunity was non-sterilizing and coincided with an anamnestic response. Single-cell RNA sequencing of lung tissue permitted high resolution analysis which is not possible in vaccinated humans. mRNA-1273 prevented inflammatory cell infiltration and the reduction of lymphocyte proportions, but enabled antiviral responses conducive to lung homeostasis. Surprisingly, infection triggered transcriptome programs in some types of immune cells from vaccinated hamsters that were shared, albeit attenuated, with mock-vaccinated hamsters. Our results support the use of mRNA-1273 in a two-dose schedule and provides insight into the potential responses within the lungs of vaccinated humans who are exposed to SARS-CoV-2.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Meyer</LastName>
                    <ForeName>Michelle</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yuan</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Edwards</LastName>
                    <ForeName>Darin</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Smith</LastName>
                    <ForeName>Gregory R</ForeName>
                    <Initials>GR</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rubenstein</LastName>
                    <ForeName>Aliza B</ForeName>
                    <Initials>AB</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ramanathan</LastName>
                    <ForeName>Palaniappan</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mire</LastName>
                    <ForeName>Chad E</ForeName>
                    <Initials>CE</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pietzsch</LastName>
                    <ForeName>Colette</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Xi</ForeName>
                    <Initials>X</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ge</LastName>
                    <ForeName>Yongchao</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cheng</LastName>
                    <ForeName>Wan Sze</ForeName>
                    <Initials>WS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Henry</LastName>
                    <ForeName>Carole</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Woods</LastName>
                    <ForeName>Angela</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>LingZhi</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stewart-Jones</LastName>
                    <ForeName>Guillaume B E</ForeName>
                    <Initials>GBE</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bock</LastName>
                    <ForeName>Kevin W</ForeName>
                    <Initials>KW</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Minai</LastName>
                    <ForeName>Mahnaz</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nagata</LastName>
                    <ForeName>Bianca M</ForeName>
                    <Initials>BM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Periasamy</LastName>
                    <ForeName>Sivakumar</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Pei-Yong</ForeName>
                    <Initials>PY</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Graham</LastName>
                    <ForeName>Barney S</ForeName>
                    <Initials>BS</Initials>
                    <Identifier Source="ORCID">0000-0001-8112-0853</Identifier>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moore</LastName>
                    <ForeName>Ian N</ForeName>
                    <Initials>IN</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ramos</LastName>
                    <ForeName>Irene</ForeName>
                    <Initials>I</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Troyanskaya</LastName>
                    <ForeName>Olga G</ForeName>
                    <Initials>OG</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zaslavsky</LastName>
                    <ForeName>Elena</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carfi</LastName>
                    <ForeName>Andrea</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sealfon</LastName>
                    <ForeName>Stuart C</ForeName>
                    <Initials>SC</Initials>
                    <Identifier Source="ORCID">0000-0001-5791-1217</Identifier>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bukreyev</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D000076942">Preprint</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>bioRxiv</MedlineTA>
            <NlmUniqueID>101680187</NlmUniqueID>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33532780</ArticleId>
            <ArticleId IdType="doi">10.1101/2021.01.25.428136</ArticleId>
            <ArticleId IdType="pmc">PMC7852274</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33531462</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>22</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>22</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2059-3635</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>6</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>02</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Signal transduction and targeted therapy</Title>
                <ISOAbbreviation>Signal Transduct Target Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need.</ArticleTitle>
            <Pagination>
                <MedlinePgn>48</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41392-021-00481-y</ELocationID>
            <Abstract>
                <AbstractText>In response to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, over 200 vaccine candidates against coronavirus disease 2019 (COVID-2019) are under development and currently moving forward at an unparalleled speed. The availability of surrogate endpoints would help to avoid large-scale filed efficacy trials and facilitate the approval of vaccine candidates, which is crucial to control COVID-19 pandemic. Several phase 3 efficacy trials of COVID-19 vaccine candidates are under way, which provide opportunities for the determination of COVID-19 correlates of protection. In this paper, we review current knowledge for existence of COVID-19 correlates of protection, methods for assessment of immune correlates of protection and issues related to COVID-19 correlates of protection.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Jin</LastName>
                    <ForeName>Pengfei</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Vaccine Clinical Evaluation, Jiangsu Province Center for Disease Control and Prevention, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Li</LastName>
                    <ForeName>Jingxin</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Vaccine Clinical Evaluation, Jiangsu Province Center for Disease Control and Prevention, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>NHC Key laboratory of Enteric Pathogenic Microbiology, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pan</LastName>
                    <ForeName>Hongxing</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Vaccine Clinical Evaluation, Jiangsu Province Center for Disease Control and Prevention, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Yanfei</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Fengcai</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Vaccine Clinical Evaluation, Jiangsu Province Center for Disease Control and Prevention, Nanjing, China. jszfc@vip.sina.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>NHC Key laboratory of Enteric Pathogenic Microbiology, Nanjing, China. jszfc@vip.sina.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing, China. jszfc@vip.sina.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>02</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Signal Transduct Target Ther</MedlineTA>
            <NlmUniqueID>101676423</NlmUniqueID>
            <ISSNLinking>2059-3635</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017326" MajorTopicYN="N">Clinical Trials, Phase III as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>3</Day>
                <Hour>5</Hour>
                <Minute>50</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33531462</ArticleId>
            <ArticleId IdType="doi">10.1038/s41392-021-00481-y</ArticleId>
            <ArticleId IdType="pii">10.1038/s41392-021-00481-y</ArticleId>
            <ArticleId IdType="pmc">PMC7851657</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2020 Aug 14;369(6505):818-823</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32616673</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2021 Jan 9;397(10269):99-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33306989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2011 Feb 26;377(9767):751-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21329971</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Jul 3;369(6499):77-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32376603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2020 May 11;221(11):1752-1756</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32232474</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2020 Jun 16;52(6):910-941</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32505227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Vaccines. 2016;15(4):455-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26560015</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Oct 2;370(6512):89-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32753554</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):516-527</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32967006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2003 Jul 4;21(23):3265-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12804857</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Vaccine Immunol. 2010 Jul;17(7):1055-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20463105</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 13;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33440088</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2020 Oct 1;222(9):1572-1574</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32845303</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 22;368(6493):832-834</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32381590</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2007 May 10;25(19):3816-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17368878</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):578-582</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32731258</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Oct 15;383(16):1544-1555</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32722908</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Infect Dis J. 2011 Dec;30(12):1081-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21983214</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Dec 4;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33276369</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 Nov 25;38(50):7892-7896</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33139139</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Oct 1;183(1):158-168.e14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32979941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2020 Oct 21;58(11):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32826322</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2021 Feb;21(2):e26-e35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33125914</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 12;383(20):1920-1931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32663912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Immunol. 2020 Aug;50:101422</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33262067</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Jun 25;181(7):1489-1501.e15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32473127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Vaccines. 2017 Sep;16(9):945-949</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28548626</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Med. 2006 May 15;25(9):1485-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16158409</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2019 Jul 02;10:1400</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31312199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2016 Apr 2;12(4):916-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26751765</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2012 Jun;54(11):1615-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22437237</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2014 Feb 27;370(9):818-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24571754</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2014;10(7):1935-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25424803</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Open Forum Infect Dis. 2015 May 14;2(2):ofv067</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26180823</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2008 Aug 1;47(3):401-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18558875</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2007 Nov 1;196(9):1279-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17922389</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):479-488</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2021 Jan;21(1):39-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33069281</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Sep 26;396(10255):887-897</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32896291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Jul 06;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32628748</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Feb 4;384(5):403-416</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33378609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2014;10(12):3659-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25483685</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 10;383(24):2320-2332</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32877576</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 17;383(25):2427-2438</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32991794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Aug 6;182(3):713-721.e9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32778225</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):583-588</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32731257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2021 Feb;21(2):181-192</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33217362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2020 Oct 23;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33190827</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2021 Dec 19;396(10267):1979-1993</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33220855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 14;369(6505):806-811</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32434945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 14;369(6505):812-817</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32434946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Vaccine Immunol. 2016 Jan 13;23(3):228-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26762363</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2007 Nov 1;196(9):1304-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17922394</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 31;383(27):2603-2615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33301246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2013 Jun 8;381(9882):2024-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23726161</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 17;383(25):2439-2450</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33053279</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33531342</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1756-1833</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>372</Volume>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>02</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMJ (Clinical research ed.)</Title>
                <ISOAbbreviation>BMJ</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Covid-19: Russian vaccine efficacy is 91.6%, show phase III trial results.</ArticleTitle>
            <Pagination>
                <MedlinePgn>n309</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.n309</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mahase</LastName>
                    <ForeName>Elisabeth</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>The BMJ.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>02</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMJ</MedlineTA>
            <NlmUniqueID>8900488</NlmUniqueID>
            <ISSNLinking>0959-8138</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>3</Day>
                <Hour>5</Hour>
                <Minute>47</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33531342</ArticleId>
            <ArticleId IdType="doi">10.1136/bmj.n309</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33527084</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">2363-6203</ISSN>
                <JournalIssue CitedMedium="Print">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Jan</Month>
                        <Day>27</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Modeling earth systems and environment</Title>
                <ISOAbbreviation>Model Earth Syst Environ</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Statistical data analysis of risk factor associated with mortality rate by COVID-19 pandemic in India.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-11</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s40808-021-01118-3</ELocationID>
            <Abstract>
                <AbstractText>The coronavirus is an infection caused by severe acute respiratory syndrome (SARS) coronavirus, known as SARS-CoV-2. It was first determined in Wuhan, China in December 2019. WHO named this virus as COVID-19. Virologist says that COVID-19 is similar to SARS and MARS virus. This deadly disease affected worldwide economically, hammering people lifestyle and also the environmental condition. After a few months, there is no vaccine to build the barricade between this virus and life. Many countries have tried to improve the methodology to control the disease and also the actual vaccine for coronavirus but not yet successful. Rapid testing, quarantine and social distancing slow down the social and economic movement. Although India, as one of the largest populated country, takes some respectable initiative after the pandemic of the novel coronavirus. According to WHO 24th May 2020 report, total 131,868 confirmed cases and killed over 3867 people by this COVID-19 pandemic. Indian government takes the initiative like janta curfew, lockdown all over the country. The main focus or aim of this study is to find the mortality rate and the recovered people at the fourth phase of lockdown, but the infected graph is daily increased in India. In the relation between active cases and the death cases, the <i>R</i><sup>2</sup> value is 0.8754. The relation between active cases and the recoveries, the <i>R</i><sup>2</sup> value is 0.9246. In between 116 days, the mortality rate is less in before lockdown (0.129%) and third phase lockdown is facing a huge mortality rate (43.496%).</AbstractText>
                <CopyrightInformation>.. The Author(s), under exclusive licence to Springer Nature Switzerland AG part of Springer Nature 2021.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Halder</LastName>
                    <ForeName>Bijay</ForeName>
                    <Initials>B</Initials>
                    <Identifier Source="ORCID">0000-0002-4279-5214</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Remote Sensing and GIS, Vidyasagar University, Midnapore, India.</Affiliation>
                        <Identifier Source="GRID">grid.412834.8</Identifier>
                        <Identifier Source="ISNI">0000 0000 9152 1805</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bandyopadhyay</LastName>
                    <ForeName>Jatisankar</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">0000-0003-2201-7105</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Remote Sensing and GIS, Vidyasagar University, Midnapore, India.</Affiliation>
                        <Identifier Source="GRID">grid.412834.8</Identifier>
                        <Identifier Source="ISNI">0000 0000 9152 1805</Identifier>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Environmental Studies, Vidyasagar University, Midnapore, India.</Affiliation>
                        <Identifier Source="GRID">grid.412834.8</Identifier>
                        <Identifier Source="ISNI">0000 0000 9152 1805</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Banik</LastName>
                    <ForeName>Papiya</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Geography, Calcutta University, Kolkata, India.</Affiliation>
                        <Identifier Source="GRID">grid.59056.3f</Identifier>
                        <Identifier Source="ISNI">0000 0001 0664 9773</Identifier>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>27</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Model Earth Syst Environ</MedlineTA>
            <NlmUniqueID>101675633</NlmUniqueID>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword>
            <Keyword MajorTopicYN="N">Global issues</Keyword>
            <Keyword MajorTopicYN="N">India</Keyword>
            <Keyword MajorTopicYN="N">Lockdown</Keyword>
            <Keyword MajorTopicYN="N">Mortality rate</Keyword>
            <Keyword MajorTopicYN="N">People health</Keyword>
        </KeywordList>
        <CoiStatement>Conflict of interestOn behalf of all authors, the corresponding author states that there is no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>11</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33527084</ArticleId>
            <ArticleId IdType="doi">10.1007/s40808-021-01118-3</ArticleId>
            <ArticleId IdType="pii">1118</ArticleId>
            <ArticleId IdType="pmc">PMC7838236</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2430-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15695582</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Death Discov. 2016 Jun 27;2:16048</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27551536</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Spectrochim Acta A Mol Biomol Spectrosc. 2019 Apr 15;213:210-217</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30690304</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Total Environ. 2020 Aug 1;728:138882</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32335410</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33526007</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Print">1480-9222</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>23</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biological procedures online</Title>
                <ISOAbbreviation>Biol Proced Online</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review.</ArticleTitle>
            <Pagination>
                <MedlinePgn>5</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12575-020-00141-5</ELocationID>
            <Abstract>
                <AbstractText>COVID-19, a pandemic of the 21st century..caused by novel coronavirus SARS-CoV-2..was originated from China and shallowed..world economy and human resource. The medical..cures..via herbal treatments, antiviral drugs, and vaccines still in progress, and studying rigorously. SARS-CoV-2 is more virulent than its ancestors due to evolution in..the spike protein(s), mediates viral attachment to the host's membranes. The SARS-CoV-2 receptor-binding spike domain associates itself with human angiotensin-converting enzyme 2 (ACE-2) receptors. It causes respiratory ailments with irregularities in the hepatic, nervous, and gastrointestinal systems, as..reported..in humans suffering from COVID-19 and reviewed in the present article. There are several approaches, have been put forward by many countries under the world health organization (WHO) recommendations and some trial drugs were..introduced for possible treatment of COVID-19, such as Lopinavir or Ritonavir, Arbidol, Chloroquine (CQ), Hydroxychloroquine (HCQ) and most important Remdesivir including other like Tocilizumab, Oritavancin, Chlorpromazine, Azithromycin, Baricitinib, etc. RT-PCR is the only and early detection test available besides the rapid test kit (serodiagnosis) used by a few countries due to unreasonable causes. Development of vaccine by several leader of pharmaceutical groups still under trial or waiting for approval for mass inoculation. Management strategies have been evolved by the recommendations of WHO, specifically important to control COVID-19 situations, in the pandemic era. This review will provide a comprehensive collection of studies to support future research and enhancement in our wisdom to combat COVID-19 pandemic and to serve humanity.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Choudhary</LastName>
                    <ForeName>Jyoti</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Chinmaya Degree College (Hemwati Nandan Bahuguna Garhwal University, Srinagar, Garhwal, Uttarakhand), Haridwar, Uttarakhand, 249401, India.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Botany and Microbiology, Gurukula Kangri Deemed to be University, Haridwar, Uttarakhand, 249404, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dheeman</LastName>
                    <ForeName>Shrivardhan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, School of Life Sciences, Sardar Bhagwan Singh University, Dehradun, Uttarakhand, 248161, India. svdheeman@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sharma</LastName>
                    <ForeName>Vipin</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceuticals Sciences, Faculty of Ayurvedic and Medicinal Sciences, Gurukula Kangri Deemed to be University, Haridwar, Uttarakhand, 249404, India. vipin@gkv.ac.in.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Katiyar</LastName>
                    <ForeName>Prashant</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Botany and Microbiology, Gurukula Kangri Deemed to be University, Haridwar, Uttarakhand, 249404, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karn</LastName>
                    <ForeName>Santosh Kumar</ForeName>
                    <Initials>SK</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-9803-4182</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Deaprtment of Biotechnology and Biochemistry, School of Life Sciences, Sardar Bhagwan Singh University, Dehradun, Uttarakhand, 248161, India. santoshkarn@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sarangi</LastName>
                    <ForeName>Manoj Kumar</ForeName>
                    <Initials>MK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences and Technology, Sardar Bhagwan Singh University, Dehradun, Uttarakhand, 248161, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chauhan</LastName>
                    <ForeName>Ankit Kumar</ForeName>
                    <Initials>AK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Botany and Microbiology, Gurukula Kangri Deemed to be University, Haridwar, Uttarakhand, 249404, India.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi, 110001, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Verma</LastName>
                    <ForeName>Gaurav</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Deaprtment of Microbiology, Shri Dev Suman Subharti Medical College, Ras Bihari Bose Subharti University, Dehradun, Uttarakhand, 248001, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baliyan</LastName>
                    <ForeName>Nitin</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Botany and Microbiology, Gurukula Kangri Deemed to be University, Haridwar, Uttarakhand, 249404, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Biol Proced Online</MedlineTA>
            <NlmUniqueID>100963717</NlmUniqueID>
            <ISSNLinking>1480-9222</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ACE-2 receptor</Keyword>
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Coronavirus</Keyword>
            <Keyword MajorTopicYN="N">Drug repurposing</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>2</Day>
                <Hour>5</Hour>
                <Minute>41</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33526007</ArticleId>
            <ArticleId IdType="doi">10.1186/s12575-020-00141-5</ArticleId>
            <ArticleId IdType="pii">10.1186/s12575-020-00141-5</ArticleId>
            <ArticleId IdType="pmc">PMC7849622</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol Methods. 2008 Sep;152(1-2):77-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18620761</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Thorac Med. 2016 Jul-Sep;11(3):211-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27512511</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2004 Jun;78(11):5642-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15140961</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32075877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Virus Res. 1997;48:1-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9233431</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Jun;92(6):568-576</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32134116</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Agents Actions Suppl. 1988;24:142-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3263755</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2003 Dec 15;168(12):1449-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12947028</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32007145</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhongguo Zhong Yao Za Zhi. 2020 May;45(10):2221-2231</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32495574</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Ther. 2010 Oct;128(1):119-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20599443</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1998 Jan;72(1):783-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9420287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Mar 26;382(13):1199-1207</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31995857</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Enzyme Inhib Med Chem. 2016;31(1):23-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25683083</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2020 Jul 1;75(7):1667-1670</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32196083</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Ayurveda Integr Med. 2020 Aug 17;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32837101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2020 Apr;8(4):420-422</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32085846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2020 May;55(5):105954</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32234467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Radiology. 2020 Apr;295(1):202-207</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32017661</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Discov Ther. 2020;14(1):58-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32147628</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mil Med Res. 2020 Mar 13;7(1):11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32169119</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):467-478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2005 Aug;51(2):98-102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16038758</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biosci Trends. 2020 Mar 16;14(1):64-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32037389</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virus Res. 2003 Dec;98(2):131-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14659560</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacokinet. 1996 Oct;31(4):257-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8896943</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31978945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2003 Aug 1;312(2):395-406</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12919744</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 1990 Feb;174(2):450-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2154882</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32020029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2001 Jan 20;279(2):371-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11162792</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci China C Life Sci. 2009 May;52(5):464-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19471869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2005 Jun;79(11):6620-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15890900</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Exp Med Biol. 2001;494:589-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11774530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2001 May 18;276(20):17515-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11278557</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gene Rep. 2020 Jun;19:100682</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32300673</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2008 Dec 4;456(7222):658-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18820679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32109013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Transl Med. 2017 Jun 28;9(396):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28659436</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 1998 Nov 2;17(21):6230-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9799232</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Digit Health. 2020 Jun;2(6):e286-e287</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32363333</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2014 Aug 07;6(8):2991-3018</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25105276</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Apr;26(4):450-452</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32284615</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Chin Med. 2020;48(3):737-762</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32164424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2002 Dec;76(24):12866-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12438612</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Chem Inf Model. 2011 Jun 27;51(6):1376-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21604711</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2016 May;15(5):327-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26868298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ACS Infect Dis. 2015 Jul 10;1(7):317-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27622822</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):e30-e31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32032529</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Pharmacol. 2019 Dec 12;10:1472</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31920659</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharm Anal. 2020 Apr;10(2):102-108</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32282863</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trials. 2018 Jan 30;19(1):81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29382391</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2019 Sep;169:104541</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31233808</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Apr 16;181(2):281-292.e6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32155444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunother Cancer. 2018 Jun 15;6(1):56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29907163</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):E8508-E8517</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28923942</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Biol. 2008 Sep 16;6(9):e226</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18798692</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proteins. 2003 Feb 15;50(3):437-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12557186</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 2007 Aug 23;50(17):4087-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17663539</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intervirology. 1998;41(6):261-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10325536</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 May 16;395(10236):1569-1578</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32423584</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol Methods. 2015 Oct;223:13-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26190637</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Struct Mol Biol. 2019 Jun;26(6):481-489</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31160783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1981 Jun;78(6):3605-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6115382</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Oct;20(10):1118-1119</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32311324</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Jun;92(6):540-545</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32108352</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biol Blood Marrow Transplant. 2019 Apr;25(4):e123-e127</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30586620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2012 Jun;4(6):1011-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22816037</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Biol. 1994 Jan 14;235(2):554-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7904655</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 1983 Apr;15(4):471-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6849784</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Feb 20;382(8):760-762</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31978944</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS Lett. 2006 May 29;580(13):3192-200</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16684538</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2004 Mar;59(3):252-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14985565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2001 Feb;75(3):1312-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11152504</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2011 Apr 15;186(8):4794-804</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21398612</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurosurg Focus. 2015 Mar;38(3):E12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25727221</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respirology. 2018 Feb;23(2):130-137</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29052924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2015 Mar 06;7(3):996-1019</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25757061</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioorg Med Chem. 2012 Oct 1;20(19):5928-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22884354</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5871-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19321428</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Adv. 2020 Jul 1;6(27):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32937441</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1990 Dec 13;348(6302):600-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2250716</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2007 Oct;30(4):297-308</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17629679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2000 Sep;74(17):8127-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10933723</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Life Sci. 2020 May 1;248:117477</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32119961</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2000 Sep 24;276(2):534-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11027509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioorg Med Chem. 2010 Nov 15;18(22):7940-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20934345</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Microbiol. 2000 Apr;49(4):313-318</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10755624</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Inflammopharmacology. 2015 Oct;23(5):231-69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26246395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 1969 Mar;4(2):203-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4306296</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Genet Evol. 2015 Jun;32:377-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25843651</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2020 May 5;172(9):577-582</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32150748</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Feb 25;323(8):707-708</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31971553</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2011 Jul 5;415(2):69-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21524776</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2006 Feb;35(2):179-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16112612</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2006 Oct;12(10):1203-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16964257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2015;11(5):1244-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25874632</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2681-2690</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30679277</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2020 May 1;130(5):2202-2205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32217834</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biol Pharm Bull. 2014;37(6):1021-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24882413</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2020 Apr 10;295(15):4773-4779</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32094225</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4240-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15010527</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2000 Jun;74(11):4967-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10799570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1896-903</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11734443</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chin J Integr Med. 2014 Jul;20(7):540-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24972581</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2011 Jan;85(2):675-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21047962</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2002 Dec;76(24):12634-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12438589</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioorg Med Chem Lett. 2010 Mar 15;20(6):1873-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20167482</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Integr Med. 2020 Mar;18(2):152-158</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32113846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Apr;580(7805):576-577</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32346146</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 May 5;:1-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32329419</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2009 Jun 18;5(6):559-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19527883</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viral Immunol. 2011 Oct;24(5):421-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21958371</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Nat Med. 2019 Jun;73(3):487-496</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30758716</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Microbiol. 2009 Jun;7(6):439-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19430490</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1995 Apr 14;270(15):8815-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7721788</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2015 Dec 25;8(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26712783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Jun;92(6):548-551</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32096567</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2003 Oct;125(4):1011-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14517783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Microbiol. 2016 Jun;24(6):490-502</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27012512</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virol J. 2005 Aug 22;2:69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16115318</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2013 Dec;67(6):606-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24096239</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105923</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32070753</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Jan 10;11(1):222</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31924756</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Apr;92(4):418-423</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31967327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aust N Z J Ophthalmol. 1987 Nov;15(4):365-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3325085</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2010 May;82(5):817-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20336760</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Panam Salud Publica. 2020 Mar 20;44:e40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32256547</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2004 Jan 30;314(1):235-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14715271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32350134</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Microbiol. 2016 Aug;14(8):523-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27344959</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Rheumatol. 1997 Jan;24(1):55-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9002011</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parasitol Res. 2009 Jul;105(1):275-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19367418</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2019 Jan 14;11(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30646565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 1989 Jun;27(6):771-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2757893</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2020 Mar 11;27(3):325-328</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32035028</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):473-475</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32043983</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biotechnol Lett. 2012 May;34(5):831-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22350287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12479-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17640882</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2008 Nov;82(22):11318-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18753196</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12543-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16116101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2003 Jun 14;361(9374):2045-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12814717</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2007 May;74(2):92-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16730806</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hong Kong Med J. 2009 Feb;15 Suppl 2:37-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19258633</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2020 Aug;56(2):105984</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32305589</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochemistry. 2004 Apr 20;43(15):4538-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15078100</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2017 Apr 10;8:15092</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28393837</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 May 12;323(18):1824-1836</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32282022</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virol J. 2019 Dec 23;16(1):163</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31870450</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cell Biol. 1984 Mar;33(2):281-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6325194</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Baillieres Clin Rheumatol. 1990 Dec;4(3):467-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2093438</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Res. 2020 Aug;158:104929</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32442720</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2003 Jul 31;349(5):508-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12890855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Rev. 2010 Jul;23(3):590-615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20610825</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 1995 Jun;39(6):696-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7654492</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomed Pharmacother. 2020 Nov;131:110668</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32861965</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Arthritis Rheum. 1993 Oct;23(2 Suppl 1):74-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8278822</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2007 Jan;54(1):28-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16542729</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32192578</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 5;383(19):1813-1826</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32445440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2011 Apr;90(1):64-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21356245</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32007143</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Planta Med. 2014 Feb;80(2-3):177-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24458263</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rapid Commun Mass Spectrom. 2011 Jun 15;25(11):1600-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21594935</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Chem Inf Model. 2020 Dec 28;60(12):5754-5770</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32551639</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Avian Pathol. 2000 Jun;29(3):207-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19184806</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Pharmacol. 1984;26(4):521-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6610555</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Metab Syndr. 2020 Jul - Aug;14(4):641-648</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32428865</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2020 Jul;158(1):e15-e19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32343968</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jun 11;382(24):2327-2336</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32275812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15214-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25288733</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Res Ther. 2017 Aug 9;19(1):183</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28793932</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2003 Nov;3(11):722-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14592603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 May 5;:1-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32329408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32142651</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Radiology. 2020 Apr;295(1):18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32003646</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Jun 29;369:m2610</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32601048</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS Res Ther. 2017 Sep 12;14(1):46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28893304</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2010 Aug;122(3):671-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19851859</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Apr 16;181(2):223-227</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32220310</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Case Rep Womens Health. 2020 May 16;27:e00221</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32426243</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2009 Mar 26;458(7237):430-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19325622</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Gesamte Virusforsch. 1972;36(1):93-104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4335025</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacokinet. 2003;42(15):1359-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14674788</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2014 May;14(5):315-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24762827</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2017 Feb 13;17(1):144</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28193191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Jul;92(7):797-806</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32198776</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Tuberc Lung Dis. 1999 Sep;3(9):756-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10488881</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lupus. 1996 Jun;5 Suppl 1:S11-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8803904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2006 Feb;6(2):67-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16439323</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Immunol. 2020 May;214:108393</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32222466</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2020 May 15;295(20):6785-6797</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32284326</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Virus Res. 2005;64:165-230</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16139595</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br Med J. 1965 Jun 5;1(5448):1467-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14288084</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2006 Jun;129(6):1441-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16778260</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32205204</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol. 1993 Jul;265(1 Pt 1):E162-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8338148</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2021 Jan 7;384(1):80-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33270381</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Ocul Pharmacol. 1994 Spring;10(1):217-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8207328</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2005 Oct;68(1):36-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16115693</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2015 Apr;478:75-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25726972</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Phytother Res. 2004 Jul;18(7):592-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15305324</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Mar;579(7798):265-269</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32015508</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33525860</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1598-9100</ISSN>
                <JournalIssue CitedMedium="Print">
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                        <Day>03</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Intestinal research</Title>
                <ISOAbbreviation>Intest Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Management of inflammatory bowel disease in the COVID-19 era.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.5217/ir.2020.00156</ELocationID>
            <Abstract>
                <AbstractText>During the coronavirus disease 2019 (COVID-19) pandemic, many unpredictable changes have occurred in the medical field. Risk of COVID-19 does not seem to increase in patients with inflammatory bowel disease (IBD) considering based on current reports. Current medications for IBD do not increase this risk; on the contrary, some of these might be used as therapeutics against COVID-19 and are under clinical trial. Unless the patients have confirmed COVID-19 and severe pneumonia or a high oxygen demand, medical treatment should be continued during the pandemic, except for the use of high-dose corticosteroids. Adherence to general recommendations such as social distancing, wearing facial masks, and vaccination, especially for pneumococcal infections and influenza, is also required. Patients with COVID-19 need to be withhold immunomodulators or biologics for at least 2 weeks and treated based on both IBD and COVID-19 severity. Prevention of IBD relapse caused by sudden medication interruption is important because negative outcomes associated with disease flare up, such as corticosteroid use or hospitalization, are much riskier than medications. The outpatient clinic and infusion center for biologics need to be reserved safe spaces, and endoscopy or surgery should be considered in urgent cases only.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Kyeong Ok</ForeName>
                    <Initials>KO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jang</LastName>
                    <ForeName>Byung Ik</ForeName>
                    <Initials>BI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>02</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>Intest Res</MedlineTA>
            <NlmUniqueID>101572802</NlmUniqueID>
            <ISSNLinking>1598-9100</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Coronavirus</Keyword>
            <Keyword MajorTopicYN="N">Inflammatory bowel disease</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>2</Day>
                <Hour>2</Hour>
                <Minute>40</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33525860</ArticleId>
            <ArticleId IdType="pii">ir.2020.00156</ArticleId>
            <ArticleId IdType="doi">10.5217/ir.2020.00156</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33525208</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>08</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2531-6745</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>91</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>11</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Acta bio-medica : Atenei Parmensis</Title>
                <ISOAbbreviation>Acta Biomed</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Italian Covid-19 Phase 2 in Piacenza: results of the first semester of 2020 and future prospective of new orthopedics surgical procedures.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e2020159</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.23750/abm.v91i4.10377</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION">During the pandemic, Piacenza's Orthopedic and Traumatology Dep. firstly dealt with the emergency with the complete closure of all the elective surgical and outpatient activities.As general population, also healthcare workers were affected by Coronavirus, increasing difficulties of epidemic management.The aim of our study is to evaluate the activity trend of the first 6months of 2020 in our hospital.Data will be compared to the two semesters of 2019, in order to have two objective samples.</AbstractText>
                <AbstractText Label="MATERIALS AND METHODS">We retrospectively analyzed all the orthopedics surgical procedures performed at Guglielmo da Saliceto Hospital (Piacenza, Emilia Romagna, Northern Italy)between 1/1/20 and 30/06/20. 2019 semesters (1/01/20-30/6/20 and 1/07/20-31/12/20) have been used as control group to evaluate the activity trend of the first six months of 2020, compared to the two semesters of 2019.</AbstractText>
                <AbstractText Label="RESULTS">We noticed a significant increase of domestic and retirement houses accidents, a consistent increase in one-month mortality rate of 2020 first semester and a decrease of mean hospitalization time.About surgical procedures, we detect a drop in the total number: in the first semester of 2020 we performed 499 (-39.9%) surgeries less than the first semester of 2019 and 337 (-30.9%) then the second one. Traumatology recorded a decrease of 27.6% than the first semester of 2019 (-204 surgeries) and of 26.3% than the second one (-191 surgeries).Concerning orthopedic procedures, in comparison to the first semester of 2019 we registered a reduction of 57.6% (-295 surgeries) and of 40.2% to the second semester (-146 surgeries).</AbstractText>
                <AbstractText Label="DISCUSSION AND CONCLUSION">Covid-19 forced a reorganization of the Italian Health System that led to a clear reduction of surgical procedures performed in the orthopedic and traumatology department.The &quot;Phase 2&quot; can't be consider the last step of the emergency.We surely will have to get used to live with this enemy, at least until we will find an effective cure or a vaccine.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Maniscalco</LastName>
                    <ForeName>Pietro</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Orthopedics and Traumatology Department, Guglielmo da Saliceto Hospital, Piacenza, Italy. P.Maniscalco@ausl.pc.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Quattrini</LastName>
                    <ForeName>Fabrizio</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>AUSL PIACENZA. f.quattrini@ausl.pc.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ciatti</LastName>
                    <ForeName>Corrado</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>AUSL PIACENZA. c.ciatti@ausl.pc.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gattoni</LastName>
                    <ForeName>Serena</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>AUSL PIACENZA. s.gattoni@ausl.pc.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Puma Pagliarello</LastName>
                    <ForeName>Calogero</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>AUSL PIACENZA. c.pumapagliarello@ausl.pc.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Burgio</LastName>
                    <ForeName>Valeria</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>AUSL PIACENZA. v.burgio@ausl.pc.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Di Stefano</LastName>
                    <ForeName>Giovanni</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>AUSL PIACENZA. g.distefano@ausl.pc.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cauteruccio</LastName>
                    <ForeName>Michele</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>AUSL PIACENZA. m.cauteruccio@ausl.pc.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Giovanelli</LastName>
                    <ForeName>Matteo</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>UNIVERSITY HOSPITAL OF PARMA. m.giovanelli@ausl.pc.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Magro</LastName>
                    <ForeName>Alessandra</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>AUSL PIACENZA. a.magro@ausl.pc.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Capelli</LastName>
                    <ForeName>Patrizio</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>AUSL PIACENZA. p.capelli@ausl.pc.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Italy</Country>
            <MedlineTA>Acta Biomed</MedlineTA>
            <NlmUniqueID>101295064</NlmUniqueID>
            <ISSNLinking>0392-4203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019637" MajorTopicYN="N">Orthopedic Procedures</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
                <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>2</Day>
                <Hour>1</Hour>
                <Minute>2</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33525208</ArticleId>
            <ArticleId IdType="doi">10.23750/abm.v91i4.10377</ArticleId>
            <ArticleId IdType="pmc">PMC7927514</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Acta Biomed. 2020 May 11;91(2):39-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32420923</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Orthop. 2020 Nov;44(11):2261-2266</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32601721</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Public Health. 2020 May;5(5):e256</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32199471</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intern Emerg Med. 2020 Aug;15(5):879-882</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32385627</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Biomed. 2020 May 11;91(2):89-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32420932</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>G Ital Nefrol. 2020 Apr 9;37(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32281756</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Biomed. 2020 May 11;91(2):97-105</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32420933</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Public Health. 2020 May;5(5):e253</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32220653</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
